Short and long-term results of transluminal coronary interventions: an angiographic perspective by Foley, D.P. (David)
SHORT AND LONG-TERM RESULTS OF 
TRANSLUMINAL 
CORONARY INTERVENTIONS: 
AN ANGIOGRAPIDC PERSPECTIVE 
KORTE EN LANGE TERMIJN RESULTATEN 
VAN TRANSLUMINALE 
CORONAIR INTERVENTIES: 
EEN ANGIOGRAFISCH PERSPECTIEF 
Proefschrift 
Ter verkrijging van de graad van doctor 
aan de Erasmus Universiteit Rotterdam 
op gezag van de rector magnificus 
Prof. dr. P.W.C Akkermans, M.A. 
en volgens besluit van het college VOOI promoties 
De openbare verdediging zal plaats vinden op 
Woensdag 14 juni 1995 am 15.45 uur 
The public defence shall take place on 
Wednesday June 14 1995 at 15.45 
door 
DAVID PATRICK FOLEY 
geboren te Limerick, Ireland 
PROMOTIECOMMISSIE 
Promotor: 
Co-promotor: 
Overige led en : 
ISBN 90-9008280-8 
Prof. Dr P.W.I.e. Serruys 
Dr. P.l. de Feyter 
Prof. Dr. l.R.T.e. Roelandt 
Prof. Dr. M.L. SimooDs 
Prof. Dr. A.V.G. Bruschke 
Financial support by the Netherlands Heart Foundation for the publication of this thesis is 
gratefully acknowledged 
2 
To Oonagh for her understanding, tolerance, encouragement and good humour, during the 
difficult years spent putting this thesis together and to Alex, whose arrival on the memorable 
day of October 7 last year, has enriched our lives beyond belief. To my parents, without 
whose unfailing support, confidence and selfless sacrifices for me over the years, I would 
certainly not be where, or what, I am today. 
3 
4 
CONTENTS 
Aclmowledgernents 
Introduction and overview 
PART I 
ANGIOGRAPHIC APPLICATION TO THE STUDY OF SHORT AND LONG TERM 
OUTCOME OF CORONARY ANGIOPLASTY ~ VALUE OF SERIAL QUANTITATIVE 
ANGIOGRAPHIC ANALYSIS 
Chapter 1 
Technological considerations and practical limitations in the use of quantitative angiography 
during percutaneous coronary recanalization. Strauss BH, Escaned J, Foley DP, di Mario C. 
Haase J, Keane D, Hermans WR, de Feyter PJ, Serruys PW. 
Prog Cardiovascular Disease 1994;36:343~63. 
Chapter 2 
Quantitative coronary angiography in interventional cardiology: application to scientific 
research and clinical practice. Foley DP, Strauss BH, Escaned J, di Mario C, Haase J, 
Keane D, Hermans WRM, Rensing BJ, de Feyter PJ, Serruys PW. 
Prog CardiovasCldar Diseases 1994;34;363~85. 
Chapter 3 
Angioscopic versus angiographic detection of intimal dissection and intracoronary thrombus. 
den Heyer 1', Foley DP, Escaned J, Hillege HL, Van Dijk RB, Serruys PW, Lie Kl. 
J Am Colt Cardiol 1994;23:649~55. 
Chapter 4 
Quantitative coronary angiography during coronary angioplasty with a single angiographic 
view: a comparison of automated edge-detection and videodensitometric techniques. Escaned 
J, Foley DP, Haase J, Di Mario C, Hermans WR, de Feyter PJ, Serrnys PW. 
Am Heart J [993; 126: 1326~33. 
Chapter 5 
Usefulness of repeat coronary angiography 24 hours after successful balloon angioplasty, to 
evaluate early luminal deterioration and facilitate quantitative analysis. }"'oley DP, Deckers 
J, van den Bas AA, Heyndrickx GR, Laarman GJ, Suryapranata H, Zijlstra F, Buller HR, 
Serruys PW. 
Am J CardioI1993;72:1341~48. 
Chapter 6 
Usefulness of quantitative and qualitative angiographic lesion morphology and dinical 
characteristics in predicting major adverse cardiac events during and after native coronary 
balloon angioplasty. Hermans WR, Foley DP, Rensing BJ, Rutsch W, Heyndriekx GR, 
Danchin N, Mast G, Hanet C, Lablanche JM, Rafflenbeul W, Uebis R, Baleon R, de Feyter 
PJ, Serrnys PW. 
Am J CardioI1993;72:14~20. 
5 
PARTH 
QUANTITATIVE ANGIOGRAPHIC EVALUATION OF LONG TERM RESULTS OF 
CORONARY ANGIOPLASTY USING DIFFERENT TRANS CATHETER DEVICES -
ACCUMULATING EVIDENCE FOR DEVICE SPECIFIC EFFECTS ON RESTENOSIS 
PROPENSITY 
Chapter 7 
The Intluence of Coronary Vessel Size on Luminal Renarrowing and Late Angiographic 
Outcome After Successful Balloon Angioplasty. Foley DP. Melkert R. Serruys PW. 
Circulation 1994;90:1239-51. 
Chapter 8 
A Comparison of Angiographic Restenosis Propensity of Excimer Laser Coronary 
Angioplasty and Balloon Angioplasty in Longer Coronary Lesions. Foley DP. Appelman YEo 
Strikwerda S. Piek n. Koolen JJ. Tijssen JP, de Feyter PJ, David GK, van Swijndregt EJ, 
Melkert R, Serruys PW. 
Submitted to Circulation, April 1995. 
Chapter 9 
A clinical and angiographic comparison of matched patients with successful directional 
atherectomy or stent implantation for primary coronary artery lesions. Umans VA, Melkert 
R, Foley DP, Serruys PW. 
Accepted for publication, pending minor revision, by Circulation in March 1995. 
Chapter 10 
Restenosis after percutaneous intervention: is there a device specificity? Foley DP, Melkert 
R, Serruys PW. 
Handbook of lnterventional Cardiology, Topol E and Serruys PW, eds. (in press 1995). 
Chapter 11 
Differences in restenosis propensity of devices for transluminal coronary intervention: a 
quantitative angiographic comparison of balloon angioplasty, directional atherectomy, stent 
implantation and excimer laser angioplasty. Foley DP, Melkert R, Umans VA, de Jaegere 
PP, Strikwerda S, de Feyter PJ, Serruys PW. 
Submitted to European Heart Journal, January 1995. 
Conclnsions 
Curriculum Vitae 
Publications 
6 
ACKNOWLEDGEMENTS 
Looking back now after 4 years at the Thoraxcentre, it is somewhat ironic to remember that the first 
kindling of my interest in the field of cardiology can be traced to my elective clinical attachment at the Beth 
Israel Hospital in Boston, which, during the course of my time at the Thoraxcentre, has been singularly our 
greatest rival in the area of quantitative angiography applied to the study of restellosis. My actual initiation to 
the Thoraxcentre, I also remember, was considerably facilitated by a rather fortuitous if somewhat painful 
occurrence (not so painful for me but rather for my promotor i). Professor Serruys, whose skills and dexterity 
in intervelltional therapeutics aTe virtually legendary, apparently was not genetically endowed with the same 
adroitness on a bicycle ... a rather simple apparatus, which has made many a Belgian kinsman, such as Eddie 
Merckx, a household name. Not to put too fine a point on it, Patrick had been accidentally disengaged from 
his mount in full Hight and suffered some physical trauma, which led to an unsolicited sabbatical period on the 
renowned 23rd floor of Erasmus Ulliversity. T therefore had the rare (4 years later 1 now know how rare indeed 
!) pleasure of having him personally answer the telephone, when I first speculatively called to enquire for 
"positions vacant" ("looking for a start", as we say in Ireland). In his famous cavalier fashion he said, "come 
up and see me sometime", so I flew to Rotterdam the following day and in a one hour meeting we drafted a 
grant proposal to the Irish Heart Foundation and that, as they say, was that. 1 suppose it was at least a year after 
my COlHlllencemeHt hefore I realised how rare was my smooth inauguration, having personally witnessed scores 
of hungry applicants, furiously and repeatedly phoning and faxing Patrick, vainly trying, like searchers of 
Bigfoot or the Yeti, to track him down. It would be tautological to say that this thesis would not have been 
possihle without his vision, wisdom, guidance and incredible enthusiasm to discuss, dissect, explore and 
speculate on any subject at any time. Even when he falls asleep in the middle of a scientific discussion (not from 
being bored of course, but usually jet lag i), he can amazingly pick up the point where he left off, which leads 
me to conclude that, unlike some of his early morning conference audiences, whom he has impishly 
reprimanded for heing stilt asleep and indulging in sexual fantasy (instead oflistening to him i), Patrick not only 
lives, eats and breathes interventional cardiology, but also dreams it! Sal LIt Patrick, or "chin chin", as the 
Japanese say!!. 
If Patrick dreams interventional cardiology, then my co-promotor, Pim de Feyter, has it for breakfast! 
By that 1 mean, he reduces the mo~t complex appearing procedure to simple "bread and butter" stuff, by a 
direct, no nonsense approach, which is a marvellous learning experience, particularly in removing the web of 
illtrigue, which is habitually woven with some zeal in some catheterization laboratories. Whenever people start 
to get carried away with "science tiction" ideas or approaches, Pim will always he the voice of reason anti 
practical COIllmon sense, especially in clinically related research, bringing us back down to earth and reminding 
us to keep it clinically relevant. For this, perhaps fundamentalist, approach and your perceptive and wis.e 
academic advice, hut perhaps more for your honesty and integrity, Pim, and for your great sense ofllUmour 
at all tilllCS, 1 am grateful for the opportunity to have worked closely with you, 1 have learned a lot. Groetjes 
Pim. 
Of course, 1 would Ilever have reached the Thoraxcentre, were it not for some considerable help. 
encouragement and advice along the way, from a large number of people. 1 must first acknowledge my parents, 
without whose support, reassurance and confidence in me to achieve that which 1 set out to achieve, T would 
probably now he at home feeding the cattle ...... which might not actually he an ullattractive option, when I 
consider that the road ahead may still be long and bumpy (not to mentiOll "grassy and wanting wear"), before 
1 reach where T think r ,Ull going. I have always known that no matter what T wanted to do, 1 could count on 
their complete encouragement and backing and always had an option to return to, if things did not work out. 
Prom an early age, I enjoyed working with my father on the land. even when the weather was rough and the 
work was heavy alld indeed, I am convinced that it has given me a considerable advantage in the medical field, 
as T had early experience of humility, of having responsibility for my actiom, of thinking on my feet and 
devdoping the most important and most underrated tllCets of medical practice .... humanity and simple common 
sensc. My mother has been a quiet source of inspiration to me, as well as to my brother and sister. Even now, 
she regularly scnJ(inizes the medical, engineering and legal sections of the newspapers lookillg for suitable 
C(lJ"eer opportunities for all three of us. T should he extremely proud if 1 could manage to reproduce for our own 
children, even to a small degree, the care, attention, stimulation, love and support, which T have been fortunate 
to have received hom my parents. Oonagh has followed me (or 1 have dragged her, depending on which way 
you look at it) from Baghdad to Dublin to Rotterdam and shortly, it would appear, to Washington DC. Without 
her ullselfish support and tolerance, as well as her determinatioll and outstandillg organizational skills, my 
career, and most certainly my life, would have nose-dived by now. Her stimulating company, quick wit and 
uncanny ahility to make me laugh at all times, have maintained. a tremendous balance between work and "real 
7 
life", preserve my sanity and keep my feel firmly rooted on the ground. 
In my professional career, I must acknowledge the support and advice of Dr Gerry Gearty, Dr Peter 
Crean and Dr Michael Walsh during my cardiology training at St James's Hospital in Dublin, who advised me 
to consider pursuing my interest in interventional cardiology in Europe, rather than Britain or North America, 
which are the more traditional routes plotted by Irish "wild geese". It was, in fact, on the prompting of Dr 
Walsh that I called Patrick and also on his encouragement that I applied for the Irish Heart Foundation 
Travelling Fellowship in Cardiology, which I was fortunate to be awarded in 1991 and for which I am 
extremely grateful. I also want to thank my elder "brother" Brendan Foley, who introduced me to the cath lab 
and taught me the ropes, when I started as a cardiology registrar at St James in 1988 and actually subsequently 
instigated enquiries towards a move to the Thoraxcenter - which, for whatever reason, did not materialise -
maybe, like many other people, they got our names mixed up ! I wish you every success on your return to our 
alma mater, Brendan, with a bit of luck, we might have a chance to work together again in the future. 
The Thoraxcentre itself, has been termed a "scientific melting pot", consisting of a broad spectrum of 
talented people from all corners of the globe, throwing their own special scientific ingredients into the pot, to 
allow a consistently high quality "haute cuisine" to be dished up to the international gourmets of the 
cardiological literature. I want to acknowledge the chief chef Od) of the department of cardiology, Prof Jos 
Roeland, not only for his supreme conduction of the multifaceted team, but also personally for the many 
fascinating conversations we have had in his office on wide ranging subjects, for paying me the great 
compliment of occasionally soliciting my advice on translingual matters and not to mention, for the intermittent 
gezeJlig "outdoor meeting" in Hoogebergsche. 
Keeping with the culinary motif, I would like to acknowledge the camaraderie of many colleagues and 
friends with whom it has been my pleasure to "cook with gas" - an expression our eminent Professor Serruys 
has recently picked up (a Belgian derivation of the Americanism "really cooking", I think), for liberal use 
during difficult coronary interventions (intended to denote satisfactory progress). I should first mention my 
(coincidentally) Irish coUeague and paranimf, David Keane.. . .but I won't. What can I say about David which 
has not already been said, and many times at that? Of course, absolutely nothing 1 What I will say is . 
that I hope he has written equally nice things about me, but, seriously, I hope the tremendous personal sacrifices 
which that affable, churlish, eminently reliable, loyal and generous to a fault, and overall excellent young man, 
has made in pursuing his goal over the last 5 years or so, will be appropriately rewarded in the near future with 
a nice juicy position in Ireland (although not before this excellent young man I). My other paranimf, Rein 
Melkert, has had a profound influence on the preparation of many of the chapters in this thesis; I couldn't have 
done it without his superior statistical and graphic contributions - although true scientists don't have deadlines, 
we managed to make most of ours over the past few years, albeit it cost us a few grey hairs and lost hairs, more 
than occasionally burning the midnight oil ! For our collaborative experiences which led to the publication of 
some of the chapters in my thesis, I thank sincerely: Walty Hermans (my first co-worker after my arrival here 
and for whom I was honoured to be invited as his paranimf), Javier Escaned (my fellow Celt, in addition to 
having one of the most fertile minds J have come across, he and his wife Maria provide the finest hospitality 
imaginable and have become close and valued personal friends to Oonagh and me and I hope our babies will 
grow to be friends also), Bradley Strauss (the principal buitenlander on the 23rd floor when I arrived, who 
stimulated me to begin a number of interesting studies, for which I am grateful), Victor Umans (Victor "JACC" 
Umans, as he is affectionately known, whose prolific output and wry wit will certainly be missed at the 
Thoraxcentre) and Peter den Heyer (my first close contact in Dutch cardiology outside the Thoraxcentre - or 
actually, since the Groningen group honoured our institution by calling their department the Thoraxcentre also, 
I suppose he isn't really "outside the Thoraxcentre" after all - who angioscopically transported me to exotic 
locations around Europe). 
I also wish to acknowledge a number of other colleagues for their friendship, assistance, support and 
good humour in creating a "gezellig" atmosphere in which to work both in the cath lab (where I really belong, 
at heart) and on the "23rd floor". In addition to my cardiological colleagues in the cath-lab: Marcel van den 
Brand, Peter Ruygrok, Carlo di Mario, Wim van der Giessen, Peter de Jaegere, Caspar LaCle, Peter Nierop, 
Ton van der Kraay, Louise Bellersen, Peter van del' Meer, all the medical, nursing, technical, computer group, 
secretarial and administrative staff associated with the catb lab, the CCU, dagbehandeling, afdeling 3-Zuid and 
1200, who are much too numerous to individually mention, have been very friendly and helpful in tolerating 
my pigeon Dutch, limited technical and computer knowledge and my somewhat rusty interventional skills, and 
have, in varying balance, helped me to improve all in a short time - 1 am grateful to you all and will remember 
how pleasant it was to have worked together with you, even for such a brief period. No thesis defence can be 
prepared at the Thoraxcentre without the vital help and prodding, inimitably provided by Marianne Eicholtz, 
whom I gratefully acknowledge. I have spent much time on the "23rd floor" over the past 4 years and have had 
the great pleasure of working closely and cooperating with a small group of excellent colleagues, who have 
8 
become friends. I would very much like to write something personal to each of these many people.. . but I 
don't want to overinflate their egos, so instead I say a big THANK YOU to : Jcan~Paul Herrman, Marie-Angel 
Morel, Yukio Ozaki, Benno Rensing, Arno Breeman, Eline van Swijndregt, Sipke Strikwerda, Jeroen Vas, Cees 
Slager, Jurgen Haase, Donald MacCleod, Marc van der Linden, Robert Gil, Jose Baptista, Nicolas Meneveau, 
Tony Violaris, Arthur Maas, Edoardo Camenzil1d, Ken Lehmatm, Jaap Hamburger, Clemens van Birgelen and 
Francesco PratL Also many thanks to Prof Piet Verdouw and his group for frequent use of the fax, emergency 
supplies of coffee and creamer and toner for the printer in our office. In addition, I thank the many people (If 
Cardialysis, with whom I had the pleasure of interaction and cooperative work, but most especially my 
colleagues at the angiographic core laboratory Diny, Ina, Tona, Connie and AnneMarie - dames, hartelijke 
bedankt voor aIle moeite, ook voor jullie geduld en voor de helemaal gezellig samenwerken "atmosphere" bij 
ons kleine afdeling; also, Caroline Terstegge and Wanda Wentowski for their invaluable, generous and congenial 
assistance in keeping me organized in the direction of clinical trials and other miscellaneous activities and Edwin 
Nibbering for lending me the computer, which allowed me to work on the thesis at home in the evenings. 
I thank our friends Caroline Deijere and Peter Paul Haverbeke for being great neighbours over the past 
3 years, and my friends at Golf Club Kralingen, particularly my fellow first team members, for heartily 
admitting me to their ranks, which has given me the opportunity to pursue (occasionally!) my second great 
passion, which, by fortunate co-incidence, provides the vital diversion required from the weighty matters of 
interventional cardiology, that great "equaliser", the "funny old game" of golf. 
Last, but certainly not least, I wish to gratefully acknowledge the financial assistance which I have 
received to facilitate the publication of this thesis (and the embrocations which will follow in the evening) from 
Sandoz Pharma Ltd. Basel, Switzerland; F Hoffman LaRoche, Basel, Switzerland; Knoll AG Ludwigshaven, 
Germany; Zeneca Pharma, Dublin, Ireland (especially my friend Tom Ryan, who, despite being a Tipperary 
man, has loyally supported me over the years, whenever I needed a little help to present my research overseas -
go mbeirimid beo ag an t-am seD arrs a Thomiiis), Bristol Myers Squibb, Dublin (Michael Dempsey, Sean 
Dowling and Fred Doherty, who have also tried to support me over the years whenever they could, especially 
ifI let them win at golf!), and Advanced Cardiovascular Systems, London, UK. 
9 
INTRODUCTION AND OVERVIEW OF THE THESIS 
General background to coronary angioplasty and introduction of new angioplasty devices 
Percutaneous Transluminal Coronary Angioplasty (PTCA) is the original term describing the technique 
of alleviating coronary artery narrowings by inflating a short balloon (8 - 45nml1ong) mounted on a long hollow 
plastic catheter, which is introdllced to the coronary artery over a thin (0.010 - 0.018 inch diameter) Hoppy 
tipped guidewire via a peripheral arterial puncture (the femoral artery in the groin being in modern times the 
most popular, then the bmchial artery at the elbow and more recently, the radial artery at the wrist). Since its 
introduction in 1977, this non-surgical alternative to coronary artery bypass graft operation (with its attendant 
risks and uw,avoury patient appeal) has undergone a metamorphosis from experimental clinical application into 
the medical specialty of "Jnterventional Cardiology". With its increasing clinical application, in addition to 
broadening indications and therapeutic possibilities, however, its limitations in consistently producing successful 
amI uncomplicated results, have been exposed. Accordingly, a medical device industry rapidly burgeoned, hand-
in-hand with the specialty of interventional cardiology itself, providing extensive refinements in guidewire and 
halloon catheter manufacture and design. Despite such advances in haUoon technology and the increasing 
experience of physicians engaged in daily practise, procedural failure, or abrupt closure of the coronary artery, 
during or shortly after angioplasty, has remained an inherent complication in 5-10 % of cases attempted. 
Perhaps more vexatiously, recurrence of renarrowing, or "restenosis", of an initially apparently 
successfully treated artery, suftlcient to require re-treatment or bypass graft surgery (or of a severity to cause 
myocardial infarction or even death) within the first 6 months, seems to have become an inevitable long lenn 
drawhack in more than one in three patients treated. These two limitations of balloon angioplasty therapy have 
consequently precipitated a furious search hy investigators worldwide for, on the one hand, a "magic bullet", 
in the guise of a hiological, phaITnacological or genetic panacea, which could be administered at the time of 
angioplasty. and perhaps for some months afterward, to control the problem of restenosis, and on the other 
hand, a "golden fleece", ill the form of an alternative device, which would improve both inmlediate success 
rates and also reduce restenosis. In the last 15 years, a myriad of pharmacological and biological agents for 
resteuosis prevention have been investigated in multicenter randomized clinical trials, with TlO convincing 
success. In additioll, over the last decade, a larger numher of new interventional devices for coronary 
rcvascularizatioll have beell progressively introduced to clinical practice, the principals among which have been 
endolulllinalmetal stents of varying composition and design, cutting devices, namely directional, ex tractional 
and rotational atherectomy and laser based devices, such as excimer laser coronary angioplasty. Each of these 
devices has staked a claim for a niche in the treatment of coronary artery disease and ralldomized clinical trials 
have been inaugurated to determine the clinical value of these new devices, compared with good old balloon 
angioplasty, which is still the mainstay of transluminal coronary intervention. 
Directiollal atherectomy did not emerge hom the multicentre randomized CAVEAT and CCAT trials 
with rhe type of superior acute and long teITn results over balloon angioplasty as had been perhaps expected by 
its champions. However, in the BENESTENT and STRESS trials, the Palmaz-Schatz stent has been perceived 
as providing superior acute and 6 month clinical and angiographic results compared with balloon angioplasty, 
although only patients with stable angina and target stenosis in a vesse1larger than 3nnll were included, which 
is an extremely circulllscribed population, so that the conclusions may not necessarily he generalized to all 
clinical situations. Nonetheless, the excitement generated among interventionaJists has led to Federal DJUg 
Administration (FDA) approval of the device for general use in the United States and to new phases of clinical 
investigation. These include studies with increasing varieties of stem and specific studies aiming to reduce the 
need for rigorous treatment with anticoagulation medication (which bas been associated with excessive incidence 
of bleeding complications), without increasing the risk of stent thrombosis and also to further improve the late 
results. oy more optimal stent implantation and u,.<;e of biologically active coatings or even hiodegradable stents. 
Excimer laser angioplasty has allowed percutaneous treatment of previously untreatabIe lesions and registry 
reports indicate satisfactory acute success, although without impressive late angiographic results. The first 
reporteu randomized clinical trial evaluating excimer laser angioplasty with conventional balloon angiopJasty, 
the AMROE trial (the angiographic aspects of which are reported in chapter 8 of this thesis), found no clinical 
or angiographic benefit of laser compared with balloon angioplasty, in terms of acute success or 6 month 
n:sults. The field of new device angioplasty is thus developing rapidly, but must he vehemently considered to 
he as yet in its infancy. 
Thoraxcentre contributions to interventional cardiology 
The clinical and research activities of the department of interventional cardiology at the Thoraxcentre 
of the Academic Hospital and Erasmus University of Rotterdam, have fimlly established this institution as a 
major source of continuing advances in both therapeutic approaches to percutaneous treatment of coronary artery 
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disease, as well as in understanding of the biological processes, triggered by instrumentation of diseased 
arteries. In particular, in the clinical arena, the imaging medium of contrast angiography has been harnessed 
to maximize its illfoTIllative capabilities, through the development of computer algorithms whkh can 
automatically recognize the enhancement of the coronary lumen provided by the direct injection of contrast 
material. The possibility to accurdte1y and precisely quantify luminal dimensions and serial changes therein over 
time, as a consequence of biological processes or mechanical interventions, has provided the physician with an 
opportunity to gain insight to these biological processes and reactions to coronary interventiun, in the clinical 
setting. As early as 1982, the application of so called "Quantitative Coronary Angiography" (QCA) for 
evaluation of coronary angioplasty was already being demonstrated and recommended by the Thoraxcentre 
group. However, as with al! new innovations, the enthusiasm of the inventors was not initially generally shared 
by their peers and it was some years later before the first major international clinical introduction of the 
Cardiovascular Angiographic Analysis System (CAAS) was witnessed, in the context of a multicentre 
randomized trial of a pharmacological agent for prevention of restenosis. Since then, quantitative angiography 
has really become the "gold standard" for investigation of biological and mechanical coronary artery 
interventions, and accordingly, fonns the basis of the studies described in this thesis. 
Purpose of this thesis 
The purpose of this thesis was twofold; firstly, to investigate and demonstrate the appropriate 
applicability of angiography, particularly quantitative angiography, to the evaluation of the acute and long telID 
effects of coronary angioplasty (chapters I - 6); secondly, to addresses one of the principal clinical issues in 
interventional cardiology today, namely, whether the type of device used for coronary angioplasty influences 
the potential for development of restenosis, or is it merely the magnitude of the result achieved at angioplasty 
alone which determines late outcome, regardless of the device used. As will emerge in this overview and in the 
thesis itself, our hypothesis has been that the device used does exert an independent influence on restenosis, as 
a consequence of the specific nature and extent of ilUury imparted to the coronary artery during intelvention, 
which is characteristic of the mechanistic effect of each different device, as well as depending on the degree 
of lumillal enlargement forced upon the diseased vesseL The finding of such a "device specific" influence on 
restenosis would carry practical implications for the future clinical use of the different devices. In chapters 7 
to 11, the following devices are evaluated: balloon angioplasty, as already briefly described, the original and 
still predominantly used coronary intervention; coronary stent implantation, first introduced in 1986 and 
comprising a balloon-expandable or self-expanding, metal coil or mesh which can be pelmanent1y placed in a 
coronary narrowing using a balloon catheter (a number of designs of varying metal composition and geometry 
are now available, 3 of which are included in the studies in this thesis); directional atherectomy, introduced in 
1989, and is essentially a cutting device intended to remove coronary atherosclerotic plaque by a hollow cone 
shaped cutter with a stabilizing balloon, which is introduced to the coronary artery over a guide wire, in similar 
fashion to balloon catheters; and finally, excimer laser coronary angioplasty, which is a method of vaporizing 
coronary artery disease using pulsed laser light, introduced through special layered fiber catheters. 
Sunmlary of the individual chapters 
Chapter 1 of this thesis provides an extem.;ive clinically relevant description of the technical aspects of 
automated quantitative angiography using the Cardiovascular Angiographic Analysis System (CAAS), including 
its evolution from research tool for evaluation of coronary artery disease to its widespread on-line clinical 
employment in interventional cardiology. Also explored are the challenges to its capacity to consistently provide 
reliahle coronary artery luminal measurements, which have been encountered through its progressive application 
to evaluation of coronary angioplasty and intervention with new devices and how we have managed to address 
some of these limitations, by systematic introduction of standardized methods of angiographic acquisition by 
clillicians and off-line quantitative analysis in a designated core laboratory. 
Chapter 2 introduces the clinical application of quantitative angiography to interventional cardiology. 
In particular, the nature and clinical relevance of the coronary luminal measurements provided by automated 
analysis is delineated and the biological insights to the process of restenosis provided by the serial application 
of quantitative angiography to clinical interventional investigations is presented. In addition, we expound the 
hypothesis of device specific ditlerences in provocation of restenosis, which is the principle subject of the 
second part of this thesis, based on some previously published circumscribed studies allli preliminary 
investigations of patient data which are comprehensively interrogated and presented in detail in chapter 10 of 
this thesis. Novel original approaches for comparative evaluation of restenosis propensity of interventionaI 
devices, using measurements provided by quantitative angiography are also proposed and foml the basis for 
lllany of the studies presented in the second part of the thesis. 
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In chapter 3, the usefulness of angiography for evaluation of two of the major unwanted potential 
consequences of coronary angioplasty, namely, intracoronary thrombus and intimal dissection, is comparatively 
evaluated using intracoronary angioscopy (an investigation which allows direct visualization of the coronary 
lumen, but without the possibilities of quantification of the lumen dimensions). It emerges that although 
angiography both detected and outruled important intimal dissections reasonably reliably, considerable intimal 
disl11ption was missed angiographical1y and the presence of intracoronary thrombus was significantly 
underestimated by angiography, despite the absence of false positive findings. Thus, ifnon-obstlllctive coronary 
thrombus is an important nidus for development of restenosis, as is generally believed, this association must 
be studied by means other than angiography. Accordingly, angiographic thrombus is not considered in the later 
chapters of this thesis dealing with detemlinants of restenosis. Similarly, based on these findings, as well as our 
prior tinding of no association between angiographica!ly visible, non obstructive dissection with late restenosis 
(J Am Coil CardioI1992;20:767-80), this angiographic feature is also not further investigated in relation to 
restenosis in this thesis. 
Chapter 4 investigates the possibility of routine use of a single angiographic projection for quantitative 
angiographic analysis, by comparing measurements obtained by automated edge detection and videodensitometry 
from orthogonal angiographic projections (angiographic recordings of the target coronary artery in perpendicular 
planes) before and after angioplasty and at 6 month follow up. If found to be as reliable as the use of multiple 
projections, this would obviously considerably facilitate interventional proceuures and simplify the perfonnance 
of serial angiography for quantitative analysis in clinical interventional trials. Our evaluatioll however, showed 
considerable variability between orthogonal measurements by both approaches at all stages of angioplasty, a 
finding which mitigates against the reliability of quantitative analysis ti'om a single angiographic projection. 
Accordingly, all studies in this thesis are based on quantitative analysis ti"OlTI multiple angiographic projections 
serially iuentically repeated before and after intervention and at foUow up. Our observation that the presence 
of angiographically visible dissectioIl post angioplasty did not adversely atiect the variability in orthogonal 
measurements, coupled with the superior agreement between orthogonal measurements pre-PTCA and at follow 
up, suggests that angiographically undetected changes in target lesioIlmorphology or geometry as a consequence 
of halloon dilatation (as demonstrated in chapter 3) may be responsible for the poor agreement between 
orthogonal measurements post-angioplasty. 
Chapter 5 deals with the important consideration of whether there are fundamental changes in the 
coromuy artery luminal dimensions within the first 24 hours, which might invalidate quantitative analysis of the 
angiogram recorded after the procedure, as has been the routine approach over the years, and mandate the use 
of repeat angiography 24 hours after angioplasty, for any clinical studies investigating restenosis - a tInding 
which would obviously have major repercussions for clinical practice, as well as research. The rigorous 
methodology applied (including, in keeping with the findings of chapter 3, the use of multiple projections 
identically repeated at 24 hours), provided highly reliable angiographic data and facilitated demonstration that 
no significant deterioration occurs at the dilated site during the first day after successful balloon angioplasty, 
so that the previously suggested phenomenon of delayed elastic recoil was not found to exist. However, because 
of a significant increase in the reference diameter of treated lesions over the 24 hours, a significant increase was 
consequently observed in derived percent diameter stenosis measurement. TIlls tinding confirms the potentially 
misleading infonllation which may be provided by use of percent diameter stenosis and re-emphasises the need 
to focus on absolute coronary luminal measurements in clinical studies. In addition, the previously Ull-
investigated post-angioplasty measurement variability of the CAAS system was found to be O.20mm, which is 
eminently acceptable, in view of the potential difficulties with analysis of post-angioplasty angiography (as 
described in chapter 3). Accordingly, the pnst-PTCA angiogram could be considered to provide a reliable image 
of the end-result of the procedure, without recourse to further repeat angiography 24 hours later. 
Tn chapter 6, SUbjective so-called "qualitative" angiographic coronary lesion morphological features, 
as well as automatically provided quantitative measurements are investigated, along with patient clinical factors, 
to detenlline their usefulness in predicting the occurrence of unfavourable outcome of coronary balloon 
angioplasty ie. occurrence of death or myocardial infarction or requirement for repeat angioplasty or for bypass 
graft surgery, during the same hospital admission. It is established that quantitative measurements were not at 
all helpful in predicting the occurrence of unfavourable outcome, but unstable angina at the time of angioplasty, 
target lesion located in the mid-segment of the artery or in a coronary bend> 4SO, type C lesions and the 
presence of an angiographically visible dissection after angioplasty were independently predictive of a greater 
likelihood of adverse cardiac events. Of course, it is not surprising that dissection is predictive of unfavourable 
outcome, since virtually al[ acute and sub-acute occlusions occurring at the time of angioplasty are associated 
with the presence of more serious types of dissection (associated with obstruction to blood flow), invariably 
leading to one of the unfavourable outcomes listed. Quantitative measures were not predictive of unfavourable 
outcome, but perhaps study of larger numbers of patients with unfavourable outcome would be required to 
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definitively corroborate this finding. 
Part two of the thesis is concerned with evaluation of late effects of intervention, specitlca!Jy, 
comparison of the long ternl effectiveness of different devices with regard to their tendencies to provoke 
reslenosis. Since different devices are more suitable for systematic use in large or small vessels, in chapter 7, 
the flrst fundamental aspect of the problem to be investigated was whether or not the size of the coronary artery 
itselfcould influence late renarrowing after angioplasty. A comprehensive investigation provided the information 
that larger vessels are independently associated with a lesser tendency to renarrowing than smaller vessels. 
Accordingly, failure to take account of the influence of vessel size in a comparison of devices might provide 
misleading results. When vessel size was controlled in multivariate analysis, the confounding influence was no 
longer evident. It is apparent therefore, that for comparative evaluation of al1giograpbic results of intervention 
by different devices, whereby fundamental differences in coronary vessel size are evident, the comparison, in 
order to provide valid results, must take account of this important confounding factor. For this reason, in 
chapters 10 and 11, where 4 patient groups treated by different devices are compared, relative measures of 
luminal cbange are used, as introduced in chapter 2, whereby the CAAS provided interpolated reference 
diameter pre-intervention is used as the constant point of reterence, rather than employ the unreliable method 
of percent diameter stenosis, as already shown. 
Chapter 8 wmpares late angiographic results of excimer laser angioplasty and balloon angioplasty 
among patients who had been enroled in a randomized comparison of these devices for treatment of longer 
wronary lesions. Accordingly, in keeping with our proposals in chapter 2 and 5, we employ absolute coronary 
measurements, since the groups have heen individually randomized and are well matched for haseliIle 
characteristics, particularly vessel size (in keeping with the findings of chapter 7). Focusing on angiographic 
restenosis propensity provides definitive findings that excimer laser is more provocative of restenosis than is 
angiopJasty alone, both in the general inter-group comparison and also in the ancillary sub-group evaluations. 
We believe this finding may be due to inherent properties of laser induced vessel injury (as it was being 
clinically employed during the course of the Amsterdam Miami ROtterdam Eindhoven (AMROE) trial) 
compared with conventional balloon injury and that it supports our hypothesis of device specific difterences in 
restenosis propensity. 
III chapter 9, we compare what may be considered in some quarters as the "devices of the future", the 
potential "golden fleece". Proponents of directional atherectomy believe this device, when optimally applied. 
lllay he the ideal interventional device, by thorough removal ofpJaque, facilitating maximization of the coronary 
lumen. On the other hand, stent enthusiasts consider implantation of a petmanent prosthesis, with its scaffolding 
and anti-recoil properties and potential to completely "noffilalize" the narrowed coronary segment, to be the 
ultimate panacea for restenosis. By individually matching patients to be compared for baseline clinical and 
angiographic characteristics, we provide a "surrogate for a randomized trial" and find that stellt implantation, 
at least in our hands, provides superior acute results. This superiority is maintained in the long tetm (6 months 
follow up) and was associated with significant clinical henetit, in temlS of reduction in frequency of major 
adverse cardiac events (as defined in cbapter 6). To confinll that such superiority is not merely a function of 
tile larger acute result, as 1\3.0, been the claim of other investigators, we perfonlled a second comparison 
involving matching of patients for the post-procedural result, as well as baseline characteristics. In tlus manner 
it emerged tllat signiticantly less renarrowing developed in the patients receiving a stent, who consequently had 
a superior late allgiographic result. This finding may be interpreted as a device specific effect, whereby 
achievement of similar lumina! increase is associated with less vessel iqjury by stent implantation than by 
directional atherectomy. 
Chapters 10 and 11 illvolve serial comparative evaluations of patient populations treated by diflerent 
interventioml devices, using the relative angiographic parameters introduced in chapter 2 and the multivariate 
modelling and graphic approach applied for the first tillle in a clinical study in cbapter 7. The first comparative 
evaluation of 4 devices which we performed is described in chapter 10. At that time (1992), we had already 
prospectively collected patient data on 1452 patients treated by balloon angioplasty, 120 hy directional 
atherectomy, 104 by Wallstent and 100 by Wiktor stent implantation, with serial quantitative angiography pre 
and post intervention and at fo!low up. Since chapter 7 showed the confounding influence of vessel size on 
outcome, relative angiographic parameters were employed to control for this. Significant differences were 
observed in angiographic restenosis propensity between the 4 devices, independent of baseline lesion severity, 
lesion location and IUlluml increase at intervention. Although the evaluations represent a novel and 
unconventional approach and, as such, require some digestion, the essence of the message can be gleaned from 
the 3 dimellsional graphs, which, interpreted at their simplest, demonstrate differences in the slnpes of the 
"planes" hetween the 4 groups and differences in the Y axis levels of the 3 points of comparison between the 
4 groups. In basic tenns, for a coronary lesion of given severity, location and vessel size, a given acute result 
will lead to differing late angiographic results, depending on the device. Unfortunately, the fact that 
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demographic differences existed between the 4 groups, could theoretically have influenced the findings, so 
detinitive conclusions can he criticized, even though the findings are quite signiticant and support the hypothesis 
espoused in chapter 2. Other studies, referred to in this chapter and in chapter 11, which included clinical and 
histological as well as angingraphic characteristics in evaluation of detenninants of restenosis, did not tInd that 
inclusion of these additional characteristics altered the fundamental angiographic relationships described. 
However, although these findings would support the validity of the angiographic results of this study, the 
evidence is somewhat circumstantial. Accordingly, further comparison between more homogenous patient groups 
treated by ditt-eren! devices was cOtt"idered necessary to further evaluate the hypothesis as described in chapter 
11. 
Chapter 11 invulves comparison of angiographic restenosis propelt"ity between a large group of patients 
trei-Ited hy halloon angioplasty (the size of this group does not unbalance the comparison, but rather increases 
the statistical power to detect important inter group differences, due to the greater number of "observations") 
and relatively large (relative to single centre experience throughout the world) groups of patients treated by 
Pallllaz-Schatz stent implantation, directional atherectomy or excimer laser angioplasty. Use of the previously 
estahlished comparative methodology again demonstrated fundamental differences in angiographic restenosis 
propensity hetween the patient groups treated hy different devices (again, independent of variations in lesion 
severity or location, vessel size or luminal increase). 
Although critics may still point to possible unseen intluences of subtle patient, procedural or lesion 
differences, these timlings are in agreement with the findings of chapters 8, 9 and 10 and, considered together, 
convey the essence of "device specific" intluences on late results of intervention and continn the validity of our 
hypothesis fommlated in chapter 2. Ultimately, to satisfactorily resolve the issue, randomized comparisons will 
be required hetween devices, with a prerequisite for optimization of acute results and with additional application 
of serial intravascular ultrasound, to possibly provide a mechanistic explanation for the findings. Appropriate 
methodology for suitable evaluation of restenosis propensity of coronary interventions is established in these 
studies. Superior devices for intervention my be considered to be those which provoke the lest degree of luminal 
renarrowing (relative luminal loss) with illcrementalluminal maximization (relative gain) during intervention. 
Useful adjunctive therapy should demonstrate a significant reduction in the relative loss respoIt<;e to increasing 
relative gain if it is to be accredited with a real influence on the process of restenosis. In the concluding chapter 
of the thesis, further interpretative consideration is given to these findings, with particular emphasis on the 
implications for clinical practice in the future. 
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TECHNOLOGICAL CONSIDERATIONS AND PRACTICAL 
LIMITATIONS IN THE USE OF QUANTITATIVE ANGIOGRAPHY 
DURING PERCUTANEOUS CORONARY RECANALIZATION. 
Strauss BH, Escaned I, Foley DP, di Mario C, Haase I, 
Keane D, Hermans lVR, de Feyter PI, Serruys PW. 
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15 
16 
Progress in 
Cardiovascular Diseases 
VOL XXXVI, NO 5 MARCH/APRIL 1994 
Technologic Considerations and Practical Limitations in the 
Use of Quantitative Angiography During Percutaneous 
Coronary Recanalization 
Bradley H. Strauss, Javier Escaned, David P. Foley, Carlo di Mario, Jurgen Haase, David Keane, 
Walter R.M. Hermans, Pim J. de Feyter, and Patrick W. Serruys 
ALTHOUGH the development of selective coronary arteriographyl rapidly led to ils 
acceptance by cardiologists as the "gold 
standard" in the diagnosis of atherosclerotic 
coronary artery disease (CAD), many authors 
have reported on the pitfalls associated with 
visual interpretation of the coronary angio-
gram.c-l) The variability associated with visual 
quantification of stenosis has been shown to be 
related not only with the degree of compromise 
of the arterial lumen,7 but also with the lack of 
uniformity ill identifying the narrowest point of 
the !Csion,~ with the quality of the angiograms,-'i 
and with mUltiple anatomical factors, including 
lesion length, vcsscl irregularity, and branch 
overlap.2 Selection of the angiographic view 
showing the stenosis at its most severe is equally 
alTected by variability.6 Although the variability 
associated with visual interprctation of coro-
nal)' arteriograms can be reduccd by a consen-
sus panel,') it is self cvident that such an ap-
proach is cumbcrsome, time-consuming, and 
cannot be applied during on-line analysis in 
cardiovascular interventions. 
The advcnt of computerized image analysis 
and quantitative coronal)' angiography (OCA) 
has made possible thc objective study of angio-
graphic images ovcr the past 15 years. During 
thc same time period, the generalization in the 
use of percutaneous revaseularization tech-
niques using balloon angioplasty and other tech-
niques such as coromu), atherectomy and stenl-
ing has expanded thc usc of QCA in both the 
clinical and research fields. As a result of 
application of these interventional techniques, 
the data obtained have to be used to provide tile 
operators with reliable information not only 
about the severity of the stenosis but also about 
aspects relevant to procedural decisions. Match-
ing the size of the intelventional device to the 
artery is requireJ during recanalization to mini-
mize vessel damage that may precipitate acute 
vessel occlusion and late restenosis. IO•11 Objec-
tive information on the changes in luminal 
dimensions obtained by the techniquc during 
the procedure may be required to decide 
whether discontinuation of the procedure or 
further recanalization is nceded. 1J.13 For the 
researcher, quantitative angiography has be-
come the main tool to assess not only the 
primary efficacy of a particular technique but 
also the luminal renarrowing in the long term. 14 
The purpose of this article is to understand 
the advantages and limitations of QCA in the 
field of in tel vent iona I cardiology. The Cardiovas-
cular Angiography Analysis System (CAAS), 
h"Om the Tfl{)ra.\·("cIIICI~ Erw.mll.1 Vnil·c/:I·in'. Rotterdam, 
The Ner!w!ia/lds. 
Dr Simms 1:1" a Research Fefloli' vf Ihe Hmrl IIII(! Siroke 
FUllndalioll of" Canada alld is cIIIH'nl!)' II .1·laj}" IIIl'mher III Ihl' 
Dil'isian of Carr/iv/vg)'. SI Michael\" ffospira/. Torollto. 011-
/((Iio. CIIIIIUIrI; Dr Foley is a rl'dpil'lll of lire 1991 Irish HCiII1 
Foundation Trill"l'/Iillg Fel/vlI';hip ill Cardiology. Dublill, Ire" 
IlIlId; Dr Di i'lariu i.1 supported I~\" ill(' EllroP1'il1l Socii''.\" of 
Cardiv/vg)' Re.l·earch Fe/lOil'Ship 1991: and Dr Keane is a 
recipil'lif ()j a Trw'£'l Grallt Fom lhe Pee/ T/1/SI for II-{,>dical 
R('.worch. VK. 
Address reprilll reql/('.I{S fa Palrick W SelTll\".I·, MD. PhD. 
Cafhef,'rizmioll Laborr/IV))". 17wraxcc/lfer/Era.mllls Ullil'el:~ity 
ROl/ai/alli. 1'0;1&11.1' 1738 •. W()() DR ROl/adom, The Nether-
lallds 
CO/~l'riglll L' /994 by W.E. SlIImdl'l:\' COlllpilll)" 
0033-0020 /W/.'I(j()5·()()() 1$5.00! 0 
Progress /() CardioviJsr;(llar Diseases, Vol XXXVI, No 5 (Marchi April), 1994: pp 343-362 
17 
developed at our institution and previously 
described in detail elsewhere, L';-18 will be used [IS 
an example, because it incorporates the two 
modalities of analysis that are more widely 
used, namely detection of luminal contours 
(so-called edge detection) and densitometry. 
These two types of analysis arc discussed sepa-
rately. A detailed comparison highlighting the 
similarities and differences between the CAAS 
and other QCA systems can be found in several 
reviews in the literature. 19.21l 
CONTOUR-DETECTION QUANTITATIVE 
ANGIOGRAPHY 
The first approach used in quantitative angi-
ography consists of the analysis of the distances 
found between the leading edges of the luminal 
silhouette. From an historical point of view, this 
constitutes the first attempt to quantify vessel 
dimensions using calipers, either manual,21,22 
sometimes with optical magnification,2."l or digi-
taPA Luminal diameters are widely used in 
quantitative angiography given the case of mea-
surement and probably because the fact that, at 
least at first glance, the information obtained 
with automated edge detection conveys inform a-
c D 
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tion comparable with that used during visual 
interpretation of the angiogrRm or hRnd-held 
calipers (although this aspect has been ques-
tioned by the work of Fleming et a1,25 who found 
a better correlation between visual estimation 
of stenosis severity and luminal area derived 
from QCA analysis). 
Despite its apparent simplicity, contour detec-
tion requires a sophisticated methodology for 
its adequate application. Because the borders of 
the luminal silhouette in the cine angiogram 
consist of a gradient of densities, identification 
of the true luminal borders is still uncertain and 
is a major cause of variability in the measure-
ments. The problem posed to automated sys-
tems of edge detection is to establish at which 
level the transition between background and 
luminal densities of the opacified vessel occurs 
(Fig 1). In most automated systems, a two-
dimensional analysis of the density observed in 
individual scanlincs perpendicular to the vessel 
centerline solves this problem. Critical changes 
in brightness are detected by using the first anel 
second derivatives of the density. The auto-
mated search is performed in consecutive scan-
lines that are repeated at close intervals over 
E 
Fig 1. Steps followed during automated detection of luminal borders from the cineangiogram are shown. (A) The borders consist 
of a gradient of denSities, posing the problem of establishing at which level the transition between background and luminal densities 
of the opacified vessel occurs. (B) A two-dimensional analysis of the density observed in individual scanlines perpendicular to the 
vessel centerline is performed. (C) The density observed in these consecutive scanlines is obtained. (D) Critical changes in 
brightness, corresponding to the transition between background and opacified lumen, are detected by using a combination of the 
first and second derivatives of the density. (Ej The identification of luminal edges is based not only on individual scanlines but also on 
the overall information obtained from neighboring scan lines, which decreases the contribution of spurious variations in density that 
are observed a single scan line (arrow in Dj. 
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the studied segmenl. The information con~ 
tained in an individual scan line may be influ-
enced by local sources of error in edge detec-
tion, such as originating branches or overlying 
structures; therefore, the automated identifica-
tion of luminal edge5 is based not only on 
individual seanlines but also on other neighbor-
ing scanlines. This identification is performed 
using so-called minimal cost algorithms, which 
facilitate edge detection over the length of the 
arterial segment being analyzed. By restricting 
the relevance of the information of each indi-
vidual scanline, minimal cost analysis assumes 
that no drastic change in the contour of the 
vessel will occur in a very short segment. Thus, 
when complex angiographic morphologies with 
overhanging edges or abrupt changes are ana-
lyzed, errors derived from pitfalls in edge detec-
tion can occur. Finally, for a more precise 
detection of the luminal edges, an iterative 
method, which involves recalculation of the 
centerline and a new detection of the luminal 
contour, is applied. Each of these steps is fully 
automatic, and the only requirement for the 
user is the selection of the segment to be 
analyzed and the identification of a few arbi-
trary eenterpoints within that se;;ment. 
Once the luminal diameters have been ob-
tained, the distance between the edges at the 
level of each individual scan line can be easily 
calculated in pixel units. Calibration of the 
system with a structure of known dimensions, 
such as the filmed catheter, makes possible the 
transformation from pixels to absolute units. 
When the diameter values are plotted against 
the length of the analyzed segment, a so-cailed 
diameter function is obtained (Fig 2). Applica-
tion of specific algorithms to the diameter 
function makes possible the calculation of a 
number of angiographic parameters. For ex-
ample, in the CAAS system, the application of a 
clllvature-detection algorithm to the diameter 
function identifies the location where a critical 
decrease in luminal dimensions (that is, one 
that is attributable to the stenosis and not to 
spurious variations in luminal diameter) occurs. 
The same principle is applied to identify both 
limits of the stenosis. Minimal luminal diameter 
(MLD) is easily identified in the diameter 
function as the lX)int with the lowest diameter 
value. 
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INTERPOLATED REFERENCE DIAMETER (RD) 
J 
DETERMINED BY 
MLD /CURVATURE ANALYSIS 
t 
EXTENT OF OBSTRUCTION 
DIAMETER FUNCTION 
Fig 2. Schematic representation of a diameter function 
curve shows MlD, interpolated reference diameter, and the 
extent (or length) 01 the obstruction as determined by the 
curvature analysis. 
For the calculation of relative measurements 
(percent diameter stenosis), MLD is compared 
with a reference segmcnt. Although the latter 
can he defined by the uscr, it is obvious that 
visual identification of a refcrence segment 
would be associated with a similar variability as 
the point of minimal diameter, particularly in 
cases where the proximal part of the arterial 
segment shows a combination of stenotic and 
ectatic areas or in cases whcre a "normal" 
portion is just not clearly available. In an at-
tempt to provide. a solution to this problem, the 
CAAS system incorporates an interpolated ref-
erencc diameter that is derivcd solely from the 
information conveyed by diameter function. In 
the CAAS system, the algorithm llsed for inter-
polation of the reference dimensions involves 
the calculation of a Drst degree polynomial, 
computed through the diameter values of the 
proximal and distal portions of the arterial 
segment, followed by a translation to the 80th 
percentile level (Fig 2). Interpolated reference 
diameter techniqllcs are also useful when re-
peated measurements of the same segment are 
required, such as during [allow-up studies after 
intervention. However, it is not possible to 
apply this technique when no reliable proximal 
or distal segment is present, such as in ostial 
lesions or in segments with incomplete opacifi-
cation of the distal segment (Fig 3). In those 
cases, the 5election of a reference segment hy 
the user is justified (Fig 4). 
REFERENCE OIAMETER 
BYPASS STENOSIS 
Fig 3. Measurement of the reference diameter for an ostial 
lesion is shown. The computer-defined reference diameter is 
ina(:(:urate in situations where there is no reliable proximal or 
distal boundary (eg, ostial lesion or lesions located at the 
origin of a side bran(:h). In this situation, the analyst must 
determine the reference diameter (user-defined). 
In the CAAS system, the comhined usc of the 
interpolated reference dimensions over the ana-
lyzed segment and the detected luminal edges 
yields an estimate of the protrusive area of the 
atheromatous plaque (Fig 5). Similarly, a sym-
metry index is calculated as the ratio of the 
angiographic plaquc observed at both luminal 
edges. 
The curvature value is an attempt to convey a 
measure of the degree of CUlvature or hending 
of the coronal)' segment being analyzed (Fig 6). 
The angiographic projection in which the vessel 
appears to bc thc least foreshortcned (ie, where 
thc measured absolute distance between thc 
proximal and distal hound aries of the segment 
is greatest) is chosen for the CUlvature analysis. 
The inflow and outflow angles are dcrived from 
the slope of the diameter function at the de-
scending and ascending limb of the diameter-
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Fig 5. Determination of the area plaque, symmetry, and 
curvature values is shown (see text for details). 
function curve at the defined site of the obstruc-
tion (Fig fi). The information derived from 
these parameters may be relevant in character-
izing the hcmorrheologic behavior of the steno-
sis and has been helpful in studying thc charac-
teristics of coronary artery lesions at risk of 
thrombotic ocdusion21i and in assessing the 
modifications in stenosis morphology after coro-
nal)' stentingY 
DENSITOMETRY 
The basic principle on which densitometl), is 
based is the existing relationship between thc 
attenuating power of the lumen filled with 
contrast medium, which is a function of luminal 
area, and the x-ray image intensity.28 From this 
information, a densitometric profilc that is pro-
portional to the cross-sectional area of the 
(- DIAMETER ECHOCATHETER 
DIAMETER C.A.A.S 
I ECHO CATHETER LOCATION 
Fig 4. The user-defined reference diameter is also useful when the exact diameter is required at a specific location in the (:otonary 
artery. (A) In the validation studies of intravascular echo catheters, the tip of the echo·catheter is visible, and the diameter of the 
segment l3.26 mm) has been determined by the eMS analysis. (B) It is also clear from the schematic diagram that different 
diameters are measured by the two methods, when the intravascular e(:ho catheter is pla(:ed in a bend in the (:oronarV artery. 
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A c 
¥--~ =W· .- OUTFLO:--
ANGLE _ --- ANGLE 
B 
DIAMETER FUNCTION (OF) 
Fig 6. Determination of inflow and outflow angles from the 
diameter function is shown (see text for details~. Inflow angle 
is the average slope of the OF between B and A; outflow angle 
is the average slope of the OF between Band C. 
lumen is obtained, irrespective of its morphol-
ogy. Thus, whereas edge detection analysis 
yields luminal diameters, densitometry provides 
an estimate of luminal area. A potential advan-
tage associated with the usc of area measure-
ments is that it may yield more relevant physi-
ologic information than luminal diameter 
mcasurements. 29 • .lJ Furthermore, luminal area 
is calculated without making assumptions on 
lumen morphology and, theoretically, with inde-
pendence from the angiographic angulation 
used. 2H On the other hand, the basic assumption 
of a correspondence between density and lumi-
nal area can be lost at every step of the 
collection, transfer, and analysis of data. Let us 
review some of these limitations. 
To obtain a reliable correlation between lumi-
nal dimensions and videodensity, complete re-
placement of blood by contrast medium during 
each injection should be ideally obtained by the 
operator. Failure to do so may induce streaming 
of contrast that may affect the detection of the 
true luminal borders. Similarly, a decrease in 
concentration of iodine within the artery may 
cause errors during the calculation of luminal 
area from the densitometric profile. Perpendicu-
larity of the x-ray beam to the analyzed segment 
is also important. 
A major problem in videodensitometric analy-
sis is derived from the presence of overlapping 
densities, corresponding to other anatomical 
structures, that can interfere with the calcula-
tion of luminal area. To correct for such patient 
structure noise, subtraction of the background 
has to be applied to obtain a net cross-sectional 
videodensitometric profile. Information ob-
tained either from an identical image obtained 
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before the injection of contrast (mask subtrac-
tion) or from the structurcs adjacent to the 
artery present in the same frame must be used 
for this purpose. Both systems of background 
correction present weak points. The former is 
affected by patient motion, particularly respira-
tion, whereas the latter is affected by the struc-
ture-related variability, which cannot be fully 
replaced by the use of linear interpolation. 
Excessive background subtraction can occur 
when other vascular structures located close to 
the vessel contour arc used by the subtraction 
algorithm or when the vessel is located in areas 
of rapid transition between dark and bright 
areas. In those cases, the subtraction can be so 
intense that the calculated cross-sectional area 
may even assume a negative value (Fig 7). 
Not ail brightness obseIVed at the end of the 
cineangiogram-video chain can be attributed to 
the attenuation of thc x-ray beam by the opaci-
fied vessel and anatomical structures. Both 
x-ray scatter and light reverberation within the 
optical systems, such as the image intensifier 
and vidco cameras (veiling glare), contribute up 
to 80% of the total light intensity.J4 When no 
correction is applied, these measured intensi-
ties are introduced in the calculation of luminal 
Fig 7. Densitometry measurements are affected and inaccu-
rate in the presence of overlapping side branches. In this 
eKample, the upper curve (the diameter function) shows an 
MlD of 2.93 mm. However, because of interference from side 
branches from the background subtraction, the densitometric-
determined MLCA (lower curve) is a negative value. 
art;,,, _ lay constitute an important source of 
error . .1·U5 The contribution of scatLcr and veiling 
glare varies with the location across the thorax, 
reaching maximum values when the coronal), 
arteries are projected in areas with a rapid 
transition between the cardiac silhouette and 
the lung field, and makes correct positioning of 
angiographic wedge filters mandatOl), during 
image acquisition to minimize this source of 
error. 
In the CAAS systcm, a luminal area function 
is constructed in an analogous fashion to that 
described for the edge detection modality and 
can be used in the calculation of interpolated 
reference area. However, a critical dilTcrcnce in 
the calculation of absolute values with both 
techniques is that densitometry relics on the 
calibration of the system using a reference 
videodensitometric profilc, which is obtained in 
a segment of known dimensions. In the CAAS 
system, this reference profile is usually obtained 
in a computer-defined disease-free segment, 
which scrves as a reference area and in which 
luminal area is calculated simultancously from 
the luminal diameter assuming that the lumen 
has a circular morphology (Fig 8). When this is 
not the case, such as in diflusely diseased 
vessels, errors in area calculation can occur. 
CatMeler tip 0 Cathate'tip 0 
(1' StenosES _<-'" MLD ~D RI V, RoferencaSlie --- '_~_~ Steno5is -- = --=-' MLCA 
Fig 8. CalCUlation of absolute vessel dimensions by edge 
detection and videodensitometric analysis. In edge detection, 
the calculation of MlD is obtained by direct comparison wilh 
the diameter of the filmed catheter. which is used to calibrate 
the system. Vid(!od(!nsitomelry yields a d(!nsitometric profile 
that has to be compar(!d with a segment of known luminal 
area. This is achiev(!d by automatic selection of a reference site 
where il is assumed that no occlusive atheromatous disease is 
present and that the lumen is circular. From the reference 
diameter (calculated from direct comparison with the coro· 
nary catheter as described above). geometric cirCUlar cross· 
sectional area at the r(!f(!rence site is calculated and compared 
with the densitometric profile at the same site. In this way, 
density units are transformed into area units (mm2). By direct 
comparison of the densitometric area, thus calCUlated at the 
reference site, and of the smallest densitometric profile in the 
stenotic segment, MLCA is derived. 
22 
STRAUSS ET AL 
Another potential source of error derived 
from thc dependency on a refcrence segment 
for the calculation of absolute videodensitomet-
ric values can be found in the differences in the 
attenuating power of the opacified reference 
and stenotic segments. Most x-ray tubes are 
polychromatic and gencrate a spectrum of radia-
tion with var)'ing associated energy. It has to be 
remembered that the Lambert Beer law, which 
is used in most QCA videodensitometric sys-
tems,l() requires a monochromatic source of 
x-rays. When the lcss energetic fraction of the 
radiation produced by the x-ray tubc is selec-
tively attenuatcd by a opaque structure, a sub-
stantial modification of brightness at the level of 
the image intensifier occurs because of thc 
penetration of a "harder" x-ray beam (beam-
hardening effect). Furthermore, because the 
column of contrast mcdium at this reference 
site has a higher attenuating power than that 
existing at the stenotic site, the characteristics 
of the densitometric profile can be modified by 
this so-called beam-hardening effect. Differ-
ences in the beam-hardening caused by the 
diITerent attenuating power of the contrast col-
limn existing at the reference and stcnotic 
segments can, when not corrected, alTcct all 
subsequent calculations of stenosis severity (Fig 
8). 
IMAGE ACQUISITION AND ANALYSIS IN 
CONTOUR DETECTION AND DENSITOMETRY 
Edge detection and densitometry share com-
mon limitations and requirements that must be 
kept in mind during their applications. In the 
fol!owing paragraphs several of these aspects 
are discussed. At the present time, images for 
QCA are obtained from cineangiograms or 
digital systems. The main advantages of using 
cine films stems from the fact that [hey have a 
higher spatial resolution than digital images. 
Furthermore, by using adequate zooming with 
optical systems, a section of the image encom-
passed in the cine framc can be selected and 
digitized for further analysis. When digital sys-
tems are used, the spatial resolution of the 
images is currently hampered by the size of the 
matrix being used (512 x 512 pixels). The use of 
cineangiograms or digital!y acquired images 
also has implications for the type of transfer 
function used during image analysis. In the 
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former, a semilogarithmic transfer function is 
needed, whereas, in digital angiograms, a linear 
relationship exists.20 As discussed above, this 
may be advantageous when densitometry is 
applied. 
During the acquisition of the cine angiogram, 
selective magnification of structures localized in 
the periphery of the image occurs. This phenom-
enon is tcrmed "pincushion distortion," and can 
be minimized by the operator through proper 
manipulation of the table and gantry to ensure a 
location of the stenosis as close to the angio-
graphic isoeenter as possible. Pincushion distor-
tion has been markcdly decreased in new genera-
tion image intensifiers. In addition to the above-
mentioned precautions, correction for the 
images obtained can be performed during off-
line analysis. For this purpose, a centimeter grid 
must be filmed in each mode of the image 
intensifier and later L1sed by the CAAS system 
to calculate a correction factor for each intersec-
tion position of the grid wires so that the 
pincushion distortion can be corrected.36 
An additional important practical point for 
the physician in all scrial studics is the require-
ment for coronary vasodilation using agents of 
comparable efficacy for every study. In a recent 
study of 202 patients,1.J the mean uiameter of a 
normal scgment of a nondilated vessel pre-
percutaneous transluminal coronary angio-
plasty (pre-PTCA), post-PTCA, and at fol-
low-up was analyzed (Table 1). Of these patients, 
34 who received intracoronary nitrates pre-
PTCA but not before the post-PTCA angiogra-
phy showed a decrease of 0.11 mm in the 
reference diameter versus the small increase of 
0.02 mm in the group that did receive postproce-
dural nitrate. Vasomotion should be controlled 
in QCA studies by means of a vasodilator drug 
that produces fast and complete vasodilation 
without significant effects on the peripheral 
circulation. At our institution, 0.1 to 0.3 mg of 
nitroglycerine or 1 to 3 mg of isosorbide dini-
trate are used before angioplasty, after the last 
baBoon inflation, and at foHow-up angiography. 
Furthermore, the use of nonionic contrast me-
dium is probably recommended because of its 
less intense effect on coronary vasomotion. 14 
Warming of contrast medium to body tempera-
ture is also recommended to minimize potential 
vasomotor effects. 
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Table 1. Influence of Vasomotor Tone on QCA Measurements 
of Nondiseased Segments 
Mean Without Nitro Wilh Nitro 
Diamater Pos!-PTCA Posl_PTCA 
(mm) (n ~ 34) (n ~ 16B) 
Pre-PTCA 3.12"- 0.63 2.74 ± 0.63 
Post·PTCA 3.01 ± 0.64 2.75 ± 0.59 
F-Up 3.18:t0.55 2.82 ± 0.63 
..l Post-pre -0.11 ± 0.27 <H> +0.02 .!. 0.2'" 
.1 F·up~pre + 0.06 ± 0.22 <H> +0.07 ± 0.22t 
Thirty-four patients did not receive intracoronary nitroglyc-
erin post·PTCA. In the nondiseased segments adjacent to the 
dilated site, in these patients the mean diameter decreased by 
0.11 mm after angioplasty compared with the pre·PTCA values 
(where nitroglycerine had been administered). This change was 
not seen in the group who received nitroglycerine post-PTCA. 
Such change in reference diameter will affect the determination 
of percentage diameter stenosis. 
Abbreviations: Nitro. nitroglycerin; F-up, follow·up. 
*P < 0.001. 
tP value is not significant. 
The ability to obtain reliable measurements 
from a single angiographic view would simplify 
enormously the use of on-line quantitative angi-
ography. Although routinely applied in many 
laboratories, little information is available on 
the variability related with this approach. When 
edge detection is used, Lesperance et aP7 have 
suggested that restricting the analysis to the 
angiographie view in which the stenoses appears 
most severe fulfiHs the degree of accuracy re-
quired in clinical practice. However, the conclu-
sions of this study were limited by the lack of a 
true standard for the assessment of precision 
and accuracy. Densitometry is an appealing 
alternative to edge detection, because the ob-
tained measurements should not he influenced 
by the angulation used, a principle supported by 
experimental in vitro studies.]1(-41 However, ma-
jor controversy remains as to the application of 
this principle in the clinical fieJd. The correla-
tion for individual measurements obtained in 
orthogonal views both before and after balloon 
angioplasty has been found by different authors 
to be high,42 moderate/' or pOOr..J4 It has also 
been found to be influenced by the stagc of the 
intervention, deteriorating after balloon angio-
plasty to an unacceplablc leveL4s In a recent 
stuuy,46 we have fOllnd that the variability of 
measurements obtained from two orthogonal 
views in a selected coronalY segment was too 
high to recommend Its application routinely. 
Although this was observed for both edge detee-
tion and videodensitometric data at all stages of 
balloon angioplasty, after balloon dilatation, 
densitometry showed significantly less variabil-
ity between orthogonal measurements than did 
edge detection. 
TECHNICAL ASPECTS OF QCA IN SPECIFIC 
RECANALIZATION TECHNIQUES 
As stated in the introduction, the develop-
ment of a variety of percutaneous recanaliza-
tion techniques has introduced unexpected re-
quirements for the analysis of vascular segments 
with conventional QCA systems. The different 
mechanisms of action associated with each tech-
nique have major implications for the perfor-
mance and interpretation of QCA analysis. In 
the following paragraphs, we discllss some of 
these aspects in the case of conventional bal-
loon angioplasty, sten! implantation, directional 
atherectomy, rotational plague ablation, and 
exeimer laser angioplasty. 
Balloon Angiup!a.\·f)' 
Balloon angioplasty constitutes the most 
widely used percutaneous recanalization tech-
nique in the coronary arteries. The mechanism 
of action of angioplasty has been described in 
detail and involves learing of the intima and 
atherosclerotic plaque, dehiscence of plaque 
from the tunic media, and variable degrees of 
medial and advcntitia disruptionYA~ From the 
point of view of this article, we can group the 
changes into three different categories: (I) the 
development of large disruption that can be 
visually identified in the coronary angiogram as 
STRAUSS ET AL 
dissection (Fig 9);4~ (2) the presence of intralu-
minal Haps and irrcgularities not actually identi-
fied angiographically but documcnted in angio-
scopie;"Ii·;i" ultrasound;".1-·"."i and pathologic 
studies;;i(, and (3) the change to noncircular 
lumen geometry secondary to balloon dilata-
tion.-l7 Several authors have suggested that these 
histopathologic changes are responsible for the 
decrease in angiographic accuracy observed 
after balloon dilatation.57-6] When opacified dur-
ing angiography, these irregularities may be 
wrongly identified as true luminal borders by 
edge detection algorithms, leading to a false 
estimation of luminal diameter. 
Dissections arc a frequent occurrence after 
PTCA, and the resulting haziness, irregular 
borders, or extravasation of contrast medium 
makes edge detection difficult (Fig 9). Few 
methodologic recommendations are available 
as to the QCA analysis of those cases. During 
the design of the MERCATOR trial, the Angio-
graphic Steering Committee of the study de-
cided that, during edge detection analysis, the 
automated mode of the computer "decides" 
whether the extraluminal defect is included or 
excluded from the analysis.4Y This is based on 
the assumption that if thcrc is no clear separa-
tion betwcen the lumen and the extravasation 
(because of the existence of large communicat-
ing channel), the application of minimum cos! 
criteria during edge dctcction (sec above) would 
incorporate the extravasation as part of the true 
lumen. On the contrary, the exclusion of the 
extravasation would be, presumably, caused by 
the presence of a steep difference in brightness 
Fig 9. Edge detection of ~ lesion after PTCA has induced ~ large dissection. IAI EKduding dissection, the MLD is 1.34 mm.1Bl 
Including the dissection, the MLO is 2.53 mm. 
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bctween the extravasation and the true lumen. 
The validity of these assumptions has yet to be 
shown and constitutes an empirical approach 
aimed to reduce subjective hi as during angio-
graphic analysis. 
The reliability of videodensitometric measure-
ments taken uncler circumstances similar to 
those found after balloon angioplasty has not 
been clearly established in an experimental 
setting. Such experimental settings have been 
based on the use of engineered phantoms either 
in vitro3~-41 or after percutaneous insertion in 
animal models.o2.Ii.l This may explain the diJIer-
ences found with results obtained in clinical 
practice, where conflicting results suggesting a 
high variability in the obtained measurements 
have been reported (Fig 1O).57.6().(,4.m 
In a previoLls study,4(] we found, using edge 
detection before and after balloon angioplasty, 
that the agreement between single orthogonal 
measurements deteriorates significantly after 
balloon dilatation. However, this deterioration 
was not related to the presence of angiographi-
cally evident dissection. As mentioned above, 
we could also note that the variability between 
orthogonal measurements obtained with densi-
tometry was less influenced by balloon dilata-
tion than was that for edge detection. This 
observation may be related to the discussed 
theoretical independence from lumen morphol-
ogy and to its relative insensitivity to imprecise 
border positioning70 ()fvideodcnsitometrie mea-
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Fig 10. Agreement between densitometric percentage of 
area stenosis and the circular (edge detection) percentage of 
area stenosis pre- and post-PTCA is shown. The mean differ-
ence (and standard deviation) for percentage of area stenosis 
between the two methods was 2.3% ., 4.0% pre-PlCA and 
2.8% :!: 18% post-PlCA. Important discrepancies (ie, large 
standard deviation) between the two methods after PTCA are 
likelv related to the noncircular. asymmetric configuration of 
the lesion after angloplasty. 
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suremcnts. Thus, although the application of 
densitometry may be currently hampered by the 
technical limitations discussed above, furthei· 
progress in solving these problems may lead to a 
satisfactory application of the technique. 
flltracU/"U!w!)' Stenting 
Three types of coronary stent (Wallstent, 
Wiktor, and Palmaz-Schatz) have been used in 
multicenter European clinical studies with angio-
graphic follow-up and subsequent detailed QCA 
analysis at the Thoraxcenter Core Labora-
tory,27.71-7+ and a fourth (Gianturco-Roubin) is 
currently being evaluated in the "baii-out" set-
ting. In all cases, the radiopacity of the stent has 
implications both for implantation and for the 
subsequent angiographic analysis, because its 
presence in the artery can interfere with edge 
detection algorithms. lil The Wallstent and the 
Palmaz-Schatz stent arc composed primarily of 
relatively radiolucent stainless steel, whereas 
clear, radiopaque tantalum is the principle con-
stituent of the Wiktor stent (Figs ItA, B, and 
C). 
A second problem with angiographic analysis 
of stented vessels is caused by the superior 
angiographic result immediately after stenting. 
Because routine mild oversizing of the stent has 
been recommended,75 the stenosis may not only 
be completely corrected but also may be overdi-
lated in comparison with the reference diam-
eter before stenting. This may cause particular 
problems with the algorithms that measure 
lesion length and the calculation of the interpo-
lated reference diameter. To bypass this prob-
lem, we arbitrarily define the length of the 
lesion after stenting as the actual length of the 
stent (which requires manual selection of the 
stent boundaries). Thus, the stented segment is 
defined for future follow-up analyses. An alter-
native to this type of analysis "per stent" is to 
perform a fully automated analysis "per vessel" 
by choosing landmarks located proximally and 
distally to the stented site (eg, branching points). 
In reporting our angiographic studies, we chose 
the pre- and post-PTCA frames to be analyzed 
"per vessel," and the post-stent and follow-up 
mms to be analyzed "per stent." This ensures 
that we can obtain measurement data relating 
to the stent itself and its immediately adjacent 
segment, rather than obtaining measurement of 
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Fe 
T, 
Mo 
Wallstent (Medinvent) Wiktor stent (Medtronlc) Palmaz·Schatz stent (J & J) 
Fig 11. The metal composition according to x·ray energy dispersion spectrometry used in three currently investigated coronary 
stents. Ta, tantalum: Mo, molybdenum; Cr, chromium; Co. cobalt; Fe. iron; Ni, nickel. (Reprinted with permission.'") 
a more severe stenosis at a separate site in the 
coronary vessel. 
Stenting has also highlighted a limitation of 
the CAAS system in determining a reference 
diameter in an overdilated segment. Theoreti-
cally, this should result in a negative value for 
diameter stenosis, because the MLD (which, as 
we already mentioned, was defined within the 
boundaries of thc stem) was actually larger than 
the reference diameter (which is determined 
according to the diameter of the proximal and 
distal segments; see Figs 12A and B). However, 
for reasons that are unclear, a negative diam-
eter stenosis has rarely occurred, and the refer-
ence diameter has virtually always remained 
larger than the MLD, in contrast to the post-
stent measurements reported by other groups. 
This may be explained in many cases by detec-
tion of an MLD within the stent because of the 
protrusion of intima between the struts or at the 
articulation point. Thus, whereas the average 
diameter within the stent may appear greater 
than that of the adjacent segments outside the 
stent, detection of a single diameter measure-
ment less than the reference diameter will 
provide a percentage of diameter stenosis 
greater than 0%. A further confounding factor 
in the determination of thc reference diameter 
after stenting is that the marked vasospasm, 
occasionally seen immediately proximal and 
distal to the stent, may persist despite nitrate 
administration. This factor must he taken into 
account during "per vessel" analysis. 
Stainless steel stents. The main problem with 
these stellts is their poor radiographic visibility 
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(Figs 13A and B). In particular, the Palmaz-
Schatz stent, which is the most difficult stent to 
visualize, can be dislodged from the balloon 
catheter and embolize distally withollt radio-
graphic evidence. Additionally, it can be quite 
difficult to ensure ideal placement of the stent 
across a lcsion. For thc analyst, it may bc 
difficult or impossihle to satisfactorily identify 
the stent boundaries, and the precise location of 
a recurrent lesion at follow-up angiography 
(within the stent or immediately adjacent) may 
be in some doubt. Careful review of the contrast-
free cineframes may be needed to detect the 
position of thc Wallstent. In our follow-up 
reports of stenting, we have always included 
lesions within and immediately adjacent to the 
stented scgment to ensure that the degrec of 
luminal renarrowing is not underestimated.73 
Talltalum stems. Although the radiopacity 
of the Wiktor stent has greatly facilitated the 
implantation procedure (Fig 14A and B), this 
particular property severely limits the assess-
ment of follow-up studies of the stent with the 
CAAS system. Several cases have now been 
documented in which the contour-detection 
program traces thc radiopaque stent wires in-
stead of the arterial borders of the narrowing 
within the stent (Fig 15). This invalidates the 
computer-derived data and requires manual 
correction of the contours by the analyst, which 
is abo difficult in a segment containing radi-
opaque wires. 
Dellsitomefl), ill stenfed vessels. In contrast to 
the situation after PTCA, therc is excellent 
agrecment between minimal luminal cross-
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Fig 12. Coronary segment overdilated by a Palmaz-Schatz stent, (A) pre-stent (B) post-stent is shown. Although MlD in the 
stented segment should be greater than its reference diameter (which is determined for the stented segment by the algorithm, for 
the most part, from the smaller proltimal and distal segments), the measurement given by the interpolat"d technique yields a 
reference diameter that is actually larger than the MLD, for reasons which are not entirely clear. Thus, th" diam"ter stenosis within 
th" stented segm"nt after implantation of an ov"rsized stent is positive (12%) rather than negative. 
Fig 13. The Wallstent (poor radiopacity), alter implantation in a saphenous vein bypass graft, is shown, on the left (A), in vessel 
opacified by (:ontrast and, on the right (B), in vessel without contrast 
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Fig 14. Wiktor stent after implantation in left anterior descending artery is shown fA) in vessel without contrast. (6) In vessel filled 
with contrast, the stent remains clearly visible. 
sectional areas (MLCAs) determined by edge 
detection and by densitometry after stent im-
plantation with the WaHstcnt.(,j The standard 
deviation of the mean dilTerences between edge 
Fig 15. Restenosis within a coronary Wiktor stent not 
recognized by edge detection is shown, Graph shows the 
diameter function (upper curve) and the denSitometric area 
function (lower curve). Outside vertical lines on the graph and 
two horizontal lines in the angiographic image are the corre-
sponding boundaries of the analyzed segment. The inner two 
vertical lines on the graph represent the minimal points on the 
diameter and densitometric graphs respectively. The edge 
detection algorithm followed the outline of the stent and was 
unable to recognize the stenosis within the stent, giving an 
MLD of 2.17 mm. A discrepancy between the two functions is 
present and most notable at the vertical line that denotes the 
MLCA determined by densitomety (Reprinted with permis-
sion.'") 
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detection and densitometric determination of 
MLCA werc 0.51 nltn! prc-PTCA, 1.22 rnm 2 
after angioplasty, and 0.79 mm~ after coronary 
stenting (Fig 16). This improvement is probably 
caused by smoothing of the vessel contours by 
MEAN DIFFERENCE (mm2) 
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Fig 16. Mean difference (and 95% confidence intervals) 
between edge detection and densitometry before and after 
PTCA and after stenting. Mean differences were slightly posi-
tive (0.31, 0.35 mm') before PTCA and alter stenting, respec-
tively, and Slightly negative (- 0.38 mm') after PTCA. The 
widest 95% confidence interval was in the analYSis after PTCA. 
indicating the poorest association between the two methods, 
compared with the analysis before PTCA and stenting. 
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the stent and remodeling of the stented segment 
into a more circular configuration (Fig 17). 
Therefore, we believe that both methods arc 
appropriate to assess the immediate results 
after stenting. In a separate in vitro study in 
which stents were placed within plexiglass phan-
toms with known luminal dimensions, the Wall-
stellt and Palmaz-Sehatz stents caused minor 
interference with the densitometric determina-
tion of MLCA within the "stenoses" (Figs ISA 
and B)7() that probably lack clinical relevance. 
Conversely, the radiopacity of the tantalum 
Wiktor stenL led to overestimation of MLCA 
measurements in these same ~tenoses. which 
varied from lOS{ to 567c· overestimation depenLl-
ing on the concentration of contrast medium 
used and on particular features of the stenosis 
(Fig lSC). Therefore, follow-up quantitative 
angiographie assessment of a lesion containing 
,1 vividly radiopaque stent may be subject to 
measurement imprecision because of this pro-
pensity for error. which appears to be inherent 
to both the edge detection and vic!eodcnsitomet-
ric methods. 
Directional Athaectomy 
Few problems have been encountered in thc 
angiographic analysis of lesions treated by direc-
tional athereetomy.77 The radiopacity of the 
device, particularly when the support balloon is 
inflated, allows excellent visualization of the 
position or the eccentric cutting apparatus (Figs 
19A and B). The vessel luminal contours arc 
typically smooth and much less ragged than 
after PTCA, facilitating edge detection analysis. 
However. despite the apparent smooth con-
tours, a discrepancy exists between analysis 
performed by edge detection and densitometry, 
similar to that which occurs after angioplasty 
(Fig 20),7~ suggesting that the vessel contour 
after atherectomy may not be as circular as it 
appears. It has been suggested that this may be 
caused hy preferential expansion of the bases of 
thc atherectomy ClltS.7'! Furthermore, QCA of 
athereetollly-treated lcsions has provided some 
insight into the mechanisms of lesion improve-
ment. Penny et aP') have shown that an average 
of approximately 2,s1J{, of the effect of atheree-
tomy could actually be attributed to tissue 
removal, although the individual values had a 
wide range (7%. [0 n%). 7'1 The correlation 
between the volume of tissue retrieved and the 
change in luminal volume was poor. The investi-
gators concluded that the major component of 
luminal improvement was caused by "facilitated 
mechanical angioplasty'· resulting from the high 
profile of the device and the low-pressure bal-
loon inJlations. Data from our angiographic 
core laboratory seem to support this hypothesis. 
In 10 patients who had angiography (with subse-
qucnt quantitative analysis) performed at base-
line arter the device had been threaded through 
the stenotic area and, again, immediately after 
the completion of the atheroma extraction pro-
Fig 17. In vitro intravascular ultrasound examination 01 left anterior descending artery that was stented 24 hours earlier lor a 
severe dissection during PTCA. (The patient died from intracerebral hemorrhage 12 hours after stenting.) The inner circle (c) is the 
actual intravascular probe itself. The outer echo_dense pattern is caused by the stent wires (large arrow). The lumen is the echo-free 
space inside the stent. The stent effectively tacked back the dissection and restored the circular configuration of the vessel 
(Reprinted with permission."') 
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ccdurc, the "Dottering effect" of the device 
accounted for 65% of the luminal improve-
ment.~() 
Rotatiollal Plaqlle Abrasion 
To date, the Thoraxcentcr experience with 
this device has been limited, with only 11 
procedures performed.S ] A unique feature of 
the Rotablator (Biophysics International) is its 
usefulncss as a calibration unit as an alternative 
to the guiding catheter. The device contains a 
burr of known size, and there is no question of 
completeness of expansion as with stents and 
PTCA catheters of specified sizes (Figs 21A and 
B). Precise measurement of the device at the 
lesion site has been useful to assess the extent of 
clastic recoil, which appears to be an important 
phenomenon, because the luminal dimension 
immediately after rotational abrasion is always 
smaller than the diameter of the burr used.~2 A 
unique feature of the Rotablator is that the 
optimal angiographic result is not realized until 
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Fig 18. Angiograms, using 50% iopamidol contrast reagent. 
of plexiglass phantom (measuring 4 x 3 mm) "stenosis": (AI 
Control, (BI Palmaz-Schatz stent within the phantom. and (CI 
Wiktor stent placed in the phantom. The graphs show the 
diameter function yielded by edge detection (upper curve) and 
the densitometric area function (lower curve). The multiple 
vertical lines in the left part of the graph and the bold vertical 
line on the extreme left of the phantom represent the user· 
defined reference segment. The boundaries of the phantom 
segment for analysis correspond with the outside vertical lines 
on the graph. The inner two vertical lines represent the minimal 
points on the diameter and densitometric graphs, respectively. 
The numbers in the graph represent the maximum and minimum 
diameter. The boundaries of the Wiktor stent are visible in the 
phantom and as a "step·up" In the densitometry graph. As a 
result of the Wiktor stent contribution to the densitometry 
values, the MLCA determination is overestimated compared 
with that for the control and the Palmaz-Schatz containing 
phantom. (Reprinted with permission.'"1 
24 hours later, because the intense vasoconstric-
tion induced by the burr is largely attenuated at 
that time (Figs 22A, il, and C). 
Ercimer Laser 
Excimer lasers have prcsented an attractive 
alternative to other forms of coronary interven-
tion, based on the experimental finding that, in 
air, a focused, pulsed, UV laser beam can 
focally ablate targeted tissue with minimal adja-
cent tissue injury. However, in the clinical 
situation, where the vessel luminal surface is 
surrounded by a blood medium, catheter tip-
tissue contact is required to avoid attenuation of 
the laser beam by the blood and to increase 
ablation efficiency. The errect of pulsed UV-
laser light delivered through contact catheters 
On tissue ablation has been investigated in vitro 
and in vivo on human and porcine aorta. ln•H•1 
Considerable tcmperature accumulation was 
found, as well as mechanical tissue damage 
caused by expansion of gaseous debris trapped 
TECHNOLOGIC ASPECTS OF DCA 
B 
Fig 19. RadiopaqtH! directional atherectomy device (Atherocath; Devices for Vascular Intervention, Redwood, CAl is shown (Al in 
circumfleK artery without contrast and (B) in circumflex artery containing contrast. 
Fig 20. Because of intense vasospasm after rotational abra-
sion, it may be necessary to repeat the study 24 hours later to 
assess the maKimal benefit. (A) Pre Rotablator MlD is 0.41 mm. 
(B) Immediately after the Rotablator, MlD is 1.24 mm. (e) 24 
hours later, MLD is 1.56 mm. 
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Fig 21. Rotational abrasion (Rotablator) in a coronary artery is shown (A) without contrast Because the burr is nondeformable 
and of known diameter, calibration of the angiogram can occur at the site of the procedure in contrast to PTeA, stenting. or 
directional atherectomy. where we use the contrast·filled guiding catheter in one cOTner of the angiogram as the scaling device. In 
this case a 1.S0-mm diameter burr was used. (8) In vessel containing contrast. the Rotablator is clearly visible. 
under the tip of the dC!ively system:~J In addi-
tion to thermal injury, dissections were ob-
served that were attributed to pressure build-up 
and expansion of a vapor cavity within adjacent 
tissue.M •HS The angiographic correlate or this 
phenomenon appears to be haziness of the 
contours of lesions treated with the excimer 
laser, with consequent complication of the imme-
diate post-procedure analysis (Figs 23A, B, and 
C). The lesion has <l typically "roughened" 
appearance and, therefore, may be particularly 
MlCA DIFFERENCE (mm2) 
2 
1.5 
, 
0.5 i 
0] 
-0.51 
-1 
-1.5~'--·-· 
.51 
l L -.01 
-.53 
PRE ATHERECTOMY 
1.69 
t" 
I 
-- - 1.21 
POST ATHERECTOMY 
Fig 22. Agreement between densitometric MLCA and the 
circular (edge detection) MLCA before and after directional 
atherectomy. Despite apparent smooth contours after atherec-
tomy. similar discrepancy exists between analyses performed 
by edge detection or densitometry as that which occurs after 
angioplasty. This may be because of preferential expansion of 
the bases of the atherectomy cuts. creating a less circular 
configuration. 
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well-suited to specific edge detection algorithms 
designcd for the evaluation of very irregular 
luminal contours. H6 Whether densitometry 
should be preferred to edge detection in the 
assessment of the specitic eiTects of the excimer 
laser in coronary intClventions remains under 
investigation. 
CONCLUSIONS 
QCA clearly presents an objective and reli-
able technique to measure corona!y luminal 
dimensions. This has been thoroughly shown for 
the edgc detection analysis. Densitometry is 
theoretically attractive but remains practically 
limited for routine clinical application at this 
time. The geometric edge detection method is 
still limited by the need for angiography of 
suitable quality that must be performed in a 
standardized fashion. Fortunately, both the 
hardware and software Llsed in QCA are under 
continuous evolution. New developments arc 
being consistently produced because the broad-
ening use of QCA in a spectrum of intervell-
Liona! situations shows technical and practical 
limitations of varying significance. In the second 
article of this series, the clinical application of 
diameter measurements obtained by automated 
edge detection is discussed, and important in-
sights into mechanisms of intervention and of 
the restenosis process are presented. 
TECHNOLOGIC ASPECTS OF OCA 
Fig 23. Excimer laser is shown. (A) Before laser 
treatment, long narrowing in left anterior descending 
artery (immediately distal to the sidebranches) is 
apparent. (8) After laser treatment, the arterial bound-
aries 01 the treated lesion show a roughened hazy 
appearance. (C) After balloon dilatation, luminal hazi-
ness is still present. 
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Quautitative Coronary Angiography (QCA) in Interventional 
Cardiology: Clinical Application of QCA Measurements 
David P. Foley, Javier Escaned, Bradley H. Strauss, Carlo di Mario, Jurgen Haase, David Keane, 
Walter R.M. Hermans, Senno J. Rensing, Pim J. de Feyter, and Patrick W. Serruys 
Q UANTITATIVE coronary angiography (OCA) has had a tremendous impact in 
the field of intelVentional cardiology. Because 
of its superior accuracy and objectivity, QCA 
has supplanted visual and hand-held caliper 
assessments of coronary artcriograms and has 
improved interobservcr and intraobserver vari-
ability,]-3 QCA is now the "gold standard" for 
the assessment of the coronary tree in the 
context of scientific rC5earch,4 although it has 
not yet gained widespread appeal for routine 
clinicaluse. 5 Until very recently, mainly because 
of the expense and time-consuming aspect in-
volved in routine clinical application of sophisti-
cated computer-based analysis, QCA has only 
been available for off-line use.(,·9 In addition, 
the extra precautions that must be taken by the 
angiographer in obtaining images suitable for 
quantitative analysis lO imply that many angio-
grams routinely performed by busy clinicians or 
in acute or emergency situations may not be 
analyzable by an automated computer-based 
system . .'> However, with the progressively increas-
ing number of clinics involved in multicenter 
restenosis prevention trials in which QCA plays 
an integral role,ll.1.l perhaps these extra precau-
tions may become routine clinical practice. 
QCA has been particularly useful in interven-
tional cardiology as the only objeetivc and 
reliable means of assessing the immediate and 
long-term clIects of coronary interventions. In 
particular, the phenomenon of restenosis has 
primarily been described and researched most 
extensively on the basis of sequential QCA 
studies. At the Thoraxcenter (Rotterdam, The 
Netherlands), we have been advocating the 
importance of QCA since the first report of its 
use by our group in 1971)1-1 and, subsequently, 
with renewed vigour after our initial experience 
with QCA in the assessment of coronalY inter-
ventions, as reported in 191)2.15 The Cardiovas-
cular Angiographic Analysis System (CAAS) 
has been extensively and rigorously validated, 11>·1~ 
and technical aspects are presented in the 
accompanying report. The entire angiographic 
database now consists of collected information 
from more than 5,000 patients who have under-
gone several dilIercnt forms of nonopcrativc 
coronaq revascularization. The principles of 
QCA, which were initially designed for diagnos-
tic studies of coronary artery disease (CAD), 
have necessarily heen adapted to more complex 
situations related to either the presence of a 
device or the elIect of an intelvention on the 
angiographic appearance of a damaged vessel. 
The introduction of several newer devices in the 
past 7 years, has presented a number of unique 
and unforeseen problems in image analysis and 
the suhsequent interpretation of important 
quantitative data, as described in the accompa-
nying report. 
The emergence of digital subtraction angiog-
raphy has allowed on-line performance of QCA 
measurements in the catheterization labora-
tory, so that a technique previously confined to 
research applications has been transformed into 
a powerful analytic tool, directly applicable to 
clinical decision making. 7.1'lThe immediate avail-
ability of QCA measurements during intcrven-
tional procedures provides a unique opportu-
nity for more aceurate selection of appropriate 
interventional devices (eg, balloon, stellt, or 
athcrotome dimension) and for continuous 
monitoring and immediate evaluation of the 
result obtained. During the last 5 years at the 
Thoraxcenter, a large clinical experience has 
been accumulated through the application of 
the Philips Digital Cardiac Imaging (DCI) Auto-
mated Coronary Analysis System. 6.'! In vivo 
study of stenosis "phantoms" placed in porcine 
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coronal)' arteries has confirmed that the accu-
racy and precision of the DCI on-line measure-
ments arc intimately comparable with those 
obtained off-line using the CAAS system, with a 
mean difference between true "phantom" steno-
sis diameter and DCI minimal luminal diameter 
(MLD) measurements of 0.08 ± 0.15 mm, for 
stenosis diameters ranging from 0.5 to 1.9 mm.B 
Therefore, we believe that the information 
presented here, mainly derived from the analy-
sis of cine-film images, can now be immediately 
applied to guide the operator during diagnostic 
and interventional procedures. 
In the preceeding article, the process and 
technical aspects of QCA arc explained and 
described in detail, and it is now (we hope) 
evident to the reader that QCA analysis is more 
than just setting up the cine film and returning 
20 to 30 minutes later for the data. Only close 
scrutiny of the analytic results, combined with 
ongoing communication between the clinician, 
the analyst, and the programmer, ensures that 
meaningful and useful data emerge from the 
use of QCA. The purpose of this review is to 
describe the insights into the short- and long-
term sequelae of the various interventional 
devices already provided by the use of QCA in 
interventionai cardiology and to explore its 
current and future applications in the compara-
tive evaluation of interventional devices. 
INFORMATION PROVIDED BY THE CAAS 
SYSTEM 
The prime aim of QCA is to provide precise 
and accurate measurements of coronary 
anatomy. The CAAS system can provide this 
information by two different methods, (1) detec-
tion of luminal borders (so called "edge 
detection "), preferably in two (or more) orthogo-
nal projections,20 to provide a three-dimen-
sional approximation of the diseased segment 
that can then be converted into absolute values 
after calibration with an object of known diam-
eter, such as the shaft of the contrast-free 
guiding catheter and (2) videodensitometry, an 
approach that describes relative cross-sectional 
luminal area by measuring and comparing the 
density of contrast in a diseased and normal 
segment. The advantage of the information 
acquired by the densitometric method is that 
meaningful data can be obtained in a single 
projection, even If the cross-sectional shape is 
highly asymmetric or eccentric. III In contrast, 
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area measurements derived from edge detec-
tion data (and specifically from MLD values), 
by definition, require an assumption of a circu-
lar cross-sectional lumen in the diseased arte-
rial segment, which is at odds with the observa-
tions of several pathologic studies.21.22 The 
intricacies and limitations of these respective 
techniques have been described in detail in the 
accompanying report and will not be discussed 
further here. 
The important parameters which can be ob-
tained by edge detection are listed below: 
1. Direct measurements 
a) MLD (Fig I) 
b) maximal luminal diameter 
c) mean luminal diameter 
d) lesion length 
e) minimal luminal cross-sectional area 
(MLCA) 
f) reference area 
The calculation of cross-sectional area mea-
surements (e, f) from the linear measurements 
obtained from the diameter function assumes a 
circular (single-plane view) or elliptic lumen 
(orthogonal biplane view). 
2. Interpolated measurements 
a) reference diameter (RD; automatic 
computer reconstruction of the as-
sumed disease-free or normal segment 
of the vessel; Fig 1) 
b) symmetry 
c) plaque area (mm2) 
B 
C 
Ref D 
3.0mm 
L;c..Z::~ 
73% D Stan 
USER DEFINED 
PROX. REF. DIAM. 
66%OS 
using fRO 
77%DSten 
USER DEFINED 
OIST. REF. DIAM. 
Mean user-defined=75%DS 
Fig 1. Graphic shows variability in percent diameter steno-
sis measurements of the same lesion caused by arbitrary 
selection of the RD by the user and also shows the more 
objective derivation of percent diameter stenosis by the 
user-independent method of the interpolated RD. For a steno-
sis where the MLD is measured at 0.8 mm, if a user-defined 
proximal or distal refenmce segment or the mean of both is 
selected then the resultant measure of percent diameter 
stenosis for the obstructing lesion is 75%, 77%, or 76%, 
respectivelV. If the computer-determined interpolated RD 
(shown as the upper and lower thick dark lines) is used, a 
diameter stenosis measurement of 66% is obtained. Pro)[. ref. 
diam., proximal reference diameter; dist, distal; MLD, minimal 
luminal diameter; %05, percent diameter stenosis. 
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3. Derived measurements 
a) percent diameter stenosis (calculated 
from the MLD and RD; Fig 1) 
b) percent (lrea stenosis (calculated from 
MLCA and reference area) 
c) curvatUTe (calculated from the center-
line of the vessel segment) 
d) inflow angle/outflow angle (calculated 
from the diameter function) 
e) roughness (calculated from the indi-
vidual contour points, separately for 
the left- and right-hand vessel contour) 
4. Hemodynamic mcasurements 
a) theoretical transstenotic pressure gradi-
ent 
b) calculated Poiseui1le resistance 
c) calculated turbulent resistance 
A WORD OF CAUTION IN THE 
INTERPRETATION OF ANGIOGRAPHIC DATA 
The limitations of angiographic information 
in the evaluation of the cxtent of coronary 
artelY disease have been welJ-recognizecPJ Af-
ter all, coronary angiography is really just a 
two-dimensional profile or "shadowgram" of an 
opaeificd vessel lumen; it merely shows the 
effect of arterial wall disease on the contour of 
the arterial lumen. Moreover, atherosclerotic 
changes in the arterial wall are not reliably or 
precisely reflected by changes in the lumen, as 
shown by intravascular ultrasound and epicar-
dial high-frequency echocardiography.24-:Y The 
variability of the atherosclerotic process, which 
may be smoothly and evenly distributed so that 
the entire lumen of a segment or vessclmay be 
equally and diffusely reduced,lo is sometimes 
beyond the scope of angiography, which may 
not detect its existence.Jo.J1 This pathologic fact 
is reflected in many nccropsy studies, where 
coronary angiography frequently underesti-
mated the severity of coronaly artery lesions or 
even missed significant narrowings in the con-
text of underlying severe diffuse atheromatolls 
CAD.32-J'i Furthermore, elliptic or D-shaped 
lumens may, depending on the views obtained, 
be misrepresented on cineangiography, result-
ing in either underestimation or overestimation 
of true stenosis severity,J6 particularly if a single 
angiographic view is used.lO The CAAS interpo-
lated-measurement approach reconstructs the 
normal segment of the vessel at the site of the 
lesion-,7 (Fig 1). Although there may be underes-
timation of the true diameter value by this 
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presumed disease-free vessel contour, this ap-
proach is inherently more objective and accu-
rate than the assumption of normality of an 
arbitrarily selected proximal or distal portion of 
the vessel as a refercnce segment. j{) In addition, 
it is obvious that the dimensions of the RD may 
change from before to after intervention, as a 
consequence of any intelvention that stretches, 
dilates, or provokes dissection or coronary vaso-
motor changes. Moreover, during follow-up, the 
apparently normal segment adjacent to a treated 
lcsion Illay be affected by the restcnosis pro-
cess . .1R.~1 
It is also important for interpreting the re-
sults of angiographic studies to know how thc 
actual Illorphologic characteristics were mea-
sured. In a recent study,4~ we found quantitative 
angiographic morphologic features generally un-
helpful in prediction of major procedural and 
in-hospital adverse cardiac complications among 
1,442 patients undergoing balloon angioplasty 
(BA), in two major European multicenter reste-
nosis prevention trials. 1l.l 2 The only features 
::lssociated with an increased likelihood of major 
cardiac complications, according to multivari-
able logistic regression analysis, were angio-
graphically visible dissection after angioplasty, 
unstable angina, and lesion location in a tortu-
ous segment, as estimated visually. No quantita-
tive angiographic morphologic characteristics 
were helpful in this regard. 
The predictability of restenosis (at 6-month 
angiographic follow-up) from baseline angio-
graphic morphology has been widely investi-
gated, and the data are extremely difficult to 
intcrpret, because of wide variations in method-
ological approach. Many studies have reported 
multiple, differing angiographic risk factors to 
be associated with a higher restenosis rate.43-47 
Part of the explanation for this diversity is that 
the definition of restenosis itself has varied 
widely, and there is still no universal consensus 
on the best methodological approach.4R We 
shall elaborate on this particular application of 
QCA, as it is of widespread intcrcst because of 
the exponential increase in the use of percutanc-
ous devices for revascularization and because of 
the continued persistencc of restenosis as the 
major limitation to maintained long-term suc-
cess of therapy with these dcvice~. In addition, 
this is the area to which our group has applied 
QCA most intensively over the past years. 
MEASUREMENT VARIABILITY AND 
RELIABILITY 
Before a discussion of the various devices 
used for coronary intelvention, the utility of the 
information generated by QCA in general (and 
the CAAS system specifically) must be ad-
dressed. Geometric information, such as MLD, 
RD, and percent diameter stenosis, represent 
the most useful and reliable information ob-
tained by this system. Angiographic morpho-
logic features that may be important to the 
clinical outcome,4Y.511 such as ulceration or com-
plex, ragged morphology, have not been a focus 
of our research, in terms of their natural history 
in large populations undergoing coronary inter-
ventions. The newer intracoronary imaging mo-
dalities of intravascular ultrasound and angio-
scopy are better suited to such study. 
The long-term lesion measurement variability 
of the CAAS system, under "worst case" or 
nonstandardized acquisition conditions, has pre-
viously been validatedY' More recently, valida-
tion studies have been performed for the QCA 
system operating on-line on the Philips DCI 
system.~·51 In addition, lesion measurement vari-
ability in the aftermath of coronary BA has also 
been investigated.5~ Our group has previously 
reported that a differencc in MLD, between two 
catheterization sessions. of more than 0.72 mm 
represents an angiographically detectable 
change. It. This does not infer physiologic signifi-
cance. It merely represents twice the standard 
deviation (ie, the 9Yfo confidence interval [CI]) 
of the mean difference between MLD measure-
ments performed on angiograms recorded J 
months apart, under angiographic conditions in 
which no attempt was made to standardize the 
inspiratory level, the volume and rate of injec-
tion of the contrast agent, the vasomotor tone or 
technical characteristics, and/or the positioning 
of the x-ray system. Therefore, a measured 
deterioration in luminal diameter greater than 
0.72 mm could be concluded, with 95% confi-
dence, to be a real detectable change and, thus, 
a definite loss in lumen, under such conditions 
as prevailed in routine clinical practice at that 
time (1984). If a more standardized acquisition 
protocol is followed, the medium-term variabil-
ity, as reported in that study, would be more 
applicable, ie, 0.44Illm. To put that index study 
in its proper perspective, it must be pointed out 
that the average RD was 3.7 mm, whereas the 
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mean RD of lesions treated by percutaneous 
transluminal coronary angioplasty (PTCA), dur-
ing the eourse of two recent, large multicenter 
clinical trials, was 2.6 mlll.ll.l~ Thus, the abso-
lute measurement of 0.72 Illm, as an index of 
detectable luminal change, is no longer relevant 
in modern studies, which use standardized an-
giographic protocols and intervene in smaller 
vessels. For this reason, in addition to the 
criticized lack of information on the post-BA 
measurement variability of the CAAS system,53 
our group has recently performed a clinical 
investigation to clarify these issues.52 Quantita-
tive analysis was performed on angiograms of 
110 patients under optimal angiographic condi-
tions ohtained immediately after angioplasty 
and, again, 24 hours later. Vasomotion was 
controlled by intracoronary nitrate before each 
angiographic run, and angiographic projections 
after angioplasty were exactly repeated at 24 
hours. At least two (orthogonal or near orthogo-
nal) views were recorded for right coronary 
artery lesions, and at least three projections 
were recorded for left anterior descending or 
circumllex arteries; all patients were fully antico-
agulated [or 24 hours. There was no difference 
in mean MLD or cross-sectional area from 
postangioplasty to 24-hours postangioplasty, and 
the variability of the mean difference was 0.20 
111m, which is not significantly dilIerent from the 
medium-term (J-hour) variability in the previ-
ously described study. This post-PTCA lesion 
measurement variability is eminently acceptible 
and shows that quantitative analysis of mUltiple 
matched views can provide extremely accurate 
and precise luminal measurements. RD in-
creased significantly during the 24-hour period 
(presumably secondary to greater vasodilatory 
efl'ect of the same dose of intracoronary nitrate 
at 24 hours relative to that immediately after 
PTCA); therefore, percent diameter stenosis 
was also found to increase signiflcantly. This 
change in percent diameter stenosis withollt any 
Change in actual MLD shows the limitations of 
preferential use of percent diameter stenosis 
measurements in clinical investigation. 
LIMITATIONS OF PERCENT DIAMETER 
STENOSIS MEASUREMENTS AND VISUAL 
ASSESSMENT OF THE ANGIOGRAM 
Percent Diameter Stenosis 
As with all new developments, physicians may 
be somewhat reluctant to abandon the familiar 
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surroundings of the tried and trusted percent 
diameter stenosis measurement in favor of the 
apparently unreal environment of MLD mea-
surement. However, it has long been our conten-
tion that percent diameter stenosis measure-
ments arc extremely unreliable, and, therefore, 
we have recommended the use of absolute 
luminal measurements.·,R,54 Use of the term 
"percent diameter stenosis" connotes the as-
sumption of the conventional measurement ap-
proach of selecting a normal-appearing seg-
ment, proximal and/or distal to the lesion of 
interest, as a point of reference. As already 
described above, this assumption of normality is 
frequently erroneous, particularly after interven-
tion and at follow-up. Therefore, percent diam-
etcr stenosis measurements are prone to consid-
erable variability (Fig 1). 
This potential for imprecision and provision 
of misleading information was shown in the past 
by Beatt et apt! and Serruys et aP4 and has been 
reiterated in two recent studies.4J . .'i2 OCA mor-
phologic features were cxamined before and 
after successful BA and at follow-up in 778 
lesions in an investigational study (as an ancil-
lary to the Multicenter European Research 
Trial with CilazapriJ after AngiopJasty to Pre-
vent Transluminal Coronary Obstruction and 
Restinosis [MERCATORJ12) that showed that 
the restenosis process affects the entire vessel 
segment which was dilated and not just the 
target lesion.4J This finding confirmed the previ-
ous findings of Beatt et al,3t! who contended that 
changes in RD occurring during follow-up invali-
dated the use of percent diameter stenosis 
measurements as an accurate estimate of lesion 
severity. Similarly, the previously mentioned 
study that used angiography after angioplasty 
and at 24 hours after angioplasty showed that 
changes in RD occurring during the 24-hour 
period had analagous implications for calcula-
tion of percent diameter stenosis. The change in 
percent diameter stenosis from after angio-
plasty to 24 hours that was observed in this 
study, if evaluated alone, would have produced 
the misleading conclusion of signific;mt deterio-
ration in lesion scverity during the first day after 
successful BA. Such a conclusion would have 
far-reaching consequences. For example, the 
deterioration could be interpreted as delayed 
elastic recoil, implying that this might play an 
important role in the process of restenosis 
(which is clearly not the case). In addition, the 
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routine application of 24-hour angiography 
might be recommended in clinical trials to 
evaluate the true result after angioplasty, after 
delayed recoil. Use of absolute luminal diam-
eter measurements allowed a cleafer and less 
ambiguous interpretation of the results of this 
study; no change in lesion severity was detected 
in the first 24 hours after successful BA, and, 
therefore, routine angiography at 24 hours is 
not clinically indicated. 
Visual Techniques 
Visual and other observer-dependent, non-
quantitative approaches of estimating percent 
luminal obstruction are known to be greatly 
associated with high intraobserver and interob-
server variability.2-4 In general, visual assess-
ment leads to overestimation of the degree of 
narrowing in severe lesions and to underestima-
tion of the sevcrity of mild or moderate le-
sions.55 Among 1,445 lesions treated by BA 
during the course of two multicenter European 
restenosis prevention trials, apart from totally 
occluded or suboecluded vessels, quantitatively 
derived percent diameter stenosis measure-
ments greater than 74% were extremely rare 
and accounted for only 5% of all lesions under-
going PTCA.56 The most severe lesion encoun-
tered had a measured diameter stenosis of 86%. 
The logic of this is shown in Fig 2, which shows 
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Fig 2. Theoretic pressure gradient calculated from the fluid 
dynamics equation, derived by Gould et al'" and Kirkeelde et 
ai,'· at assumed flow rates of 1 to 5 mll s is shown. Vessel size 
(2.6 mm) and lesion length (6.5 mm) were taken as the means 
for the combined patient popUlations enrolled In two Euro-
pean multicenter clinical, restenosls prevention trials.11.!l It is 
readily appreciated thet when MlD is less than 0.5 mm 
(diameter stenosis more than approKimately 81%), the pres-
sure gradient across the stenosis is well beyond the physi-
ologic range at an assumed resting flow rate of 1 mll s. 
(Reprinted with permission from the American College of 
Cardiology. 56) 
the pressure gradients (as calculated using the 
fluid dynamic equations devised in the past by 
Gould et al,s7 Young et al,Sl! Gould et al,5Y and 
Kirkeeide et al(,()) across a stenosis with a length 
of 6.5 mm and an interpolated RD of 2.6 mm, 
the mean values observed during these trials, at 
assumed How levels ranging from 1 mL/s at rest 
to 5 mLis at maximal hyperemia. It is clear that 
the pressure gradient neeessal)' to maintain rest 
flow at 1 mLis is moving beyond the physiologic 
range when the MLD is less than 0.5 mm, 
which, for a 2.6 mm vessel, represents a diam-
eter stenosis value of greater than XO%. Antero-
grade flow through lesions approaching this 
severity wi!! tend to decrease below that re-
quired to maintain patenc)', and the lesion 
becomes occluded, as opposed to a gradual, 
incremental progression of stenosis over time to 
eventual occlusion. 
To clinicians unfamiliar with QCA, these 
values for critical lesions may appear low, but in 
fact, a quantitatively measured diameter steno-
sis of 74% corresponds with an area stenosis of 
approximately 93%.-)6 Fleming et aJ'i5 have sug-
gested that visual overestimations of percent 
diameter stenosis arise because of the observer 
perceiving the area stenosis but calling it diam-
eter stenosis. It has been shown that an area 
stenosis greater than 7(H;:) is associated with a 
reduction in coronary now reserve to less than 
1,61/)2 ie, when the ability of the vessel to dilate 
and increase blood flow to the area of myocar-
dium supplied, in response to various stimuli 
(reactive coronary hyperemia), is abolished. A 
simple clinical quantitative angiographic study 
from our group63 explored the reliability of 
visual estimates of coronary artery stenosis in 
the 90% range and asked the clinically relevant 
question of whether the 90% stenosis actually 
exists. The conclusion was that, excluding le-
sions where the anterograde blood flow was 
Thrombolysis in Myocardial Infarction (TIMI) 
grade I or in occasional cases, TIMI grade 2 (ie, 
subtotal or functional occlusions), authentic 
90% diameter stenoses probably do not exist. In 
this study, interventionalists were asked to esti-
mate the percent diameter stenosis of and TIMI 
grade blood flow through the target lesion 
before BA. Blood flow was again recorded after 
guidewire insertion across the target lesion. The 
likelihood of flow reduction or occlusion after 
insertion of the guidewire was predicted on the 
basis of the visual estimation of stenosis severity 
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(percent diameter stenosis) and the quantita-
tively measured vessel size (interpolated RD) 
and was compared with actual blood now. For 
example, if the observer estimated a 90% diam-
eter stenosis and the vessel diameter was quan-
titatively measured at 3 mm, the residual lumen 
diameter, according to the visual estimate, would 
be 0.3 mm. Thus, introduction of an 0.018-in 
guidewire (0.48 mm) should cause total occlu-
sion of the vessel, and this stenosis grading was 
classified as a "predicted occlusion." Although 
observers frequently provided estimates of ste-
nosis severity corresponding with predicted oc-
clusion, actual occlusion or flow reduction by 
one or more TIMI grades rarely occurred. In all 
cases where guide wire insertion across the 
target lesion caused flow reduction, baseline 
flow had been classified as TIMI grade 1 or, 
occasionally, grade 2. Thus, it could be con-
cluded that, where anterograde blood flow is 
normal, lesion severity never reaches a diameter 
stenosis of 90%. Therefore, angiographic evalu-
ation systems that allow classification of lesions 
of stich severity do not reflect actual lesion 
dimensions and describe lesions that are not 
physiologically possible and, thus, arc unsuit-
able for important studies. Specific training in 
quantitative coronary analysis can actually im-
prove the discriminant ability of the observer in 
visual estimation of the severity of coronal), 
stenosis, as observed by Fleming et a!.'i~ and also 
recently reported by Danchin et aL r)~ 
PHYSIOLOGIC CORRELATIONS OF MINIMAL 
LUMINAL DIAMETER 
The physiologic significance of a coronary 
obstruction will depend on a number of factors, 
but the absolute MLD has been shown to be the 
most important of these.(,Il·rJ2.65.68 Rensing et a169 
have reported that recurrence of (or freedom 
from) angina can be predicted, with 72(70 accu-
racy, by MLD threshold of 1.45 mm at 6-month 
angiographic follow-up after single-lesion SA. 
Similarly, the likelihood of a positive or negative 
exercise test by bicycle ergomeh), could be 
predicted with 62% certainty by a measured 
MLD of 1.46 mll1. In other words, a patient with 
MLD at follow-up of greater than 1.45 mm will 
probably be free from anginal symptoms with 
72% certainty, and a symptomatic patient has a 
72% chance of having an MLD of less than J.45 
mm. Of course, this measurement will have 
different relevance in smaller or larger vessels, 
OCA IN INTERVENTIONAL CARDIOLOGY 
Hnd this important aspect was also investigated. 
It was found that the relevant MLD threshold in 
smaller vessels (vessels less than the median 
value of 2.63 mm) that predicted anginal recur-
fence or ischemia on exercise testing was 1.37 
mm and thal the corresponding value in larger 
vessels (> 2.03 mm) was 1.53 mm. Correspond-
ing measures of percent diameter stenosis were 
also provided, but, considering what has already 
been stated regarding the reliability of these 
measurements, they must be cautiollsly inter-
preted. Thus, simple quantitative angiographic 
luminal measurements ean provide important 
and clinically useful, functional infOfmation. 
The significance of the degree of ehange in 
lumen dimensions during follow-up after angio-
plasty was also investigated in this study hut is, 
however, much more difficult to interpret. 
Clearly, a deterioration in MLD of 0.72 nun, for 
example, is likely to have greater functional 
importance in a 2.6-mm diameter vessel than in 
a 5-mm diameter vessel, but the functional 
significance of the change ultimately depends 
on the final luminal diameter (as well as thc 
alllount of myocardium at risk and the level of 
physical performance required by the individual 
patient). Thus, loss of as mueh as 2mtn in MLD 
may cause no functional deterioration, if the 
finallumcn diameter at follow-up is more than 
1.53 mm (obviously such changes would only be 
possible in vessel largcr than 3.5 mm). By 
contrast, loss of as little as 0.5 mm during 
follow-up may be of definite clinical rc\evance, 
if the final MLD is 1 mm. These findings might 
reflect either a suboptimal initial angiographie 
result in a 2.5-mm vessel or a reasonably good, 
immediate result in a 1.5- to 2-mm vessel. 
The degree of absolute luminal change neces-
sary to cause a physiologically significant effect 
is, therefore, impossible to accurately catego-
rize because of the relativc importance of other 
factors. Thus, the phenomenon of luminal renar-
rowing after interventions can be most objec-
tively and definitively evaluated using a continu-
ous and purely anatomic approach. Ultimately, 
the real value oj" QCA is the provision of 
objective and reproducible measurements oj" 
luminal dimensions, which facilitates the study 
of the natural history of both atheromatous 
coronary disease23 and long-term outcome after 
interventions,411 in populations of patients rather 
than in individual patient management deci-
sions. The impending widespread availability of 
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QCA for routine on-line use in the catheteriza-
tion room7.9 may allow sllch an application. 
OCA AND SPECIFIC CORONARY DEVICES 
Percutaneous Transluminal Coronary 
Angioplasty 
/lIsiRhts Illto the l1lerapclItic Mechanism of 
Balloon Angioplast)' 
Although our initial analytic approach to 
serial angiographic studies in patients treated 
by B;\ was restricted to repeated measurements 
of the lesion site, the development of several 
new concepts related to mechanisms of balloon 
dilatation requircd extension of our measure-
ments to include the inflated haJloon. These 
included stretch (theoretic maximal gain in 
diameter or area during the angioplasty proce-
dure), elastic recoil (which clearly affects the 
immediate result after angioplasty), and bal1oon-
artery ratio (which afi"ects both the extent of 
recoil and the likelihood of dissection). Before 
these assessments, the inflated balloon was used 
as a scaling device and (incorrectly) assumed to 
be uniform along the entire balloon length, at a 
diameter according to the manufacturer's speci-
fications. Monson et ([1711 have previously re-
ported that the nominal balloon size is almost 
nevcr achieved over the entire balloon length. 
Measuring the balloon diameter over its entire 
length in 453 patients, during an average infla-
tion pressure of 8.3 ± 2.h atm, Hermans et aFI 
observed a difference betwcen the nomina! 
balloon diameter of D.3 ± 0.29 mm with the 
measured mean diameter and of 0.66 ± D.J2 
mm with the minimal balloon diameter. In 
addition, a difference of D.59 ± 0.23 nHll in 
diameter was found between the minima! and 
maximal balloon diameter (Fig 3). Tllese differ-
ences resulted in large variations in the calcu-
lilted stretch, clastic recoil, and balloon-artery 
ratio, depending on the balloon measurement 
chosen. It was conduded that, for clinical stud-
ies, it is essential to measure thc actual diam-
eter of the inflated balloon (minimal, mean, and 
maximal diameter), because the theoretic in-
flated diametcr cannot be assumed and will 
provide unreliable results. It was recommended 
that stretch be calculated as the minimal mea-
sured diameter (or cross-scctional area) of the 
largest, fully intlated balloon used during the 
procedure minus the MLD hefore angioplasty 
then corrected for the vessel size, for which 
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Fig 3. Nonuniform balloon inflation during BA is shown. (A) Pre-PTCA MLD of 1.22 mm is shown. (B) During balloon inflation with 
a 3.S-mm (manufacturer specification) balloon, the minimal balloon diameter is 2.01 mm, and the maximal balloon diameter is 3.27 
mm. (Reprinted with permission.7l) 
purpose the interpolated RD before angio-
plasty should be used. Elastic recoil should be 
calculated as the difference between the MLD 
(or cross-sectional area) after angioplasty and 
the minimal balloon diameter (or cross-sec-
tional area) at the highest inflation pressure, 
corrected for vessel size, and balloon-artelY 
ratio is best calculated as the ratio of the RD (or 
reference area) of the inflated balloon (calcu-
lated by the automatic contour detection pro-
gram) and vessel size. The equations used are as 
follows; stretch = MLD (MLCA) inflated bal-
loon - MLD (MLCA) pre-PTCA/vessel size; 
recoil = MLD (MLCA) inflated balloon -
MLD (MLCA) post-PTCA/vessel size; and bal-
loon/artery ratio = MLD (MLCA) inflated 
balloon/vessel size where vessel size is the 
interpolated RD (or reference area) pre-
PTCA. 
The immediate result of PTCA is influenced 
by both plastic (dissections, intima! tears) and 
elastic changes in the vessel wall. Experimental 
."tudies have shown that part of the angioplasty 
mechanism consists of stretching the vessel wall 
with a resulting fusiform dilation or localized 
aneurysm formationJ2 However, recent intravas-
cular ultrasound studies have clearly shown that 
the major effect of bal100n dilatation is plaque 
rupture and compression and vessel wall tear-
ing, with stretching of the nondiseased vessel 
wall playing only a minor role.29 This group has 
also previously reported that, in lesions where 
no ultrasonographieally assessed plaque rup-
ture was produced by angioplasty, a Significantly 
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higher restenosis rate, evaluated angiographi-
cally Llsing a categoric definition, was subse-
quently [ound.2H 
Rensing et aiD have noted that elastic recoil 
after coronalY angioplasty results in a mean 
decrease of 50% in luminal cross-sectional area 
immediately after balloon deflation. A fol-
low-up study showed that asymmetric lesions, 
lesions located in less angulated parts of the 
artery, and lesions with a low plaque content 
showed more elastic recoiJ.74 Furthermore, le-
sions located in distal parts of the coronary tree 
were a1.<;o associated with more clastic recoil. 
probably because of relative balloon ovcrsizing. 
However, although clastic recoil appears to be 
an important component of the initial response 
of the vessel to balloon dilatation, 24-hour 
angiographic study showed no additional de-
layed recoil,52.74 a finding which has been con-
firmed by other groupS.75-77 More importantly 
perhaps, multivariate analysis in a large patient 
group has shown no relationship between the 
extent of elastic recoil at the time of PTCA and 
late luminal renarrowing.7~ Conversely, recent 
preliminary investigations using intravascular 
ultrasound in small patient groups have con-
cluded that chronic elastic recoil during fol-
low-up after successful transluminal interven-
tion may have a more considerable effect 011 
luminal renarrowing than does intimal hyperpla-
sia,79.Ro and an angiographic study has reported 
that luminal loss during the first 24 hours is 
associated with a significantly higher incidence 
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of late restenosis.H1 However, these studies can 
be criticized for using a categoric definition of 
restcnosis, therefore, the results are difficult to 
evaluate in terms of reliability in describing an 
association between two phenomena. Undoubt-
edly, some lesions do deteriorate markedly 
during the first day; however, a similar number 
undergo additional luminal increase, and the 
vast majority display minimal change, so that 
the overall mean change in MLD is essentially 
zero (Fig 4). It has been shown by Rensing et 
al~6 and by Kuntz et al 82 that luminal diameter 
measurements before and after angioplasty and 
at follow-up, as well as the change in lumen 
during follow-up, arc normally distributed; thus, 
a continuous statistical approach is appropriate 
when examining angiographic phenomena. In 
the 24-hour angiographic study, the combined 
use of quantitative measurement of the luminal 
dimensions in mil!imeters and a continuous 
statistical approach showed a more complete 
picture than would have been provided by the 
usc of percentage of diameter stenosis measure-
ments and a categoric analytic approach, permit-
ting a clearer interpretation of the data and a 
better understanding of the underlying pro-
cesses. Thus, it could be properly concluded, in 
agreement with our previous findings7.1.7-1 and 
those of other investigators,75.76 that elastic 
recoil is an instantaneous phenomenon occur-
ring immediately after balloon deflation with no 
further luminal deterioration within the next 24 
hours. Ultimately, these conflicting conclusions 
need to be further evaluated and reconciled, 
and serial studies using intravascular ultrasound 
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Fig 4. Cumulative distribution curves 01 MlD immediately 
after SA and 24 hours later, in 110 successfully dilated tElsions, 
show that there was no deterioration in lesion severity over 
the 24-hour period. 
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and quantitative angiography in parallel would 
be of major interest in laying the matter to rest. 
]m·ights to the Restenosis Process Through 
Application of QCA 10 Clinical Trials 
The largest experience in the Thoraxcenter 
database consists of serial angiographic studies 
in patients treated by PTCA, which have shown 
several important aspects of QCA. Firstly, the 
reproducibility of the CAAS system is extremely 
high. In several large trials, comparable values 
have been obtained in the determination of 
MLD pre-PTCA, post-PTCA, and at 6-month 
foHow_Up.ll.l~54.Kl Based on data obtained from 
these QCA studies, a number of important 
observations on restenosis after BA has been 
made. 
It became apparent that the process of reste-
nosis tends to affect aH treated lesions to some 
degree and that this process could be detected 
angiographically as progressive luminal renar-
rowing, which was detectable as early as 1 
month post-PTCA and did not appear to ad-
vance beyond 4 months after the procedure.54 
These findings were corroborated by Nobuyoshi 
et al.·l~ Restenosis rate was shown to depend 
most on the actual critcrion used and, thus, 
varied accordingly.54 In addition, the RD of 
treated vessels was found to decrease signifI-
cantly during foHow-up after BA, leading to the 
conclusion that percent diameter stenosis mea-
surements fail to detect true changes in luminal 
dimensions.3~ Measuremcnts of MLD and RD 
were noted to be normally distributed, 3~ which 
wou!djustify a continuous rather than categoric 
approach to description of the long-term out-
come. It was recommended that restenosis 
should be assessed by repeat angiography and 
ascertained according to the change in absolute 
quantitative measurements of the luminal diam-
eter. 54 Differences between findings of angio-
graphic restenosis-prevention trials were sug-
gested to arise from three important sources: 1) 
insufficient patient numbers and incomplete 
angiographic follow-up; 2) lise of inherently 
variable user-dependent angiographic measure-
ment techniques; and 3) inconsistencies in the 
approaches used to evaluate restenosis, which 
do not distinguish between the result of angio-
plasty and the restenosis process.84.85 The need 
for fuH angiographic follow-up in all clinical 
studies examining the restenosis issue was advo-
cated,k4 and a continuous rather than categoric 
statistical approach was recommended 8f1 to pro-
vide a more sensitive evaluation of the efIect of 
a therapeutic agent on the renarrowing process. 
Moreover, a continuous approach was shown to 
require considerably fewer patients to reHect a 
significant treatment elTect than would the usc 
of categoric eritcria,kn 
Application of a continuous approach to 
1,445 lesions treated in the aforementioned 
European trials confirmed that luminal renar-
rowing during follow-up is undouhtedly nor-
mally distributed in the treated populationY" 
This finding contrasts sharply with the conven-
tional clinical belief of an all-or-nothing phenom-
enon, supported hy the findings of King et alk7 
through the usc of clinical evaluation of angio-
grams, that luminal renarrowing occurs in some 
lesions but not in others (ie, a bimodal distribu-
tion), In agreement with the report by Rensing 
et a]56 of a Gaussian distribution for luminal 
changes after BA, Kuntz et al~~ reported the 
finding of a normal unimodal distribution for 
late loss in patients treated by directional coro-
nary atherectomy (DCA) or stent implantation. 
In addition, contrary to popular belief, Her-
mans et aJkll found no differences in restenosis 
between coronary segments, using either a cat-
egoric definition of greater than 50% diameter 
stenosis at follow-lip or a continuous approach 
that compared absolute changes in MLD ad-
justed for the vessel size. These resulLs collec-
tively show that restenosis is an ubiquitous and 
normally distributed biologic phenomenon with-
out any predilection for a particular site in the 
coronalY tree and also show the limitations of 
the use of the term "restenosis rate" to ad-
equately describe long-term outcome after inter-
vention. However, in contrast to the findings of 
Hermans et al,~~ Kuntz et alo~ have recently 
reported the finding of a higher restenosis rate 
and loss index (late loss in lumen diameter 
divided by acute gain) in left anterior descend-
ing compared with right or circumflex artery 
lesions treated by DCA or stent implantation. 
The results of this study must be cautiously 
interpreted because the patient group treated 
by stent implantation was small (n = 90) com-
pared with that treated by atherectomy 
(n = 310). The distribution of treated vessels 
was dilTerent in the two groups; lesions were 
mainly located in the proximal segments, clini-
cal characteristics were not reported or in-
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cluded in the analyses, and angiographie fol-
low-up was incomplete (82%), Although this 
study raises an interesting question and uses a 
comprehensive, continuous analytic approach 
to challenge previous findings by Hermans et 
al,~'~ we believe that the Hermans et al analysis, 
in a homogenous patient group treated by BA 
with 94% angiographic follow-up of 1,452 le-
sions (which were widely distributed throughout 
the coronary tree), carries more weight at this 
time. Of course, the conflicting findings of these 
studies may reflect diO'ering consequences of 
DCA or stent implantation and BA. Intuitively, 
it is difficult to reason wby one coronary artery 
should have a greater propensity for neointimal 
response than another, regardless of how the 
injury is imparted. Nevertheless, these conflict-
ing conclusions clearly require further study and 
resolution. 
QCA has been useful to clarify conflicting 
data in the literature regarding angiographic 
risk factors associated with restenosis. Previous 
studies using univariate or multivariate analysis 
with restenosis rate as the dependent factor 
have provided conflicting reports of risk factors 
for restenosisY'~(, Our group has applied a 
continuous approach to studying the long-term 
outcome after BA, and we have found, in a 
number of separate studies, that the propor-
tional luminal increase at angioplasty, or rela-
tive gain in MLD (MLD post-PTCA - pre-
PTCA, adjusted for vessel size), to be the 
strongest predictor of absolute luminal loss 
during follow_llp.7~.K'i.911"JI Other factors were 
also found to be independently associated with 
greater lumen renarrowing, namely lesion sever-
ity before angioplasty, lesion length, angio-
graphic evidence of thrombus, and total occlu-
sion hefore PTCA. 
Our interpretation of this data is that a large 
luminal improvement after PTCA imparts 
deeper arterial injury and provokes a more 
aggressive fibroprollferative vcssel wall reac-
tion, resulting in greater luminal renarrowing. 
This obselvation concurs with previolls patho-
logic and experimental findings,'I2.9R in particu-
lar with the Mayo Clinic model that used 
endoluminal stent oversizing to induce graded 
arterial injury in porcine coronary arteries.~'1 
Other groups, using various methods of quanti-
tation of luminal dimensions, have also re-
ported a direct relationship between angio-
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graphic luminal increase at intervention and the 
subsequent renarrowing. HJO-HJ3 
Alternative Devices for Percutaneous 
Revascularization 
QCA Evaluatioll of the Immediate Therapeutic 
Effects of Devices 
Stent implantation. The ability of an endolu-
minal prosthesis to maintain luminal patency 
after failed SA was the original indication for 
implantation of these devices.104 Serruys et alHJ5 
investigated serial geometric changes in stenosis 
morphology in 19 patients after BA and then 
after stent implantation by quantitative angio-
graphic measurements of luminal dimensions, 
of the theoretic transstenotic pressure gradient, 
and of Poiseuille and turbulence resistance. The 
self-expanding stainless steel mesh stent pro-
duced additional immediate luminal dilatation 
resulting in decrease in both the Poiseuille and 
the turbulence resistance and in theoretic trans-
stenotic pressure gradient, in addition to the 
expeetcd scaffolding effect. Puel et al llJ6 re-
ported a deterioration in MLD and MLCA at 3 
months, among 11 patients similarly studied and 
fol!owed up; however, this change was not 
associated with any significant increase in trans-
stenotic pressure gradient at assumed How rates 
of 1 to 3 em/s. The conclusion of these studies 
was that this device had a dilating function, in 
addition to its stenting role, that might be of 
value in preventing abrupt closure and resteno-
sis after conventional SA. Further studies of 
luminal geometry after stent implantation by 
Strauss et alHJ7 showed that both the agreement 
and mean difference between luminal cross-
sectional area measurements obtained by edge 
detection and videodensitometry deterioratcd 
markedly from before to after SA, but were 
then considerably reimproved after stent implan-
tation. This effect of stenting was attributed to 
smoothing of the vessel contour aftcr stent 
implantation and also to vessel remodelling 
toward a more circular configuration. Beatt et 
al lOH reported an extra feature of the self-
expanding stainless steel mesh stent, namely 
additional luminal improvement during the first 
24 hours, clearly indicating its negation of elas-
tic recoil and justifying its description as sc1f-
expanding. However, evaluation of the early 
clinical experience with this device was unduly 
disconcerting because of an unacceptably high 
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frequency of acute and subacute stent thrombo-
sis, lU9 temporarily quelling the early enthusiasm 
of some of its proponents. 110 Nevertheless, per-
sistence with the clinical application of endolu-
minal stents, incorporating increasing attention 
to control of coagulation, to refinement in stent 
composition and design, and to deployment 
techniques has yielded progressive improve-
ments in early clinical success.111.11S 
Morphologic changes brought about by the 
balloon-expandable tantalum coil (Wiktor) stent 
were investigated by Serruys et ai, 116 with the 
additional aspect of examining recoil after im-
plantation. This prosthesis was found to pro-
duce geometric improvements similar to those 
previously reported for the self-expanding stain-
less steel mcsh stent. The smaller mean diam-
eter of the stented segment (2.88 ± 0.43 mm) 
compared with the mean diameter of the fully 
inflated balloon (2.98 ± 0.44 mm) suggested 
some minor recoil in the stented segment (3% 
diameter reduction, compared with a mean of 
approximately 33% diameter reduction after 
conventional BA).73 In addition, it was noted 
that the balloon did not achieve the diameter 
spccified (3.35 ± 0.36 mm) at the recommended 
inflation pressures for stent deployment, per-
haps because of the opposing forces of both the 
stent and thc arterial wall itself. 
Haude et al117 have recently investigated the 
occurrence of elastic recoil immediately after 
sequential BA and Palmaz-Schatz stent implan-
tation and found that this device almost com-
pletely eliminated recoil (31 % diameter recoil 
[48% area recoil] for BA, compared with 3.5% 
[5.1 % area] after stent implantation), thus, 
decreasing the impact of long-term intimal hy-
perplasia on the residual lumen dimensions. 
An experimental in vitro study investigated 
the interference caused by stainless steel and 
tantalum stents to the densitometric measure-
mcnt process and found that only tantalum 
stents were prone to produce serious overestima-
tion of the MLCA within the stent, which would 
be accentuated by incomplete vessel opacifica-
tion by radiographic eontrast.ll~ For this reason, 
edge detection has been the preferred quantita-
tive analytic method applied to assessment of 
angiographic results of stentingwith this prosthe-
sis. 
Directional coronal)' atherectomy. DCA may 
cause luminal improvement hy a combination of 
dilatation and plaque removal.jj~-121 In a cohort 
of 10 patients (among a total series of 113 
patients), Umans et alB" examined quantitative 
angiographic lesion morphology before and af-
ter passage of the atherectomy device and aftcr 
activation of the device with plaque retrieval to 
determine the degree of luminal increase 
achieved by the procedure, which may he attrib-
uted Lo lesion stretching or dilatation merely by 
the passage of the device (so called "Dotter" 
effect). The MLD increased from 0.97 ± 0.32 
mm before atherectomy to 1.85 ± 0.37 after 
crossing the lesion and then to 2.38 ± 0.33 after 
plaque removal. Among a selected matched 
patient group undergoing BA, MLD increased 
from 1.10 ± 0.30 mm to 1.9 ± 0.40 mm, showing 
that the Dotter effect produced a luminal in-
creasc virtually equivalent to that achieved by 
BA and accounted for 62% of the total luminal 
increase achieved by DCA. After DCA, the 
agreement between edge detection and vid-
eodensitometry measurements was found to 
deteriorate somewhat compared with that be-
fore DCA, although there was minimal discrep-
ancy between the mean cross-sectional area 
measurements obtained by each approach (0.28 
mm2), in agrecment with previous reports. ulI.m 
As will be evident from the accompanying 
report on the technical aspects of these measure-
ment techniques, discrepancy (edge detection! 
videodensitometry mismatch) is most likely to 
be explained by the presence of a noncircular 
lumen morphology. The improved agreement 
after stent implantation, as dcscribed above, is 
believed to be because of the fashioning of a 
circular lumen by the device; thus, it was con-
cluded that the finding of a reasonable level of 
agreement after DCA may imply lumcn mor-
phology that is close to circular.ll~.ln This inter-
pretation is at variance with the report by Penny 
et al 121 who postulated a clover-leaf-shaped 
luminal configuration after DCA. However, the 
two studies are in accordance regarding the 
relative contribution of dilatation and plaque 
removal to the luminal improvement achieved 
by DCA. Our group has not specifically exam-
ined elastic rccoil after DCA, but a recent 
report from Kimball et aim suggests signifi-
cantly less clastic recoil after DCA 
(23.5% :t 16%) than after BA (41.6% ± 13.8%). 
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COMPARATIVE EVALUATION OF LONG-TERM 
THERAPEUTIC EFFICACY OF DEVICES 
The safety and immediate efficacy of alterna-
tive devices for percutaneous coronary revascu~ 
larization have now been satisfactorily proven 
by many investigators. The next logical step is 
critical evaluation and comparison of the vari-
ous devices to determine long-term benefit in 
terms of degree of luminal renarrowing pro-
voked by intervention. Comparison between 
devices is hampered by a number of clinical and 
angiographic factors that are most objectively 
surmounted by randomized clinical trials, a 
number of which are in progress or are already 
completed.124.125 
Because of the difference in vessel size among 
lesions treated by these respective devices, it 
has heen our contention that direct compari-
sons could not validly be made without taking 
this factor into consideration. In fact, compari-
son of acute and late angiographic results of any 
intervention between individual patients is simi-
larly ambiguous unless vessel size is compa-
rable. Two possible solutions have been applied 
by aUf group to surmount this obstacle. The first 
involves the selection of lesions; lesions to be 
compared should be selected according to ves-
sel size and lumen diameter before intervention 
so that the baseline lesion characteristics are 
similar, hence the matching process by which 
unmatchable lesions will be excluded from the 
comparison. The second approach is to include 
all patients in the comparison but to adjust or 
normalize absolute luminal changes at interven-
tion and during follow-up for the individual 
vessel size for each lesion, as explained further 
below. 
Matching 
According to this comparative method, le-
sions to be compared are selected from baseline 
angiograms by an independent observer who is 
unaware of clinical or procedural details or of 
the 6-month angiographic outcome. The tech-
nique l26 is based on three principles. 1) The 
angiographic dimensions of matched lesions arc 
assumed to be "identical"; 2) the observed 
difference between the two identical lesions 
must be within the range of the CAAS analysis 
reproducibility of 0.1 mm (1 SD); and 3) the size 
(RD) of the matched vessels are selected within 
a range of ±0.3 mm (3 SD; ie, tJ9% CI) (Tables 1 
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Tabj", 1. Quantitativ", Comparison of the Imm",diate and 
Long· Term Results of DCA Versus SA (Matched Data) 
Measurement COA 
" 
P Value 
RD(mm) 
Pm 3.03 3.07 NS 
MLD (mm) 
Pm 1.08 1.15 NS 
Post 2.61 1.92 10- 5 
F/U 1.69 1.57 NS 
<'>In MLD (mm) 
Post·Pre (gain) 1.53 0.77 10-5 
Post·F/U (loss) 0.92 0.35 10 ' 
Matching of lesions to compare interventions is shown. 
Abbreviations: NS, not significant; FlU, follow·up. 
and 2). Thus, two comparable groups of lesions 
treated by different devices are derived. The 
acute and long-term clinical and angiographic 
effects of intervention may then be compared. 
We have, thus far, applied this technique in 
comparing DCA and stent implantation with 
conventional BA.126.128 DCA was found not only 
to achieve greater luminal increase than SA but 
also 10 he attended by greater luminal loss 
during follow-up, so that the ultimate angio-
graphic outcome was similar in each group (Figs 
SA and B). Stent implantation also achieved 
significantly greater luminal improvement than 
did SA; however, although attended by greater 
luminal loss than that for BA, the MLD at 
follow-up in lesions treated by stenl implanta-
tion was significantly greater (Figs SC and D). J:27 
Important lessons have been learned from these 
studies that may be considered as surrogates for 
randomized trials. In fact, the angiographic 
findings in the matched comparison of DCA 
and SA could be interpreted as predicting the 
angiographic outcome of the CAVEAT study. 12<1 
Table 2. Matched Preprocedural Stenosis Characteristics 01 
Patients With Successful Dir",ctional Coronary Ath",rectomy 
Versus Balloon Angioplasty 
Measurernell( COA 
" 
PValue 
RD(mm) 3.03 3.07 NS 
MLD (mm) 1.09 1.15 NS 
D·STEN (%1 64 63 NS 
A PLAO (mm') 95 8.4 NS 
Curvature 15.9 22.2 <.02 
Symmetry 0.6 0.5 NS 
Length (mm) 6.8 6.5 NS 
No significant differences exist between the Iwo groups 
before the procedure except for a lower curvature value for 
lesions treated by DCA. 
Abbreviations: D·STEN, diameter stenosis; A PLAO, area 
plaque; Length, I"'ngth ollesioll. 
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The final results of the Benestent triaPl1 are 
eagerly awaited, and, among the findings, it will 
be interesting to note whether the matching 
study mentioned here provided an equally close 
prediction of the angiographic outcome. 
Independent of the vessel size treated, DCA 
and stent implantation arc both clearly capable 
of greater luminal increase than is conventional 
SA. Each of these new devices also provokes a 
greater loss in lumen during follow-up that, 
according to the injury/hyperplasia hypothesis, 
is likely to be a direct consequence of the 
greater luminal increase. Moreover, studies lIS-
ing multivariate analysis techniques in patients 
treated by stent implantation 129 and DCA!3U 
have shown the strongest determinant of lumi-
nal narrowing during follow-up to be the lumi-
nal gain achieved at intelvention. Other groups 
have reported a direct association of luminal 
gain at intelvention with late luminal loss after 
DCA or stent implantation or after BA.H2.1II1.W3 
Greater loss observed after LIse of the new 
devices compared with that for conventional 
SA is generally attributed to the greater luminal 
increase achieved by these devices, which pre-
sumably cause deeper vessel wall injury in the 
process. 
Kuntz et al have gone a step further and 
concluded that the greatest determinant of 
long-term angiographic outcome after interven-
tion is the immediate postprocedural result, and 
this determinant is independent of the device 
used to achieve this result.J(]U.101 Our findings in 
the matching studies would suggest Ihat sten! 
implantation is associated with a better long-
term angiographic outcome than BAm; how-
ever, DCA did not appear to provide a superior 
long-term benefit. 12H To adequately address the 
dilemma further, studies matching DCA with 
stent implantation are underway. In addition, 
Illore sophisticated matching techniques may he 
used to provide specific answers to questions, 
such as, if the baseline vessel size and lesion 
severity and the immediate postproceduraJ re-
sult are similar in patients treated by different 
devices, does the I1broproliferative hyperplastic 
response vary according to the device used? 
Relative Gain, Relative Loss, and Net Gain 
Index 
These indices of luminal change are derived 
hy normalizing absolute gain, loss, and net gain, 
respectively, for the individual vessel size. To 
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Fig 5. Comparison of immediate and long-term angiographic outcome of BA with DCA and stent implantation using cumulative 
distribution curves applied to matched patient groups. The )(-a)(is represents the measured MLO, and the y-a)(is represents the 
cumulative frequency (in percentage of the total) of lesions corresponding to a given MLD measurement. fA) Preprocedure and 
immediately postprocedure results for PTCA and DCA /n = 90 lesions); /B) postprocedure and follow-up results for PTCA and DCA; 
(C) preprocedure and immediately postprocedure for PTCA and the Wallstent /n == 93 lesions); and {OJ postprocedure and follow-up 
for PTCA and the Wallstent. 
provide a constant and objective point of refer-
ence, the interpolated RD before intervention 
is used for the vessel size. As mentioned previ-
ously, this is the closest angiographic approxima-
tion of the disease free or normal vessel diam-
eter. These relative measurements are not 
interchangable with changes in conventional 
percent diameter stenosis, because selection of 
the RD is quite dilIcrent, as explaincd earlier 
(Fig 1). The matching procedure, as described 
above, is inherently selective, and many lesions 
cannot bc compared becausc of lack of a ~-;uit­
able partner. However, by normalizing for ves-
sel sizc, any lesion may bc compared with any 
other with respect to changes at intervention 
and during follow-up. Using this approach, 
applied to patient groups treated by DCA, BA, 
or implantation of a self-expanding stainless 
steel mesh stent or of a balloon-expandable 
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tantalum coil stent, we have reported, in all of 
the groups, a direct linear relationship between 
relative luminal increase at intervention and 
subsequent deterioration during follow-up; how-
ever, this relationship dilTcrs considerably among 
the groups (Fig o).Lll Although there were 
definite demographic variations, which may 
partly explain the observed differences, we be-
lieve sufficient evidence was presented to specu-
late that the findings reflect device-specific varia-
tions in the injury/hypeq11asia relationship that 
need to be further investigated. According to 
these findings, the stainless steel mesh stent and 
BA display a better profile than DCA or tanta-
lum coil stent implantation, in terms of provok-
ing less relative luminal loss at increasing levels 
of relative lumina! gain. These findings are in 
conflict with the previously mentioned reports 
of Kuntz et al,IOII.IOl perhaps because of differ-
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Fig 6. Linear regression relationship of relative gain I 
relative loss of patients treated by 4 different interventional 
devices are shown with th!! line of identity. It can be appr!!ci-
ated that a device whose r!!gression lin!! has a steep slop!! (!!g, 
DCA) could be consider!!d to be associated with a worse 
profile than could one with a gentle line-slope (eg, the MESH 
stent). insofar as a greater relative loss is associated with any 
given relative gain. It is additionally clear that each device is 
associated with the achievement 01 progressively increasing 
net gain index (the perpendicular distance from the regression 
line to the identity Une) at increasing levels of relative luminal 
gain. DCA (n = 118 lesions); COIL, baUoon·expandable tanta· 
lum coil stent (n = 101 lesions); MESH, self·expanding stain-
less steel mesh stent (n = 110 lesions); PTCA (n = 1435 Ie· 
sions). 
ences in methodological approach, whereby 
they have used absolute (not adjusted for the 
vessel size) luminal measurements. In these 
studies, their conclusion of no difference in 
proliferative response to the devices is based on 
the finding of similar loss index for each patient 
group and of absence of an independent influ-
ence of the device used on late loss in multivari-
ate analysis of the patient groups combined. 
However, possible effects of specific interac-
tions between the individual device and the gain 
achieved, on the late loss, were not taken into 
account as independent factors. 
Despite these differences in approach and 
final conclusions, it is clear that the immediate 
aim of intervention must be to safely achieve as 
great an angiographic luminal improvement as 
possible with each device, because it can be 
extrapolated from Fig 7 that progressively 
greater, relative luminal gain yields proportion-
ally increasing net gain (each regression line is 
beneath and diverging from the identity line so 
that a greater net gain index is associated with 
increasing relative luminal gain, despite the 
concomitantly increasing, relative luminal loss). 
i\ proviso to this general recommendation is 
that the achievement of great luminal improve-
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ments is obviously more safely possible by stent 
implantation than by BA or DCi\. Aiming to 
obliterate the target lesion by balloon dilatation 
is not a legitimate endpoint of intervention with 
this device, because of the inevitable elastic 
recoil and the risk of vessel wall dissection. 
Similarly, by its vel)' nature, aggressive DCA is 
attended by some risk of vessel pcrforation. In 
addition, Umans ct al bave suggested that DCA 
should not bc used in smaller vessels ( < 2.5-mm 
RD), evcn if smaller cutters are uscd, because 
of the apparently aggrcssive, intimal response 
as a likely conseqllence of deeper vessel wall 
injury in thesc vessels. However, Kuntz et aJl J2 
have reported a general trend toward an im-
proved long-term angiographic result when me-
dial or adventitial tissue is retrievcd; this con-
trasts with previous reports by Garratt et a1. 1.'1.' 
Neverthcless, it is becoming increasingly appar-
ent that, in genera!, interventions in larger 
vessels may be associated with a better long-
term outcome. Qur group has reported that 
relative luminal deterioration during follow-up 
after DCA, BA, and balloon-expandable tanta-
lum-coil stent implantation is greater in smaller 
vessels, which appears to be a consequence of 
increasing relative luminal gain achieved at 
intelvention (Fig 7).1J~ In addition, Kuntz et al 
2.5 3 3_5 4 4.5 
VESSEL SIZE (mm) 
Fig 7. Relative luminal gain lREL GAIN; left panel) and loss 
/REL LOSS; right panel) according to vessel size in increments 
of 0.5 mm, for the patient groups described in Fig 6. A pattern 
of decreasing relative luminal loss with increasing vessel size 
is apparent for each device except for the MESH stent, and a 
similar pattern is observed for relative luminal gain. This 
finding would suggest that previous observations of lower 
tendency to restenosis in larger vessels is, in fact. a conse-
quence of less relative luminal increase at intervention in these 
vessels compared with that for smaller vessels. A constant 
relationship betwe!!n relative gain and relative loss at all 
vessel sizes, for each device, can be appreciated. Thus the 
restenosis process would appear to be independent of vessel 
size but strongly dictated by the degree of relative luminal 
gain at intervention, as shown in Fig 6. 
have reported lower restenosis rates in larger 
vessels treated by DCA or stent implantation. HHI 
Thus, the "bigger is better" philosophy may be 
more properly interpreted to mean that interven-
tion in a bigger vessel is associated with a better 
long-telm outcome as opposed to the initially 
rcported intention that a bigger lumen after 
intervention is associated with a better long-
term outcome, because larger postprocedural 
and follow-up lumen are naturally associated 
with larger vessels. 
ANGIOGRAPHIC EVALUATION IN 
RANDOMIZED TRIALS COMPARING 
INTERVENTIONAL DEVICES 
Important multicenter trials, examining the 
impact of various pharmacologic agents, or new 
interventional devices on restcnosis arc now 
being assessed in core laboratories n5·1.17 using 
quantitatively derived parameters, particularly 
MLD,us In addition, increasing attention is 
being paid to the usc of intraeoron,ITY nitrate 
and replication of the angiographic projections 
before and after intelVention and at follow-
Up.IIS 
However, many studies continue to report 
results in terms of percent diameter stenosis 
measurements and restenosis rates. We have 
already described our strong rescrvations con-
cerning the usc of percent diameter stenosis 
measurements in important clinical trials. Simi-
larly restenosis rates are, as explained, inher-
ently misleading and inaccurate and have little 
relevance to the description of the ubiquitous 
and dynamic process of lumilwl renarrow-
ing.-'i('·H~ If long-term clinical outcome is to be 
reported, the frequency of occurence of lesion 
severity at follow-up angiography of more than 
50% diameter stenosis is entirely inappropriate 
because it yields no information on actual lesion 
deterioration intervention and, also, because 
this approach equally categorizes patients with 
a diameter narrowing of 50% and those with a 
totally occluded vessel. Similarly, those with a 
completely normal artery, 0% stenosis, would 
be classified in the same group as those with a 
4t)% diameter narrowing. Reporting on the 
occurrence of major cardiac complications or 
major adverse cardiac events (death, myocar-
dial infarction, coronary artery bypass graft 
surgely, reintelvention~2) in the follow-up pe-
riod, a technique used in many current multi-
center trials, presents considerably more rel-
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evant and useful clinical information regarding 
long-term clinical success of therapy than the 
so-called clinical restenosis definition. 
Angiographic outcome must be evaluated 
using a continuous approach to provide sensi-
tive evaluation of the usefulness of new thera-
pcutic strategies. In addition, 100% QCA fol-
low-up is desirable to measure absolute luminal 
dimensions before and after intervention and at 
follow-up in all patients. In randomized trials 
the baseline characteristics of the treatcd groups 
are assumed to be similar, so that the acute and 
long-term effects of intelvention may be directly 
compared, as has been presented in restenosis 
prevention trials aftcr BA, 11.12.1\3 in the recently 
complcted CAVEAT,I)4 and in the soon-to-be 
completed Benestent111 trials. There are three 
important angiographic aspects of interven-
tiona I results that need to be considered for 
thorough comparative evaluation of these trials. 
First, the long-term angiographic outcome 
should reflect patient status at follow-up. To 
this end, the MLD at follow-up has been shown 
to havc relevant clinical eorrelations('" and is the 
most unambiguous comparative measure of this 
aspect both for the individual patient and the 
treated group. Second, the net angiographic 
benefit of the intelvention (the angiographie 
balance of relative luminal improvement at 
intervention and relative luminal loss during 
follow-up) may be considered to convey a com-
parative measure of the ultimate effectiveness 
of the device, in providing luminal improvement 
from before intelVention to follow-up. We would 
suggest that the net angiographic benefit, nor-
malized for the vessel size (what our group has 
termed the net gain index), is the most useful 
index in this regard. Finally, the overall elIect of 
the device on the process of restenosis within 
the treated population may be evaluated using 
the relative gain/relative loss relationship as an 
angiographic surrogate for the wall injury/ 
fibroproliferative response relationship and may 
be compared between groups. Within a random-
ized trial, whereby all baseline characteristics 
are comparable, any differences in this relation-
ship may be attributed to real device effects. 
Kuntz et al have proposed the use of a loss 
indexg2.g9.IIIIUUI (absolute loss corrected for abso-
lute gain) as a measure of the proliferative 
potential of an instrumented vessel to evaluate 
the effectiveness of a therapeutic strategy. In 
essence, this is the regression coefficient of the 
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Fig 8, (AI Linear regression (y = a + bx) of absolute loss on absolute gain and relative loss on relative gain for the DCA group 
shown in Fig 6, with the individual data points included (n = 118), is shown. In the relative gainlrelatlve loss graph (B), the 
denominator is the same for the cah:ulation of relative measurements (ie, the interpolated RD before DCA), and, thus, the loss/ gain 
relationship will be exactly the same as the relative loss/relative gain, for each lesion; however, the resultant population 
relationships are clearly not identical. This is because of changes in spatial orientation of individual lesions, with respect to ea(:h 
other, on normalization for the vessel size, as shown. For the reasons given in the text as well as for the obviously stronger 
correlation (d, we consider the relative loss/relative gain relationship to be more meaningful and useful lor comparative purposes 
between patient groups treated by different interventions. The loss index would be 0.62, whereas a relative loss index would be 0.75. 
r, Pearson's product moment correlation coefficient; p, statistical certainty of a linear relationship between the dependent (loss, 
relative loss) and independent (gain, relative lossl variables. 
gain !loss relationship, which is similar (but not 
identical) to the relative gain/relative loss rela-
tionship (Fig 8), and may be a useful simple 
index. However, we have reservations regarding 
its sensitivity, because two widely separated 
population responses of lumina! loss to luminal 
gain may he described by the samc loss index, 
which would misleadingly convey similar prolif-
erative rcsponse to a given level of injUl)' (Fig 
2 
1.5 
Loss (mm) 
Device A;y =: 0.2 + OAx 
Device B;y = -0.2 + O.4x 
_---1 
a.5 _-- I __ -PeviceB! 
o 
-a.5~-­
o 0.5 1.5 
Gain (mm) 
----~, 
~ 
2 2.5 3 
Fig 9, Schematic drawing shows potentia! limitations of 
the loss index. Both deVice A and device B would have a loss 
index of 0.4, yet it is clear that in the achlevemellt of acute gain 
of 2 mm, device A would provoke a late loss of 1.2 mm, 
whereas device B would provoke a loss of 0.8 mm. This is a 
purely hypothetical example whereby other factors, not consid· 
ered in the analysis, are likely to explain the different popula-
tion responses; however, it must be remembered that. in 
reality, the restenosis phenomenon is clearly multifactorial, 
and such a scenario may not be completely unrealistic. 
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9). In addition, the potentially wide and variable 
range of individual responses cannot he commu-
nicated by the simple loss index. Thus, because 
we consider normalization of luminal changes 
for vessel size to he an integral step to compara-
tive evaluation, we believe the linear regression 
display of relative luminal loss on relative lumi-
nal gain (Figs 6 and t-\) to be the most informa-
tive angiographic exploration of the restenosis 
" 
Tilickness = .34'lnlury ,. .072 
,=,84 
1.5 2.5 
Mean Injury Score 
Fig 10. The relationship between wall injury score and 
measured neointimal thickness, in a stented porcine model, as 
reported by Schwartz et a!," is shown, Compare this with the 
relative gain/relative loss relationships displayed in Figs 6 and 
8. Certain similarities are apparent that stimulate the spe(:ula-
tion that these QCA indices may represent relevant correlates 
of arterial wall injury and neointimal response, which may be 
of some value for clinical restenosis studies. (Reprinted with 
permission."') 
process (arterial wall injury/hyperplastic re-
sponse; Fig 10). 
CONCLUSION AND EPILOGUE 
Through the extensive application of QCA to 
large patient populations undergoing translumi-
nal interventions, with comprehensive scrutiny 
and analysis of the data provided, our group and 
others have developed and continue to explore 
pertinent and contributory concepts to the un-
derstanding of the immediate and long-term 
responses to coronary vessel intervention. Rapid 
advances in alternative imaging techniques 
should not be visualized as compcting with 
QCA but, rather, as mutually complementary 
methods of providing increasingly comprehen-
sive assessment of coronalY luminal obstruc-
tions and the outcome of therapeutic interven-
tions. Correlations between the information 
provided hy these techniqucs and quantitatizve 
angiographic data will be of major clinical 
interest. 
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Although in clinical practice, most of these 
techniques are, as yet, invcstigational and tend 
to be used mainly in large academic institutions, 
increasingly sophisticated QCA analysis pro-
grams have been adapted for on-line use and 
produce rapid, accurate, and precise measure-
ment of luminal dimensions in the catheteriza-
tion room, as well as off-line in the analysis 
room or core laboratory. Thcse continuing devel-
opments, together with universal usc of cinean-
giography or digital angiography by intervention-
alists, are likely to cement the position of QCA 
as the "gold standard" in coronary luminal 
examination for the forsccablc future. Thus, the 
clinical use of QCA on-line during intervention 
has barely been explored but presents exciting 
and fascinating prospects. We hope that this 
and the accompanying report will provide some 
gcneral and specific, theoretic and practical 
guidance for the interventionalist embarking on 
the fantastic voyage into the realms of QCA. 
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CHAPTER 3 
ANGIOSCOPIC VERSUS ANGIOGRAPHIC DETECTION OF 
INTIMAL DISSECTION AND INTRACORONARY THROMBUS. 
den Heyer P, Foley DP, Escaned J, Hillege HL, 
Van Dijk RE, Semrys PW, Lie KI . 
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Angioscopic Versus Angiographic Detection of Intimal Dissection and 
Intracoronary Thrombus 
PETER DEN HEIlER, MD, PHD, DAVID P. FOLEY, MD,' JAVIER ESCANED, MD,' 
HANS L. HILLEGE, MD, RENE B. VAN DUK, MD, PHD, PATRICK W. SERRUYS, MD, PHD, FACC,' 
KONG I. LIE, MD, PIID 
Gronillgen and Rotterdam, The Netherlallds 
Objectives. This study was undertaken to compare corunary 
angioscupy with angiography for the detection of intimal dissec-
tion and intracoron311' thrombus, 
Backgroulld. It has been demonstrated previuusly that coro· 
nary angioscopy provides more intravascular detail than cinean-
giography. Both imaging methuds have to be compared directly to 
assess the additional diagnostic value of angioscopy, 
Methods. The angiograms and videotapes of 52 patients who 
had undergone anbFjoscoPy were reviewed independently by two 
obsen'ers unaware of other findings. Classic angiographic defini-
tions were used for dissection and thrombus. Angioscopic dissec-
tion was defined as visible cracks or IIssures on the lumen surface 
or mobile protruding structures that are contiguous with the 
vessel wall, Angioscopic thrombus was defined as a red, white or 
mixed red and white intraluminal mass. 
Coronary angioscopy is a relatively new technique for imaging 
the vascular inner surface and intraluminal structures of the 
coronalY arteries (1-3). The recent introduction of a small, 
flexible, wire-guided, high resolution coronary angioscopy sys-
tem hm; led to an increasing acceptance of this imaging method 
for clinical and investigational purposes (4-8). From the 
beginning of its clinical application, it has been recognized that 
angioscopy provides more intravascular detail than can be 
detected with angiography. The presence of intmcoronary 
thrombus and intimal dissection has been clearly documented 
in angiographically unremarkable vessels (9-15). 
Coronary angiography, by contrast, is accepted as the 
standard for imaging the coronary arteries and is irreplaceable 
for routine patient care in diagnostic and interventiona! cardi-
ology. However, with the increasing availability of angioscopy 
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ReSlIlfs. Angiography and angioscopy were in agreement in 40,4% 
of cases in the absence of thrombus and in 11.5% in the presence of 
thrombus. No fewer than 25 (48.1%) angioscopically observed 
thrombi remained undetected at angiography. With angioscopy as 
the standard, although the specificity of angiography for thrombus 
was 100%, sensitivity was very low at 190/0, Angioscopic dissection was 
present in 40 patients (76.lJOk) versus angiographic dissection in 15 
patients (28.8%). With regard to dissection, there was no correlation 
between the two imaging methods (rq. = 0.15, p = 0.29). 
Conclusiolls. Coronary angiography underestimates the pres-
ence of intracOl"onary thrombus. Angioscopy and angiography are 
complementary techniques for detecting and grading intimal 
dissections. 
(J Am Coli Cart/iol 1994;24:649-54) 
and its potential for rapid and comprehensive direct visualiza-
tion of the coronalY lumen, the definition of intracoronary 
thrombus and intimal dissection by angiography must be 
questioned. The purpose of this study was to compare and 
contrast imaging information obtained in 52 patients under-
going coronary angioplasty, using a combination of angiogra-
phy and angioscopy, with specific attention to the detection of 
intracoronary thrombus and intimal dissection. 
Methods 
Patients. At the catheterization laboratories of the Univer-
sity Hospital Groningen and the Thoraxcenter, Rotterdam, the 
Netherlands, 52 patients (mean age 60.5 years, range 40 to 76) 
underwent coronary angioscopy before (15 patients) or after 
(37 patients) coronary banoon angioplasty. 
Coronary angioscopy. Angioscopy was performed with the 
ImageCath system (Baxter, IntelVentional Cardiology Divi-
sion). Visualization of the coronary lumen is facilitated by low 
pressure inflation of a proximal cuff (maximal diameter 6 mm) 
and continuous flushing of prewarmed normal saline solution 
at 40 ml/min through the irrigation channel of the angioscope. 
Specific features of the angioscope include a mobile fiber 
bundle allowing 5-cm longitudinal movement after cuff infla-
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Tahle 1. Classification System for Angioscopic 'I'hromhw, 
and Dissection 
Dissection 
Not asscssnbk, not ,'pplicabk 
NOlle 
Small ,urfacc disruption, (flaps) 
Largc dissectioll 
Red thrombus 
o Not a,sessab!c, IlOt applicable 
NOllc 
Onc lining thrombus 
Multiple lining thromlm, 
Protruding thrombus, <'h of lumen 
Protrmiing thrombus. '/.1_'" Ill' lumcn 
(, Protruding thrombu" ','1_;', of lum~n 
White thrombus 
o Not as,essab!c. not ilpphGlhle 
None 
Onc lining thrombus 
Multiple lining thrombu,> 
I'rotl'lIdinl! thromhus, < 1,/, of lum~n 
Prot, UJillg thrombus, " of lunwn 
Protruding throlllhu'>, ''-:'-'/, of lumell 
Mixnl red/white thrombu, 
o Not ass~ssabk. not applicable 
None 
One lilling thrombus 
iVlultipie lining till'Omhu, 
4 Protrudillg thmmilll', < I , of IUIl1~n 
5 Protruding lilrombll" 1/,_ 'i\ oj'lumen 
Protruding tllrombm" 2 ,_'/-, of IUIll~n 
tion. AI! angioscopic images were recorded on Super-VHS 
videotape. 
Cornllary angiography. Coronary angiography was per· 
formed according to the normal routine of both catheterization 
laboratories, with multiple projections of the treated coronary 
artery segments both before and after angioplasty. The angio-
grams were reeorded;at 12.5 to 25 frames/s on cinefilm. 
Dat.'l acquisitinn and definitiulls. The angioscopic videotape 
recordings were reviewed in a predetermined random order by 
two intelventional cardiologists with ample experience in angios-
copy. The presence of dissection and thrombus was scored with 
the use of a classification system to provide grading scales for 
these diagnoses (Table I). Presence of thrombus was ~ubclassified 
as red, white or mixed red and white. The angioscopic definition 
for a thrombus was as follows: red, white or mixed red and white, 
intraluminal, superficial or protruding mass, adherent to the 
vessel surfaee but dearly a separate strut::Lure. A white thrombus 
should fuHll1 Ihe additional criterion of a shaR.~y, irregular and 
cotton wool-like appearance. The magnitude of a protruding 
thrombus, classified as grades 4 to 6, was determined by visual 
estimation. Angioscopic dissection was defined as visible cracks or 
fissures on the lumen surface or mobile protruding structures that 
are contiguous with the vessel wall and of homogeneous appear-
ance with the vessel wall. These definitions and classifications of 
thrombus and disset::Lion are part of an angioscopic classification 
system that was developed and evaluated by the European 
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Table 2. Mouified National Hearl. Lung, and Bloou Institute 
Clas~i!ication of Angiographic Dissection 
No dissection 
'!)'pe A Sm,,11 radiolucent area within th~ lumen of 11l~ vessel di,appearing 
wilh th~ passage of contr",t malerial 
Typ~ B filling defect pari,lIeito thc IUlllen 01 [lie vcssel disappearing with 
[he pas'>i1!te or contrast matni"l 
Tl'p~ C Dissection protruding oUhidc the lumen of the v~ .... eI persiMing 
after pnssilg~ or the conll<lsl maTerial 
Typ~ D I Spiral-,hap~tl filling defect with normal runoff of Ih~ cOlltrast 
material ill the anterograde liow 
Type D2 Spirnl-shilped filling defect with tlelayed runoff of Ihe contrast 
Type r 
Type F 
mat~rial in thc <mlerugracic' How 
l'en;islent lumen filling deject with delay~tl runofI 01 [h~ conlnlst 
matnial in Ihe distal vessel 
Filling defect accompanied by total occlusion 
Working Group on CorOllalY Angioscopy (16). Intraobselver and 
interobserver agreements of angioscopic recordings, evaluated by 
this working group, were considered acceptable. Intraobserver 
and interobserver agreements for the angioscopic presence of red 
thrombus were found to be 9]% and 81%, respectively. For 
dissection, illtraob.~elver agreement was ~7% and 73% for inter-
obselVer agreement. 
The cineangiograms were scored off-line by the same observ-
ers in blinded manner in a different random order. Intimal 
dissection was deflned as intraluminal filling defeds, el\.travasa-
lion of contrast material or linear lumen density staining and was 
categorized according to modified National Heart, Lung, and 
Blood Institute criteria (Table 2) (17-20). Angiographic evidence 
of intracoronary thrombus was defined as the presence of an 
intraluminal central filling defect or lucency surrounded by con-
trast material, seen in multiple projections and with absence of 
caleifications within the defect (21). 
Statistical analysis. The angioscopic and angiographic ab-
sence, presence or degree of dissection and thrombus was 
scored by consensus of the two obselvers. If they differeu in 
their judgment, consensus was reached by the opinion of a 
third, independent obselver. The obselvers were uninformed 
of all patient data to allow for independent, unbiased review of 
angioscopic images and angiograms. 
Cross-tables were made to compare angioscopic and angio-
graphic scores. Correlations were calculated llsing the Spear-
man rank-order correlation coefficient r, and the phi coefiident 
for 2 X 2 tables (r4,). These correlations were computed using 
the SPSS statistical package, version 5.01. Statistical signifi-
cance was set at the 51),." level (p < [1.05). 
Results 
There were no major complications caused by angioscopy in 
this patient cohort. There was one case of ventricular fibrilla-
tion, which was easily cardiovertable, resulting from an exces-
sively long period of ischemia during our learning curve. 
Severe eoronalY spasm, air embolism, angiographic evidence 
of dissection caused by angioscopy, balloon orwire entrapment 
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Table 3. Angioscupic Thrombus Grade Versus Angiographic 
Thromhus Presence 
An~iographic 
Thromhus 
Absent 
Angioscopic Thrombus Grade 
21 
(40,4%) (13.5%) " (21.1%) 
, 
(7.7%) 
1 
(1.9%) 
(3.8%) (1.9'k) 
Prc);cnl 1 
(1.9<;Q 
3 
(5.8<;; ) 
Data presented arc numlx:r ('if,) of p.lIicnts. 
I 
(L9'j, ) 
or trauma caused by the ocelusion cuti' did not occur in th is 
patient group. 
Coronary angiOS{;{lPY revealed both intraeoronary thrombus 
and dissection in many angiographically unremarkable vessels. 
Intracol'onary thrombus. All intraluminal filling defects 
fulfilling the criteria for thrombus that were observed with 
angiography were confirmed by angioscopy as representing 
in!racoronary thrombus. The angioscopie score of thrombus 
versus the absence or presence of thrombus at angiography is 
presented in Table 3. Angiographic evidence of thromhus was 
reported in only six cases. Angioscopy, by contrast, revealed 31 
(59.6%) cases of intracorollary thrombus, varying from a single 
lining thrombus to large occluding thrombi. The distrihution of 
the colors of the thrombi that were detected was as follows: 24 
cases of red thromhus, 6 cases of mixed thrombus and 1 purely 
white thrombus. 
Table 4 shows the presence or absence (angioscopy grade 
>2) of thrombus in a 2 X 2 cross-table. There is agreement 
between angiography and angioscopy in 21 cases (40.4%) with 
regard to the absence of thrombus and ill 6 cases (11.5%) with 
regard tn the presence of thrombus. However, no fewer than 
25 (48.1%) angioscopically observed thrombi remained unde· 
tected at angiography. This underdetection was independent of 
the thrombus color; in othe r words, white or mixed thrombus 
was missed by angiography as often as red thrombus. COIl1-
p<lred with angioscopy, there were no false negative angio-
graphic thrombu.~ obselvations. There was a weak but signifi-
cant correlation between angiographic and angioscopic 
presence or absence of thrombus (r<l' = 0.30, P ;= 0.03) . A 
typical example of intracorunary thrombus formation detected 
by <lngioscopy bu t obscured by angiography is presented in 
Figure I. 
Scnsitil'ity and spcritirity. On the basis of these findings, as 
well as on previous publications (9,14,22- 24), angioscopy can 
be rcgmded as the most reliable means of in vivo detection of 
Table 4. Angiuscopic Versus Angingraphic Thmmhus 
Angiogr~ph ic 
Thromuus 
Angioscnpi(' ll1Tomhus (2:gratk 2) 
Ahsenl 
Prese nt 
Absettt 
21 
(4I1A'Ii ) 
D~t.t prcsctJlcd are tlumhn (<'/,) of palicnls. 
Present 
2S 
(~8.t%) 
" (llj'fl; ) 
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Figure 1. Coronary angiogram (left anterior oblique view with cranial 
angulation) showing a signillcanl stenosis in Ihe left anlerior descend-
ing wronary artel),. The lesion hilS <1 smooth angiographic lIppearance. 
without filling defects suggestive or inlracoronary thrombus. Coronary 
angioswpy reveals Iwo fairly large red thrombi located on the 
proximill side of the eccenlric narrowing. 
intracoronalY thrombus. Accordingly, to enhance the interpre-
tation of our data, we used angioscopy as the standard to calculate 
the sensitivity and specificity of angiography for thrombus. Al-
though the specificity of angiography for thrombus was 100%, 
sensitivity was velY low at 19.4%. The positive predictive value 
was 100%; the negative predictive value 45.7%. It can be argued 
that the allgiographic criteria for thrombus (intraluminal filling 
defect surmunded by contrast in Illultiple projections) allow 
detection of only larger, IUlTlen space-occupying thrombi (25). 
FurthellllOre, although the angioscopic presence of red thrombus 
haS heen validateu in a postmortem study by Siegel et al. (14), it 
can he argued that wall hemorrhage after angioplasty may he 
misinterpreted as lining red thrombus. TIlerd'orc, we recalculated 
these variables enunting only protruding thromhi (grade 4 or 
more) as positive angioscopic thrombus obselvatiolls, disregard-
ing mural, lining thrombi. This had only a minOT innuencc on the 
oUlcome: Sensitivity of angiography for thrombus using angios-
copy as the standard was 22.2%, specil1city 90.7%, positive 
predictive value 33.3% and negative predictive value 84.8%. 
Dissection , Table 5 represents the comparison of angio-
graphic and angioscopic dissection. Type A, 8 and Dl dissec-
tions were seen with angiography in these patients. There 
appeared to be no relation to angioscopic intimal dissection 
grade (Spearman correlation coefficient 0.21, p = 0.14) . The 
variahles were dichotomized to test whether the angioscopic 
Table 5. Angioscopic Dissection Grade Versus Angiogrllphic 
Dissection Type 
Angiography 
No disseclion 
Type A tlisscctiotl 
Typ~ B dis.~~[tilln 
Type 01 tlis,,"etion 
Atlgioscopic lJissec tiotl Grade 
(no tli~~ection ) (~m~1l di~rurtion~) (targt! dissection) 
iO 
(19.2'4) 
(3.S'it) 
(17..1'1 ) 
I 
(1.9'1-) 
is 
(.HNf ) 
2 
(.un) 
(17.3'1 ) 
Data pr<'se ttled are number ('"i-) of patients. 
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Table 6. Angioscopic Versus Angiographic Dissection 
Angiographic 
Dissection 
Angioscopic Dis.'leclion (""grade 2) 
Absent 
Present 
Absent 
10 
(11,1,2%) 
2 
(3.8%) 
Data prcsented are number (%) of palients. 
Present 
27 
(5 t.9%) 
]J 
(25.(1%) 
presence or absence of dissection had a relat ion to any type of 
angiographic dissection (Table 6). These data show angio-
scopic dissect ion in 40 patients (76.9%) versus angiographic 
dissection in 15 patients (28.8%), again without any correlation 
(r." = 0.15, P = 0.29). There were two cases of angiographie 
dissection that were not detectcd by angioscopy. Surface 
disruptions arc typically seen with angioscopy aftcr halloon 
angioplasty (4,12), as was the case in all postangioplasty 
observations in this study. Small surface disruptions, like small 
thrombi , may easily be missed with angiography and may not 
have clinical consequences. These small flaps may even be 
regarded as the "normal" aspect of the vascular wall after 
balloon angioplasty. For this reason the analysis was repeated, 
comparing only large angioscopic dissections with all types of 
angiographic dissections, but, again, it did not yield a signi fi-
cant correlation between the two imaging methods (r", = 0.23, 
P = 0.10). Figure 2 shows an example of a dissection found 
with angioscopy that was not visible on the angiogram. 
Discussion 
Contrast cineangiography is accepted as the standard im-
aging method for the coronary arteries. Although angiography 
provides ind ispensable anatomic information and has set the 
standard for quantifying stenotic lesions (26) both before and 
after angioplasty (27), it can be questioned if it still should be 
regarded as a sufficient means of imaging for studies that 
require a reliable detection of intracoronary thrombus and 
intimal dissection. The value of such angiographic studies must 
be open to question, particularly if they address the sequelae of 
intracoronary thrombus (28-32). 
Implications. Adequate angioscopic evaluation of intra-
coronary thrombus can have an impact on routine patient care 
as well , for instance, in the dctermination of the optimal 
management in cases of suboptimal angioplasty result or 
abrupt reclosu re. Al l nine patients in this study with protruding 
thrombi (;=:grade 4) at angioscopy were treated with adju nctive 
intraeoronary thrombolysis. lntraeoronary thrombus was 
present in 8 of the 15 pat ients who undetwent angioscopy 
before angioplasty (six cases grade 3, and two cases grade 4 
thrombus). All of these eight patients had unstable angina, as 
opposed to two of seven patients without intracoronary throm-
bus before angioplasty. This higher illcidence of thrombus in 
patients with unstable angina is in accord with other angio-
scopic studies (5,6,24). Sassower et al. (33) and Knopf et al. (8) 
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Figure 2. Po~tangiop[asty commlTY angiogram (Ief! anterior oblique 
view) of the right coronary artery with an angiographically optimal 
result, without evidence of dissection. At angioscopy, a targe intimal 
dissection with while mobile flaps is observed. 
have identified the clinical relevance of reliable angioscopic 
thrombus detection during coronary angioplasty in cases of 
abrupt closure, unstable angina and acute myocardial infarc-
tion. We previously reported two cases of subacu te stenl 
occlusion where angioscopy helped to distinguish dissection 
from thrombosis as the primary cause (34). 
TIle high sensitivity of angioscopy for the detection of throm· 
bus potentially has clinically relevant implications. Used before 
the intervention, angioscopy may predict a high incidence of acute 
or abrupt closure if intracoronary thrombus is detected. Another 
potentially useful application of angioscopy is in the emergency 
situation: when an acute ()(.'Clusion occurs or threatens to occur 
after angioplasty, it is of utmost importance to be able to 
differentiate between thrombus and dissection as the primary 
cause for this adver;se outcome. The selection of the optimal 
emergency strategy, such as stent implantation, prolonged infla-
tion of autoperfusion balloon catheters or intracoronary throm-
bolysis, could be facilitated byangioscopy. 
This study was undertaken to compare Objectively the 
usefulness of angioscopy and conventional angiography for 
detcction of intracoronary thrombus and in timal dissection. 
Contrasting conclusions may be drawn from the findings with 
respect to these respective diagnoses. Thc sensitivity and 
specificity of angiography for thrombus detection clearly indi-
cate that angiography underestimates the prcsenee of throm-
hus. The vast majority of angioscopical1y observed thrombi 
rcmain obscured at angiography. For dissect ion, however, 
angiography and angioscopy appear to bc complementary 
imaging techniques. There were two cases in which angioscopy 
missed the dissection although it was evident on the angio-
gram. Both were type B dissect ions, with a fill ing defect 
parallel to the lumen that must have remained hidden from 
angioscopic view. Dissection was not seen on angiography in 
the IS patients who were studied before angioplasty. With 
angioscopy, dissection was scored in nine of these patients (six 
cases grade 2 and three cases grade 3 dissection). It is likely 
that angioscopically observed dissections in this prea ngioplasty 
situation represent spontaneous dissections or ruptured 
plaques. 
Study limitations. Our study has the limitations of a retro-
spective investigation. Not all types of dissection were present 
fAce Vol. 24, N(). -' 
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in this group, which included patients with both preangioplasty 
and postangioplasty lesions. As a result, a positive correlation 
betwcen angiographic dissection type and angioscopic dissec-
tion grade may not be excluded but may merely not have been 
confirmed with this Iimitcd number of 52 paired observations, 
We found a considerable angiographic underestimation of 
thrombus. This may result in part from tbe strict angiographic 
critcria for thrombus. More libcral criteria undoubtedly would 
result in increased sensitivity at the cost of a much lower 
specificity. Another problem, which may result in inaccurate 
estimation of angiographic sensitivity and specificity for throm-
bus and dissection, arises from the difficult angiographic 
distinction between these two diagnoscs. Thrombi may have 
been misinterpreted as dissections, and vice versa. In five of six 
cases of angiographic thrombus, dissection was present as well. 
There were four cases of angiographic thrombus that corre-
lated with angioscopic lining thrombus. By contrast, because 
lining mural thrombus is not very bulky, in gencral it would not 
be detected by angiography (25), so it is highly probable that 
the lumen filling defects that were observed in these cases were 
caused by concomitant dissection. In fact, thcre proved to be a 
large angioseopic dissection (grade 3) in thrcc of thcse four 
cases, and small surface disruptions (grade 2) in one case. 
Thus, an even lower angiographic sensitivity for thrombus may 
have been found if a differcnt patient group, with intracoronary 
thrombus but without dissection, had been studied. 
Intravascular ultrasound imaging is another new imaging 
tool for intraluminal structures (as well as for vascular wall 
properties). Although it does not have ideal properties for 
thrombus detection, intraluminal ultrasound imaging has the 
potential for superior imaging of intimal dissection (35-38), 
with thc ability to discern plaque fracture from more extensive 
disruption that includes the internal elastic lamina. Future 
studies should address the combined use of all available 
coronary imaging techniques. 
Conclusions. Coronary angiography considerably undcres-
timates the presence of intracoronal1' thrombus. In studies that 
requirc reliable detection of thromhus, coronary angioscopy is 
the imaging tool of choice. Angioscopy and angiography are 
complemental1' techniques for detcetion and grading of inti-
mal dissections. 
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CHAPTER 4 
QUANTITATIVE CORONARY ANGIOGRAPHY DURING 
CORONARY ANGIOPLASTY WITH A SINGLE ANGIOGRAPHIC 
VIEW: A COMPARISON OF AUTOMATED EDGE-DETECTION 
AND VIDEODENSITOMETRIC TECHNIQUES. 
Escaned J, Foley DP, Haase J, Di Mario C, 
Hermans WR, de Feyter PJ, Serruys PW. 
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Quantitative angiography during coronary 
angioplasty with a single angiographic view: A 
comparison of automated edge detection and 
videodensitometric techniques 
Little information is available on the reliability of coronary luminal measurements obtained from 
quantitative analysis of a single angiographic view, an approach that is central to the practical 
use of on-line quantitative angiography. In the present study we investigated the contribution of 
two different techniques of quantitative angiography, edge detection (ED) and videodensitometry 
(VD), to the application of this concept during coronary angioplasly. Forty-six balloon angioplasty 
procedures were included in this study, all of them performed in a stenosis located in the mid 
right coronary segment. This coronary location was chosen to optimize data collection on luminal 
morphology and to minimize the number of factors that may adversely affect quantitative 
analysis with both techniques. In all cases two orthogonal angiographic projections were 
obtained before, after balloon dilatation, and at follow-up. Correlation coefficients and 
differences between orthogonal measurements obtained with each technique were used to 
evaluate the agreement between orthogonal readings at every stage of the procedure. The 
obtained correlation coefficients and mean differences (MD) between orthogonal measurements 
were as follows: before percutaneous transluminal coronary angiography (PTCA), 0.67 (MO 
0.01 ± 0.47 mm2) and 0.57 (MO 0.05 ± 0.64 mm2) for ED and VO, respectively (Pitman's test for 
SO, p < 0.05); after balloon dilatation, 0.32 (MD -0.56 ± 1.53 mm2) and 0.53 (MD -0.15 1: 1.43 
mm2) for ED and VO, respectively (paired t test for MO, p < 0.05); and at fot/ow-up 0.79 (MD 
- 0.15 ± 0.97 mm2) and 0.73 (MO 0.17 ± 1.16 mm2) for ED and VD, respectively (p ~ NS). The 
presence of coronary dissection did not influence the variability in measurements observed after 
balloon dilatation. A considerable variability between orthogonal cross-sectional area 
measurements obtained with ED and VO was observed at all stages of coronary angioplasty, a 
finding that does not support the clinical application of area measurements with ED or VO from a 
single view. Similar observations were made after the exclusion of angiographically evident 
dissections. However, after balloon dilatation the agreement between orthogonal area 
measurements was significantly better with VO than with ED. Our results provide new inSights 
into the problems posed by coronary intervention with respect to the on-line angiographic 
assessment of such interllention and to the potential solution of these problems. With either of 
these two quantitative techniques, area measurements obtained from a single angiographic view 
should be interpreted with caution. (AM HEART J 1993;126:1326-33.) 
Javier Escaned, MD, David P. Foley, MB, ChB, MRCPI, Jurgen Haase, MD, 
Carlo Di Mario, MD, Walter R. Hermans, MD, Pim ,J. de Fey tel', MD, PhD, and 
Patrick W. Serruys, MD, PhD Rotterdam, The Netherlands 
The growing demand for the use of on-line quantita~ 
tive angiography during interventional procedures is 
currently hampered by two major limitations. First, 
although averaging of measurements obtained in 
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different angiographic views is accepted as the opti-
mal method for quantifying coronary stenosis,l-:! this 
approach appears too cumbersome for its application 
during coronary intervention. Second, quantitative 
analysis of intervening segments appear to be less 
reliable than that performed in nonintervening seg-
ments.3.7 It remains unclear whether either of the two 
main alternative techniques of quantitative analysis, 
namely videodensiLometric and edge detection, can 
offer a distinct solution to these problems. The rou-
tine use of quantitative angiography would be facil-
itated and more widely applied during interventional 
procedures if accurate measurements could be ob-
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tained from t.he analysis of a single angiographic 
view, To that end, videodensitometry might be the 
most preferable technique since, at least theoreti-
cally, measurements are independent of the angio-
graphic projection used. Other authors8 have sug-
gested that analysis of a selected single angiographic 
view, using edge detection, may also be accurate 
enough for clinical purposes. With respect. t.o the loss 
of accuracy of quantitative angiography postinter-
vention, no clear agreement has been reached on the 
mechanisms causing increased variability of mea-
surements in the int.ervening segment. If this IS the 
result. of complex changes in luminal geometry, vid-
eodensitometry might be the method of choice, since 
luminal area measurement by t.his technique is inde-
pendent of lumen morphology. However, up to now 
videodensitometric studies in the context. of balloon 
angioplasty have yielded conflicting results.4-7, 9, 10 
To shed further light on these topics, we investi-
gated the degree of agreement between cross-sec-
tional area measurements obtained in two orthogonal 
angiographic projections during balloon angioplasty. 
Our first objective was to test whether the use of a 
single angiographic view is sufficiently accurate fm 
its clinical use. Furthermore, we wanted to test 
whether in this regard videodensitometry is superior 
to edge detection analysis. Finally, we investigat.ed 
whether the agreement between measurements ob-
tained in two orthogonal views changes significantly 
during the different stages of coronary intervention. 
By limiting the study t.o a selected coronary segment 
with ideal characteristics for both videodensitometry 
and edge detection, the effect of luminal changes 
caused by balloon dilatation on both types of quan-
titative analysis was highlight.ed. Edge detection and 
videodensitometry analysis were performed sepa-
rately. Qualitative analysis of the dilated segment 
was also performed to assess the impact of angio-
graphically evident dissection on single-plane analy-
sis and on both modalities of quantitative angiogra-
phy. 
METHODS 
Study population. The study population consisted of 
653 patients having balloon angioplasty procedures who 
were included in the efficacy analysis of the Multicenter 
European Research trial with Cilazapril after Angioplasty 
to prevent Transluminal coronary Obstruction and Rest-
enosis (MERCATOR).!1 The study showed that ciiazapril, 
5 mg twice a day, does not influence the development of 
restenosis or of patient clinical outcome during the first 6 
months after balloon angioplasty. All 653 patients had had 
a successful procedure and underwent follow-up angiogra-
phy at 26 ± 3 weeks after the procedure or earlier if symp-
toms had recurred. All 72 percutaneous transluminal cor-
onary angiopiasty (PTCA) procedures performed in a mid 
right coronary artery stenosis were initially considered. 
Escaned et at. 
This segment was chosen as presenting the ideal anatomic 
characteristics for quantitative angiographic analysis: min-
imal foreshortening in the right and left anterior oblique 
views, few side branches, and virtual absence of vessel 
overlap. Lack of orthogonal angiographic projections or 
follow-up angiography, and total coronary occlusion at any 
stage of the study were exclusion criteria. 
Image acquisition. Image acquisition was standardized 
to ensure exact reproducibility of the measurements before 
PTCA, after PTCA, and at foHow-up. The same angio-
graphic angulations were used throughout the study. In· 
tracoronary nitrates (nitroglycerine, 0.3 mg, OJ· isosorbide 
dinitrate, 1 mg) were given before image acquisition to en-
sure full vasodilation of epicardial vessels. So that they 
could be used as a scaling device during quantitative anal-
ysis, all catheter tips were filmed empty of contrast medium 
before each injection and were stored after the procedure 
for future micrometric measurement.12 
Quantitative angiographic analysis. All 35 mm films 
were analyzed at acore laboratory (Cardiaiysis, Rotterdam, 
The Netherlands) using the Cardiovascular Angiography 
Analysis System (CAAS). The automated edge detection 
and videodensitometric techniques used in this system 
have been described in detail elsewhere,I:1-Hl as has its val-
idation in vitr013 and in vivo using precision-drilled acrylic 
plastic models inserted percutaneously in a in vivo swine 
model. 17, 18 All measurements were performed in end-dias· 
tolic frames with optimal vessel opacification. Before 
quantitative analysis, all contour positions of the catheter 
tip and arterial segment were corrected for pincushion dis-
tortion induced by the individual intel1sifiers. 
Edge detection. After a region of interest measuring 
512 X 512 pixels was selected and digitized using a high-fi-
delity charge-coupled device (CCD) videocamera, luminal 
edges were detected using a weighted sum of the first and 
second derivative functions of the brightness profile of each 
vessel scan line. A diameter function was determined by 
computing the shortest distance between the left and right. 
contour positions. Conversion of these measurements to 
absolute values was achieved by using the catheter tip as 
a scaling device. From the diameter fUnction, a computer-
derived estimation of the original arterial dimension at the 
site of obstruction or an interpolated reference diameter 
was also calculated. 
Videodensitometry. Videodensitometry is based upon 
the existing relationship between the attenuating power of 
the lumen filled with contrast medium and the x-ray image 
intensit.y. From this information a densitometric profile 
that is proportional to the cross-sectional area of the lumen 
was obtained. Subtraction of patient structure noise was 
applied after computing the linear regression line through 
the bacltground pixels located left and right of the detected 
luminal contours. A cross-sectional area function on the 
analyzed segment was obtained by acquiring consecutive 
densitometric profiles in all scan lines perpendicular to the 
vessel. From this area function an interpolated reference 
area was calculated in a similar way to that described in the 
edge detection algorithm. Conversion of the individual 
videodensitometric profiles to absolute values was per-
formed after a transformation of t.he videodensitometric 
profile found at the reference diameter with the corre-
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sponding geometric area (calculat.ed from the reference di-
ameter and assuming a circular cross sect.ion at that point). 
The cross-sectional area at. the narrowest point was iden-
t.ified and was expressed in square millimeters. No correc-
tion for veiling glare was introduced. 
Assessment of dissection. Coronary dissection follow-
ing balloon angiopiasty was recorded by two independent 
observers using a modification of the criteria defined by the 
Nationtl.l Heart, Lung, and Blood Institute. l !) A dissection 
was classified as a small radiolucent area within the lumen 
of the vessel (type A), a nonpersist.ing or persisting ex-
travasation of contrm;t medium (type B 01' C, respectively), 
a spiral-shaped filling defect with or without delayed ante-
grade flow (types Rand D, respect.ively), or a Jilling defect 
causing total coronary occlusion (type F). The presence of 
angiographic dissection may constitute a source of vari-
ability during quantitative analysis. Following the recom-
mendations of the angiographic committee of the MER-
CATOR study, identification of t.he luminal borders in 
vessels with evident angiographic dissection was performed 
always using the automated edge detection mode with no 
manual correction by the analyst. In this way, subjective 
bias was minimized. 
Statistical analysis. Mean values ± standnrd deviation 
were calculat.ed for all measurements obtained before 
PTCA, after PTCA, and at follow-up. Pearson's product 
moment correlation coetlicients were calculated for orthog-
onal measurements. The agreement between orthogonal 
measurements was also studied using the mean (accuracy) 
and the standard deviation (precision) of the differences 
between measurements obtained in orthogonal views.2o 
quantitative data were compared using one-way analysis of 
variance. Paired two-tailed t tests were used when required 
to compare mean values. Comparisons between standard 
deviations were performed using Pitman's test. A p value 
<0.05 was considered statistically significant. 
RESULTS 
Of the 72 successful PTCA procedures performed 
in the midsegment of the right coronary artery, eight 
were total occlusions at baseline or follow-up and 
were excluded. In addition, 18 cases lacked satisfac-
tory orthogonal angiographic assessment and were 
also excluded. The remaining 46 cases constitute the 
population of this study. Orthogonality between 
right and left anterior oblique views was 90.00 ± 
14.43 degrees. Coronary dissection immediately after 
PTCA was documented in 16 cases. The dissection 
was classified as type A in six cases, type B in nine 
cases, and type E in one case. Negative videodensit-
ometric measurements were obtained in two cases 
before PTCA and in one case at follow-up. The cause 
of negative readings may be found in an excessive 
background subtraction when bright areas are close 
enough to the analyzed vessel to fall within the region 
of interest. These cases were excluded only from the 
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analysis at that particular stage of the study (pre-
PTCA and follow-up, respectively). 
The mean minimal luminal cross-sectional areas 
(±SD) obtained by averaging videodensitometry 
values from orthogonal views were 1.00 ± 0_96, 
3.1 ± 1.68, and 2.6 ± 1.fiO mm 2 before PTCA, after 
PTCA, and at follow-up, respectively. Averaged edge 
detection measurements were 1.11 ± 0.53, 3.17 ± 
1.05, and 2.63 ± 1.31 mm2, respect.ively. 
Fig. 1 shows the correlation bet.ween pairs of 
orthogonal measurements obtained by using either 
videodensitometry or edge detection. The degree of 
agreement between these values is further illustrated 
with the mean difference between both measure-
ments and its standard deviation (Fig. 2). Before an-
gioplasty, the accuracy of measurements obtained 
from a single view is similar using videodensit.ometry 
or edge detection (mean difference -0.05 and -0.01, 
respectively), although the precision of edge detec-
tion was significantly higher than that of videoden-
sitometry (standard deviations 0.47 and 0.64 mm~ for 
edge detect.ion and videodensitomet.ry, respectively, 
p ~ 0.023). 
After balloon dilatation, the agreement between 
ort.hogonal measurements decreased for both video-
densitometry and edge detection. The mean differ-
ence between orthogonal values was -0.15 ± 1.43 
mm~ and -0.56 ± 1.53 mm 2 1'01' videodensitometry 
and edge detection, respectively (p < 0.05). To in-
vestigate the contribution of vessel dissection to t.he 
observed loss of agreement. between orthogonal mea-
surements, the same analysis was applied separately 
t.o vessels with and without dissection (Fig. 3). No 
significant. difference in the mean value or in the 
standard deviation of the difference between orthog-
onal values was found between groups. 
At follow-up, the difference between orthogonal 
views was 0.17 ± 1.16 mm2 and -0.15 ± 0.97 mm 2 
for videodensitometry and edge det.ection, respec-
tively. There was nO significant difference in the pre-
cision of these measurements. 
To study the contribution of recorded vessel dis-
section to the loss of agreement bet.ween orthogonal 
views after balloon dilatation, a separate analysis of 
the between-projection differences in minimallumi-
nal area was applied to vessels with and without dis-
section (Fig. 3). The mean difference in cases without 
dissection was -0.62 ± 1.21 mm and -0.19 ± 1.49 
mm2 for edge detection and videodensitometric mea-
surements, respectively. In those cases with angio-
graphically det.ectable dissection, the differences ob-
tained were -0.46 ± 2.04 mm and -0.06 ± 1.35 mm2 
for edge detect.ion and videodensitometric measure-
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Fig. 1. Correlation between minimal luminal cross-sectional area measurements obtained in two orthog-
onal projections, The results obtained with automated edge detection and videodensitometric analysis in 
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ED, Edge detection; VD, videodensitometry. 
ments, respectively. No significant differences in ac-
curacy or precision were found with respect to the 
type of analysis applied (edge detection or videoden-
sitometry) or to the presence or absence of recorded 
coronary dissection. 
DISCUSSION 
Edge detection and videodensitometric algorithms 
are built-in features of most new digital angiographic 
systems, a fact that may contribute to the widespread 
use of on-line quantitative coronary angiography in 
the near future. Although the performance of quan-
74 
titative analysis from a single angiographic view is 
central to the practical use of these systems during 
routine procedures, little information is available on 
the variability between measurements obtained from 
orthogonal views. It has been argued that a signifi-
cant variability would be expected when non circular 
lumens are measured from different angiographic 
projections. Two main alternatives have been put 
forward to solve this problem. Lesperance et a1.8 sug-
gested that limiting the analysis to the angiographic 
view in which the stenoses appears most severe might 
fulfill the degree of accuracy required in clinical 
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Fig. 3. Mean differences between minimal luminal cross-sectional area measurements obtained in two or-
thogonal projections immediately after balloon dilatation. Results obtained in cases with and without. an-
giographically detectable dissection are shown separately. The mean difference ± 1 standard deviation 
(shadowed area) is shown. ED, Edge detection; VD, videodensitometry. 
practice. A second approach, based on initial results 
obtained in in vitro phantoms, suggested that the use 
of videodensitometry would be advantageous, since 
accurate measurements were obtained independent 
of angiographic projection and lumen morpholo-
gy.'~' 21, 22 Validation studies of videodensitometry in 
conditions closer to those found in clinical practice 
have been performed, including videodensitometry 
in postmortem specimens23 or in engineered angio-
graphic phantoms implanted in animal models. 18,24 
However, conflicting results have been reported when 
videodensitometry was used during coronary angio-
plasty. The correlation for individual measurements 
obtained in orthogonal views both before and after 
balloon angioplasty has been found by different au-
thors to be high,S moderate,5 or poor.4 The deteriora-
tion caused by balloon angioplasty in the agreement 
of videodensitomet.ric measurements obtained from 
different angulations has also been reported in one 
study and was found to be unacceptably large. 6 
Two of the objectives of the present study were to 
test whether the use of a single angiographic view is 
sufficiently accurate for clinical use, and whether in 
such regard the use of videodensitometry offers any 
advantages over edge detection. We found that in the 
postangiopJasty period videodensitometry yields a 
significantly better agreement between orthogonal 
measurements than edge detection. However, further 
analysis of the results obtained (Fig. 1, left panel and 
center panel) demonstrated that the clinical rele-
vance of this difference may be negligible. This con-
clusion was arrived at by setting the limits of agree-
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ment as the standard deviation of the differences ob-
served between orthogonal measurements, according 
to the method proposed by Bland and Altman. 2o It 
led us to conclude that the overall variability between 
orthogonal measurements of cross-sectional area ob-
served before and after coronary angioplasty makes 
single-plane quant.itative angiography with either 
edge detection or videodensitometry too unreliable 
to be used in routine clinical practice. Although our 
conclusions are based on the analysis of a single cor-
onary segment and therefore should be extrapolated 
with caution to other vascular segments, the fact that 
the mid-right. coronary segment represents the "best 
scenario" for quantitative analysis makes us believe 
that even worse correlations would be expected if 
other segments of the coronary tree were to be 
included. 
We also investigated whether the agreement be-
tween orthogonal measurements changes signifi-
cantly during percutaneous intervention, In fact, we 
found that the agreement between single orthogonal 
cross-sectional area measurements obtained with ei-
ther of the two techniques considered deteriorates 
significantly after balloon dilatation. Since tearing of 
the intima and atherosclerotic plaque, dehiscence of 
plaque from the tunica media, and variable degrees 
of medial and adventitial disruption are known to be 
common after balloon dilat.ation,25 observations sim-
ilar to ours have been attributed to the effect of these 
histopathologic changes on angiographic accura-
cy,:'l, 4, 6, 26 However, given the characteristics of these 
st.udies, such a relationship could not been clearly 
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Fig. 4. Quantitative analysis of a stenosis in the circumflex coronary artery (A) performed immediately 
after balloon dilatation. Although no angiographic dissection was evident and edge detection analysis sug-
gested a major improvement in luminal area, intravascular ultrasound (8) revealed that the detected edges 
corresponded to a nearly cumplete plaque dehiscence from the surrounding media and that luminal gain 
was clearly overestimated by angiography. During ultrasound imaging a side branch (sb) located at the di-
latation site was chosen as a landmark. 
established; experimental phantoms have a fixed lu-
minal morphology and are free of wall disruption, 
and most previous clinical works have excluded or 
have not recorded the presence of coronary dissec-
tion. 
To provide further insights, we limited the collec-
tion of angiographic data to a coronary segment with 
ideal characteristics for quantitative analysis. In do-
ing so, a true "in vivo vascular phantom" was 
obtained in which the occurrence and type of vessel 
dissection were also documented. As shown in Fig. 3, 
one of our conclusions is that the increased variabil-
ity between orthogonal measurements observed after 
balloon angioplasty may not be ascribed solely to the 
presence of angiographically evident dissection. This 
suggests that lesser or occult changes in vessel mor-
phology must account for the loss of accuracy of 
quantitative angiography at this stage. Two major 
types of changes may account for this phenomenon. 
The first is the presence of intraluminal flaps and ir-
regularities not actually identified angiographically 
but present after balloon dilatation, as reported in 
angioscopic,27, 28 ultrasound,29 and pathologic stud-
ies.30 When opacified during angiography, these ir-
regularities can be wrongly identified as the true lu-
minal borders by edge detection algorithms, leading 
to a false estimation of luminal diameter. The second 
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is the change to noncircular lumen geometry conse-
quent to balloon dilatation. 25 Pathologic studies have 
shown that slit-like or very irregular lumens are 
rarely seen in native vessels with noncom plica ted 
atherosclerotic plaques;ql a fact that may explain the 
excellent agl'eement between orthogonal measure-
ments obtained with both edge detection and video-
densitometry in an in vitro study using human cor-
onary stenosis,23 as well as the better agreement be-
tween orthogonal edge detection measurements 
found at baseline in the present study (Figs. 1 and 2). 
These two potential sources of error are illustrated in 
Fig. 4, where the result of balloon dilatation in a cir-
cumflex stenosis is assessed using edge detection 
quantitative angiography and intravascular ultra-
sound. 
It has been shown above that, although the overall 
variability in orthogonal cross-sectional area mea-
surements was very high, videodensitometry was less 
influenced by balloon dilatation than was edge de-
tection. This observation may be related to video-
densitometry's theoretical independence from lumen 
morphology and to its relative insensitivity to im-
precise border positioning.22 In addition, although 
videodensitometry's application may be currently 
hampered by technical factors (for example, unsatis-
factory background subtraction), it may in the future 
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Pre PTCA Post PTCA Follow-up 
Fig. 5. Proposed anatomopathologic basis for the loss of agreement between orthogonal measurements 
during the different stages of balloon angioplasty. Following balloon dilatation the luminal cross-sectional 
area is overestimated by the use of geometric measurements (dotted circles) as a result of the identification 
of disrupted edges as true luminal borders and because ofthe noncircular luminal geometry. Healing oflu-
minal disruption leads to a more regular luminal morphology and to a better agreement between orthog-
onal measurements at follow-up (see text for details). 
constitute a valid alternative to averaging of multiple 
views. On the contrary, the identification of dis-
rupted luminal edges and the assumption of an un-
likely circular lumen morphology by edge detection 
algorithms easily lead to discrepancies in measure-
ments obtained from a different angiographic view or 
with videodensitometric analysis, as illustrated in 
Fig. 5. In this regard, a previous work26 has shown 
that COl·onary stenting reduces t.he variability be-
tween videodensitometric and edge detection mea-
surements. This is presumably a result. of the scaf-
folding effect of t.he stent on intraluminal irregular-
ities and the achievement of a more circular luminal 
cross section, as documented by intravascular ultra-
sound studies peI"fonned immediately after stent 
implantation. 32 In our work the improvement in 
agreement between orthogonal area measurements 
at follow-up may be explained by the development of 
a more regular luminal cross-section by filling of in-
traluminal flaps and by smoothing of luminal irreg-
ularities during the reparative vessel response that 
follows balloon dilatation25 (Fig. 5). 
Study limitations. Since this study was limited to the 
mid-right coronary artery segment, some of the results ob-
tained are not necessarily applicable to other coronary lo-
cations. Errors can be introduced during the calibration of 
the syst.em when catheters are used as scaling devices.~~ To 
minimize some of the possible sources of error, all catheter 
tips were filmed unfilled, saved after the procedure, and 
micrometered at the time of quantitative analysis. 12 How-
ever, inaccuracies induced by out-of-plane position of the 
catheter may have occurred. Although correction for a pin-
cushion effect in the individual intensifiers was performed, 
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other described sources of distortion cannot be ruled out,3.1 
but their effect on measuremenis of the size range of cor" 
onary arteries is expected to be negligible. The effect of 
some of the physical variables potentially affecting video-
densitometric analysis may be higher in the mid-right cor-
onary than in other coronary segments. Beam hardening 
and veiling glare are more intense in regions of rapid tran-
sition from dark to bright areas,·15 as often happens when 
the mid-right. coronary artery is visualized in the left ante-
rior oblique view. Although it has been proposed by other 
authors,35. 36 no correction for these factors was introduced 
in our analysis. 
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TO EVALUATE EARLY LUMINAL DETERIORATION AND 
FACILITATE QUANTITATIVE ANALYSIS. 
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Usefulness of Repeat Coronary Angiography 24-
Hours After Successful Balloon Angioplasty to 
Evaluate Early luminal Deterioration and 
facilitate Quantitative Analysis 
David P. Foley, MS, SCh, MRCPI, Jaap Deckers, MD, PhD, Arjan A. van den 80S, MD, 
Guy R. Heyndrickx, MD, Gert-Jan Laarman, MD, PhD, Harryanto Suryapranata, MD, PhD, 
Felix Zijlstra, MD, PhD, and Patrick W. Serruys, MD, PhD 
Because of the unavoidable occurrence of vessel 
disruption after successful coronary balloon angi· 
oplasty, the reliability of quantitative angiograptJ.. 
ic analysis in that setting has been questioned. 
For this reason and the suggested occurrence of 
delayed elastic recoil, repeat angiography at 24 
hours has been advocated in clinical intervention-
al trials. In this study, these issues are confronted 
by performing comprehensive quantitative analy-
sis (Cardiovascular Angiographic Analysis System) 
of coronary angiograms, acquired in multiple 
identical projections immediately after and 24 
hours after angioplasty, in 102 patients with 110 
successfully dilated lesions. Vasomotion was con-
trolled by jntracoronary nitrate before angiogra-
phy and all patients were fully anticoagulated (ac-
tivated partial thromboplastin time 85 to 120 sec-
onds) for >24 hours. Paired Student's ttests 
applied to angiographic measurements revealed 
that there was no significant deterioration in mini-
mal luminal diameter or cross-sectional area from 
immediately after angioplasty to 24 hours later. It 
can thus be inferred that there is no phenomenon 
of delayed elastic recoil, at least during this time 
period. Measurement accuracy and precision of 
the Cardiovascular Angiographic Analysis System 
from the postangioplasty angiogram are highly 
acceptable, at <0.01 and ± 0.20 mm, respectively. 
Therefore, it is concluded that routine repeat 24-
hour angiography is not indicated after success-
ful angioplasty. A highly significant increase (p 
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<0.001) in reference diameter (+0.11 ± 0.18 mm) 
was responsible for the apparent increase in pe,.. 
cent diameter stenosis (2.4 ± 7%), a finding that 
demonstrates the potential for error by selective 
application of percent diameter stenosis measure-
ments alone. Preferential use of absolute luminal 
measurements is thus strongly recommended for 
clinical trials with angiographic monitoring. 
(Am J CardioI1993;72:1341-1l47) 
Computer-assisted quantitative analysis systems have become the gold standard for measuring coronary angiographic luminal dimensions, as 
demonstrated in clinical studies of interventional devices 
and phannacologic agents <lUlled at "restenosis preven-
tion".1-5 However, one of the main criticisms of quanti-
tative angiography has been the potential measurement 
inaccuracy and imprecision immedi<ltely after apparent-
1y successful balloon <lngioplasty.6 DisnJptions of vessel 
luminal contour almost always occur,7-9 although only 
seen angiographically as "dissection" in one third of 
cases,IO It could thus be hypothesized that angiography 
24 hours after intervention might provide a better sub-
strate for the measurement of luminal dimensions in 
clinical studies, 1 1 Moreover, bec<luse up to 50% of 
achiev<lble luminal increase may be lost immediately af-
ter balloon deflation, due to elastic recoil,12 it could be 
suggested that repeat early angiography should be per-
formed to assess the probability of further delayed elas-
tic recoil. Such practice could lead to prolonged hospi-
talization and additional risk of morbidity, an increase in 
the work load of the medical staff of catheterization lab-
oratories, and ultimately, increased health care costs. 
Furthennore, routine angiography at 24 hours could re-
duce the likelihood of infonned consent for percutane-
ous interventions, especially in clinical trials. This study 
investig<ltes the need for repeat angiography 24 hours 
after successful balloon <lngioplasty and provides an op-
p0l1unity to examine the postangioplasty measurement 
variability of the C<lrdiovasclliar Angiographic Analysis 
System, hitherto unpublished. 
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TABLE I Flow Chart from Randomization in the Safety Trial to 
Suitability for This Quantitative Angiographic Ancillary Study 
Number of 
Patients 
Patient enrolled in randomized study 118 
Patients excluded after enrollment 
No angioplasty performed 
Failure to cross lesion 4 
Previously unrecognized left main lesion 1 
Took heparin during previous 24 hours 3 
Randomized to receive heparin or hirudin ITO 
Failure to successfully dilate all target lesions 2 
Major adverse cardiac events within 24 hours 
Death 0 
Myocardial infarction 1 
Emergency bypass graft surgery 3 
Myocardial infarction + emergency surgery 1 
Repeat angioplasty 0 
Complete (thrombotic) occlusion at 24 hours 1 
wilhout major adverse event -
Successful angioplasty + salisfaclory quantitative 102 
analysis postangioplasty + 24 hrs 
METHOOS 
Patients: The study population comprised 102 pa-
tients who underwent successful balloon angiopla<;ty of 
110 lesions and had quantitative coronary angiography 
perronned before, immediately after, and 24 hours after 
angioplasty as part of a safety and efficacy trial of a new 
anticoagulant preparation, details of which are published 
elsewhere. 13 The study was performed in full accor-
dance with the principles of the "Declaration of Helsin-
ki," as well as specific local laws and regulations of 
each participating center. Before randomization, each pa-
tient gave written informed consent according to the 
requirements of the local institution. 
Table I displays the source of the 102 patients as-
sessed in this study. The aim of this study was to focus 
on luminal dimensional changes occuning during 24 
hours, and assess the reliability of the angiogram imme-
diately after angioplasty for quantitative analysis. There-
fore, only patients with successfully dilated lesions and 
quantitative angiographic analysis both immediately 
after, and 24 hours after angioplasty were included in 
the study. Successful angioplasty was defined according 
to the conventionally applied method in clinical practice 
and trials4.5 - a diameter stenosis <50% after angio-
plasty, as visually assessed by the interventionalist. Clin-
ical outcome of the remaining 16 patients in the safety 
and efficacy trial, who were not included in this study, 
has been described elsewhere. i3 The patient population 
is, in general, demographically representative of modem 
clinical experience with coronary balloon angioplasty4,5 
in patients with stable angina (Table II). All patients had 
symptomatic obstructive coronary artery disease of at 
least 1 vessel, which was deemed suitable for treatment 
by angioplasty. The angioplasty procedure itself was per-
formed according to the routine practice of the individ-
ual interventionalist. 
Anticoagulation: Patients were randomly allocated 
to receive intravenous heparin or recombinant hirudin at 
doses sufficient to maintain activated partial thrombo-
plastin time (monitored before, after; and 6, 12 and 24 
lABLE II Clinical Data and Target lesion Distribution in 102 
Patients 
Age (years) 58 (35-74) 
Men (%) 83 (78) 
Previous MI (%) 39 (37) 
Diabetes mellitus (%) 5 (5) 
Hypertension (%) 32 (30) 
Current smokers (%) 25 (24) 
Angiographic coronary disease pattem 
l-vessel disease (%) 87 (82) 
2-vessel disease (%) 17 (16) 
3-vessel disease (%) 2 (2) 
CcS functional classification 
lorll(%) 59 (56) 
IIlorIV(%) 47 (44) 
Medication 
Long·acting nitrates (%) 51 (48) 
~ blOCkers (%) 80 (75) 
Calcium anlagonist ('Yo) 72 (68) 
Acetylsalicylic acid (%) 88 (83) 
Angiographic lesion location of dilated segments 
Left anlerior descending 40% 
Circumflex 30% 
Right coronary artery 29% 
Left main stem 1% 
'" 
Canadian Cardiovascular Society; MI myocardial infarction 
hours after angioplasty) at 85 to 120 seconds for 24 
hours. Dosage adjustments were made accordingly if 
levels were outside this target therapeutic range. Assays 
of prothrombin fragments F j and F2, fibrinopeptide A, 
thrombin-antithrombin III complexes, anti-factor I1a and 
Xa activity, D-dimer, tissue-type plasminogen activator 
and plasminogen activator inhibitor antigen were per-
formed. The collectively analyzed fmdings illustrated 
that, in general, thrombin generation was effectively in-
hibited by both anticoagulants throughout the 24-hour 
study period.13 Thus, it would appear that the antico-
agulant dosage regimens were adequate in each patient 
group. 
Coronary angiographic procedures to facilitate 
quantitative analysfs: Angiograms wele carefully re-
corded according to the requirements of the computer-
assisted Cardiova<;cular Angiographic Analysis System: 
(1) avoidance of projections in which the spine or other 
structures, or closely parallel or overlapping side-branch-
es, obscure the vessel segment of interest; (2) filming of 
the lesion and segment of interest a<; close to the field cen-
ter as possible, and in ::::2, preferably orthogonal, projec-
tions fur the right coronary artery, and ::::3 projections 
(separated by ::::30°) for the left coronary artery, ideally at 
the end of a full inspiration; (3) vasomotion controlled by 
intracoronary nitrate (isosorbide dinitrate 1 to 3 mg or 
glycerol trinitrate 0.1 to OJ mg) before angiography, 
and before, immediately after, and 24 hours after balloon 
angioplasty; (4) to ensure exact comparability of angio-
graphic measurements, angiography was perfonned in 
exactly similar projections (which are precisely recorded 
at each catheterization session) using a fixed-table ap-
proach before, immediately after, and 24 hours after angio-
plasty; (5) coronary artelies were optimally opacified using 
nOrllonic contrast which had been prewanned to 37°C for 
::::3 complete cardiac cycles; (6) guidewire and balloon 
catheter were removed before the final postangioplasty 
THE AMERICAN JOURNAL OF CARDIOLOGY VOLUME 72 DECEMBER 15, 1993 
82 
TASLE III Quantitative Angiographic Measurements Before, Immediately After and 24 Hours After Angiography Given as Means of the 
Multiple Matched Projections ± SD 
Mean Diff, SDofMBanDiff. p Value of 
ImmBdiately 24 HoufsAfter 24 Hours After Mean Dift. 
Before After 24 Hams After (accuracy) (precision) (paired t test) 
MinimalllJminal diameter (mm) 1.03 ± 0.40 1.72 ± 0.36 1.72 ± 0.39 0.007 ±0.20 0.74 
Minimal luminal cross-sectional area (mm2) 0.92 ± 0.85 2.57 ± 1.51 2.64 ± 1.53 0.07 ±0.85 0.42 
% area stenosis (%) 84,9 ± lO.3 57.9 ± 12.8 59.8 ± 14.1 1.9 ±14.1 0.17 
Lesion length (mm) 5.91 ± 1.95 5.71 ± 1.7S 5.75 ± 1.79 0.05 ±1.3 0,72 
Lesion symmetry (ratio) 0.57 ± 0.20 0.50 ± 0.20 0.49 ± O.lS -0,02 ±0.20 0,37 
Interpolated reference diameter (mm)* 2.67 ± 0.64 2.72 ± 0.58 2.83 ± 0.59 0.11 ±O,lS <0.0001 
% diameter stenosis (%) 60.6 ± 12.9 36.3 ± 7.9 38.7 ± 8.7 2.4 ±7.0 0.0005 
Reference area (mm2) 5,95 ± 3,02 6.lO ± 2,73 6.61 ± 2.93 0.51 ±0.84 <0.0001 
Plaque area (mm2) 6.40 ± 3.39 4.30 ± 2.35 4,92 ± 2.S2 0.62 ±1.48 <0.0001 
'The interpolated reference diameter is the computer reconstruction of the original "disease-free" vessel dimensions over the analyzed "egme~t. The,.dual diameter measurement 
take~ as the refere~ce diameter. and thus as the "v""sel sIZe," is the interpotated d,amelrlc me~,uremenl.t the site of the mDst severe narrowing (mlmmalluminal d,ameter), thus 
prov,dlng an objective and user·independentest,mat,on of the actual "normal" d,ameterat that SIte, In the absence of anydosease. 15-11 
Diff. = differeflCe. 
TASLEIV Quantitative Angiographic Measurements from a Total of 308 Individual Projections, Identically Reproduced (matched) 
After Angioplasty and at 24 Hours 
Mean Dift. p VallJeof 
After 24 Hours After 24 Hours After Mean Oiff. 
SlJbsegmentallesion location (subsegmentl-6)* 2.44 ± 1.1 2.43 ± 1.2 -0.01 :t 0.73 0,75 
MinimalllJminal diameter (mm) 1.70 ± 0.40 1.71 ± 0.41 0.0008 ± 0.27 0,60 
Minimal luminal cross·sectional area (mm2) 2.45 ± 1.63 2.50 ± 1.63 0.05 ± 1.3 0,50 
% area stenosis (%) 59.0.:t 18.4 61.3 ± 19.6 2,2 ± 21.2 0.07 
Lesion length (mm) 5.72.:t 2.35 5.81 ± 2.42 0,09 ± 2.07 0.45 
Lesion symmetl)' (ratio) 0.50 ± 0.27 0.49 ± 0.26 0,01 ± 0.31 0.70 
Interpolated reference diameter (mm) 2.70 ± 0.60 2.82 ± 0.59 0,12 ± 0.29 <0.0001 
Reference area (mm2) 6,01 ± 2,Sl 6,55 ± 2.95 0,54 ± 1.35 <0.0001 
% diameter stenosis (%) 36.5 ± 10.4 39.0 ± 11.0 2.5.:t 10.0 <0.0001 
Plaque area (mm2) 4.29 ± 2.92 4.91 ± 3.55 0.62 ± 2.49 <0.0001 
'The Cardiovascular AngioBra~hic AnalySiS System approach automatically subdiVides tile arterial segment to be analyzed (defined from side branch to side branch) i~to 6 
subsegments of"'luallength: a mmimal. mean and maximal diameter are determined (as well as a range of add,tlonal parameters) for each subsegment. The sub,egmeotal tocatlOn ot 
the minimal luminal diameter within the arterial segment can thus be identified and compared over sequential analy,e, 
Values are expressed as mean ± SD 
Diff. = difference. 
angiographic recordings; and (7) to enable accurate 
calibration, the contrast-empty angiographic catheter14 
(at least 7Fr) was filmed before each contrast injection 
and after the procedure, and the distal 20 cm of each 
catheter used was enclosed with the angiogram for micro-
metric measurement at the core laboratory. 
Quantitative and qualitative angiographic analysis: 
In the core laboratory, quantitative angiographic analysis 
was perfonned by independent analysts without any 
knowledge of clinical details, using the Cardiovascular 
Angiographic Analysis System, which has been previ-
ously described in detail elsewhere.15- 17 To facilitate the 
provision of objective, reliable and reproducible mea-
surements, end-diastolic cine-frames were selected for 
analysis from non- or minimally foreshortened pro-jec-
tions by 2 experienced observers. To conliIrn that each 
lesion was quantitatively analyzed in the same projec-
tions on the pre-, and post- and 24-hour angiograms, a 
Polaroid® print was made of each analysis. Absolute lu-
minal measurements were obtained using the known di-
ameter of the angiographic catheter. 14 Corrections were 
automatically made for so-called pincushion distortion, 
in nonisocentrically filmed catheter or target lesion posi-
tions. Comprehensive lesion measurements were provid~ 
ed, including minimal luminal diameter (!vILD), inter-
polated reference diameter, lesion length, plaque area 
and percent diameter stenosis derived as: [(1 - !vILD)/ 
interpolated reference diameter] X 100%). In addition, 
video densitometric measurements of minimal luminal 
cross-sectional area (MLCA), reference area and area 
stenosis were produced. In this study, the averaged val-
ues separately presented for each measurement parame-
ter are means of the multiple projections filmed for each 
lesion and of the individual projections. 
Statistical analysis: Since the focus of the study is 
on potential changes in lesion severity during the 24 
hours after successful angioplasty, a lesion-specific ap-
proach was applied to evaluation of the results. Quanti-
tatively measured and derived values are given as mean 
± SD. Paired Student's t tests are used to compare an-
giographic measurements immediately after and 24 
hours after angioplasty. Accuracy and precision of mea-
surements obtained from the immediate postangioplasty 
angiogram are defined according to the method suggest-
ed by Bland and Altman,18 i.e., accuracy is the mean 
difference between the measurement immediately after 
and 24 hours after angioplasty, and the precision (or 
measurement variability) is the standard deviation of this 
mean difference using the 24-hour measurement as the 
standard against which to compare the measurements 
obtained immediately after angioplasty. Linear regres-
sion analysis and Pearson's product moment correlation 
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coefficient are used to further evaluate the relation be-
tween these measurements. 
RESULTS 
Angiographically visible dissection was present in 
31 % of lesions immediately after successful angioplas-
ty. Of these, 15% were type A, 9% type B and 7% type 
C dissections. 
Table ill shows that no significant change was ob-
served in :MLD or in :MLCA immediately after or 24 
hours after angioplasty. Because of the significant in-
crease in reference diameter, a significant increase was 
also observed in percent diameter stenosis: from 36% 
immediately after to 39% 24 hours after angioplasty 
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(p = 0.0005). Despite the significant increase in refer-
ence area, percent area stenosis did not change signifi-
candy during the 24-hour period, although a trend 
toward increase was observed. The increase in reference 
diameter was also responsible for the observed signifi-
cant increase in plaque area, because the edge-detection 
algorithm calculates plaque area automatically from the 
reference diameter function and the actual detected ar-
terial contours. There was no significant change in le-
sion length or symmetry immediately after to 24 hours 
after angioplasty. 
The postangioplasty accuracy and precision of the 
:MLD measurement was found to be <0.01 and ± 0.20 
mm, respectively (Table III). 
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Considering quantitative measurements obtained 
from each individual projection immediately after and 
24 hours after angioplasty separate measurements, there 
were a total of 308 matched pairs of projections of the 
110 lesions analyzed (Table IV), giving an average of 2.8 
views per lesion. The subsegmentallocation of the MLD 
of the lesion did not vary during this time. Similar to 
the mean overall findings, there was no significant dif-
ference in :MLD, MLCA, lesion length or symmetry 
immediately after angioplasty to 24 hours after angiog-
raphy. A significant increa:;e in reference diameter, ref-
erence area and percent diameter :;tenosis was observed, 
as well as a trend toward an increase in area stenosis, 
confirming the mean overall results. 
The correlation between quantitative angiographic 
measurements immediately after and 24 hours after an-
gioplasty was excellent for ab:;olute luminal measure-
ments of MLD and cross-sectional area (Figure 1), ref-
erence diameter and reference area (Figure 2). However, 
the correlation was not as good for the relative measure-
ment:; of percent diameter and area stenoses (Figure 3). 
Although 4 lesions had detectable deterioration (a 
statistically significant decrease fTom the time immedi-
ately after to 24 hours after angioplasty) in MLD (3 in 
the cross-sectional area), only 1 lesion had a clear dete-
rioration in MLD (Figure 1, left) and 2 in MLCA (Fig-
ure I, right) (from postangioplasty to 24 hours). No suc-
cessfully dilated lesion was considered to require re-
dilatation during or after the 24 hours. 
DISCUSSION 
In thi:; :;tudy we have addressed the issues of reliabil-
ity of the angiogram immediately after angioplasty for 
quantitative analysis and the occurrence of delayed elas-
tic recoil in the first 24 hours after angioplasty by per-
fanning repeat angiography immediately after and 24 
hours after angioplasty. To maximize objectivity in the 
evaluation of the occun'ence of a real phenomenon, we 
10 20 30 40 50 
%Diameter Stenosis post 
60 
attempted to petform the study under "ideal" angio-
graphic conditions. Thus, the angiographic table height 
is kept constant at all stages and exactly the same angi-
ographic projections are repeated for each individual 
patient at 24 hours as done immediately after angio-
plasty. In addition, to avoid the potentially confounding 
influence of vasomotion and thrombosis, intracoronary 
nitrate was administered before angiography, and all pa-
tients underwent complete anticoagulation for the 24-
hour period. 
Whether the mean of the multiple matched projec-
tion:; was considered or each projection was considered 
as a separate measurement, no change in MLD (mea-
sured by an edge detection approach) or in MLCA 
(measured by videodensitometry) was detected from 
immediately after to 24 hours after balloon angioplasty, 
which leads to the following intelpretative statements. 
1. lbere is no need for routine 24-hour angiogra-
phy: After successful balloon angioplasty, immediate 
angiography is just as reliable a substrate for quantita-
tive analysis as angiography at 24 hours. Thus, the pres-
ence of angiograpbically visible but nonocclusive dissec-
lion in 31% of lesions (similar to previou:; reportslO,ll) 
clearly does not unduly intetfere with the quantitative 
analysis. A recent study, examining reliability of post-
angioplasty angiography, stratified patients according to 
whether or not angiographic complications after angio-
plasty occurred, and found a significant difference in 
:MLD (measured by a hand-tracing technique from mag-
nified angiographic images) between post- and 24-hour 
angioplasty in the complicated versus uncomplicated 
groups. J I Although apparently similar, that study and 
this present study are .in fact difficult to compare over-
all since our study was intended to answer the question 
of whether routine repeat angiography is necessaty at 24 
hours in patients with successful balloon angioplasty, 
and the previous study examined the effect of angio-
graphic complications on reliability of quantitative an-
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play, ft would appear that 6 lesions undenvent significant early deterioration in lesion severity ("early restenosis"). This 
discrepancy with the absolute minimal luminal diameter measurements is due to the increase in reference diameter (Figure 
2, left), as described in the text. 
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giography. Patients in whom balloon angioplasty was 
not satisfactorily successful, for whatever reason, need 
to be managed differently (perhaps including repeat an-
giography), and is not an issue in this report. In lesions 
without important angiographic complications, Preisack 
et aP I also found no significant change in absolute mini-
mal luminal dimensions during 24 hours, in general 
agreement with our tindings and a previous report from 
Laannan et aJ.l9 
Thus, it must be concluded that the additional risk of 
patient morbidity (± mOitality) prolonged hospitaliza-
tion, as well as health care worker and specialist time, 
labor and cost involved in carrying out routine repeat 24-
hour angiography would yield no extra information or 
benefit and is clearly not wananted. 
2. ~ measurement .-liIy is high-
ly acceptable: The postballoon angiopiasty lesion mea-
surement accuracy of the Cardiovascular Angiographic 
Analysis System is <0.01 mm and the variability is ± 0.2 
mm, which in our estimation is eminently acceptable. 
Twice this lesion measurement variability (± 0.4 nml) 
identifies (with 95% confidence) lesions in which a real, 
detectable ("significant") luminal decrease (or increase) 
occurs over time. Three times the variability (± 0.6 mm) 
will provide 99% confidence for the detection of a real 
change in luminal dimensions. Thus, in this study, 4 
lesions showed a detectable deterioration during 24 
hours (Figure I, left). Although we do not advocate the 
application of a categorical approach to evaluating long-
tenn angiographic outcome of interventions,2 it may 
occasionally be desirable to stratify patients or lesions 
according to the degree of luminal change developing 
over time. To this end, the application of lesion mea-
surement variability of the particular measurement sys-
tem involved is recommended as the stratification 
method. Measurement variability may vary from system 
to system, and is a vital piece of information necessary 
for the purpose of objective comparison of the results of 
intervention trials using different angiographic measure-
ment systems. 
The measurement variability reported here is consid-
erably different from that previously reported in patients 
undergoing diagnostic coronary angiography a mean of 
90 days apart, without therapeutic intervention (0.72 
mm).16 The reasons for this difference need to be high-
lighted: In the original study published in 1985, mean 
vessel size was 3.7 mm, compared with 2.7 mm in this 
study (which is repre~entative of current experience4.5). 
The former study was perrormed under a self-pro-
claimed "worst-case scenario," i.e., unmatched angi-
ographic projections, no particular care taken in record-
ing angiograms suitable for quantitative analysis, no 
vasomotor control, and so forth, whereas the current 
study was perrormed under ideal angiographic condi-
tions, as outlined previously. Because such procedures 
are routinely perfonned in all important angiographic 
sludies,4.5 the lesion measurement variability previously 
reported is no longer relevant. It is worth noling, how-
ever, that the medium term measurement variability 
(obtained using vasomotion control and matched projec-
tions) previously reported was 0.20 mm,16 exactly the 
same as found in this study. Recent experimental inves-
tigations of the accuracy and precision of off-line and 
on-line quantitative angiographic analysis (using digital 
and cineangiographic recording of ~wine "phantom" 
coronary steno~es of known dimensions) revealed a 
measurement accuracy of -0.07 mm and a precision of 
± 0.2 mm (measured dimension of the phantom steno-
ses versu<; actual phantom dimension).2o These findings 
are collectively indicative of the high level of accuracy 
and precision of the IvlLD measurement by the Cardio-
vascular Angiographic Analysis System, even in the af-
tennath of balloon angioplasty. 
3. There is no delayed elastic recoil afief success-
ful angioplasty: Previous reports l2,21 that elastic recoil 
is an instantaneous phenomenon occurring immediately 
after balloon deflation and that no additional recoil 
occurs during the next 24 hours are confinned. Nobu-
yoshi el aJ22 previously reported a 16% incidence of 
"early restenosis" based on the measurement variabili-
ty of their quantitative angiographic measurement sys-
tem, in accordance with a significant decrease in MLD 
during 24 hours after successful angioplasty. In our 
patient group, only 4 lesions (3.6%) had a significant 
luminal decrease from postangioplasty to 24 hours. The 
reasons for this disagreement may lie in the method-
ologic and quantitative angiographic approaches. For 
example, intracoronary nitrate may not have been con-
sistently administered before angiography by Nobuyoshi 
et al, who also used only a videodensitometric approach 
to estimate diameter, a method better suited to cross-sec-
tional area measurements. 17,23 In addition, it is worth 
noting the apparent increase in MLD between 1 day and 
I month (almost to the level of the postangioplasty 
result), and the lack of correlation between the change 
within 24 hours and the long-tenn change at 6 months, 
which could not be explained. Either the reliability of 
their 24-hour mea<;urement~ must be questioned, or the 
possibility of early mural thrombus formation with later 
resolution (since their patients were not anticoagulated 
for 24 hours) must also be considered as a possible 
explanation for the early luminal deterioration and sub-
sequent improvement. According to biochemical and 
angiographic evidence, with adequate anticoagulation 
control in this study (having excluded patients with com-
plicated angioplasty or major adverse cardiac events), 
there appeared to be no significant thrombus formation 
during the first 24 hours after successful balloon angio-
plasty. 
4. pefCeflt diameter stenosis is an unreliable mea-
surement: The Significant increase in interpolated refer-
ence diameter from postangioplasty to 24 hours is re-
sponsible for the observed increase in measured percent 
diameter stenosis. This finding reiterates conclusions of 
previous studies24,25 regarding potential for misinfonna-
tion by preferential use of percent diameter stenosis for 
description of the severity of luminal obstructions. Fig-
ures I to 3 further illustrate the imprecision of percent 
versus absolute measurement parameters. 
TIle increase in reference vessel dimensions may be 
due to greater effectiveness of intracoronary nitrate at 24 
hours on the relatively disease-free vessel segment. The 
vasoconstrictive ~timulus of the dilatation procedure and 
the release of vasoactive substances from the damaged 
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endothelium and platelets may prevent inunediate real~ 
ization of dimensional increase in the relatively undis-
eased vessel adjacent to the target lesion. 
Study limitations: Patients with unstable angina re-
ceiving intravenous heparin were excluded. It could be 
suggested that unstable lesions might "behave" differ-
ently during the 24 hours after successful angioplasty, 
since it is known that unstable angina predisposes to 
periprocedural and in-hospital major adverse cardiac 
events.26 This limitation would need to be addressed by 
further study in "unstable" patients. 
Perhaps the ideal test of accuracy and precision of 
quantitative angiography, according to current technol-
ogy, would involve comparison with intravascular ultra-
sound findings. 7,H,27 However, it must be recognized that 
intravascular ultrasound is itself fraught by considerable 
limitations. It cannot be usefully applied to the evalua-
tion of severe stenoses or to extremely tortuous or small 
vessels, which makes complete preinterventional assess-
ment impossible in a large proportion of lesions treated 
in daily practiceS (average MLD in recent "restenosis 
prevention trials" was approximately 1 mm45). FUlther-
more, "good" quality images may not be obtainable in 
certain clinical situations, such as the presence of inti-
mal disruptions after angioplasty.2s Until the vessel wall 
and lumen areas are more objectively and reproducibly 
quantifiable by intravascular ultrasound, quantitative 
angiography must still be considered as the "gold stan-
dard." 
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CHAPTER 6 
USEFULNESS OF QUANTITATIVE AND QUALITATIVE 
ANGIOGRAPHIC LESION MORPHOLOGY AND CLINICAL 
CHARACTERISTICS IN PREDICTING MAJOR ADVERSE 
CARDIAC EVENTS DURING AND AFTER 
NATIVE CORONARY BALLOON ANGIOPLASTY. 
Hermans WR, Foley DP, Rensing Bl, Rutsch W, Heyndrickx GR, 
Danchin N, Mast G, Hanet C, Lablanche 1M, Rafflenbeul W, 
Uebis R, Balcon R, de Feyter Pl, Serruys pw. 
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Usefulness of Quantitative and Qualitative 
Angiographic Lesion Morphology, and Clinical 
Characteristics in Predicting Major Adverse 
Cardiac Events During and After Native 
Coronary Balloon Angioplasty 
Walter R. M. Hermans, MD, David P. Foley, MB, MRCPI, Benno J. Rensing, MD, 
Wolfgang Rutsch, MD, Guy R. Heyndrickx, MD, Nicolas Danchin, MD, Gijs Mast, MD, 
Claude Hanet, MD, Jean·Marc Lablanche, MD, Wolfgang Rafflenbeul, MD, Rainer Uebis, MD, 
Raphael Balcon, MD, Pim J. de Feyter, MD, and Patrick W. Serruys, MD, 
on Behalf of the CARPORT and MERCATOR Study Groups' 
Major, adverse cardiac events (death, myocardial 
infarction, bypass surgery and reintervention) 0c-
cur in 4 to 7% of all patients undergoing coronary 
balloon angioplasty. Prospectively collected clini-
cal data, and angiographic quantitative and quali-
tative lesion morphologic assessment and proce-
dural factors were examined to determine 
whether the occulTence of these events could be 
predicted. Of 1,442 patients undergoing balloon 
angioplasty for native primary coronary disease in 
2 European multicenter trials, 69 had major, ad-
verse cardiac procedural or in-hospital complica-
tions after 2':1 balloon inflation and were randomly 
matched with patients who completed an uncom-
plicated in-hospital course after successful angio-
plasty. No quantitative angiographic variable was 
associated with major adverse cardiac events in 
univariate and multivariate analyses. Univariate 
analysis showed that major adverse cardiac 
events were associated with the following prepro-
cedural variables: (1) unstable angina (odds ratio 
[OR] 3.11; p <0.0001), (2) type C lesion (OR 2.53; 
P <0.004), (3) lesion location at a bend >45° (OR 
2.34; p <0.004), and (4) stenosis located in the 
middle segment of the artery dilated (OR 1.88; P 
<0.03); and with the following postprocedural vari-
able: angiographically visible dissection (OR 5.39; 
P <0.0001). Multivariate logistic analysis was per-
formed to identify variables independently corre-
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lated with the occurrence of major adverse cardi~ 
ae events. The preprocedural multivariate model 
entered unstable angina (OR 3.77; p <0.0003), le-
sions located at a bend >450 (OR 2.87; p <0.0005), 
and stenosis located in the middle portion of the 
artery dilated (OR 1.95; p <0.04). If all variables 
were included, then angiographically visible dis--
section (OR 6.58; p <0.0001), unstable angina (OR 
3.46; P <0.002) and lesions located at a bend >45° 
(OR 2.54; p <O.OOG) were independent predictors 
of major adverse cardiac events. 
(Am J CardioI1993;72:14-20) 
I n the initial' 'National Heart, Lung, and Blood Insti-tule Percutaneous Transluminal Coronary Angio-plasty Registry" publication, which described the 
immediate results of patients treated by balloon angio-
plasty, major adverse cardiac events (i.e., death, myo-
cardial infarction, coronary artery bypass grafting and 
repeat dilatation) were reported in 13.6% of patients.! 
Because of improvement .in operator experience, as we 11 
as radiographic equipment and balloon catheter design 
over the succeeding 5 years, this percentage decreased 
to 4 to 7%, despite extension of the indications for coro-
nary balloon angioplasty to include patients aged> 70 
years, and those with multivessel disease or poor left 
ventricular function, prior bypass surgery, and more se-
vere and complex lesions.2-6 Many clinical factors such 
as multivessel disease, female gender, unstable ,mgina 
and multiple lesions, as well as qualitative angiograph-
ic lesion morphology, including eccentricity, presence of 
calcium, lesion length, stenosis at a bend, stenosis at a 
branch point, presence of thrombus, and complex le-
sions, have been suggested to be predictors of a major 
procedural or in-hospital car<:iiac event.3 Y Previous stud-
ies used visual interpretation of the coronary angiogram, 
which is now known to be limited by considerable .inter-
and intraobserver variability.!0-!2 Thus, quantitative 
coronary angiographic systems are now the "gold stan-
dard" for objective geometric assessment of coronary 
narrowings, and for assessing the short- and long-term 
results of interventions. 13,!4 In addition to the actual de-
gree of lumen narrow.ing, these quantitative coronary 
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systems can also provide detailed lesion morphologic 
characteristics such as lesion length, atherosclerotic 
plaque area, lesion eccentricity and vessel curvature.13 
The present study investigated whether comprehensive 
evaluation of lesion morphology by quantitative coro-
nary analysis, in addition to conventional qualitative as-
sessment, and inclusion of baseline, clinical characteris-
tics and procedural details, could identify patients at par-
ticularly high risk for major procedural or in-hospital 
adverse cardiac events. The identiJication of risk factors 
for the occurrence of these complications may be of 
considerable clinical value in deciding which paticnts or 
lesions would be suitable for an alternative treatment to 
balloon angioplasty. 
METHODS 
In all, 1,442 patients were enrolled in 2 randomized, 
double-blind, placebo-controlled, restenosis prevention 
trials (CARPORT In = 707] and MERCATOR In = 
735]) bctween December 1987 and June 1990. Neither 
trial (described in detail previously) found any clinical 
or angiographic benefit from the agent under investiga-
tion. 15.16 For the purpose of this ancillary study, the pa-
tient cohort comprised those who had major procedural 
or in-hospital complications (as previously deJined) after 
~ balloon inflation, regardless of the final result of bal-
loon angioplasty (group I; n = 69). Each patient in group 
I was randomly matched with 3 control patients by the 
date of angiopla,<;ty (to the neare.~t week in the same hos-
pital) (group II; n = 207) to assess the predictability of 
n1<:uor adverse cardiac events. In cases of multilesion di-
latation, the most severe lesion was selected and used 
for comparison. Each available cineangiogram was sep-
arately reviewed by 2 experienced interventionalists who 
were unaware of clinical or procedural information, or 
the outcomc of intelvention. 
Percutaneous transluminal coronary angioplasty 
procedure and angiographic analysis: At the begin-
ning of the angioplasty procedure, all patients received a 
bolus of 10,000 IU of intravenous heparin; for prolonged 
procedurcs, an additional infusion of 5,000 IU/hour was 
coIllinenced after 2 hours and continued until the end of 
the procedure. Aspirin was routinely administered to all 
patients in the :MERCATOR trial and to those random-
ized to placebo in the CARPORT trial.I).11i Use of a cal-
cium antagonist was pennitted for 24 to 48 hours after 
coronary balloon angioplasty. The choices of guiding 
catheter, guide wire, balloon type, inflation duration and 
pressure were made by the operator. Primary angioplas-
ty success was deJined at thc time the guidc catheter was 
removed as diameter stcnosis <50% by visual estimation, 
without the occurrcnce of a major adverse cardiac event. 
At Icast 2 angiographic projections (orthogonal if 
possible) were recorded in such a way that they were 
suitable for quantitative analysis by thc Coronary Angi-
ography Analysis System, which was validated and de-
scribed in dctail previously. D An example of an analy-
sis is shown in Figure I. 
The absolute stenosis and referencc diameters were 
measured by thc computer llsing the known contrast-
empty, guiding catheter diameter as a scaling device. For 
that purpose, the catheter tips were retained for accurate 
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measurement with a micrometer. To achieve maxinlal 
coronary vasodilation, either nitroglycerin (0.1 to 0.3 
mg) or isosorbide dinitrate (1 to 3 mg) was administered 
(intracoronary) to each affected coronaIy artery before 
angiography. All contour positions of the catheter and 
arterial segment were cOlTected for "pincushion (listor-
tion" introduced by the image intensiJiers. Because the 
algorithm cannot measure total occlusions or lesions 
with T1m)mbolysis in Myocardial Infarction grade I per-
fusion, a value of ° mm was substituted for the mini-
mal lumen diameter aIId 100% for percent diameter 
stenosis in such cases. 
Variables used in the analysis: BASELINE CLINICAL 
CHARACTERISTICS: The following patient-relatcd variablcs 
were recorded in the patient files: age, gender, duration 
of angina, cholesterol level, previous myocaI'dial infarc-
tion, cLUrent smoking, diabetes mellitus, cxtent of athero-
sclerotic disease (single or multivesscl), CanadiaII Car-
diovasculaI' Society aIlgina classification, and unstable 
angina (defined as pain at rest needing treatment with 
intravenous nitratcs).17 
QUAIJTATlVE ANGlOGRAPl-IlC C1IARACTElUSTlCS: The 
following qualitative lesion parameters were assessed: 
(1) vessel dilated (right, left anterior descending or left 
circumflex); and (2) location of thc stenosis in the ves-
sel dilated, according to the numeric scheme proposcd 
by Austen et al. If\ T1le following subdivisions were used 
for location of the stenosis: proximal corresponding with 
segmenL<; I, 6 and II; middle umesponding with seg-
ments 2, 7, 13 and 15; distal corresponding with seg-
FIGURE 1. Single-frame angiogram of proximal left anterior 
descending (LAD) artery stenosis before dilatation in right 
anterior oblique (300 ) projection. Quantitative coronary anal-
ysis was pelfonned using Cardiovascular Angiography Analy· 
sis System. Arterial boundaries automatically detected by 
system are shown on angiogram, and diameter function 
curve derived from these contours by interpolating is shown 
in middle part of figure (upper curve). Lower horizontal line 
(1.04 mm) is minimal lumen diameter. Outside vertical lines 
on graph, and 2 vertical lines on angiogram are lesion 
boundaries (lesion length 8.6 mm). Innermost vertical line is 
position of minimal luminal diameter, and point where this 
line intersects diameter function curve (upper horizontal 
line) is considered reference diameter (3.25 mm; value not 
shown). Lesion length is automatically detennined by curva-
ture analysis of detected vessel contours. 
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ments 8 to 10, 12 and 14; (3) type of lesion, defined by 
a modified Ambrose classification, as follows: concen-
tric, eccentric (a stenosis asymmetrically positioned in 
the vessel in any nonforeshOitened angiographic projec-
tion), tandem (2 discrete lesions in the same coronary 
segment separated by an apparently normal segment), 
multiple ilTegularities (~2 serial diffuse irregularities in 
the same coronary segment), and totally occluded ves-
Sc!19; (4) a bend >45 0 was considered present if in any 
nonforeshortened projection, the balloon in position to 
dilate was located in a pOltion of the vessel with a ~45° 
angulation at end-diastole20; (5) presence of a side 
branch in the lesion to be dilated; (6) presence of a side 
branch, separ·ate from the actuallcsion but within the di-
lated segment; (7) presence of intracoronaIY thrombus 
(a noncalcified filling defect within the lumen, sur-
rounded by contrast material observed in multiple pro-
jections or the persistence of contrast material within the 
lumen, or a visible embolization of intraluminal material 
"downstream")21; (8) presence of calcification (defined 
as fixed radiopaque densities in the area of the stenosis 
to be dilated); and (9) type of lesion (A, B or C) ac-
cording to the American College of Cardiology/Ameri-
can HeaIt Association Task Foree.~2 
QUANTITAT!VEL Y ANGlOGRAPH!C CHARACTER!STTCS: The 
foUowing quantitative measurements were obtained: mini-
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FIGURE 2. Area between actual and reconstructed contours 
at obstruction site is measure of amount of atheroscterotic 
plaque. Length of obstruction is determined from diameter 
function on basis of automatically detected curvature anaty-
sis without interference by analyst. Symmetry is defined as 
coefficient of left- and right-hand distance between recon-
structed interpolated reference diameter and actuat vessel 
contours at site of obstruction. In this equation, largest dis-
tance between actual and reconstructed contours becomes 
denominator, so that symmetrical lesion has vatue of 1, and 
a severely eccentric lesion has value of O. To assess extent 
of coronary bending, curvature value at obstruction site is 
computed as average value of all individual curvature val-
ues along centerline of coronary segment, with curvature 
defined by rate of change of angle through which tangent to 
curve turns in mOving along curve, and which for circte is 
equal to reciprocal of radius. Curvature value and symmetry 
index are determined in projection in least foreshortened 
view (in which analyzed segment was longest between 2 de-
fined landmarks and is expressed as continuous integer 
value, ranging from 0 for straight segment to 90 for seg-
ment with 90° bend). MLD = minimal lumen diameter. 
mal lumen and interpolated reference diameters, diame-
ter stenosis, lesion length and eeeenlTicity, atheroscleroti·c 
plaque area and vessel CUlvature (Figure 2). 
PROCEDURAL j·ACTORS: Balloon-artery ratio was used 
to assess the suitability of the balloon size for the ves-
sel segment, and was defined as the ratio between the 
measured mean balloon size and the (interpolated) refer-
ence diameter of the dilated segment. Angiographically 
visible dissections were defined according to modified 
National Heart, Lung, and Blood Institute eriteria.12 
Reproducibility of morphologic assessment: Inter-
observer variability of the 2 reviewers for qualitative le-
sion assessment was examined in an arbitrarily selected 
number of lesions. The coronary angioplasty films of 
138 patients with 151 lesions (consecutive films reach-
ing the core laboratory) were independently assessed for 
the diverse lesion morphologic characteristics by each 
observer on 2 separate occasions, 3 months apart, with 
blinding for earlier assessment. Interobsclver discordance 
was as follows: lesion eccentricity 21 %; branch poirlt lo-
cation 29%; branch point location in dilated segment 
19%; bend point location 14%; presence of thrombus 
2%; presence of calcification 10%; presence of dissection 
11 %; and lesion type according to the American College 
of Cardiology/American Heart Association Task Force 
classification 25%. 
Statistical analysis; Analyses were pelionned to test 
the hypothesis that clinical, qualitative and quantitative 
lesion morphologic and procedural characteristics are 
important detem1inants of m<0or adverse cardiac events. 
The risk of major cardiac adverse events for each vari-
able was expre~sed as an odds ratio: (probability of an 
event vaI·iable present/probability of no event variable 
present)/(probability of an event variable ah~enl/probability 
of no event variable absent). 
Continuous var·iables were dichotomized by cut fXlinh; 
derived by dividing the data i.nto 2 groups, each con-
taining approximately 50% of the popUlation. This meth-
od of subdivision has the advantage of being consistent 
for all variables and thus avoids any bias in selection of 
subgroups, which may be pClfom1ed to emphasize a par-
ticular point. An odds ratio (OR) of 1 for a particular 
variable suggests that its presence poses no additional 
risk for a major event. An OR > or <I suggests addi-
tional or reduced risk, respectively. The 95% confidence 
intervals (CI) were calculated to describe the statistical 
certainty. If the CI included 1, no significant ineretlsed 
or reduced risk was deemed to be conferred by the vari-
able. Multivariate analysis by mUltiple logistic regres-
sion was perfo011ed to identify var·iables independently 
correlated with the occurrence of a major cardiac, pro-
cedural or in-hospital adverse event, using only those 
variables significant at the p <0.1 level in the univariate 
analysis. All statistical analyses were pelfonned with a 
commercial statistical package (BMDP Statistical Soft-
ware Package 1990). 
RESULTS 
Of 1,442 patients recruited, balloon angioplasty was 
not perfonned in 9 patients, because the lesion severity 
had changed or because of equipment failure. A further 
43 patients had (sub)totally occluded lesions that could 
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TABLE I Clinical Variables and the Risl{ for a Major Procedural or In-Hospital Adverse 
Cardiac Event 
Patient Positive Patient Negative 
for Variable for Variable 
Variable (event/total) (event/total) Odds Ratio (95% CI) 
Myocardial infarction (hislory) 23/107 46/169 0,73 (0.41 to 1.30) 
Currently smoking 10/45 59/231 0.83 (0.39 to 1.79) 
Multivessel coronary narrowing 29/117 39/146 0.89 (0,51 to 1.51) 
Oiabetes mellitus 6/25 63/251 0.94 (0.36 to 2.46) 
Age « 58 years) 35/136 34/140 1_08 (0.63 to 1.86) 
Duration of angina (> 142 days) 35/137 31/135 1.15 (0.66 to 2.01) 
Total cholesterol 34/129 271132 1.39 (0.78 to 2.48) 
«6.2 mmol/L; <240 mg/dl) 
Canadian Cardiovascular Society 47/169 21/100 1.45 (0.81 to 2.61) 
class III or IV 
Meo 59/221 10/55 1.64 (0.78 to 3,46) 
Unstable angina 29/69 39/206 3.11 0.72105.61) 
" 
LOnfldence mte",ai. 
TABLE II Lesion and Procedural Variables, and the Risk for a Major Procedural or 
In-Hospital Adverse Cardiac Event 
Patient Positive Patient Negative 
for Variable for Variable 
Variable (event/total) (event/total) Odds RatiO (95% el) 
Coronary artery dilated 
Right 15/67 54/209 0.83 (0.43 to 1,59) 
Left CIrcumflex 17/72 52/204 0.90 (0.48 to 1.69) 
Left anterior descending 37/137 32/139 1.24 (0.72 to 2.14) 
Multiple site dilated 12/45 571231 1.11 (0.54 to 2.29) 
Total occlusion 8/24 61/252 1.57 (0.64 to 3.84) 
Middle portion of vessel dilated 36/112 33/164 L88 (1.08 to 3.26) 
Lesion morphology quantitatively derived 
before angloplasty 
Symmetry index «0.34)" 301121 32/131 1.00 (0.56 to 1.77) 
Minimalilimen diameter (> 0.98 mm) 35/l39 34/l37 1.02 (0.59 to 1.76) 
Diameter stenosis « 62%) 35/136 34/l40 1.08 (0.63 to 1.86) 
Length lesion (> 5.8 mm)* 32/127 29/125 1.12 (0.63 to 1.99) 
Vessel size (> 2.53 mm) 37/140 30/134 1.25 (0,72 to 2.17) 
Atherosclerotic plaque (> 6_1 mm2)* 351127 26/125 1.45 (0.81 to 2.59) 
Curvature index (> 19)~ 37/128 24/124 1.69 (0.94 to 3.05) 
Lesion morphology; qualitative assessment 
Side branch in area of balloon 46/186 20{80 0_99 (0.54 to 1.81) 
Calcified lesio~ 9/33 57/233 1.16 (0,51 to 2.63) 
Side branch if) stenosis 38/l44 28/122 1.20 (0.69 to 2, 11) 
Eccentric located stenosis 36/130 30/l36 1.31 (0.75 to 2.28) 
Bend> 45" 31/86 351180 2.340.31 to 4.15) 
Type C lesion 19/46 471220 2.53 (1.32 to 4.86) 
Procedural variables 
Balloon--artery ratio (> 1.02) 17/110 16/105 1.02 (0.48 to 2,14) 
Thrombus after dilatation 4/7 62/259 4.31 (0.94 to 19.80) 
Intimal tear or dissection 47/111 19/155 5.39 (2.90to 10,00) 
'Although 276 lesions were analyzed in total, some could not be analy,ed tor certam vanables 
CI = conMence Interval 
be neither reached nor crossed with the guide wire or 
balloon catheter. Thus, of 1,390 patients in whom bal-
loon dilatation was actually perfonned, 69 had a major 
adverse cardiac event. Myocardial infarction occurred 
during or shortly after the procedure in 15 patients (l %) 
and during the hospital stay in an additional 22 (1.5%). 
Emergency coronary bypass graft surgery was necessary 
immediately after unsuccessful coronary balloon angio-
plasty in 18 patients (l.3°h,), and the indication for 
surgery occurred after leaving the catheterization labo-
ratory in a fUl1her 9 (1%). In 5 patients, a redilatation 
was performed during the hospital stay. No patient died 
dUling the procedure or hospital stay. 
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Clinical characteristics as predictors of major ad-
verse cardiac events (Table I): Patients with unstable 
angina had more coronary events than did those without 
unstable angina (OR 3.11; p <0.0001; 95% CI 1.72 to 
5.61). Age, gender, duration of angina, serum cholester-
ol, history of myocardial infarction, diabetes mellitus, 
multivessel disease and Canadian Cardiovascular Soci-
ety angina class did not influence the occun'ence of a 
major adverse cardiac event. 
Angiographic lesion characteristics as predictors 
of major adverse cardiac events (Table II): Location 
of the target lesion in the middle segment of the coro-
nary artelY dilated (OR 1.88; p <0.03; 95% CI 1.08 to 
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3.26), lesions located at a bend >45° (OR 2.34; P 
<0.004; 95% CI 1.31 to 4.15), and type C lesions (OR 
2.53; P <0.004; 95% CI 1.32 to 4.86) were significant-
ly associated with the occurrence of major adverse car-
diac events; no other lesion morphologic characteristic 
(whether assessed qualitatively or by quantitative analy-
sis) prcdicted subsequent development of these events. 
Procedural predictors of major adverse cardiac 
events: The presence of any type of angiographically 
visible dissection after the procedure was strongly asso-
ciated with the subsequent occurrence of a major ad-
verse cardiac event (OR 5.39; P <0.0001; 95% CI 2.9 to 
10.0). Neither thrombus after dilatation nor balloon-ar-
tery ratio was found to be predictive of major adverse 
cardiac events (Table II). 
Logistic regression analysis: In considering only 
baseline preprocedural factors, the model entered unsta-
ble angina (OR 3.77; p <0.0003; 95% CI 1.89 to 7.48). 
lesions located at a bend >45° (OR 2.87; P <0.0005; 
95% CI 1.47 to 5.59), and stenosis located in the mid-
dle portion of the artery dilated (OR 1.95; p <0.04; 95% 
CI 1.01 to 2.74). When postprocedural variables were 
added, then unstable angina (OR 3.46; P <0.002; 95% 
CI 1.67 to 7.17), lesions located at a bend >450 (OR 
2.54; P <0.006; 95% CI 1.26 to 5.13), and angiograph-
ically visible dissection (OR 6.58; P <0.0001; 95% CI 
3.17 to 13.7) were independent predictors of major ad-
verse cardiac events. 
DISCUSSION 
Despite the improvements in equipment and tech-
nique that have made it possible to dilate >90 to 95% 
of coronary obstructions, the OCCUlTence of procedural 
and in-hospital cardiac adverse events due to acute or 
subacute vessel closure continues to be largely unpredict-
able. The reported frequency of so-called major cardiac 
adverse events depends on the time window applied-
after the patient left the catheterization laboratory 1 to 
2%, or during and after the procedure 4 to 7%. In the 
present study, major adverse cardiac events were ob-
served in 33 of 1,390 patients (2.4%) after;;.:1 balloon 
inflation in the catheterization room and in a fUlther 36 
(2.6%) during the hospitalization period. 
Risk factors of major procedural and in-hospital 
adverse cardiac events: In 1988, Ellis et aP reported 
the results of 4,772 procedures perfooned between April 
1, 19R2 and March 31, 1986, and found (using multi-
variate analysis) 7 independent preprocedural factors re-
lated to abrupt vessel closure: stenosis length ~2 lumen 
diameters, female gender, stenosis at a bend point ~45°, 
stenosis at a branch point, stenosis-associated thrombus 
(filling defect or staining), other stenoses in the same 
vessel, and multivessel disease. They concluded that al-
though an estimation of risk can be obtained before per-
forming coronary balloon angioplasty, the most power-
ful predictors of closure can only be assessed during the 
procedure (postangioplasty percent diameter stenosis, in-
timal tear or dissection, and prolonged postangioplasty 
use of heparin). The 1985-1986 National, Heart, Lung, 
and Blood Institute Percutaneous Transluminal Coronary 
Angioplasty Registry study analyzed 1,801 patients, and 
revealed that baseline factors inherently associated with 
increased occlusion rates included 3-vessel disease, 
high-risk status for surgery, and acute coronary insuffi-
ciency, and lesion characteristics included severe steno-
sis before coronary angioplasty, diffuse disease or mul-
tiple discrete lesions, thrombus and collateral flow from 
the lesion. De Feyter et al5 reported an acute coronary 
artery occlusion rate of 7.3% (total population 1,423), 
with unstable angina, multivessel disease and complex 
lesions as predictors for closure during or after the pro-
cedure. 
In all the aforementioned studies that involved large 
groups of patients, lesion characteristics were visually 
assessed. No data are available on the predictability of 
major cardiac complications from quantitative COrollary 
analysis, which has now emerged as the gold standard 
for assessment of long-teon angiographic outcome of 
percutaneous transluminal coronary interventions. 15,16 In 
addition to the "simple" quantitative parameters of min-
imal lumen (obstruction) diameter, reference diameter 
(or vessel size) and percent diameter stenosis, quan-
titative analysis computes length of the obstruction, area 
of atherosclerotic plaque, symmetry index of the .steno-
sis, and curvature of the vessel. In the present study, 
quantitative coronary analysis was combined with as-
sessment of qualitative lesion morphology and clinical 
characteristics to determine whether this thorough, inte-
grated approach could improve the prediction of major 
adverse cardiac events. 
The present results are in agreement with those of 
the earlier published studies showing that unstable angi-
na, lesions located at a bend >45°, and angiographical-
Iy visible dissection after angioplasty were independent 
predictors of major procedural or in-hospital cardiac 
events. Lesion morphology as assessed by quantitative 
coronary analysis was not useful for the prediction of 
major adverse cardiac events. 
'The well-described association of unstable angina 
with the occurrence of major adverse cardiac events was 
confirmed in this study. Patients presenting with the clin-
ical syndrome of unstable angina continue to provide the 
clinician with the difficult task of selecting a suitable 
management strategy that usually needs to be applied on 
an urgent basis. The increasing use of intracoronary an-
gioscopy may be helpful in subslratifying these patients 
and therefore guiding therapeutic slrategies that may im-
prove short- and long-leon outcome.23 
The location of the target lesion in a bend >45° was 
previously identified by Ellis et aJ3 as a risk factor for 
acute vessel closure. Their explanation was that the bal-
loon must necessarily tear an atherosclerotic fixed and 
rigid bend lesion, as it straightens and stretches the le-
sion. In addition, the maximal stress is several times 
greater when there is a geometric discontinuity in the 
object to which the stress is applied. 
The association of midsegment balloon dilatation 
with a greater risk of major adverse cardiac events is not 
readily explicable and could simply be a chance finding. 
The most powerful predictor for major adverse car-
diac events is the occurrence of an angiographically visi-
ble dissection after angioplasty, which is not surprising 
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because all patients with procedural events had a dissec-
tion with How limitation on their postdilatation angio-
gram, in agreement with previous reports.J·9 
Other investigators have found that thrombus on the 
predilatation angiogram was predictive for a major ad-
verse cardiac event.·1-'i However, thrombus was seldom 
observed on the predilatation angiogram in the present 
study, although unstable angina, in which the presence 
of intracoronary thrombus is frequently observed,2324 
was a risk factor for a major adverse cardiac event. In 
this study, patients with unstable angina were aggres-
sively treated with intravenous heparin that may have ef· 
fectively dealt with intracoronary thrombus in some 
cases. Therefore. thrombus was not a remarkable angio-
graphic reature in the study. 
In contrast with Black et al,9 the balioon-artelY ratio 
was not a factor ror predicting major adverse cardiac 
events in the present study, although there was a dificr-
ence in definition. Because of such previously published 
findings, many investigators may have carefully ensured 
appropriate matching of balloon with artery size. 
From the literature, one would expect that dilation or 
type C lesions would he a risk ractor for a major ad-
verse cardiac event, because it is associated with a <60t;f; 
acute success rate according to the AmeJican College of 
Cardiology/Amelican Hemt Association Task Force.:!2 
However, a recent study or 1,000 lesions by Myler et 
al25 repolted an angioplasty success rate of 90% for type 
C iesiom, which was only slightly less than that for type 
A and B. In the present study, type C lesions were pre-
dictive of lm~or adverse cardiac events in univariate but 
not multivariate analysis. The relatively high discor-
dance between observers suggests that the use of this 
subjective evaluation should be cautiously interpreted.2fi 
Study limitations: The study cohort of this retro-
spective analysis compJised patients recruited for 2 mul-
ticenter. restenosis, phannacologic prevention trials in 
Europe. Althougil in both tJials, consecutive patients of 
the participating clinics were recruited, only 259() of 
those undergoing angioplasty were recruited, because 2':1 
specitic exclusion critelion was found. 15.l 0 
In the CARPORT trial, patients treated with the new 
thromboxane A2-receptor blockade did not receive as-
phin before or dllling the angioplasty procedure, but all 
others did; this may have influenced thc incidence of 
major adverse cardiac events.n 
Although the Cardiovascular Angiography Analysis 
System has been validated and extensively described in 
the literature, validation studies of quantitatively derived, 
lesion morphologic characteJistics such as lesion length 
and eccentricity. and vessel curvature have not been per-
fonned. 13 
Coronary imgiography, as a 2-dimensional silhouette 
of the vesscl lumen, is inherently limited for the assess-
ment of atherosclerotic plaque morphology. as has been 
increasingly demonstrated by intravascular ultrasound 
techniques.::>g FU1thermore, the use of objective quanti-
tative analysis does not provide illsight to the prediction 
of major adverse cardiac events rrom angiograpbic mea-
surements and lesion morphology. Newer and more so-
phisticated quantitative amllysis system.s may be more 
helpful in this regard29; however, the combined use of 
illtracoronru), angioscopy and ultrasound is more likely 
to shed new light on the continued unpredictability of 
major adverse cardiac events after coronary interven-
tions. 
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CHAPTER 7 
THE INFLUENCE OF CORONARY VESSEL SIZE ON LUMINAL 
RENARROWING AND LATE ANGIOGRAPHIC OUTCOME 
AFTER SUCCESSFUL BALLOON ANGIOPLASTY. 
Foley DP, Melkert R, Serruys PW. 
CIRCULATION 1994;90:1239-51. 
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Influence of Coronary Vessel Size on 
Renarrowing Process and Late Angiographic 
Outcome After Successful Balloon Angioplasty 
David P. Foley, MB Beh, MRCPI; Rein Melkcrt, MD; Patrick W. Serruys, MD, PhD, FACe, 
on behalf of the CARPORT, MERCATOR, MARCATOR, and PARK Inve~tigators 
Backgrou1/d Allhough coronary angioplasty is increasingly 
applied in the treatment of multivessel disease and a broad-
ening range of vessel size, the inHuence of VtsscJ size itself on 
the late results of intervention is unresolved. An int1uence of 
vessel SiLt on late outcome would carry implications for the 
"pplicalion and evaluation of intervenlional devices, which are 
sdcctively used in larger or smaller vessels. The purpose of the 
present study was to investigate the intluence of ves~e1 size on 
both the restenosis process and late angiographic outcome in a 
largc homogeneou~ patient group after successful percutane-
ous transluminal coronary angioplasty (PTCA). 
Methods alld Resfllts Thc study population wmprised 30n 
paticnts with 3736 successfully dilalcd native primary coronary 
artery lesions and satisfactory quantitative angiographic analy-
sis in multiple identical projections before and aftcr PTCA and 
al a 6-month follow-up. Late luminal loss, minimal luminal 
diameter (MLD) at follow-up, and net luminal gain, as well as 
percenl diameter stenusis at follow-up, net gain in pcrcent 
diameter stenosi~, rcstenosis rales (according to three delini-
lions), and nct gain index, wcrc all compared among ninc 
equally sizcd groups (noniles) according to vessd sizc. A direct 
influcnce of vessel size on eontinuou& measurcs of late result 
was also evaluated by linear rcgrcssion. These evaluation~ 
provided conflicting information with no consistent influence 
~thOUgh it is becoming generally appreei<lted that safe maximization of the short-term result of translumin<ll coronary intervention is the opti-
mal practical approach to augment late outcome, I II 
increasing intervention in multivessel disease and in a 
broadening range of vessel size raises the issue of 
whether the size of the vessel itself influences late 
results. Lower restenosis rates have been reported in 
larger vessels fo!lowing balloon angioplasty and other 
devices in some studies2.3 but not in others.I. 12-15 Larger 
vessel size has been reported to predict greater minimal 
luminal diameter (MLD) at follow-up, as a measure of 
late outcome, in patients treated by directional atherec-
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of vessel size emerging. To elucidate the independent influ-
ence of vessel size on the restenosis proceSS (late lo~s) and late 
angiographic outcome (MLD at follow-up), multiple lincar 
rcgression analysis was performed taking into account luminal 
gain, preprocedural MLD, and lesion location. In this manner, 
ve&sel size was found 10 be excrt a significantly positive 
influence on MLD at follow-up (P<.OD01) and an equally 
negative effect on loss. Correcting for vessel size by u~ing 
percent stcnosis measurements led to an anticipated neutral-
ization of this influence. Lesion location in the left anterior 
descending coronary artery was found to be independently 
associated with greater loss and smallcr MLD at follow-up 
(1'<.0001 ). 
COl/elflsions Incrcasing coronary vessel ~ize was found to 
be indepcndcntly predictive of decreasing late luminal loss and 
incrcasing follow-up MLD after successful halloon angio-
plasty. Apparently superior or inferior late angiographic re-
sults of new interventional devices may thus bc cxplaincd in 
part by preferential usc in larger or smaller vessels, respec-
tively. Devices that can safely optimize the short-term result of 
intervention may realize their ultimate long-term valuc in 
larger coronary vessels. (Circulatioll. 1994;90:1239-1251.) 
Key Words • quantitative angiography • angioplasty • 
restenosis 
tomy or stent imp!antation.3•9 On the other hand, IUl11i-
nalloss, as a measure of the restenosis process, has not 
been found to vary with vessel size.·"l.7·'uH7 Thus, the 
influence of vessel size on the restenosis process and 
late angiographic outcome after successful angioplas.ty 
is unresolved. A significant inOuenee of vessel size on 
late results would carry implications for selection of 
patients and lesions for intervention as weI! as for the 
use of new devices for intervention. For example, the 
reported superiority of stent implantation and direc-
tional atherectomy over conventional balloon angio-
plasty~ (, might be related to their general application to 
larger vessels. Similarly, the use of excimer laser angio-
plasty and rotational athereetomy in smaller vessels 
might explain in part the somewhat discouraging late 
results associated with these devices. 18. 19 
The purpose of the present study was to compre-
hensively investigate the influence of vessel size on 
both the restenosis process (luminal loss) and the 
angiographic outcome (follow-up luminal diametcr)~·ll) 
after successful baUoon angioplasty in a large homo-
geneous patient population with serial quantitative 
angiography before and after angioplasty and at a 
6-month follow-up. 
Circulatiun Vat 90, No 3 Seplcillber ]994 
Methods 
The study population comprised 3072 patients with 373() 
native coronary arterial lesions successfully treated by balloon 
angioplasty (percutaneous transluminal coronary angioplasty 
lPTCAll (postprocedural diameter stenosis <50'/(.) during 
[our major multicenter pharmacological restenosis prevention 
trials. Details of the trials have bcen prescnted or pub-
lished.21 .2 " In each of these trials, the agent under investigation 
was found to have no significant eITect on either clinical or 
angiographic outcome by either univariate and multivariate 
analysis, so, for the purposes of the present study, all the 
patients wcre pooled and considered as Ont~ group. Angio-
graphic follow-up with comprehensivc automatcd quantitative 
analysis performed by independent blinded analysts in an 
oIT-line core laboratory was peJtormed on it total of Y3.4% of 
thc study population. With the aim of evaluating the biological 
process of restenosis from the quantitative angiographic per-
spective, homogeneity of the population was a legitimate 
prime concern. Because there is an inevitable contribution of 
thromhosis to coronary occlusion after angioplasty and oc-
cluded lesions at baseline may behave differently during and 
aftcr angioplasty,~5.~(O 264 lesions that were occluded at base-
line and an additional 167 that became occluded during 
follow-up were excluded for the study, as well as three left 
nlllin lesions. 
Quantitative Angiographic Methodology 
StandardizatiOIl of Image ACQlli!.itioll by IIll!estigat01:~ 
Coronary angiography, bdore and after angioplasty and at 
follow-up after 26±2 weeks, was recorded for quantitative 
analysis using the Cardiovascular Angiogmphic An[jlysi.~ Sys-
tem (CAAS) (PTE Mcdical) at the angiograpilic cure labora-
tory. All invcstigators were given specific guidelines by the 
core laboratory to standardize angiographic acquisition and 
ensure reproducibility of quantitative analysis, as previously 
described,n.l,~ The most important features of standardization 
of image acquisition are, lirst, u~e of multiple projections for 
each lesion, identieaHy repeated bdore and after angioplasty 
and at follow-up angiography ("multiple matched projec-
tions"); second, usc of 0.1 to 0.3 mg nitroglycerin IC or 1 to 3 
mg isosorbide dinitrate IC hefore each set of angiographie 
recordings to control vasomotor tone; and, third, recording ot 
the contrast-frec angiographit cathcter tip17.24 immcdiately 
before eath contrast injection and enclosure of the cleaned tip 
(distal 1lJ cm) of each catheter with the cindilrn to facilitlll!: 
later calibration durillg analysis at the core laboratory. 
Quantitative AnalY!l·is 
Thc procedural and technical details of quantitative analy~is 
using CAAS have been well described elsewhere.!8,3o-'\''. The 
important standardized features of the specific core laboratory 
approach used arc as follow~: selection of cineframes for 
analysis by independent panel assessmcnt based on frames 
selected by the investigator and taking into account thc 
rcquirement of absence of overlapping side branches and 
clarity of luminal contours in nonforeshortened projections at 
end diastole. For each analysis, the micrometrically measured 
catheter tip was used for calibration against the automatically 
detccted contours of its angiographically recorded contrast" 
free image. The artcrial segments to be analyzed were identi-
fied hetween major proximal and distal side branches. The 
only other user interaction required in the analysis of the panel 
selected cineframe was the arhitrary selection of center points 
within the identified arterial segment, which are subsequently 
Hutom<1tically readj\l~ted after contour detection. The refer-
ence diameter of the target lesion is automatically derived hy 
the algorithm based on a first-degree polynomial through 
diametric mca~urements made at every scan line proximal and 
distal to the lesion itself. followed by a translation to the 80th 
percentile level, allowing for tapering of the vessel distal to 
102 
side hranches.·'-' The measurement taken as the reference 
di,lmeter for the lesion, or interpolatcd reference diameter, is 
the vallie of the polynomial (the "diameter function curve") at 
the site of the MLD, The advantages of this approach are that 
it is essentially user independent and thus highly reproducible 
and that the measurement taken is based on multiple mea-
surements (evcry pixel) proximal and distal to the lesion. The 
limitation is observed in ostial lesions where no proximal 
segment exisb and in difl'lIsely diseascd or severely ectatic 
segments. However, in clinical trials of balloon angioplasty, 
thc majority of lesions tend to be nonostial and discrete. lI . N 
Before automatic calculation of absolute mcasurements (in 
millimeters), all contour positions of the catheter and seg-
ment wcre corrected for pincushion distortion introduced by 
the image inten~ifiers. To ensure serial analysis was consis-
tently performed in identical prujections, photographs were 
saved or each analysis. Before the algorithm cannot measure 
total occlusions or lesions with Thrombolysis in Myocardial 
Infarction (TIM1) flow grade I, a valli!: of 0 mm is impute-d 
for MLD and 100% for percent diamcter stenosis. Finally, all 
measurements were the mean values of the multiple matched 
projections. 
Specific Angiographk Parameters of Interest 
MLD of the analyzed segment is measured in millimeters. 
Gain and los~, respectively, represent the improvement in 
MLD achieved at intervention (MLD afler PTCA minus MLD 
before PTCA) and the change at follow-up (MLD after PTCA 
minus MLD at tullow-up). Net gain is the net angiogmphic 
improvement from before angioplasty to follow-up (MLD at 
follow-up minus MLD after PTCJ\). Loss index, as defined by 
Kuntz et aV~ repre.~cnts late loss expressed as a fraction of 
acute gain (loss/gain). The "vessel size" is represented by the 
interpolatcd reference diamcter before intervention, so cho-
sen because it is the closest and most objective angiographic 
approximation available of the discase-free or "normal" vcssel 
diameterl{)·2<uo and avoids the variability ill the reference 
diametcr as a consequence of intervention and of the restc-
nosis process. IO.20,35.'" 
Binary definitions for the occurrence of reslenosis were 
applied: (1) diameter stenosis ~50% at follow-up (traditional 
"clinical"· definition of restenosis); (2) lo~s during follOW-lip 
>50% of the gain at l'TCA (National Heart, Lung, and Blood 
Institute definition 4); (3) loss during follow-up >0.40 mm 
(twice the post-PTCA lesion measurement variability of the 
CAAS systemJ7 ). 
Statistical Analysis 
Statistical analyses were carried out using a commercially 
available statistical software package (SAS, SAS Institute Inc) 
using a lesion-based approach, as has been prcviou~ly justi-
lied.l(d7,3~ The 3302 lesions were divided into nine approxi-
mately equal-sized groups ("Iloniles") according to vcssel size. 
The incidence orhinary restenosis, according to the definitions 
given ahove, was compared among noniles by X' test. The 
influence of vessel size on luminal loss and MLD at follow-up, 
a~ well as percent diamcter stenosis and loss index, was 
evaluated by AN OVA of mean values per nonile and in simple 
linear regression analysis. 
Multiple linear regression analysis was used to take account 
of the known influences of preprocedural MLD (lesion sever-
ity) and acute gain (the input of the physician)3-',.!J,lh.luu .. I4.4U 
and the unresolved influence of the epicardial lesion loca-
tion~·"·'7.4I..12 in evaluating the influence of vessd size on 
luminal loss and MLD at follow-up. Since addition of either 
the luminal gain or postprocedura) MLD variable to a model 
already including preprocedural MLD Jllakc~ the same statj~­
tical contribution to the 111odel, a choice was made to use the 
gain variable, sinl-'C thi~ term better cnnveys the dynnmic effeet 
of intervention. 
TABLE 1. Demographic Data of Total Population 
No. of patients 
Lesions, n 
Male, % 
Mean age, Y 
Diabetes, % 
Anginal status (Canadian Cardiovascular 
Society Class), % 
III 
IV 
Unstable angina, % 
Total coronary occlusion before angioplasty, % 
Total occlusion at follow-up, % 
Lesion distribution of 3302 lesions, n (%) 
Left anterior descending coronary artery 
Circumflex artery 
Right coronary artery 
3072 
3736 
80 
56.4±9.6 
7 
13 
31 
38 
18 
27 
7.1 
4.5 
1428 (43) 
819 (25) 
1055 (32) 
The influence of vessel size on percent diameter stenosis at 
follow-up was also evalualed, sin<.:c thi~ is the conventional 
clinically applied measure of coronary slI;:nosis scvcrity, cor-
rected for vessel size. In the multivariate model. preprm;cdural 
MLD and gain were replaced by measures of percenl diameter 
stenosis bcforepre and gain in percent diamet~r stenosis. 
Results 
Baseline demographic charactcristics (Table 1) con-
firm that the patient group is rcprescntative of current 
clinical practice with balloon angioplasty. The 3302 
lesions wcre well distributed throughout the coronary 
tree: 43% in the left anterior descending coronary 
artery (LAD), 25% in the circumflex artery, and 320;(· in 
the right coronary artery. 
Univariate Analysis 
A mean of 2.12 sets of identically matched angio-
graphic projections per lesion (ranging from a l.7 for the 
diagonal branches of the LAD and the distal right 
coronary and circumflex to 2.5 for the proximal circum-
flex) had satisfactory quantitative analysis before and 
after PTCA and at follow-up. Preprocedural percent 
diameter stenosis appears comparatively mild since total 
occlusions were excluded (see Tables 2 and 3). 
Restellos;s Rate 
The influcnce of vessel size on the restenosis rate (Fig 
lA) depended on the definition used. The frequency of 
diameter stenosis ~50% at follow-up varied signifi-
canUy throughout the noniles (P=.002), as did the 
frequency of loss >0.40 mm (P<.OOOl), with a general 
increase with vessel size. However, there was no varia-
tion in the frequency of loss> 50Sh of the initial gain 
(P~.41). 
Percent Diameter Stenosis at Follow-up 
Percent diameter stenosis at foHow-up displaycd a 
minor but significant (P<.OOl), increase with vessel size 
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(Fig 1 B). Although percent stenosis before and after 
PTCA showed a similar general pattern, there was no 
variation in the loss (increase) in percent stenosis 
during follow-up (P=.l1). Since the acute gain (de-
crease) in percent stenosis significantly increased with 
vessel size (P<.OOOI), the net gain in percent stenosi,~ at 
follow-up was also observed to increase with vessel size. 
Lllminal Lo.~s and MLD at Follow-up 
Luminal loss showed a significant variation through-
out the nonile divisions (Table 2; P=.006), with a 
general but inconsistent pattern of increase with vcssel 
size (Fig IC). Although loss increased with vessel size 
(loss=0.13±0.04· vessel size; P=.005), the association 
was weak (Fig 2A). Because of the significantly increas-
ing acute luminal gain achieved in larger vessels (Fig 1 C; 
gain=0.21±0.13 . vessel size; P<.OOOI), however, a sig-
nificant increase in net lumina! gain (Table 2) and in 
MLD at follow-up (Fig 2B; MLD at follow-up= 
OAR±0.40 . vessel size; P< .0(01) was also observed with 
increasing vessel sizc. 
Loss Index 
No significant variation in loss index (Fig ID) was 
observed throughout the nonilcs, apparenUy due to the 
wide variahility in this parameter in this population 
(P~.71). 
These analyscs did nol clarify the influence of vessel 
size on late angiographic results of angioplasty, al-
though the balance of findings suggested a beneficial 
effect of larger vessel size. To further elucidate the 
relation betwecn vessel size and the restenosis process 
and late angiographie outcome, multiple linear regres-
sion analysis was carried out, taking into account the 
influences of gain and MLD before PTCA on loss and 
MLD at follow-up (Fig 2C through 2F), as well as the 
inlluencc of lesion location. 
Multiple Linear Regression Analysis 
In multiple linear regression analysis, vessel size was 
found to demonstrate an independent negative influ-
ence on luminal loss and an identical positive influence 
on MLD at follow-up (P<.OOOI; Table 3, Figs 3 and 4). 
To further illuminate these findings, three-dimensional 
graphs have been constructed in which the influence of 
vessel size is represented using llOnile divisions as 
already defined. The negative influence of vessel size on 
loss is appreciated from Fig 3 by the parallel downward 
shift oJ the regression plane with increasing vessel size 
(lhe contrasting univariate finding of increasing loss 
with vessel size is due to the effect of increasing MLD 
before PTCA and gain in larger vessels [Fig 3, especially 
Fig 3A]). Analogously, the equal and opposite influence 
oJ vessel size on MLD at follow-up is demonstrated in 
Fig 4 by the parallel upward shift in the regression 
plancs. With a l-mm increase in vessel size (while the 
other parameters remain constant), therc would be elil 
estimated decrease in loss of 0.14 mOl and an identical 
increase in MLD at Jollow-up. Accordingly, it must be 
concluded that late results of successful balloon angio-
plasty are bettcr in larger vessels. Correcting for vessel 
size, using percent diameter stenosis measurements, 
eft"ectively neutralized this significant influence on out-
come (P=.68; Table 4). 
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TABLE 2, Quantitative Angiographic Measurements Before and After Angioplasty and at Follow~up and Restenosis 
Rates Compared Within Nine Equally Sized Groups (Noniles) According to Vessel Size 
Overall Nonile 1 Nonile 2 Nonile 3 Nonile 4 Nonlle 5 Nonile 6 
No. of lesions 3302 366 368 367 361 377 360 
ReID pre, mm 2.63±0.55 1.78±0.17 2.11±0.07 2.30±0.05 2.44±0,04 2,59±0.05 2.75±0.04 
ReID post, mm 2.70±0.58 2.01 ±0.31 2.26±0.25 2.40±0.21 2.53±0.24 2.64±0.24 2.77±0.23 
ReID fup, mm 2.70±0.55 1.99±0.37 2.26±0.30 2.40±0.30 2.53±0.35 2.64±0.34 2.78±0.33 
MLO pre, mm 1.08±0.29 0.85±0.17 0.95±0.21 1.00±0.21 1.02±0.22 1.08±0.23 1.09±0.26 
MLO posl, mm 1.75±0.37 1.36±0.27 1.51±0.27 1.60±0.23 1.68±0.27 1.73±0.27 1.80±0.27 
MLO fup, mm 1.53±0.47 1,20±0.33 1.32±0.34 1.38±0.38 1.46±0.38 1.51±0.39 1.53±0.44 
% OS pre 58.2±9.87 51.5±9.9 55.0±9.6 56.4±9.2 58.1 ±9.1 58.3±8.8 60.1 ±9,5 
% OS posl 34.5±9.41 31,2±1O.7 33.2±9.7 33,0±9.7 33.5±8.7 34.1±9.2 34.7±9.0 
% OS fup 42.8±14.0 39.2±13.3 41.4±13.7 42.2±14.5 42.1±12.9 42.5±13.6 44.9±14.9 
Gain, mm 0.67±0.35 0.51 ±0.28 0.56±0.29 0.60±0.27 0.66±0.33 0.66±0.31 0.71 ±0.34 
Loss, mm 0.22±0.42 0.16±0.34 0.19±0.38 0.22±0.37 0.22±0.41 0.22±0.39 0.28±0.45 
Net gain,mm 0.45±0.44 0.35±0.33 0.37±0.35 0.38±0.39 0.44±0.42 0.43±0.41 0.43±0.45 
Loss index 0.27±1.99 0.31±1.47 0.25± 1.99 0.26±3.21 0.30±-2.37 0.34±1.85 0.43±1.16 
Loss>gain/2 39.0% 39.1% 39.7% 42,0% 38.0% 38.2% 43.1% 
% OS2:50% 31.6% 23.2% 28.5% 30.0% 29.0% 32.6% 37.3% 
Loss>O.4 mm 31.7"/" 22.7% 26.3% 30.8% 31.0% 32.9% 37.5% 
ReiD indicates reference diameter; MLD, minimal luminal diameter; pre, before; post, after; fup, follow-up; and % OS, percent diameter 
stenosis. 
Gain, loss, nel gain, loss index, and reslenosis criteria are defined in the lexl. P value refers 10 ANOVA of mean values or to,\'2 test, 
where appropriate. %DS pre appear moderate, as lolal occlusions are excluded. 
Influence of Gain and MLLJ Be.fore PTCA 011 Loss 
alld MLD at Follow-lip 
Luminal gain and MLD before PTCA exerted signif-
icant positive independent influences (P< .0001) on loss 
and MLD at fo\!ow-up (Table 3), which do not vary with 
increasing vessel size confirmed by the consistent slope 
of the regression planes, from right to left or front to 
back, throughout the noniles. The negative univariate 
influence of MLD before PTCA on loss (Fig 2C) was in 
contrast with this significant positive influence (Fig 3) 
and is due to the inJluence of luminal gain (Fig 5). 
According to the models and figures, the steeper right-
to-left slope in the loss figure (Fig 3), compared with 
MLD at follow-up (Fig 4), means that with increasing 
gain, the expected incremental increase in loss is greater 
than the incremental increase in MLD at follow-up. 
Specifically, from Table 3, for a I-mm increase in gain, 
the estimated increase in loss would be 0.fi2 mm com-
pared with a 0.38-mm increase in MLD at follow-up. 
From the clinical perspective, maximization of the lu-
minal increase would he worthwhile, according to this 
finding. Increasing MLD hefore PTCA provides a 
greater increase in MLD at follow-up than in loss, since 
the front-to-back slope of each regression plane is 
steeper in the MLD On follow-up graphs. Thus, a 1-mm 
increase in MLD before PTCA would provide an esti-
mated O.69-mm increase in MLD at follow-up and a 
O.31-mm increase in loss (Table 3). Also, greater per-
cent stenosis before PTCA and gain in percent stenosis 
were associated with greater percent stenosis at fol-
low-up (Table 4). Accordingly, angioplasty in progres-
sively milder lesions is associated with improving 
outcome. 
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Influence of Lesion Location 011 Late Results 
Lesion location in the LAD (compared with right or 
circumflex artery) was associated with greater loss and 
smaller MLD at follow-up as well as with greater 
percent stenosis at follow-up (P<.OOOl). 
Discussion 
Univariate Analysis: Conflicting Findings 
ll1e influence of vessel size on the restenosis process 
and the angiographic outcome was not elucidated using 
univariate analysis. The restenosis rate per nonile de-
pended on the definition used, which is not surprising, 
in view of extensive previous work highlighting the 
limitations of a categorical approach tu evaluation of 
the long-term outcome of intervention. IU ,II.W.31.3S·3H Al-
though greater percent diameter stenosis at follow-up 
was observed in larger vessels, final net improvement in 
percent stenosis was actually considerably greater in 
larger vessels (Table 2, Fig 18). Similarly, although 
luminal loss was observed to increase with vessel size, a 
striking increase in final net gain in MLD was also 
observed. These increasing net improvements in larger 
vessels appeared to be due to the significantly greater 
acute results achieved (Tahle 2, Figs 1 and 2) and 
translated into significantly greater MLD at follow-up in 
larger vessels (Tahle 2, Figs 1 and 2). Loss index 
(loss/gain, as a proposed measure of the "proliferative 
potential of an instrumented vesseJ-+2"), was not influ-
enced by vessel size. This was mainly due to its wide 
variability, explicable by the frequent finding of negligi-
ble luminal gain by CAAS after visually assessed suc-
cessful angioplasty (Fig 2E and 2F). After successful 
stent implantation or atherectomy, there is virtually 
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TABLE 2. Continued always a substantial acute gain,3.5.R.34.43.46 so regardless 
of the degree of subsequent change, large negative or 
positive values for loss index are rare. Collectively, 
although there is a general, but not systematic, trend 
toward better late results in larger vessels, these findings 
do not provide a clear message, with the conclusions of 
one approach conflicting with those of another. 
Nonile 7 
372 
2.92±0.06 
2.94±0.25 
2.95±0.33 
1.17±0.26 
1.90±0.26 
1.64±0.45 
59.8±9.1 
35.0±8.6 
44.1±14.9 
0.73±0.34 
0.26±0.46 
0.47±0.47 
0.21±2.05 
39.0% 
33.3% 
34.1% 
Nonile 8 
363 
3.15±0.08 
3.13±0.27 
3.14±0.37 
1.22±0.27 
1.99±0.32 
1.74±0.44 
61.1 ±S.7 
36.2±9.1 
44.3±13.1 
0.77±0.3S 
0.25±0.47 
0.51 ±0.47 
0.23±1.54 
38.3% 
35.3% 
35.3% 
Nonile 9 
368 
3.64±0.31 
3.59±0.39 
3.56±0.50 
1.34±0.37 
2.18±0.36 
1.95±0.52 
63.2±9.S 
38.9±9.7 
44.9±13.8 
0.84±0.43 
0.23±0.50 
0.61±0.51 
0.12±1.47 
34.0% 
34.5% 
34.8% 
p 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
<.0001 
.006 
.02 
71 
.41 
.002 
<.0001 
Multiple Regression Analysis: Influence of Vessel 
Size on Late Results 
In multiple regression analysis, vessel size was dem-
onstrated to have a significant independent positive 
influence on MLD at follow-up (Table 3, Fig 3) and an 
equally negative effect on luminal loss (Table 3, Fig 4), 
in contrast to the increase in median loss with vessel size 
seen in univariate analysis (Figs 2A and 3). This is a 
consequence of the greater gain and MLD before 
PTCA in larger vessels, as illustrated in Fig 3. It must be 
recognized, therefore, that for all its attractive simplic-
ity, univariate analysis does not provide a true evalua-
tion of the apparently multifactorial phenomenon of 
restenosis, due to an inability to take account of impor-
tant confounding factors. The findings may be explained 
through the convcntional hypothesis that vessel injury 
is directly related to the degree of neointimal re-
sponse. 47- 4 'J It is logical that achieving a given luminal 
gain, in a lesion of given MLD before PTCA, would 
result in diminishing wall injury in progressively larger 
TABLE 3. Multiple Linear Regression to Determine Independent Influence of Vessel Size on Luminal Loss; MLD at 
Follow-up, Taking Account of MLD Before Angioplasty, Luminal Gain, and Lesion Location in Left Anterior 
Descending Coronary Artery; and True Corollary Nature of Loss and MLD at Follow-up by Simple Stepwise 
Mathematical Derivation of Exact Model for Loss Starting With Model for MLD at Follow-up 
(A) LUminal Loss During Follow-up (B) MLD at Follow-up 
EstImated Estimated 
Coefficient SEE P Coefficient SEE 
Intercept -.11 .04 .002 .11 .04 
Vessel Size -.14 .02 <.0001 .14 .02 
MLD pre .31 .03 <.0001 .69 .03 
Gain .62 .02 <.0001 38 .02 
LAD .07 .01 <.0001 -.07 .01 
P<.0001; R2=.17. P<.0001; R2=.32. 
(C) Mathematical Derivation of Loss Model From MLD at Follow-up Model 
The model for loss may be mathematically derived from the model for MLD at follow-up as follows: 
MLD fup=0.11 +0.14' VS+0.69· MLD pre+0.38 . gain-0.07 . LAD 
Loss=MLD post-MLD fup; but: MLD post=(MLD pre+gain); so: 
Loss=(MLD pre+gain}-(MLD fup); therefore: 
Loss=(MLD pre+gain}-{O.11 +0.14' VS+0.69· MLD pre+0.38· gain-0.07· LAD} 
Removing the brackets, this equation may be rewritten as: 
loss=MLD pre+gain-0.ll-0.14· VS-0.69· MLD pre-0.38· gain+0.07· LAD 
This equation may then be rearranged as follows: 
Loss={MLD pre-0.69· MLD pre}+{gain-0.38· gain)-0.11-0.14· VS+0.07· LAD 
or according to the original format: 
loss=-0.11-0.14· VS+(MLD pre-0.69· MLD pre)+(gain-0.38· gain) +0.07 . LAD 
Loss=-0.11-0.14· VS+0.31 MLD pre+0.62 gain+0.07 . LAD 
P 
.002 
<.0001 
<.0001 
<.0001 
<.0001 
MlD indicates minimal luminal diameter; pre, before angioplasty; vs, vessel size; fup, follow-up; post, after angioplasty; and LAD, left 
anterior descending coronary artery. 
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FIG 1. A through D, Plots of inlluence of vessel size, divided in 
noniles, on (A) restenosis rates (incidence in percent), according 
to three binary delinilions. Loss >0.5*gain indicates loss during 
follow-up 01 more than half the gain at percutaneous transluminal 
coronary angioplasty (PTCA); %DS at FlU 250, percent diame-
ter stenosis at follow-up of more than 50%; and loss> 0.4 mm, 
loss during follow-up of more than 0.4 mm, which is twice the 
poslangioplasty lesion measurement variability of the CMS 
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vessels. Less injury would result in less neointimal 
formation, measured as less angiographic loss, leaving a 
greater MLD at follow-up. We can use the multivariate 
models to illustrate this: In a lesion with a pre-PTCA 
MLD of 0.5 mm, achieving an acute gain of 1.5 mm 
would result in a loss of 0.72 mm in a small vessel (1.83 
mm) and 0.48 mm in a large vessel (3.56 mm). The 
estimated MLD at follow-up in the small vessel would 
be 1.28 mm compared with 1.52 mm in the large vessel. 
The gain of 1.5 mm would cause actual overenlargement 
of the small vessel and thus considerably greater wall 
injury than in the larger ve.'"sel (in which a 1.5-mm gain 
would provide a comparatively modest acute result), so 
that less loss would be provoked and a greater MLD at 
follow-up is provided in the large vessel. Of course, this 
does not present a good reason to accept marginal 
interventional results in larger vessels, since if a gain of 
2.5 mm (instead of 1.5 mm) had been achieved in the 
large vessel, an MLD at follow-up of 1.90 mm could be 
anticipated, even if greater loss would be provoked (1. 10 
mm). In agreement with reports based on stcnt implan-
tation and directional atherectomy,3-'J maximization of 
the acute result must be generally recommended as the 
goal of intervention. Neutralization of tbe independent 
influence of vessel size by using percent stenosis would 
be expected, since percentage measurements inherently 
precorrect for the influence of vessel size and since the 
proportional vessel injury would be similar across all 
vessel sizes when percent stenosis before PTCA and 
gain in percent stenosis are constant. Accordingly, the 
observed advantage of larger vessels seems to be a 
simple mechanical privilege rather than a cryptic bio-
logical phenomenon that protects larger vessels . 
Use of a Dual Approach and Value of a 
Selective Model 
A number of recent studies have used comprehensive 
multivariate analysis to predict luminal loss, MLD or 
percent diameter stenosis at follow-up, or occurrence of 
binary "restenosis,I-7.9-16" using clinical, procedural, an-
giograpbic, and histological variables. Despite its thor-
oughness, the potential flaw of such an approach is that 
some of the angiographic variables used provide overlap-
ping infonnation (cg, preproccdural MLD, gain, and 
postprocedural MLD). Also, inclusion of relative (per-
cent stenosis or relative luminal changes) and absolute 
parameters may also be criticized for incoI1-<;istency of 
approach. This may partly explain why different factors 
have been found to predict luminal loss, MLD at follow-
up, percent diameter stenosis at follow-up, and binary 
restenosis in different studies. I-3,6.7.'J.l2-17 For this reason, 
even when the evaluation of late results of intervention 
was restricted to a "dual approach," greater luminal loss 
after directional atherectomy was found to be deter-
mined by greater luminal increase and greater 
system. B, %DS at follow up, as we!! as %DS before and after 
PTCA and acute decrease in %DS immediately after PTCA and 
late increase in %DS during follow-up. C, lUminal loss and MLD at 
follow-up, as well as MlD before and after PlCA and acute gain. 
D, Loss index. In B through D, mean values and 95% confidence 
intervals (Cis) of each parameter are provided for each nonile. 
Actual differences between the noniles are provided in Table 2. 
MlD indicates minimal luminal diameter; %DS, percent diameter 
stenosis; FUP, follow-up; PRE, before; and POST, after. 
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FIG 2. A through F, Scatterplols of linear regression analysis, with 95% confidence intervals, of loss and MLD at follow-up with each of 
vessel size (A and 8), gain (e and D), and MLD before (E and F). MLD indicates minimal luminal diameter; FUP, follow-up; PAE, before; 
and PTCA, percutaneous Iransluminal coronary angioplasty. Note that the x- and y-axis scales vary according to the parameters 
displayed. 
MLD before PTCA, whereas greater MLD at follow-up 
was determined by larger vessel size, postproceduraI 
lumen, and non-LAD locatioo.9 In the present study, in 
addition to the use of a dual approach, a selective 
multivariate model was used to isolate the principal 
angiographic factors (ie, preprocedural MLD, luminal 
increase, and lesion location) and investigate their dy-
namic interrelationships and their respective effects on 
the influence on vessel size and late results of balloon 
angioplasty. Although the need to usc a "dual ap-
proach9 " has been recognized lO,]] and may be clinically 
obvious, the truly converse nature of luminal loss and 
MLD at follow-up, as correlates of the restenosis process 
and the late angiographic outcome, respectively, has not 
107 
been previously demonstrated and was only facilitated in 
this study by application of the selective model. This has 
been illustrated in Table 3C by simple mathematical 
derivation of the findings for loss through the findings for 
the MLD at follow-up. Much of the debate regarding 
determination of "restenosis" after transluminal coro-
nary interventions has been due to preferential consid-
eration by investigators of one or other of these opposite 
"end points10,1!,](,,]7,20" or of binary restenosis.L2·4,7,!1-
lS,.l~,40 The opposite points of focus have been descrip-
tively tenned the "doughnut" and the "hole," respective-
ly,1O·1!·49 and studies aimed at investigation of the late 
clinical and/or angiographic outcome will require to 
focus on the MLD at follow-up (the hole), whereas those 
, WI , 
9 , n~ 
§ 
n;l 
"' 
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FIG 3, A and B, Three-dimensional schematic and scatter plot that depict the 
influence of vessel size (VS; interpolated reference diameter before angioplasty) on 
luminal loss, considering the influence of gain and minimal luminal diameter (MLO) 
belore angioplasty (PRE) (Table 3A). Vessel size is represented using the noniles, as 
described in the text. Loss is on the (vertical) y axis, and gain is on the x axis 
(increasing from right to left) for illustrative purposes, and MLO before angioplasty is 
on the z axis (increasing 'rom front to back). For consistency, the limits of each axis 
are equal for each nonile. The actual range of gain and MLO before angioplasty for 
the lesions within each nonile is represented by the outlined rectangle within each 
"regression plane." Purely for Illustrative purposes, the lesions have been assem· 
bled in nine rows containing eQual numbers of lesions, both from Iront to back and 
from side to side. The yellow dot in the center of the red rectangle represents the 
median loss lor the nonile, displayed numerically on the y axis. Although the 
regreSSion plane shifts progressively downward with Increasing vessel size, indicat-
ing decreasing estimated loss for any given gain and MLO before angioplasty 
(emphasized by a pale blue dot at the upper left corner of each regression plane), the 
median loss is observed to actually increase. This finding is highlighted in Fig 3B by 
including only the median loss and the upper border of the regression planes and 
can be explained by the confounding effect 01 MLO before angioplasty and gain, 
whereby there is a preponderance of lesions with small MLO before angioplasty and 
small gain in small vessels and greater MLO before angioplasty and greater gain in 
larger vessels (conveyed in the graphs by progressive movement 01 the rectangle 
from right to left and Iront to back). 
evaluating the restenosis process will need to evaluate 
the loss (the doughnut) and a thorough study must 
ultima tely adopt a dual approach.9 •u 
dellt equal and opposite effects of vessel size 011 the 
rcstenmds process and nngiographic outcome. The ob-
vious clinicil l interpretation of th is finding is that inter-
vention in larger vessels is inherent ly likely to be asso-
ciated wit h a more favorab le lo ng-term outcome. 
Accordi ng to this scheme, it wou ld be appropria te 10 
concl ude Ihal not on ly dues a " bigger" ga in indepen-
den tly yield a " better" outcome,ll as is also con firmed in 
this study (Tab le 3B, Fig 4) hul also that, in deed , a 
" bette r" long-term outcome may be ant icipated, afte r 
intervention in a " bigger" vessel. This finding may 
partly explain the reported ly superior long-term resul ts 
of directional a th erectomy and ste n! imp lantation in 
observa tional studies, compared with results of conve n-
tiona l ba lloon angioplasty,4 " si nce (hese devices a re 
generally restricted to more proximal segments in larger 
Cli nical Imp liea lions of Ihe Findi ngs: An Ad ded 
Meaning to "Bigger Is BeUer" 
Previous studies have reported lower categorically 
defi ned rcstenosis rates in la rge r vesse ls after balloon 
angiop lasty,2 d irectional atherectomy, an d sten! implan-
tation,J whereas others have fou nd no relation between 
vessel size and incidence of rcste nosis.1 2·1.'i.40 Moreover. 
while greater MLD at fOllow-up after d irectiona l 
athereetomy or stent implan tationJ"1 was predicted by 
larger vessel size, lumina l loss was not inHuenced by the 
vessel size in these or other studies.9•16 This study would 
th us appear to be the firs t to demonstra le the indepen-
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FIG 4. Schematic with approach similar 10 that of Fig 3A to represent the model for minimal luminal diameter (MlD) at follow-up (FUP) 
(y axis). The equal but opposite effect of vessel size on MlD at follow-up compared with luminal loss is displayed here by the 
progressively upward shift of the regression planes with increasing vessel size, to the same degree as the downward shift observed in 
Fig 3. The median MlD at follow-up also consistently increases with increasing vessel size. PRE indicates MlD before balloon 
angioplasty; VS, vessel size (interpolated reference diameter before angioplasty). 
coronary vesscls. Moreover, the finding augurs well for 
continued use of Ihese devices in larger vessels, as not 
only is it possible 10 take advantage of their mechanical 
superiority over balloon angioplasty in larger vessels3• 
1I .2tJ..l-IAJ · 4{i but the independent beneficial effect of in-
tervention in a larger vessel per se may also be realized . 
Likewise, the nega tive influence of smaller vessels on 
late outcome does not herald a bright future for devices 
more practically suited to smaller vesse ls, namely, rota-
blator and excimer laser. Although excimer laser is 
increasingly associated with improved short-term clini-
ca l success in unfavorable corollilry lesions,so signifi -
TABLE 4. Multiple Linear Regression to Evaluate 
Influence 01 Vessel Size on Percent Olameter Stenosis 
at Follow-up, Using Same Approach as In Table 3 but 
Percent Diameter Stenosis Before and Atter 
Angloplasty In Place 01 Minimal lumInal Diameter 
Belore Angloplasty and Gain 
Estimated 
CoeffIcient SEE p 
Intercept 13.7 1.57 <.0001 
Vessel size .19 .45 .6a 
% DS pre .64 .03 <.0001 
Gain in % OS .33 .02 <.0001 
LAD LSI .47 .001 
DS indicates diameter stenosis; pre, before angioplasty; and 
LAD, left anterior descending coronary artery. 
P<.OOOI; R2 =. 12. 
canlly greater loss and smaller MLD at follow-up have 
been reported in a matched comparison with balloon 
angioplasty.51 Late resu lts aftcr successfu l high-speed 
rotational a thercctomy are no more encouraging,l ,} so 
applicat ion of these devices may be inherently doomed 
to comparatively poor long-term results, partly due to 
their preferential use in smaller vessels. 
Implications fol' Comparative Studies 
In randomized trial s, such as CAVEAT (Coronary 
Angioplasty Versus Excisional Atherectomy TriaJ)1I and 
CCAT (Canadia n Corona ry Athcrcctomy Trial),·4 all 
patient characteristics are considered equally distrib-
uted, enabling direct compa risons of outcome. Thus, in 
these trials, no significant difference in late angio-
graphic resu lts was reported, despite the greater initial 
luminal increase noted in the atherectomy-Irea ted 
groups. In the BENEstent (Belgium Netherlands stent) 
and STRESS (STent RESstenosis Study) randomized 
trials of Palmaz-Schatz sten! implantation and balloon 
angioplasly, a significant long-term advantage of stent 
implantation over convcntional balloon angioplasty has 
becn reported.4.'1 .46 Comparison of late results of diffe r-
ent intervent ions in observat ional studies could be 
considered misleading, unless either the groups are 
suitably matched for ves.'\el size.'l·~ )·5 l or differences in 
vessel size arc taken into accounl. lO Separate observa-
tional studies in corona ry lesions specifically matched 
for vessel size, as a "surrogate" for a randomized trial 
comparing athcreelomyO and stent implanta tionS with 
balloon angiop lasly, in retrospect had actually predicted 
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the outcome of the four randomized trials mentioned. 
Such matching studies may thus provide useful informa-
tion in comparing outcumes of different interventions, 
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FIG 5. A through D, Confounding effect of gain on the relation 
between minimal luminal diameter (MlD) before angioplasty 
(PRE) and loss is shown by representing the entire lesion 
population with loss on the y axis, gain on the x axis, and MLD 
before angioplasty on the z axis. Purely for illustrative purposes, 
the lesions have been assembled in nine rows (containing equal 
numbers of lesions) from front to back and from side to side. The 
actual number of lesions at each of the thus created 81 possible 
positions in this graph is represented by the diameter of the 
sphere. The corresponding loss at each position is represented 
by the vertical height at the center of the sphere. To demonstrate 
the influence of gain on the relation between MlD before 
angioplasty and \uminalloss, the rows from front to back on the 
extreme left and right have then been isolated from the remain-
ing lesions, which have been obscured for this purpose (Fig 4B). 
The graph has then been rotated clockwise until these two rows 
are visualized two-dimensionally from left to right with MlD 
before angioplasty now occupying the horizontal axis (Fig 4C). It 
is appreciated that the top row in C depicts lesions with greater 
gain, and the bottom row depicts lesions with lesser gain. Both 
rows display the consistent positive multivariate relationship 
between MlD before angioplasty and loss. When the two rows 
are merged, because of the preponderance of lesions with a 
small MlD before angioplasty in which a large gain is achieved 
and of those with a large MlD before angioplasty in which a 
small gain was achieved, the positive relation between MLD 
before angioplasty and loss is actually reversed, depicting the 
univariate relation, as observed in Fig 2C. 
since the important and confounding influence of vessel 
size on late results is balanced. 
Inftuence of Lesion Location on Late Results 
Greater luminal loss, smaller MLD at follow-up, and 
greater percent stenosis at follow-up are associated with 
lesion location in the LAD, independent of luminal in-
crease and lesion severity before PTCA. Previous studies 
in patients treated by balloon angioplasty have reported 
increased restenosis rates in LAD lesions2,!3; others found 
no association between lesion location and restenosis 
rates, luminal loss, or relative luminal IOSSI6,41; and one 
study reported less relative loss in right coronary artery 
lesions.17 Location in the right coronary artery was also 
found to predict less late loss, larger MLD at follow-up, 
and lower incidence of restenosis in patients treated by 
directional atherectomy or stent implantation.3 
Subsequently, in a larger study,42 the same authors 
found LAD location to be the strongest independent 
predictor of binary restenosis and percent stenosis at 
follow-up. Other investigators have found LAD location 
to predict smaller MLD at follow-up, but not luminal 
loss, after directional atherectomyY In randomized 
studies, the CAVEAT trial reported improved long-
term angiographic outcome in LAD lesions treated by 
atherectomy compared with balloon angioplasty,8 
whereas in the CCAT trial, which compared directional 
atherectomy and balloon angioplasty for proximal LAD 
lesions only, no advantage of DCA was found.44 In this 
study of 3302 lesions, the association of LAD lesion 
location with less favorable long-term results is inescap-
able. However, a plausible explanation for this has not 
yet been advanced. Greater frequency of intimal hyper-
plasia was found in tissue retrieved by directional 
atherectomy from primary lesions of the LAD com-
pared with RCA and cireumflex,52 which might convey 
an increased propensity to renarrowing after initially 
successful angioplasty in LAD lesions. Such findings 
deserve prospective histological confirmation in larger 
studies, and further reports from CA VEA TR may be 
helpful. Also, since chronic recoil, measured by serial 
intracoronary ultrasound, has been advanced as a major 
component of late restenosis,53 its distribution through-
out the coronary vessels is of major interest, if the 
phenomenon can indeed be verified and reliably 
quantified. 
Reference Diameter Changes: Implications for 
Percent Stenosis Measurements 
Reference diameter changes from postangioplasty to 
24 hours have been found to erroneously indicate 
deterioration in lesion severity during this time, 
whereas MLD and area remained unchanged.37 Simi-
larly, apparently normal coronary segments adjacent to 
a target lesion may be involved in the restenosis process 
(since these are invariably subjected to the trauma of 
balloon dilatation) and provide misleading percent ste-
nosis measurements at follow_up.35.3f, . .18 In this study, a 
significant increase in interpolated reference diameter 
was observed from before to after angioplasty, which 
was maintained at follow-up and the variability of this 
parameter also increased from before to after PTCA to 
follow-up (Table 2). When reference diameter is mea-
sured by arbitrary selection of normal-appearing seg-
ments adjacent to the stenotic lesion, variability of 
percent diameter stenosis measurement increases even 
fUrther. 1O•2fl.J 1.35-3S Although traditional percent diame-
ter stenosis continues to appropriately form the corner-
stone of clinical practice, its reliability in clinical studies 
of the biological process of restenosis must therefore be 
questioned. Absolute luminal measurements, which are 
much more precisely obtained by quantitative angio-
graphic analysis,28.30,32.36.J7 must be preferentially rec-
ommended. According to the findings in this study, the 
effect of the vessel size must be taken into account when 
evaluating late results of intervention, especially in 
comparative studies. To this end, a constant, objective, 
and reproducible measure of vessel size is recom-
mended, namely, the interpolated reference diameter 
before intervention. With increasing availability of re-
liable on-line quantitative analysis,54.55 the clinical util-
ity of such measurements must not be underestimated, 
since extrapolation of experience using automated anal-
ysis has been shown to be eminently applicable to the 
clinical interpretation of coronary angiograms.56.57 
Study Limitations 
Various clinical and biological factors may theoreti-
cally modify the influence of vessel size on late angio-
graphic outcome and deserve evaluation in future stud-
ies. However, it is worth noting that although some 
clinical factors have been found to be independently 
correlated with luminal renarrowing (eg, diabetes and 
duration of angina before angioplastyI6), a recent study 
found no clinical, procedural, or histological factors to 
influence the relations between quantitative angio-
graphic parameters.9 The predictive value of the multi-
variate models in this study could be considered poor 
(although 32% of the variance of MLD at follow-up was 
explained by the model), this is a limitation of applying 
simple geometric principles to a compound, multifacto-
rial phenomenon. Nevertheless, the intention of the 
study and, particularly, the multiple regression analysis 
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was not to "predict" restenosis but rather to evaluate 
the independent influence of vessel size on the late 
results of angioplasty. 
Summary and Conclusions 
Vessel size is an important determinant of the extent 
of the renarrowing process and MLD at follow-up after 
successful angioplasty. An extra dimension may be 
added to the "bigger is better" maxim, namely, that 
"bigger vessels have a better outcome." Predisposition 
of stent implantation and directional athcrectomy to 
larger coronary vessels may partly explain their re-
ported superior late results compared with "plain old" 
balloon angioplasty, and the rather poor results of 
excimer laser angioplasty and rotational atherectomy 
may be partly due to their use in smaller vessels. By 
extension, the results portend well for continued appli-
cation of devices that can safely and consistently achieve 
large increases in luminal dimensions at intervention, 
whose ultimate benefit may be most effectively realized 
in larger vessels. 
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ABSTRACT 
Background: Excimer laser coronary anginplasty has become widely used for coronary angioplasty, on the basis 
of atheroma ablation and particularly because of clinical success in lesion subsets considered unfavourable for 
conventional balloon angioplasty. The AMROE (Amstenlam-Miami-ROtterdam-Eilldhovell) trial was the first 
ralldomized clinical trial designed to compare acute and long term clinical and angiographic results of ELCA 
with balloon angiopiasty, for treatment of longer coronary lesions in patients with stable angina. 
Purpose: The purpose of this ancillary study was to compare angiographic restennsis propensity of ELCA with 
BA alllong ratiems who bad initially successful intervention and seriallJuantitativc coronary angiographic fol!ow 
up ill the AM ROE trial. 
Results: Procedural success (diameter stenosis < 50%, without a major adverse cardiac event) was achieved 
in ! 26 (80 %) of 151 patients randomly assigned to excimer laser, amI in 132 (79 %) of 157 patients randomized 
to BA. Among patiellts eligible for angiographic follow up, 120 with 124 lesions in the ELCA treated group 
(93 %) and J 23 with 126 lesion.<; in the balloon angioplasty treated group (91 %), had quantitative angiographic 
follow up and were eligible for this study. Despite achievement of a significantly greater acute lumen diameter 
in (he ELCA group (1.69null versus I . 59null, p= .05), greater late loss suhsequently developed (0.52nu11 versus 
0.34mlll. p = .04) and the follow up luminal diameter was not significantly different (1.17mlll versus 1.25111m, 
p=.30). In addition, a significantly greater loss index was obsetved for the ELCA treated lesions (0.74 versus 
0.36, p=.02) as well as tretlds towards higher incidence of clinical restenosis (53 % versus 41 %, p=.058). Tn 
llluitiple linear regression analysis to predict loss and MLD at follow up, a trend towards an independent 
intluence of the device used for intervention was ohserved favouring balloon angioplasty (p=.08). Further 
analyses to comparatively evaluate angiographic restenosis propensity of ELCA and BA in certain lesion subsets 
revealed a consistently greater loss index associated with ELCA for treatment of smaller vessels « <2.5mm), 
0.98 versus 0.45, p = .06), longer lesions (( > 9mm) , 0.71 versus 0.38, p= .05) and among the more optimally 
treated lesions (post procedural MLD > 1.67mm), 0.51 versus 0.20, p=.05). 
COllclusirms: These tindings indicate that excimer laser coronary angioplasty is associated with a greater 
restenosis propensity than conventional balloon angioplasty. This may he due to more extensive or intense vessel 
wall injury caused during intervention by laser than conventional balloon alone. New developments in laser 
technique and particularly in catheter technology, which promise to reduce the tissue ahlation : injury ratio, will 
he required to justify continued use of this powerful intervelltional tool. 
INTRODUCTION 
Excimer laser coronary angioplasty was introduced as an alternative device for percutaneous coronary 
revascularization, with the working hypothesis that ahlation of atheromatous tissue would allow successful 
recanalization of diseased coronary arteries [1-31. Ohservational studies and registry hased reports have shown 
that ELCA can achieve acute procedural success which is comparable or superior to other percutaneous devices 
ill diHicult lesion suh-sets, such as longer lesions, ostial lesiOlL~ and especially in smaller vessels and total 
coronary occlusion l5-91. The ahsence of a randomized clinical trial comparing ELCA with conventional 
angiorlasty, with regard to long terIll as well as acute, clinical and angiograpiIic outcome, stimulated the 
inauguration of the AM ROE (AmsterdaIn-Miami-ROtterdam-Eindhoven) trial in 1991. This trial, in which 
patients requiring treatment of longer coronary lesions (~ IOmm), were randomly assigned to conventional BA 
or ELCA, has now been completed. Essentially, no significant difference was detected between the treatment 
groups, ill acute or 6 month angiographic or clinical outcome llOJ. 
Because of a prior report of less favourable late angiographic results after ELCA compared with 
halloon angioplasty, in a matched patient comparison [Ill, the study described in this report was designed to 
comrrehensive1y investigate whether device specific differences in restenosis propensity can be detected between 
these treatment modalities, among the patients randomized in the AMROE trial. To facilitate tilis, multivariate 
analysis was applied t(l investigate the allgiographic detemlinants of luminal loss and minimal luminal diameter 
at follow up, to evaluate the possibility of a device specific effect on late angiographic outcome. In addition, 
suh-group allalyses were performed, to ascertain whether differences in outcome were evident between the 
treatment groups, accordillg to lesion length, vessel size, total coronary occlusion or the magnitude of the acute 
result. 
PATIENTS AND METHODS 
Patient popUlation 
Between Septemher 1991 and November 1993, a total of 308 patients (330 lesions) were randomized 
ill the Amsterdam-Rotterdam comparative evaluation of excimer laser angioplasty and balloon angioplasty for 
treatment of longer coronary lesions (patient demographics are provided in tahle I). Of these, lSI patients with 
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158 lesions were randomly assigned to excilller laser and 157 with 167 lesions to balloon angioplasty 
(angiographic lesion characteristics are given in table 2). Procedural success (diameter stenosis < 50% at the 
end of the procedure, without the occurrence of a major adverse cardiac event [121) was achieved in 126 of 158 
(80%) lesions treated hy ELCA and 132 of the 167 (79%) lesions treated by balloon angioplasty. Among 
patients eligible for angiographic follow up, a total of 120 with 124 lesions in the ELCA treated group (93 %) 
and 123 with 126 lesions in the balloonangioplasty treated group (91 %), had quantitative angiographic follow 
up and were eligible for this study. 
Table 1: Demographic characteristics of the patients included in the AMROE trial. 
Patients 
Lesions 
Age 
Gender (M:F) 
Diabetes (%) 
History of Smoking 
Currently smoking 
Hypertension 
Hypercholesterolemia 
Prior myocardial infmction 
Prior CABG 
Prior PTCA 
Anginal status: 
Non-exertional angina 
CCS I 
CCS II 
CCS III 
CCS IV 
A ngiographic 1 vessel disease 
A ngiographic 2 vessel disease 
Angiographic 3 vessel disease 
Target lesion location: LAD 
Lesion type: 
(ACC/AHA) 
Estimated length: 
RCA 
Cx 
A 
B1 
B2 
C 
< 10mlll 
10-201ll1ll 
>20mm 
unknown 
ELCA BA 
151 157 
158 [67 
58.1 59.4 
115:36 114:43 
[5 20 
74 68 
33 36 
57 
58 
70 
10 
16 
11 
44 
82 
14 
77 
83 
51 
17 
61 
56 
41 
1 
83 
74 
[ 
122 
33 
2 
50 
59 
68 
13 
25 
8 
49 
86 
14 
81 
79 
63 
15 
64 
61 
42 
2 
7[ 
94 
3 
109 
44 
11 
The randomization process, inclusion and exclusion criteria and procedural protocols of the laser and 
halloon angioplasty procedures have been described in detail in the main trial report. In summary, patients with 
stahle angina and a native primary coronary lesion longer than 10nllll by visual assessment, suitable for 
treatment by excimer laser angioplasty or balloon angioplasty, were eligible. The laser systems in use were the 
Dytner 200+ (Advanced Interventional Systems Inc., Irvine, Ca.), with a pulse duration of 210 nanosecomls 
and a repetition rate of 20Hz, delivered by 1.3mlll, 1.6mm or 2.0mm catheters, at a fluence of 4S-6S111J/mm2, 
used in 80% of the patients and the CVX-300 system (Spectranetics, Colorado Springs, Colo.), which emits 
a pulse duration of 13Sns at a repetition rate of 2SHz, delivered by 1.4mlll, 1.7nml or 2.0nllll catheters, with 
a similar tluence. Adjunctive balloon angioplasty was perfonned when clinically necessary to improve the acute 
angiographic result. Conventional balloon angioplasty was performed according to the standard clinical practice 
of the operator. 
Quantitative Angiography: 
All patients had serial coronary angiography in multiple projections, identically repeated pre and post 
procedure and for all follow-up angiograms. Routine follow up angiography was scheduled for 26±2 weeks 
after intervention. Angiographic acquisition was standardized, according to previously puhlished guidelines [13-
lSI. to ::;uit automated analysis at the core laboratory using the Cardiovascular Angiographic Analysis System, 
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the methodology and technical aspects of which have been extensively described in detail in previous reports 
[141. Similarly, the core laboratory approach to screening and analysis of angiograms followed a standardized 
protocol, which has also been previously described [13-15j. 
Analytical approach 
To investigate whether excimer laser or balloon therapy in this trial were more or less successful, in 
teITns of propensity to late angiographic restenosis in : (i) larger or smaller vessels, (ii) longer or shorter lesions 
and (iii) after more or less optimal acute results had been achieved, both groups were divided at the median 
value for each of these parameters (vessel size, lesion length and post procedural minimal luminal diameter, 
respectively). Comparisons were then made, with respect to angiographic dimensions before amI. after treatment 
and at follow up, as well as in acute luminal gain, late luminal. loss, loss index (loss/gain) and in binary 
restenosis rates, according to a number of widely known criteria. In addition, to detemline whether epicardial 
lesion location influenced results, angiographic parameters were compared between treatment groups for the 3 
epicardial vessels. To investigate a general device specitic effect on late angiographic results, multiple linear 
regression analysis was perfonned, flTst taking the entire group of 250 lesion as a single group amI. then in the 
suh-group analyses. In the models for luminal loss and minimal luminal diameter at follow up, the "dummy" 
device variable was illcluded, as well as the known determining influence of vessel diameter, epicardial location, 
haseline lesion severity (minimal luminal diameter pre), acute luminal increase (acute gain) and lesion length 
[Ill. 
Statistics 
Statistical analyses were perfomled using the commercial SAS (SAS Institute Inc, Cary, North 
Carolina) package. Mean, standard deviation, minimum, maximum and median values are provided tor all 
parameters, where appropriate. Inter-group comparisow; of continuous variables afe pertlmned using the 
student's t test and of categorical variables using the chi-square test. Univariate and multivariate analysis were 
also perfoTIned to evaluate deterullnants of luminal loss and minimal luminal diameter at follow up and to 
investigate an independent device specitlc effect on these parameters. 
RESULTS 
General compmisoll of angiographic findings between ELCA and PTCA groups 
Table 2 provides direct comparisons of baseline, post-procedural and follow up angiographic parameters 
between the ELCA and BA groups. To deterullne the influence of lesions which were totally occluded at 
baseline or hecame occluded at follow up, comparisons were made between the respective popUlations, includitlg 
or excluding these lesions aod no detectable effect was detected, so the remainder of this evaluation will focus 
on the entire lesion groups. 
Table 2: Overall quantitative angiographic characteristics of the lesions with successful intervention and QCA 
pre, post and at follow up. 
ELCA BA 
(Il~ 124) (n~126) 
Vessel size (lim) 2.51 ±0.47 2.47 ±0.59 .60 
Lesion length (mm) 9Al±l.55 8.91±1.66 .13 
MLD pre (mm) 0.77 ±0.44 0.77±0.47 .96 
MLD post (mm) 1.69±OA1 l.59±0.34 .05 
MLD fup (mm) l.17±O.71 1.25±0.68 .14 
% DS pre 68.5± 18.3 68.9± 18.6 .86 
% DS post 37.6±1D.3 38.0±8.9 .76 
% DS fup 56.1 ±23.2 52.6±23A .24 
Acute Gain (mm) 0.91 ±0.53 O.82±0.50 .15 
Late Loss (m111) O.52±O.70 0.34±0.62 .04 
Net Gain (mm) OAO±0.69 OA8±O.66 .14 
Loss Index O.74± 1.57 0.36±1.26 .03 
DS 2:: 50% 53.2% 41.3% .06 
Loss 2:: 0.4mm 48A% 35.7% .04 
Loss 2: gainl2 49.2% 38.1 % .07 
Total occlusion pre 20.2% 20.6% .93 
Total occlusion fup 16.9% 14.3% .56 
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Virtually identical baseline lesion characteristics are evident in the two groups. A significantly greater 
acute lumen diameter was achieved in the ELCA group (1.69Illlll versus 1.59mm, p= .OS), hut as a consequence 
of the greater late loss (0.52mm versus 0.34mm, p=.04), this initial advantage was attenuated and the follow 
up luminal diameter was not signiticantly different, although a slight trend in favour of the halloon treated group 
was evident (l.2Smlll versus 1.17mm, p=.30). A significantly greater loss index is observed for the ELCA 
treated lesions (0.74 versus 0.36, p=.02). In addition, trends are observed tuwards higher incidem.:e of a 
stenosis;:::: 50 % (S3 % versus 41 %, p = .058) and greater frequency of a loss ~ half the initial gain (49 % versus 
38%, p=.077) and of a loss;:::: 0.4nu11 (48% versus 36%, p=.04), in the ELCA compared to the balloon 
group. Simple linear regression analysis revealed a sOlllewhat greater incremental increase in luItlinalloss with 
increasing luminal gain, in the laser group (lineslope 0.52 versus 0.40, p = .08, figure 1). 
In multiple lillear regression analysis to predict loss and MLD at follow up, a trend towards an independent 
intluence of the device used for intervention was observed favouring balloonangioplasty (p = .08). The following 
l1\odels were obtained: 
Loss 0.35 - 0.28 Vessel size + 0.26 MLD pre + 0.71 gain - 0.11 device 
MLD at follow up - 0.3S + 0.28 Vessel size + 0.74 MLD pre + 0.29 gain + D.l1 device 
(where halloon = 1 alld ELCA = D) 
Comparison of ELCA alld PTCA ill smaller al/d larger vessels 
To investigate whether ELCA or BA achieved better late angiographic in large or small vessels, the 
population was divided at the median vessel size of 2.49mm. Table 4 provides comparisons of baseline and 
ilcute illHllate ilngiograpitic res-ults hetween treatment groups. Tn smaller vessels, although haseline vessel size 
was significantly greater in the ELCA group and a marginally greater post procedural lumen was achieved by 
ELCA, there was a trend towards greater late loss after ELCA (0.46mlll versus O.28rum, p=O.07), and late 
lumina! diameter was similar (l.02mIll versus 1.1 lImn, p=O.30). However it considerahly greater loss index 
was observed in the ELCA group (0.98 versus 0.4S, p=.06). 
In larger vessels, again ELCA achieved a marginally greater post-procedural lumen (1.89nu11 vs 
1.80nnll; p=.1 I), a somewhat greater loss was also ohserved in the ELCA group (0.57mm compared with 
O.4lmlll, p=O. IS) and a trend towards a larger follow up lumen was evident in the BA group (1.40mm vs 
1.31 nllll; p = .16). This non-signit1cant angiographic henefit of BA was also manifest as a lesser loss index (0.27 
versus O. SI, P =.16) allli translated into a statistically lower recurrence of a stenosis greater than 50% at follow 
up angiography (34% versus 5S%, p=.02). 
Comparison of ELCA and PTCA after IIsuh-optima/ 1I and "optimal" acute results 
Division of the trcatment groups according to the post-procedural result gave a threshold minimal 
luminal diameter post of 1.67mm (tahle 5). For the group thus temled "sub-optimal", vessel size was greater 
in the ELCA group (2.30mm versus 2.17nlln,p=.OS). No differences in post-procedural or follow up results 
were ohsCfved and although the loss index was considerahly greater in the ELCA group (0.98 versus 0.52), due 
to wide variability, this ditTerence was not significant (p=0.14). 
Among "optimally treated" lesions, the vessel diameter did not difkr between the groups. The acute luminal 
gain was significantly greater in the ELCA group, giving a significantly greater post-procedural result (1. 99mm 
versus 1. 86mm, p =.006). However, during follow up, signifiC<lI1tly greater late loss accrued in the ELCA group 
(0.65mm versus D.36mm, p=.02) so that the net gain was similar between the groups and the minimal luminal 
diameter at {"ollow up actually showed a favourable trend for the BA treated group (1.50Hun versus 1.34null, 
p=O.IO). Accordingly the loss index was greater in the ELCA treated group (O.SI versus 0.20, p=.05) and 
in addition, the incidence of hinary restenosis was significantly greater among ELCA treated lesions (55% 
versus 33%, p=.OIS). 
Comparison of ELCA and PTCA according to lesion length 
Comparisons of outcome according to lesion length are shown in table 6. In the treatment of shorter 
coronary lesions (less than 8. 98nllu, with a mean of 6.48mm), no signif1cant differences in outcome were 
detected hetween the groups, although similar trends as previously noted, including a larger acute gain in the 
ELCA group (0.91mlll vcrsus 0.8Imm), followed by a somewhat greater late loss (0.47mm versus 0.36mm) 
and a grcater loss index (0.78 versus 0.33, p=0.14). For longer lesions (greater than 8.98mm, with a mean 
of 12.25nlln), ELCA again provided a somewhat greater acute !uminal result (MLD post = 1.71mm versus 
1.60uun, p=O.IO), hut was attended by a significantly greater late luminal loss (O.56nlll1 versus 0.32mm, 
p=.05), so (hat BA provided a larger, albeit not statistically significant, net gain (O.Slmm versus 0.36mm, 
p=.16) and a grcater lumen at follow up (1.29mm versus 1.1Smm, p=D.17). Again, the loss index was 
significalHly greater in the ELCA group (0.71 versus 0.38, p=.05). The binary restenosis rate in the ELCA 
group was significantly greater (52% versus 32%, p=.02). In multiple linear regression analysis in this 
subgroup ()f longer lesions, ELCA was retained as (Ill independent detenninant of greater late loss and a smaller 
luminal diameter lit follow up (p=0.08). 
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Table 3. Acute and late results of ELCA and PTCA groups by vessel size, divided into "smaller" and "larger" vessels, at the median for the entire group (2.49mlll) 
Smaller vessels (1.39 - 2.49mm) Larger Vessels (2.49 - 5.34uun) 
ELCA BA [LCA BA 
Vessel size (mm) 2.13±0.24 2.03 ±0.26 .03 2.88±0.31 2.90±0.50 .81 
Lesion length (mm) 9.12±3.35 8.99±3.83 .89 10.03cc4.04 8.94±3.44 .29 
MLO pre (nun) 0.74±0.40 0.68±O.39 AO 0.SO±0.48 0.87 ±0.52 .46 
MLD post (mm) 1.48::,::0.38 1.39±0.22 .08 1.89±0.33 1.80±0.31 .13 
MLD fup (mm) 1.02±O.66 1.l1±0.60 .46 1.31 ±O. 74 1.40±0.73 .54 
% DS pre 64.9± 19.1 66.6± 18.8 .62 72.0± 16.9 70.9± IS.4 .75 
% DS post 38.1±12.5 37.6±9.2 .77 37.0±7.6 38.2±8.7 .41 
% OS fur 56.5±24.5 52.2±24.3 .34 55.6±21.6 53.1 ±22.8 .52 
Acute Gain (mm) 0.74±0.50 0.70±0.40 .63 1.09±0.52 0.93±0.55 .11 
Late Loss (nilll) 0.46±O.69 0.28±0.60 .12 0.57±0.72 0.41 ±0.64 .17 
Net Gain (mm) 0.28±0.68 0.43 ±0.67 .24 0.51 ±0.69 0.53 ±0.66 .90 
Loss Index 0.98±2.10 OA5± 1.19 .08 0.51 ±0.66 0.27 ± 1.33 .21 
DS ;::: 50% 33.9% 34.4% .95 54.8% 34.4% .02 
Loss;::: 0.4mm 45.2% 32.8% .16 51.6% 39.1 % .16 
Loss ;::: gain!2 48.1 % 41% Al 50.0% 35.9% .11 
Total occlusion pTe 17.7% 21.3% .61 22.6% 20.3% .76 
Total occlusion fup 21% 14.8% .37 12.9% 14.1% .85 
'" Table 4. Acute and late results of ELCA and PTCA by lesion length, divided iIlto "shorter" and "longer" lesions, at the median lesion length for the entire group (8. 93mm). 
Shoner lesions (3.10 - 8,93nilll) Longer lesions (8.98 - 2L59nun) 
ELCA BA ELCA SA 
Vessel size (nilll) 2.40±0.43 2.41 ±0.45 .84 2.62±0.48 2.54±0.70 A6 
Lesion length (mm) 6.48±1.42 6.08 ± 1.21 .18 12.25±3.11 11.60±3.08 .24 
MLD pre (mm) 0.75±OA4 0.77±OA9 .78 0.79±OA5 0.78±0.45 .87 
MLD post (nml) 1.66±OAI 1.59±0.31 .27 1.71 ±0.40 1.61 ±0.38 .14 
MLO fur (u1Jn) 1.19±0.73 1.22±0.63 .77 1.15±0.69 1.29±0.74 .29 
% OS pre 68.5± 18.7 68.0± 19.0 .89 68.5±18.1 69.6±18.4 ,73 
% OS post 36.3 ±9.8 36.1±7.9 .90 38,8±IO.7 39.7 ±9.6 .65 
% OS fup 54.2±24.2 51.7±22.2 .54 57.9±22.3 53.6±24.7 .32 
Acute Gain (nun) 0.91 ±0.50 0.82±0.52 .30 0.92±0.57 0.83 ±0.47 .33 
Late Loss (mm) 0.47±0.71 0.37 ±0.56 .35 0.56±0.70 0.32±0.69 .05 
Net Gain (nun) 0.44±0.70 0.45 ±0.64 .92 0.36±0.69 0.51 ±0.69 .16 
Loss Index 0.78±2.06 0.34± 1.49 .17 0.71 ±0.84 0.38 ± 1.06 .05 
OS ;::: 50% 37.1 % 37.1 % 1.0 51.6% 31.7% .02 
Loss;::: OAnml 45.2% 26.0% .71 51.6% 30.2% .01 
Loss;::: gain!2 45.2% 38.7% .47 53.2% 38.1 % .08 
Total occlusion pre 21.0% 14% .83 19.4% 19.1 % .96 
Total occlusion fup 17.7% 8.0% .46 16,\% 15.9% .97 
Comparison of ELCA and PTCA according to epicardial lesion location 
Comparison of angiographic outcome according to epicardial lesion location is provided in table 7. 
Among the 45 ELCA and 56 BA treated lesions located in the LAD, no significant differences in baseline 
features, acute angiographic results or late angiographic outcome were observed. 
Among the 45 ELCA ami 38 BA treated lesions in the RCA, ELCA achieved a signiticantly greater acute 
lumimtl gain (1.06mm versus 0,7Inul1,p=.003), yielding a greater MLD post than BA (l.84mm versus 
1.65mm, p=.03). However, due to a non-significantly greater luminal loss in the ELCA treated lesions 
(0.57mm versus 0.37m, p=O.lS), follow up luminal diameter was similar between the two groups (1.27mm 
in each group). Although loss index was once again larger in the ELCA group (0.54 versus 0.36), this 
difference was not statistically significant (p=0,30). 
Among the 34 ELCA and 31 BA treated lesions located in the circumflex, vessel diameter was similar 
but, there was a treml towards a larger MLD pre in the ELCA group (0.80mm versus 0.62mm, p=O.Il) and 
also a trend towards a smaller acute gain in the ELCA group (0.76mm versus 0.95mm, p=O.IO), so that 
theacutc post-procedural luminal diameter was similar (1.561ll11l ven.us 1. 57mm). However, during tollow up, 
late loss was significantly greater in the ELCA group (0. 52mm versus 0.22mm, p=O.05), so that the net gain 
was significantly greater in the BA group (O.73mm versus 0.24mm, p=.003) and the follow up luminal 
diameter was significantly larger (1. 35111m versus 1.04mlll, p=.05) and the diameter stenosis significantly less 
(45.4 % versus 56.2 %, p= .06) in the BA group. TIle loss index was concomitantly signiticantly larger in the 
ELCA group (0.77 versus 0.08, p=.008). Accordingly, in multiple linear regression analysis applied to 
cin.:umtlex lesions, the device used was associated with a significant independent influence on the late loss and 
lumen diameter at follow up, in favour of balloon angioplasty (p = .OI). Concomitantly, binary restenosis rates 
were significantly higher in the laser treated circumtlex lesions (50% versus 23%, p=.02). 
DISCUSSION 
in this comparison of angiographic results obtained by excimer laser coronary angioplasty and 
conventional balloon angioplasty in the randomized AMROE trial (among the lesions which were initially 
successfully treated and had quantitative angiographic tollow-up), it may be concluded that ELCA was 
associated with less hlVourable late angiographic results, due to a greater restenosis propensity, as delineated 
hy the increased angiographic loss index and by the greater loss response to increasing luminal gain. 
Increased restellos;s propellsity of ELCA compared with PTCA 
General overall comparison revealed that ELCA with adjunctive baUoon angioplasty provided a greater 
acute lumen, which according to the "bigger is better" hypothesis and the generalized model of restenosis 
[16, 17 j, should also provide a greater late lumen. This was not the case however, and greater late luminal loss 
after ELCA led to similar late luminal diameter (although a marginally larger lumen was actually evident in the 
BA treated group). The calculated loss index, which was introduced as a measure of angiographic restenosis 
propensity lISI and previously reported not to vary among patients treated by balloon angioplasty, stent 
implantation, directional atherectomy or excimer laser angioplasty [16,17,19], was found to be signiticantly 
higher in the ELCA treated lesions, suggesting that ELCA therapy, at least in this randomized trial, inherently 
provokes a greater degree of luminal renarrowing than balloon angioplasty. The sub-group analyses substantiate 
this finding, whereby consistently greater loss index is found for ELCA compared with PTCA in virtually all 
suh-group comparisons, especially for lesions located in the circumflex and right coronary arteries, in shorter 
lesions, in smaller vessels and after achievement of more optimal results. 
Since the acute results of hoth therapies were similar and actually tended to be somewhat superior in 
the ELCA treated group, such an increased restenosis propensity of excimer laser angioplasty may be considered 
to be a manifestation of the injury/hyperplasia phenomenon r20,21], whereby the injury imparted to the vessel 
wall by excimer laser in the achievement of an apparently similar interventional result may provoke a greater 
renarrowing response than does halloonangioplasty. Compared with plaque stretching, compression and variable 
degrees of mechanical vessel wall dissection by conventional angioplasty l22-241, generation of high pressure 
acoustic shockwaves of up to hundreds of atmospheres [41 amI of fast imploding and expanding vapour bubbles 
at energy levels higher than 17mJ/mm2[251 by ELCA, are known to cause extensive intimal dissection, medial 
necrosis and internal elastic lamina abrasion {2S,27j. In addition, photodissociation at the laser tip produces 
illsoluhle gas tormation which has no escape route and ultraviolet radiation itself has been suggested to be 
somewhat mutagenic [26]. Accordingly, perhaps it is not that surprising to timl an increased angiographic 
restenosis propensity after ELCA compared with BA, especially when it is recognized that ELCA is also 
followed by balloon dilatation injury, in virtually all cases. 
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Table 5. Acute and late results of ELCA and PTCA according to the acute luminal diameter, divided into "less optimal" and "more optimal", at the median (1. 67mm). 
"Less optimal" acute MLD (0.91 - 1.67mm) "More optimal" acute MLD (1.67 - 2.93nun) 
ELCA BA ELCA BA 
Vessel size (mm) 2.30±O.40 2.17±O.38 .06 2.71 ±0.44 2.78±0.61 A8 
Lesion length (nml) 9.28±3.04 8.74±3.78 .38 9.62±4.18 9.14±3.83 .50 
MLD pre (nun) 0.73±OA6 0.64±0.43 .27 0.81 ±OA2 O.91±O.47 .22 
MLD post (mm) l.38±0.28 1.33±0.I8 .22 !.99±0.26 !'86±0.25 .006 
MLD fup (mm) !.OO±0.62 1.01 ±0.59 .96 1.34±0.76 1.50±0.69 .10 
% DS pre 67.5±20.5 70.5±I9.1 Al 69.5±I5.8 67.2± 18.3 .46 
% DS post 41.5± 11.6 40.7±9.2 .65 33.7±6.8 35.2±7.8 .24 
% DS fup 57.7±23.4 56.3±25.1 .76 54.4±22.7 49.1 ±21.4 .18 
Acute Gain (mm) 0.65±OA7 0.69±0.45 .65 l.l8±OA6 0.95±0.51 .01 
Late Loss (mm) 0.38±0.61 0.33 ±O.61 .60 0.65±0.77 0.36±0.64 .02 
Net Gain (oun) 0.27±0.67 0.36±0.65 A2 0.53±0.70 0.59±0.66 .59 
Loss Index 0.98±2.I1 0.52±1.21 .14 0.51 ±0.64 0.20±1.l0 .09 
DS ;::: 50% 51.6% 50.0% .86 54.8% 33.3% .01 
Loss ~ OAmm 41.2% 33.9% .35 54.8% 38.1 % .06 
Loss ;;:: gain/2 46.8% 41.9% .59 51.6% 34.9% .06 
Total occlusion pre 24.2% 25.8% .84 16.1 % 15.9% .97 
Total occlusion fup 19.4% 19.4% LO 14.5% 9.5% .39 
Table 6. Comparison of quantitative angiographic acute and late results between the ELCA and PTCA groups according to epicardial lesion location. 
Left anterior descending location Right coronary artery location Circumflex location 
ELCA BA ELCA BA ELCA BA 
(n~45) (n~56) (n~45) (n~38) (n~34) (n~3I) 
Vessel size (nnn) 2.47 ±OA9 2.4l±OA8 .52 2.65±0.45 2.60±0.78 .74 2.37±0.43 2.45±OA9 .51 
Lesion length (unn) 8.81 ±3.95 8.90±4.06 .18 9.98±3.95 8.98±3.27 .38 9.29±3.23 8.88±3.75 A3 
MLD pee (mm) 0.74±OA6 0.76±OA6 .83 0.79±OA5 0.93 ±OA5 .14 0.80±OA2 0.62±OA6 .11 
MLD post (mm) !.63±0.37 1.5S±0.31 A9 !'84±0.46 L65±0.36 .03 1.56±0.32 1.57 ±0.37 .88 
MLD fup (mm) l.l7±0.59 l.l9±0.65 .84 1.27 ±0.86 1.27 ±O. 76 .99 !.O4±0.63 1.35±0.68 .05 
% DS pre 69.2±20A 68A±17.8 .85 69.6±I7.1 65.4± 18.8 .29 66.0±I7.1 73.7±I9.5 .lD 
% DS post 38.0±lD.I 37.3±9.0 .69 37.1±12.4 39.7±9.7 .78 37.7±7.8 36.9 ± 7.6 .69 
% DS fup 54.9±20.4 53.9±22.3 .81 57.2±25.1 56.9±25A .94 56.2±24.8 45A±22.1 .06 
Acute Gain (nun) 0.89±O.52 0.82±0.46 .50 1.06±0.57 0.7I±0.43 .003 0.76±0.46 0.95±0.61 .15 
Late Loss (mm) 0.46±0.64 0.39±0.57 .56 0.57 ±0.85 0.37±0.66 .24 0.52±0.57 0.22±0.67 .05 
Net Gain (mm) 0.43±0.70 0.4l±0.61 .97 0.49±0.73 0.34±0.71 .36 0.24±0.63 0.73±0.66 .aJ3 
Loss Index 0.94±2.24 0.52±0.80 .19 0.54±O.74 0.36± 1.96 .61 0.77 ± 1.27 0.08±0.72 fm 
DS ~ 50% 55.6% 48.2% .46 53.3% 47.4% .59 50.0% 22.6% .02 
Loss;;=: O.4rnm 46.7% 37.5% .35 46.7% 39.5% .51 52.9% 29.0% .05 
Loss ;;=: gain/2 48.9% 41.1% .43 46.7% 44.7% .86 52.9% 25.8% .03 
Total occlusion pre 24.4% 19.6% .56 20.0% 13.2% Al 14.7% 32.3% .09 
Total occlusion fup 11.1% 14.3 % .64 20.0% 18.4% .86 20.6% 9.7% .22 
Figure 1: Linear regression analysis comparing the relationship between luminal increase at intervention and loss during follow up between PTCA and 
ELCA. Somewhat greater luminal loss can be anticipated after ELCA than PTCA at increasing luminal gain. 
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Comparison with other studies - el'idence for device specific effects 01/ resteuosis after illlen'elllion 
Supportive findings have heen reported by a recent ohselvational study comparing excimer laser 
angioplasty awl balloon angioplasty in patients matched for haseline clinical and angiographic chamcreristics 
[IIJ. When these results are interpreted together with the findings of other observational studies in matched [28-
30J and ullll1atched comparisons t31 ,321, it hypothesis of device specific influences on late angiographic results 
of intervention IIIay he supported [33,34]. The opposing flildings of the previously IIIentiolled studies represent 
the alternative viewpoint of what may actually be considered something of a conundlUlll in interventional 
cardiology, namely whether or not the device chosen for intervention may exert a specitic influence on the 
propensity for luminal renarrowing and restellosis after coronary intelventions 135]. That the magnitude of the 
acute luminal result exacts an integral determining influence on the late interventional outcome now seems 
beyond douht r 13, 16-19,28-391, as is confirrlled also in tltis study, by the significampositive association between 
acute gain and late luminal diameter illlHultivariate analysis (in addition, considerably greater late lumen is 
evident muong "optimal" compared with "sub-optimal" acute results), What remains to he resolved is whether 
there illay be an additional individual effect of the device used for intervention. The results of this 
evalu<ltiollstrongly support the existence of such an eHect, which might be considered responsible for fhe 
COilsistently less favourahle late angiographic results obselved for ELCA treatment in patients, who, it must be 
rCIllembered, demonstmte similar haseline clinical characteristics and angiographic morphology and in whom, 
acute post-procedural rcsults tended to be actually somewhat superior to those achieved by balloon allgioplasty 
alone. 
lllsighls pmvidet! by sub-set analyses 
Given the previously proposed role of excimer laser angioplasty, for the treatment of lesions 
unfavourable for COllventional angioplasty rSJ, it is noteworthy that in {his study, ELCA achieved less favoumble 
late results ill the longer lesion sub-set, demonstrating particularly greater loss index compared with PTCA. 
Similarly, inclusiOll or omission of totally occluded lesions from analysis did not alter the t1ndings of greater 
restenosis propen.".ity associated with ELCA. Also, ill smaller vessels, loss index was significantly greater in 
the ELCA treated group. In the "more optimal" acute result sub-group comparison, PTCA also achieved more 
favourahle late allgiographic results, despite the fact that the acute result had been significantly larger in the 
ELCA treated group. 
The strikingly more favourable late angiographic outcome after PTCA compared with ELCA among 
circumflex lesions is a curious finding. Although the number oflesions located in the circumflex artery in each 
group is small (34 ill the ELCA group and 31 in the PTCA group), the groups are well hal anced and 
comparable for both haseline and post-procedural angiographic measurements. TllUS the sigltificantly greater 
luminal loss alld smaller follow up lumen in the ELCA group call be interpreted as being due to the greater 
restellosis propensity of ELCA, reflected by the significantly greater loss index. A trend toward greater loss 
index was also observed among right coronary artery lesions treated by ELCA. It is also worth noting, that in 
colltm~t to other studies in patients treated by hallooll angioplasty and other devices r 13, 16-18J, lesion location 
in the LAD was not found to he an independent detenninant of greater luminal renarrowing in multivariate 
analysis in this study. 
Clinical implicatiolls 
Ultimately, the findings of a greater restenosis propensity ofELCA compared with conventional hal loon 
angioplasty raise seriOliS doubts as to the long tenn effectiveness of this treatment modality, at least according 
to the prevailing interventional pmctice during the course of this trial. It must be considered that if the capacity 
of ELCA to ablate atherosclerotic tissue alld to recanalize unfavourable coronary lesions, is to he utilized to its 
fullest extellt, the demonstmted increased propensity to luminal renarrowing must be overcome. This may be 
considered as having 2 perspectives: tirst, the simple mechanical aspect of optimization or acute results to 
compensate for the increased restenosis propensity, thus use of progressively larger catheters to ablate lllore 
tissue and facilitate more optimal adjunctive balloon angioplasty, or by clinical reflection on adjunctive use of 
illtracofOnary stent implantation, which would carry additional risks and potential I1Iultiplicatiollof costs 136,37]; 
second and still the major challenge in intetventional cardiology, the prohlem of attempting to actually reduce 
the degree of restenosis. This latter aspect may actually be promisingly addressed in the near future, by a 
combination of the rather simple technique of saline infusion at the laser tip during each ablation lUll, coupled 
with slow catheter advallcement (O.Sllllll/i;eCol1d) but more excitingly by a revolutionary development in laser 
catheter design. This will entail some diminution in individual fiber diameter to reduce the mechanical dead 
space, hut more importantly, through employment of a silica window at the catheter tip to diverge the emitted 
light heam."., a hOlllogenous light distribution at the target is achieved, which has already been conVincingly 
deJUollstrated ill experimental studies to produce effective and virtually atraull1atic tissue ahlation. Further, with 
increase in the ablating surface and decrease in effective dead space, less energy is required for tissue ablation, 
wherehy at 9mJ/Illlllc a rate of hUm per 30 seconds and at 15mJ/nuu", Inllu per 7.5 seconds have heen 
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demonstrated in human atherosclerotic tissue, compared with no ablation at 30mJ/mm2 using a conventional 
1.41ll1l1 laser catheter (PW Serruys personal communication). 
Limitations 
Although this study has been performed in the context of randomized clinical trial, it involves post-hoc 
iUllilyses, which were not prospectively included in the study design and as such the specific sub-studies 
described here may be considered "observational". The overall patient numbers are relatively small, compared 
with the patient numbers reported in some clinical ELCA registry reports f7-9] and those recruited in 
randomized trials of other devices [36-391. Nevertheless, the strong points of the trial are meticulous and 
comprehensive prospective data collection and, ill particular, the virtually complete quantitative angiographic 
follow-up in all patients who underwent an initially successful intervention. The 80% procedural success rate 
with ELCA is less than in some registry based reports, which may relate to the inclusion of 30% of lesions with 
functional or total occlusion and inclusion in the report of all patients randomized, whether the lesion was 
crossed by guidewire or not, whereas in registry reports, patients are only included if the lesion is successfully 
crossed by guidewire l7-91. Of the 138 lesions randomized to ELCA which were successfully crossed by 
guidewire and in which an attempt was made to treat by excimer laser, 126 yielded procedural success giving 
a 92 % success rate, which is certainly comparable to registry reports. During the course of this study, saline 
infusion at the c.:atheter tip during laser activtion (to reduce shock wave and vapour bubhle formation), has 
beUlllle incorporated into clinical practice by many practitioners, so that the basic technique practiced throughout 
most of this study may now he considered inappropriate. However, although carrying some implication for 
restenosis provocation, it WitS the universal clinical prac.:tice during most of the study period and must thus he 
considered more a general technical limitation in prevailing excimer laser technique rather than a specific 
limitation of this study. 
Conclusions 
Among the patients successfully treated by excimer laser coronary angioplasty and or balloon 
angioplasty in the AMROE trial, despite comparable or event somewhat superior acute angiographic results, 
excimer laser was found to be associated with a significantly greater angiographic restenosis propensity. This 
finding may he related to inherently greater vessel wall injury during the laser procedure than by balloon 
angioplastyalolle. Fundamental improvements in laser technology appear to be required to address this issue, 
so that this powerful interventional tool may retain a suitable role in percutaneous coronary revascularizatioll. 
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Abstract 
Background: Directional atherectomy and coronary stellt implantation have been shown to achieve a more 
optimal acute result which subsequently may lead to a more favorable long-temt augiographic and less target 
vessel revascularizatiolls than angioplasty. However, it remains to be detennined whether one of these devices 
lllay in fact provide consistently superior results than the other. 
Objectives: This study was designed to compare tht! long-tenn clinical and angiographic effects of successful 
directional atherectomy and stent implantation and to examine whether restenosis is related to the mechanism 
of luminal improvement as well as the extent of luminal gain. 
Methods: To allow meaningful comparisons a prospectively collected series of 117 patients successfully treated 
by atherectomy were imlividually matched with a prospectively collected series of 117 patients successfully 
treated by stent implantation. Matching for baseline characteristics identified patients with identical lesion 
location and lesion severity and acute and late angiographic and clinical outcome were compared. To evaluate 
the possibility of a device-effect on restenosis, patients were further matched for acute angiographic outcome, 
as well as haseline characteristics, providing 150 matched patients for comparison. As confinnatory analysis, 
multivariate models were constructed to predict late lumen diameter. 
Results: Matching resulted in two comparahle groups with equivalent baseline clinical and stenosis 
characteristics. Atherectomy led to a smaller acute gain than stenting and because late loss was similar in both 
groups, stenting resulted in a larger late lumen (1.96 mm. vs 1.66 mm.;p < 0.000 I). When matched for acute gain 
and baseline characteristics, luminal loss was more pronounced after atherectomy and thus the minimal luminal 
diameter at follow-up differed significantly between the two groups (1.66 mm vs 1.90 mm;p=0.004). This 
heneficial angiograpitic effect of stenting was accompanied hy a reduced need for repeat interventions. 
Multivariate analysis confirmed the independent effect of device used, whereby less loss and greater follow-up 
lumen was predicted for stent implantation compared with atherectomy. 
Conclusions: Successful stent implantation proviued a more favorable long-teml angiograpmc outcome, a 
reduction in restenosis rate and need for target lesion revascularization than atherectomy. This favorable effect 
is not only related to a larger acute gain but stenting also seems to attenuate of late lumen loss. 
INTRODUCTION 
The importance of optimization of acute interventional results with all treatment devices is now well 
recognized 1.1-13]. However, it remains to be detennined whether the extent of the vessel wall healing process 
after an intracoronary intervention, and therefore, the angiographic outcome, is also influenced by the specific 
mechanism of an interventional device. An initial exploration of such a relationship between device-specificity 
and restenosis using the loss index as an angiographic correlate of the "proportional injury model [1 ,2J" could 
not detect such an independent effect even if the results were corrected for the difference in acute gain which 
has been shown to be the most important predictors of restenosis rI ,4,5,7 ,9]. On the other hanu, our group has 
hypothesized that the varying mechanisms of action of interventional devices might induce varying degrees of 
luminal renarrowing in patients matched for clinical and lesion characteristics [7 ,8J. Tn order to try to reconcile 
these two viewpoints, an automated case-match method inwhich patients are matched for haseline and procedural 
characteristics is developed to explore differences in late outcome hetween patients treated with new devices. 
An additional advantage of this matching technique is the possihility to assess the long-term results without a 
collillearity between acute gain and device. 
Recently, directional atherectomy and coronary stenting have been evaluated against conventional 
balloon angioplasty for their ability to .reduce restenosis [1O-13J. Although hoth tec1miques achieved a greater 
luminal gain than balloon angioplasty, only the stent reduced the restenosis rate significantly [12, 13}. WItile 
these trials showed a comparable luminal gain after atherectomy and stenting, we recognized that the difference 
in luminal renarrowing following atherectomy and stenting may relate to either the extent or the mechanism 
(debulking versus scatlolding) of luminal improvement. Tn this stuuy we comparatively evaluated successful 
directional atherectomy and stent implantation in a prospectively collected series of 234 patients using the 
previously validated matching methodology. By matching for acute angiograpilic outcome, as well as baseline 
characteristics, we extended our observations and tested the hypothesis that each device has unique properties 
with respect to luminal renarrowing which are indepenuent of clinical, angiographic or procedural 
characteristics. 
PATIENTS AND METHODS 
Atherectomy patients: From September 1989 through March 1994, 208 patients underwent 214 directional 
atherectomy procedures for native coronary or bypass graft lesions. Of these, 150 consecutive patients (who 
underwent 157 successful proceuures) presently have had a 6 months f{1110W-UP angiography (angiographic 
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follow-up rate of 90 %). For the purpose of this study, the late outcome of atherectomy was compareu with that 
of stenting for consecutive native primary lesions. Therefore patients with restenotic lesions and patients with 
a subacute coronary occlusion <24 hours were excluded. Of the 150 patients, 3 were treated for a lesion in 
a venous bypass graft and 13 had an atherectomy for 18 restenotic lesions after a previous angioplasty. Thus, 
134 patients who underwent 136 successful atherectomy procedures for native primary coronary artery uisease 
were eligihle for matching. 
Ste11t patients: From January 1990 through March 1994, 240 patients were successfully treated by Palmaz 
Schatz stent implantation at the Thoraxcenter. Of these, 213 patients had a stent electively implanted for a 
primary coronary lesion without clinical sequehle (i.e. no sub-acute occlusion). Of these, 179 consecutive 
patients presently have had a 6 months fullow-up angiography and were thm eligible for matching. 
Prior to intervention, patients had dot . .'umented myocardial ischemia which required revascularization. Patients 
were selected for directional atherectomy or stellt implantation when they presented with a stenosis in a proximal 
non-tortuous coronary artery with a presumeu reference diameter> 2.51llm. All patients gave informed consent 
and were prospectively scheduled for 6-months angiography which was completed in 90 % of the patients. TIle 
study was approved by the hospital's Institutional Review Board. All clinical and angiographic data were 
collected prospectively. 
Atherectomy and slellting procedural details: The atherectomy procedure was perfonlled as descrihed 
previously [7,8,9,121. Briefly, the atherectomy device was directed over a !,'lliue-wire and positioned across the 
stenosis. The support balloon was then intlated up to 7.5 psi, the cutter was retracted and balloon inflation 
pressure was increased to maximally 45 psi. TIle driving motor was activated and the rotating cutter was slowly 
auvanced to cut and collect the protruding atherosclerotic lesion in the collecting chamber located at the tip of 
the catheter. After every pass the balloon was deflated and either removed or repositioned. The following 
atherectomy devices were used: 6 Fr device in 34% and the 7 Fr device in 66% of the patients. Adjunctive 
ballooll dilatation was perfomled in 23 %. While an optimum angiographic result was sought for each lesion 
treated, the procedure was cott"idered angiographically successful when the residual diameter stenosis was less 
than 50% after tissue retrieval. This dassic definition of success should he viewed in the historical perspective, 
while nowadays a luminal gain of at least 0.7 mm or a post-atherectomy diameter stenosis <20% may be 
deemed necessary before considering the procedure as successful as recently observed in retrospective analyses 
[2j and as defined in the ongoing atherectomy trials (BOAT, OARS, EUROCARE). 
Stenting was pedonned via the femoral approach and the stent was delivered by inflation of the halloon 
which contained the crimped stent. The following Palmaz Schatz stents were implanted: 3.0 mIll (46%), 3.5 
uun (39%) amI 4.0 mm (18%). Additional intra-stent balloon dilatation was perfonned in 27 (23%) patients, 
Anticoagulation during and following stent implantation was given act:ording to the protocol and contained 
heparin, dextran, dipyridamole, aspirin and warfarin for three months. Patients were monitored as described 
earlier 17,8,9,12j. 
Quantitative coronary angiography: Quantitative analysis of the coronary segments was performed with the 
computer based Coronary Angiography Analysis System (CAAS), which has heen previously validated and 
descrihed in detail, including the standardized angiographic acquisition and core laboratory assessment and 
analysis methods [8,12,17,18j. 
Matching process: The process of matching for clinical and angiographic characteristit:$ has been previously 
descrihed f7 ,8,15.1. Lesions were individually matched according to location, minimal luminal diameter aand 
interpolated reference diameter. According to previously described principles (i) the angiographic dimensions 
of matched lesions are assumed to he "identical" , (ii) the ohserved difference between the two" identical" lesions 
must be within the range of the reproducibility of the CAAS analysis, 0.1 nun (= I SD) and (iii) the reference 
diameter of the lesions to be matched are selected within a range of ± 0.3 mm (=3 SD) 18,17,18]. Clinical 
faaors such as gender, diabetes, hypercholesterolemia and non-exertional angina were taken into account. 
The automated matching progranune, carried out in blinded fashion, iuentified 117 patients with 117 lesions 
treated by atherectomy which individually matched 117 patients with 117 lesions successfully treated by stent 
implantation (diameter stenosis < 50 % on visual inspection). The remaining patients (13 %) of the atherectmny 
cohan could not be matched because no identical stent patient was found according to the pre-specified matching 
criteria. The clinical and angiographic details of the two groups arc given in Table 1. In the second matt:hing 
programme, where post procedural minimal luminal diameter was addeu to the paranleters for matching, 75 
patients could he matched from each Imetment group and constituted the study population for specific evaluation 
of the influence of the device itself of late results. 
Clil1icaljollow-llP: All patients were prospectively seen at the outpatient clinical at regular time intervals during 
a 7 months follow-up period. The clinical endpoints were the following: death, myocardial infarction, coronary 
artery bypass grafting and repeat percutaneous intervention. Death was defineu to include all death, Myocardial 
infarction was detineu as the occurrence of a new abnonnal Q-wave and an increase in creatine kinase more 
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than twice the upper limit of nOITllaL Revascularization of the target lesion was detined as angioplasty or bypass 
surgery perfomled because of restenosis of the target lesion in association with angina, objective evidence of 
myocardial ischemia Dr both. 
Statistics: The unit of analysis reported here is the lesion, not the patient. All values are expressed as mean 
values ± I SO}. Comparisons of continuous parameters between the two groups were perfomled using the 
paired student's I-test. Selected angiographic variables were evaluated by univariate regression analysis for their 
correlatioll with absolute luminal loss and minimal luminal diameter at follow-up. Multivariate stepwise 
regressioll analysis using a commercially available statistical software package (SAS, SAS lnstitute Inc, Cary, 
North Carolina) was utilized to take account of the influence of lesion location, pre-procedural minimal luminal 
diameter, acute luminal gain amI vessel size in evaluating their contribution to the minimal luminal diameter 
at follow-up atHl late luminal loss, as previously described f31. Differences between categorical variables were 
tested with the chi-square and Fisher exact tests as appmpriate. Target lesion revascularization was analyzed 
by means of Kaplan-Meier survival curves, with differences between the two groups compared by Wilcoxon 
test. Differences were cunsidered statistically significant where the p-value was less than 0.05. 
RESULTS 
Outcome of tile matching process (Table 1); The automated computer matching programme provided 117 paired 
atherectomy and stell( patients with comparable clinical and angiographic characteristics (lesion location and 
severity). The 234 patients were predominantly male with a mean age of 57 ± I I years. Patients were 
predominantly treated for stable angina according to the American Heart Association classification. By matching 
design no difference in lesion distribution exists between the atherectomy and stent group: left anterior 
descendiIlg (77% vs 77%), right coronary artery (15% vs 15%) and left circumflex artery (8% vs 8%). No 
differences between the groups were found for risk factors tor coronary artery disease or preceding 
cardiovascular events such as infarction or bypass surgery. By study design, no signiticant differences between 
the atherectomy and stent group were tound in baseline quantitative angiographic parameters: mean vessel size 
(3.09 ± 0.45 vs 3.10 ± 0.44 mrn), pre-procedural minimal luminal diameter (1.12 ± 0.29 nUll vs I. 12 ± 0.27 
nun) and percentage diameter stenosis (64 ± 8% vs 64 ± 8%) respectively. 
Table 1 Clinical and angiographic characteristics of the 117 study patients 
AtherectolllY Stent p-value 
Age (yr) 58 ± II 57 ± 10 NS 
Male (%) 76 81 NS 
Vessel treated (%) 
LAD 77 77 NS 
LCX 8 8 NS 
RCA 15 15 NS 
Non-exertional angina (%) 38 48 NS 
Previous infarction (%) 25 18 NS 
Previous CABG (%) 0 0 NS 
Diabetes (%) 6 9 NS 
Hypercholesterolemia( %) 24 23 NS 
LAD=left anterior descending coronary artery, LCX=left circumflex, RCA = right cmonary artery, 
CABG=coronary artery bypass grafting, Min Luminal Diameter=minimalluminal diameter. 
Immediate and late outcome after matching for baseline cllamctetistics (table 2, 3 and figure 1): 
The reference diameters were not significantly different after atherectomy or stentillg (3.23 ± 0.46 mm 
vs 3.22 ± 0.41 tlUll;p=0.83). Directional atherectomy resulted in a smaller acute gain in minimal luminal 
diameter (1.20 ± 0.46 mm versus 1.41 ± 0.39 1ll1ll;p=O.002) with a consequently lower post-procedural 
minimal luminal diameter (2.32 ± 0.41 mm versus 2.53 ± 0.37 nun;p<O.OOI) and concomitantly higher 
percent diameter stenosis (28 ± 10% versus 21 ± 7%;p<0.001). Because absolute loss during follow-up did 
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Figure 1: Cumulative frequency curves to illustrate acute and follow-up effects in minimal luminal diameter (MLD) of directional atherectomy and stent 
implantation in patients matched for lesion location and severity. Stent implantation is associated with significantly greater acute and 6 month results. 
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not differ significantly (0.66 ± 0.58 mm vs 0.57 ± 0.53 mm;p=0.22), the initial favorable acute result 
following stenting was maintained during follow-up. Thus, the minimal luminal diameter at follow-up after 
atherectomy was significantly lower than after stenting (1.66 ± 0.55 mm versus 1. 96 ± 0.52 mm; p < 0.0001). 
Accordingly, atherectomy yielded a lower net gain (0.54 ± 0.58 vs 0.84 ± 0.53;p<0.0001) and a higher 
percentage diameter stenosis at follow-up (44 ± 16 % vs 35 ± 13 %;p < 0.0001). The restenosis rate (diameter 
stenosis at follow-up> 50%) after stenting was significantly lower (14 % vs 36 % ;p= .0053) and late clillical 
follow-up which was 100 % complete, was also more favorable, with a reduced need for repeat revascularization 
(12 % versus 23% ;p=0.05)(figureIII). In simple linear regression analysis, the well described linear relationship 
was observed between acute gain and late loss in the two groups, with a steeper line slope in the atherectomy 
group (0.50) than in the stent group (0.30) although, apparently because of data scatter giving wide confidence 
intelvals, this difference did not reach statistical significance. 
In multivariate analysis, lesion location, ves::;el size, minimal luminal diameter pre-intervention, ab::;olute 
gain and device type were identified as independent predictors of the absolute luminal los::; and minimal lumilJaI 
diatlleter at follow-up. The models can be described by the following equations: 
(i) loss = -0.35 - 0.24 vessel size + 0.63 gain + 0.58 MLD pre + 0.16 LAD + 0.22 device. 
(ii)MLD at follow-up = 0.35 + 0.24 vessel size + 0.37 gain + 0.42 MLD pre - 0.16 LAD - 0.22 device. 
(where atherectomy = 1 and stenting =O)(LAD lesion = 1, non-LAD lesion =0). 
Table 2. Comparison of quantitative angiographic data of 234 matched patients who underwent atherectomy or 
::;tent implantation for similar lesion ::;everity 
Atherectomy Stent p-value 
(n~117) (n~ 117) 
Reference diameter pre (nrnl) 3.09 + 0.45 3. IO + 0.44 NS 
MinilllallumiIlal diameter pre (mill) 1.12 ± 0.29 1.12 ± 0.27 NS 
Minimal luminal diatlleter post (mm) 2.32 + 0.41 2.53 ± 0.37 0.001 
Minimal luminal diameter f-up (mill) 1.66 ± 0.55 1.96 ± 0.51 0.0001 
Diameter ::;tenosis pre (%) 64 ± 8 64 ± 8 0.0001 
Diatlleter stenosis post (%) 28 + 10 21 + 7 0.0001 
Diameter ::;tenosis f-up (%) 44 ± 17 35 ± 13 0.0001 
Absolute luminal loss (mm) 0.66 ± 0.58 0.57 ± 0.47 NS 
Relative luminal los::; 0.22 + 0.19 0.19+0.15 NS 
Resteno::;is rate (%) 36 14 0.005 
Lesion length (mm) 6.83 ± 2.54 7.23 ± 2.05 NS 
Synmletry index pre 0.45 ± 0.25 0.37 ± 0.25 NS 
TABLE 3. Long-term clinical outcome after ::;uccessful atherectomy and stent implantation in matched patient::;. 
Atherectomy Stent 
Death (%) 0 0 NS 
Myocardial infarction (%) 3 3 NS 
CABG (%) 3 2 NS 
Repeat PTCA (%) 20 10 0.Q7 
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Figure 2: The graphic display of the immediate and late results after atherectomy and stenting in patients who were matched for acute results as well as 
baseline characteristics. Stent implantation is associated with superior late results, due to less luminal loss than directional atherectomy. 
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Immediate alld late outcome lifter matching for procedural outcome as well as baseline characteristics (table 
4, figure 2): 
Matching for procedural outcome (MLD post = 2.41 ± 0.29nilll vs 2.42 ± 0.28 mill ;p=0.84), as 
well as baseline characteristics (vessel size = 3.06 ± 0.43 mm vs 3.05 ± 0.42 nnn;p=O.93), (MLD pre = 
1.09 ± 0.25 nun vs 1.08 ± 0.24 nml;p=0.98) identified 75 pair::; of matched atherectomy and stent patients. 
Despite the similar acute gain achieved by each device (1.33 ± 0.37 rnm vs 1.34 ± 0.34 nuu;p=O.86), dIe 
atherectomy patients had a significantly greater late lo::;s (0.75 ± 0.57 mOl vs 0.52 ± 0.44nuu;p <0.006) so 
that the residualminilllalluminal diameter at follow-up was ::;ignificantly smaller (1.66 ± 0.53 mill v::; 1.90 ± 
0.46 nun;p < 0.004) and percentage diameter stenosis at follow-up greater (43 ± 17 % vs 36 ± 12 %;p < 0.004) 
after atherectolllY than after ::;tenting. Additionally, the restenosis rate (diameter ::;tenosis at follow-up> 50%) 
after stenting were significantly lower than after atherectomy (12 % vs 32 %;p = .00026). 
The multivariate model::; to predict late loss and residual diameter at follow-up were found to be: 
(i) loss = -0.74 - O. 18 vessel size + 0.68 Gain + 0.76 MLD pre + 0.13 LAD + 0.24 device. 
(ii)MLD at follow-tip = 0.74 + 0.18 vessel ::;ize + 0.32 gain + 0.24 MLD pre - 0.13 LAD - 0.24 device. 
(where atherectolllY = I and stenting=O). 
After matching for procedural outcome, thus, the greater lo::;s observed after directional atherectorny 
is reflected hy the finding in multivariate analy::;is of a significant independent effect of the device used, wherehy 
less late loss and greater minimal luminal diameter at follow-up is predicted for stent implantation. 
Table 4. Comparison of quantitative angiographic data of 150 matched patiellts who underwent atherectomy or 
stelll implantation for similar lesion severity and procedural outcome. 
Atherectomy Stent p-value 
(n~75) (n~75) 
RefereJlce diameter pre (mm) 3.06 ± 0.43 3.05 ± 0.42 NS 
Minimal luminal diameter pre (mm) 1.09 + 0.25 1.08 ± 0.24 NS 
Minimal luminal diameter po::;t (mm) 2.41 ± 0.29 2.42 ± 0.28 NS 
Minimal luminal diameter f-up (mm) 1.66 ± 0.53 1.90 ± 0.47 0.0035 
Diameter stenosis pre (%) 64 ± 8 64 + 7 NS 
Diameter stenosis po::;t (%) 25 ± 7 22 ± 7 0.0064 
Diameter stenosis f-up (%) 43 ± 17 36 ± 12 0.0035 
Absolute luminal loss (mm) 0.75 + 0.57 0.52 + 0.44 0.0056 
Relative luminal loss 0.25 ± 0.18 0.18 ± 0.14 0.0082 
Resteno::;is rate (%) 32 12 0.0003 
Lesion length (mm) 6.88 + 2.34 7.40 + 2.24 NS 
Symmetry index 0.41 ± 0.25 0.36 ± 0.23 NS 
DISCUSSION 
In this study, we have compared the immediate and long-teml clinical and angiographic effects of 
successful directional atherectomy and stent implantation for primary coronary artery lesions. The major 
fIndings of this study are threefold: (1) in matched patients with similar lesion severity and location, steIltjng 
is associated with a significalltly larger acute lumen which is preserved during follow-up and is reflected by a 
conc01uitant reduced need for target lesion revascularizations during the fir::;t 6 month::;, (2) when the procedural 
result and baseline characteristics are matched, stent implantation is tound to provide a superior late 
angiograpbic outcome due to significant less luminal renarrowing than after atherectomy and (3) these fmding::; 
Illay consider a device specific effect on luminal renarrowing, independent of baseline characteristics or acute 
procedural result. 
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Figure 3: Cumulative curves for target lesion revascularization. Fewer patients in the stent treated group than in the atherectomy treated group 
needed revascularization (repeat angioplasty or coronary artery bypass surgery) of the target artery (p=O.05). 
Matching 
Despite their dinicalnecessity, randomized clinical trials of new coronary interventional devices are 
associated with certain limitations, in evaluating the inherent effect of the device itself on late angiographic 
results of intervention, since randomization is carried out before intervention and the acute interventional result 
may differ with the treatment strategies being compared, as shown in recent major trials n. In order to 
speciti.cally evaluate the influence of the device used for intervention, independent of acute procedural results, 
in this study, we applied the previously validated concept of matching [7,8,15, 19,20,22J to the atherectomy and 
stent populations. In particular, the confounding effects of unequal vessel size and acute luminal gain which have 
been shown to be independent predictors of restenosis [4,5,9J and which call1lot be controlled in randomized 
studies, are avoided by this matching technique. Furthermore, matching a study population with a reference 
patient group of similar characteristics can compemate for some of the limitations of nonrandornized studies 
such as population heterogeneity [21J. Despite a potential patient selection bias in matching studies, our 
atherectomy ami stent patients had comparable angiograpmc characteristics and acute outcome as the CAVEAT, 
CCAT and BENESTENT and STRESS patients [1O-13J. This indicates that the findings in our comparative 
study Illay be applicable to patients selected for stenting or atherectomy and could he useful in pla1ming future 
trials. 
Determillants of a favorable 10ng~tel1ll outcome 
When we first studied the differences between restenosis after atherectomy and balloon angioplasty in 
a matched series, we not only observed a linear relationship between acute gain and late loss hut in addition 
recognized that the slope of this regression line may represent an index of luminal renarrowing specific for each 
treatment modality f7,8,22J. In a subsequent matching study, we further extended this observation and could 
indeed demonstrate that the process of luminal renarrowing was not only dependent on the extent but also on 
the mechanism ofluminal improvement f20J. These observations lllay implicate that a beneficial late outcome 
(an he achieved Llsing a device which can associate a large acute gain with a favorable relationship between the 
degree of vessel wall injury and vessel wall response. In this study, we compared the two available devices 
which have the capacity to consistently achieve a large acute gain and fOllnd that the long-terrn outcome after 
steM implantation is signiticantly superior to atherectomy. A superior acute gain achieved by stenting in patients 
matched only for baseline characteristics indicates dIat the improved angiogmphic outcome of stenting may be 
due to the combination of the extent and possibly the mechanism of luminal increase. 
Why should stellt implantatioll provide superior results to atherectomy ? 
The comprehensive analysis of long-tenn outcome of stellt implantation and atherectomy suggests that 
the scal10lding effect of stenting may lead to less luminal loss with a larger late lumen at follow-up compared 
to the debulking mechanism of directional atherectomy in matched patients. Multivariate analysis confirmed the 
significant independent influence of the devi(.;e used whereby less late loss and a larger lumen diameter at 
follow-up was predicted for stent implantation compared with directional atherectomy. Earlier observational 
angiographic studies have demonstrated that this beneti.cial effect may be secondary to less elastic recoil f231 
or to restoring the " Glagovian balance" between plaque and luminal area [241. FurthemlOre, by using (.;oronary 
angioscopy and ultrasound techniques, Baptista et al l25J have demonstrated that stenting reduces the amount 
of trauma to the vessel wall compared with atherectomy, which ultimately may lead to a reduced vessel wall 
healing response (i.e. renarrowing). Recently, these suggestions have been shown to be a valid explanation for 
the favorable IOllg-tenll stenting effect. In a well controlled IVUS study, Mintz et al have shown that luminal 
renarrowing after stenting is predominantly the result of intimal hyperplasia with a negligable amount of recoil 
f26J. Similarly, Kimura et al have documented the timing of restenosis following atherectomy and stenting using 
serial ultrasound measurements (personal communication). They found an increase in external elastic membrane 
area (EEM) during the first month after stenting which remained stable thereafter, as opposed to a reduction 
in EEM area after atherectomy. 
Therefore, the favorable stent effect found in this study concurs with the angioscopic tIndings of a 
smoother and more circular vessel wall configuration after stentillg than atherectomy l27,281 and the s(.;affolding 
effect of stenting as demonstrated in serial ultrasound studies f26,29J. It seems unlikely that this favorable 
scaffolding effect of stenting is attributable to a difference in treatment strategy (optimal stenting versus less 
optimal atherectomy) sin(.;e this effect is avoided by matching for baseline characteristics and outcome. The post-
atherectolllY luminal diameter found in this series is comparable with that observed in CCAT and CAVEAT 
pO, 11"] although smaller than in the series of Kuntz et aliI ,6], while our stem results are comparable to the 
BENESTENT, STRESS and Palmaz Schatz Stent Study f12, 13,30J. FurthemlOre such an ohservation does not 
influence the conclusions of the present study because the linear relationship hetween acute gain and late loss 
is maintained at all levels of gain showing a fllVorable effect (lower slope value) for stenting when compared 
with atherectomy. 
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Clinical implications 
The favorahle angiograpbic outcome of ~tenting i~ further underlined by a significant reduction in the 
clinical need for target-vessel revascularization~. In accordance with Baim and Kuntz [31], we have refrained 
from using the composite "any event" clinical end-point criteria to compare stenting with atherectomy to 
consider the potentially "noise" induced by non-device related cardiac events. Using such "filtered clinical end 
poilJt~ [311", we found all agreement between quantitative angiographic follow-up and the late clinical course 
emphasizing the need for a dual approach (angiographic and clinical follow-up) in that quantitative angiography 
demonstrates the mechanistic explanation of the favorable stent results while clinical follow-up provide the 
clinical implications of this finding. The 12% restenosis rate after successful stenting found in this study is 
similar to the 14 % resteno."is rate of successfully stented patient~ in the BENESTENT trial112J (i.e. succe~sful 
stent implantation without subacute occlu~ion) and comparable to the recent publicised preliminary finding~ of 
the pilot pha~e BENESTENT 11 [321. Accordingly, given the choice between these two powerful treatment 
modalities, (It thi~ time, ~tellt implantation would appear to be associated with more favourable acute and long 
leon clinical and angiographic results and must therefore be recommended a~ tir~t choice over directional 
atherectomy, ill appropriate clinical and morphological circumstances. 
LIMITATIONS 
It should be empha~ized that matching of pro~pectively collected patients i~ retrospective in nature and may have 
led to a selection bias such a~ the selection of larger vessels. inherent to the purpose of this study, only patients 
who underwent a succes~ful procedure were matched and included in this study and we acknowledge that the 
re~ults apply to a restricted atherectomy or stent population who underwent a ~ucce~~ful procedure. 
Whether the favorahle stent effect observed in tlus study is only due to a scaffolding effect or could also be due 
to a difference in anticoagulation therapy, acute recoil or po~t-procedural vessel wall configuration is beyond 
the ~·;cope of this ~tudy. However, variou~ reports have ruled out an effect of anticoagulatiolll33-351 while in 
this study the effect of acute recoil was minimized by the u~e of a meticulous approach as described earlier 
[7,20J. Criticism of the "sub-optimal re~ult" in the atherectomy group, may be valid in the view of tlle very 
latest opinions that a post-procedural ~teno~is < 20% must be achieved. However such criticism appeals equally 
to the stenl group and we helieve doe~ not detract from the findings of a device specific effect of stenting in 
the context of ~imilar acute result~. Confirmation of the~e findings in the future among optimally treated lesions 
may be required. In fact our data underscore the need for optimal result~, especially for atherectomy, to 
accommodate late luminal renarrowing. 
CONCLUSIONS 
In matched patiems, succe~sful stent implantation provided a more favorahle long-ternl angiographic 
outcome, with a reduction in re~tenosis rate and need for subsequent reva~cularization, compared with 
directional athereetnmy. This favorable effect is not only related to a larger acute gain but also to a device-
specitic efteet, whereby less renarrowing is provoked by stent implantation for a given degree of acute gain. 
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RESTENOSIS AFTER PERCUTANEOUS INTERVENTION: 
IS THERE A DEVICE SPECIFICITY? 
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The burning question in interventional cardiolo-
f,'Y is, apart from different physical capacity of 
devices for acute luminal improvements, is there 
a device specificity in restenosis provocation? 
New devices for percutaneous coronary revascu-
larization are increasingly being applied in clini-
cal practice and are being critically compared 
with conventional balloon angioplasty in ran-
domized clinical trials [l·--4 .. J. Although direc-
H(mal atherectomy was found to achieve signifi-
cantly greater acute luminal improvements than 
balloon angioplasty, this advantage was not con-
vincingly maintained in the long term [1--,2··J. 
Although observational studies in specialized 
centers employing a more aggressive approach 
have reported superior immediate angiographic 
results [5··,6·-J than in the Coronary Angioplasty 
Versus Excisional Atherectomy Trial (CAVEAT) or 
Canadian Coronary Atherectomy Trial (CCAT), 
"stand alone" atherectomy, without adjunctive 
balloon angioplasty to optimize acute results 
might partly explain the somewhat disappoint-
ing late outcome of these trials. The magnitude 
of the acute interventional result has been 
reported to be the greatest determinant of late 
outcome and reduced binary restenosis rates, 
regardless of the interventional device used 
[1·",6"·,7J. If this is true, devices that can achieve 
the greatest acute luminal increase should be 
favored for intervention, where possible. 
Randomized comparison of Palmaz-Schatz stent 
implantation with conventional balloon angio-
plasty in North America and Europe has shown 
maintained superior long-term angiographic 
results after stent implantation 13·.,4 .. J. It can 
only be speculated, however, that the sole expla-
nation for this was the magnitude of the acute 
result and not partly a device-specinc advantage 
of the stent itself. Pindings of an inherent device-
specific advantage or disadvantage in influenc-
ing late interventional results, independent of 
acute luminal increase, would cany considerable 
implications for their clinical application, as well 
as for the design of future randomized trials. 
Because of the variations in bulk and operating 
characteristics of different devices, as well as 
SUitability of application with respect to clinical 
factors and lesion morphology, especially vessel 
size, randomized comparisons between multiple 
devices are not really feasible at this time. 
Therefore, most comparative information has 
been derived from observational experience, 
which is subject to variable degrees of theoretical 
and practical limitation due to population size, 
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patient selection bias, practical experience with 
the device-learning curve, incomplete angio-
graphic follow-up, angiographic measure-
ment methodology-and definition of study 
endpoints, such as restenosis [8,9"',10"]. 
COMPARATIVE STUDIES USING A 
MATCHING APPROACH 
To circllmvent some of these limitations, OLlr 
group has implemented two approaches to 
making comparisons of outcome between 
patients treated by different devices [9··,1l·!. 
The Hrst involves a priori selection of patients 
and lesions that are individually matched 
between the treatment groups to be com-
pared according to a number of key criteria 
[12,13",]4··J. Initially, vvith the aim of compar-
ing outcome in small patient groups treated by 
directional atherectomy and stent implantation 
compared with similar patients from a large 
population treated by balloon angioplasty, the 
criteria for satisfactory individual matching 
were limited to epicardial lesion location and 
reference vessel diameter and minimal luminal 
diameter (MLD) preintervention [121. With 
expanding treatment groups, parameters for 
matching could be extended to gender, anginal 
status, and presence or absence of diabetes and 
hypercholesterolemia [13 ... J. Nevertheless, these 
additional features did not change the study 
outcome in terms of comparative late angio-
graphic results [13"']' so it would appear that 
matching on angiographic principles provides a 
convenient surrogate for a randomized compar-
ison [14 .. J. The outcome of two studies, in retro-
spect, could he considered to have predicted the 
results of the currently completed randomized 
trials of balloon angioplasty with directional 
atherectomy and stent implantation. As in 
CAVEAT and CCAT, no significant difference 
could he detected in MLD at follow- up between 
patients treated by directional atherectomy 
compared with balloon angioplasty [13"1. while 
stent implantation was ohserved to provide a 
Significantly improved angiographic outcome 
over percutaneous transluminal coronary angio-
plasty (PTCA) [14"'], as has been reported by the 
Benestent [3·") and Stent Restenosis Study 
(STRESS) [4··J. In a study comparing the angio-
graphic outcome of excimer laser angioplasty 
with balloon angioplasty in matched lesions, vir-
tually identical acute angiographic results were 
observed in the two groups, thus providing two 
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groups matched for the acute luminal gain, as 
well as baseline characteristics [1S"J. 
Significantly greater renarrowing was observed 
in the excimer laser-treated group, so that at fol-
low-up these patients exhibited significantly 
smaller residual luminal diameter at the treated 
site. The results of this study showed that the 
greater renarrowing observed in the excimer 
laser-treated group must have been a conse-
quence of greater neointimal formation, which 
in theory could be related to the specific type of 
injury caused by excimer laser angioplasty. 
To address the issue of device specificity, 
appropriate comparative evaluation of the long-
term angiographic results of stent implantation, 
directional atherectomy, conventional balloon 
angioplasty, excimer laser angioplasty, rotational 
atherectomy, and other devices, the next series 
of comparative evaluati()ns using this matching 
approach will compare outcome in patients 
wherein the immediate result of intervention as 
well as the baseline characteristics are individu-
ally matched. Therefore, possible differences in 
late results could be interpreted to be due to 
device-specific effects on the vessel wall in the 
achievement of the acute result. To facilitate 
such precise matching in patient groups of ade-
quate size, large pools of patients treated by 
each device (with comprehensive prospective 
clinical evaluation and complete and carefully 
controlled and standardized quantitative angio-
graphic follow-up) will be required. This may 
take some time. 
AN ALTERNATIVE COMPARATIVE 
APPROACH USING RELATIVE 
ANGlO GRAPHIC MEASUREMENTS 
In the absence of sufficient patient numbers for 
such specific and sophisticated matching stud-
ies, comparative evaluation in nonmatched 
groups treated by different interventional 
devices may be carried out where the important 
confounding parameters are taken into account. 
In a comprehensive evaluation in over 3000 
patients with full quantitative angiographic fol-
low-up after successful balloon angioplasty, our 
group has recently found that the degree of 
luminal renarrowit~g during follow-up and the 
MLD at follow-up are determined to a signifi-
cant degree by the reference vessel size l161. For 
this reason, as well as the inherent selectivity 
in application of different devices to vessels of 
different diameter, this parameter mllst be taken 
into account in comparative studies. Despite its 
clinical utility, percent diameter stenosis mea-
surements arc associated with wide variability 
due to changes in reference diameter as a conse-
quence of intervention and of the restenosis 
process [8,17,18,19"1. Therefore, these cannot 
be reliably used as a correction factor for vessel 
diameter in important research studies. We have 
therefore adopted the approach of relating 
changes in minimal luminal diameter after 
intervention and during follow-up to the mea-
sured reference diameter preintervention as a 
constant point of reference. Furthermore, to 
avoid the imprecision and poor reproducibility 
of traditional subjective measurement of refer-
ence diameter, the Cardiovascular Angiographic 
Analysis System provides an automated interpo-
lated reference diameter [20,211. Thus, relative 
gain (proportional luminal increase at interven-
tion), relative loss (proportional luminal renar-
rowing during follow-up) and net gain index 
(proportional luminal benefit at follow-up as a 
consequence of intervention) are derived 
[900 ,12,13",14",22,231. In addition, according to 
this method, proportional luminal diameter at 
any point in time is measured as a proportional 
lumen and not as a proportional stenosis, as 
conveyed by the conventional percent diameter 
stenosis approach. To clearly differentiate these, 
we have coined the term relative lumen pre in-
tcrvention, postintervention, and at follow-up 
[11 0 J. This approach allows comparison of 
immediate and late luminal changes between 
patient groups routinely treated by different 
devices, wherein the average vessel size in which 
target lesions are located may be widely differ-
ent, such as those treated by stent implantation 
compared with balloon angioplasty. 
The purpose of the evaluation we describe 
here was to investigate the possibility of a device 
specifiCity in determining the extent of the 
restenosis process and the late angiographic 
outcome of intervention in patients treated by 
either balloon angioplasty, directional atherec-
tomy, or implantation of a self-expanding stain-
less steel mesh stent (Wallstent, Schneider, 
13uelach, Switzerland) or a balloon-expandable 
tantalum coil stent (Wiktor stent, Medtronic 
Inc., Minneapolis, MN), using this measurement 
approach to correct for the influence of the 
expected differences in basic vessel size betvveen 
such patient groups. 
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POPULATION AND METHODOLOGY 
The study population comprised 1234 patients 
(l452 lesions) tfeated by balloon angioplasty, 
120 patients (l231p.sions) undergoing directional 
coronaryatherectomy, 106 patients (110 lesions) 
in whom an endoluminal self-expanding stain-
less steel mesh stent was implanted, and 100 
patients (lOllesions) treated by balloon expand-
able tantalum coil stent implantation for native 
coronary artery disease. Pertinent baseline 
demographic data arc given in Table 13-l. 
Patients treated by i-JaUoon angioplasty had 
been enrolled in two separate European multi-
center placebo-controlled restenosis prevention 
trials, the details of which have already been 
published [24,25). In each of these trials the 
pharmacologic agent under investigation was 
found to have no significant effect on either clin-
ical or angiographic outcome by both univariate 
and multivariate analyses, so for the purposes of 
the present study, all the patients were pooled 
and considered as one group. Entry criteria for 
these two studies were similar. All patients with 
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angiographically proven atherosclerotic native 
primary coronary artery disease affecting single 
or multiple vessels, and with clinical symptoms 
of stable or unstable angina pectoris who were 
scheduled for balloon angioplasty were consid-
ered for inclusion. Only those having a success-
ful dilatation, defined by the operator as a reduc-
tion in lesion severity to less than 50% diameter 
stenosis, were actually included in the trials for 
the ultimate assessment of angiographic out-
come. Eventually, a total of 1234 patients with 
1452 lesions had full angiographic follow-up 
(94% angiographic follow-up rate). 
Directional coronary atherectomy (DCA) 
using the Simpson AtheroCath (Devices for 
Vascular Intervention, Redwood, CAL was per-
formed as a primary procedure in 70% of 
patients, as a bailout following complicated bal-
loon angioplasty in 5% of patients, and for 
restenosis following previous intervention in 
25% of patients at two specialized institutions. 
The atherectomy procedure has been previously 
described in detail elsewhere !12,26]. 
TABLE 13-1. DEMOGRAPHIC DATA FOR 
THE COMPLETE PATIENT GROUPS' 
Balloon Directional Balloon~ Self~expanding 
angioplasty atherectomy expandable stent stent 
Patients, n 1234 120 100 104 
Lesions, n 1435 123 101 110 
Male/Female, n (%) 987/247 (80/20) 97/23 (81/19) 85/15 (85/15) 87/17(84/16) 
Age, y 56.4±9 S7.6±10.8 5fi.6±11 .7 S7±11 
Lesion type (primary), % 100 70 0 51 
Lesion type (restenosis), % a 30 100 49 
Bail-out procedure, % 0 5 0 33 
Vessel, % 
LAD 47 65 52 55 
RCA 30 22 34 3S 
LCX 23 13 14 10 
Total occlusion 
preintervention, % 4 0 0 4 
Diabetes, % 7 6 12 5 
CCS III or IV angina, % 52 73 68 56 
Unstable angina, % 28 51 40 26 
*Male/female ralios, age, treated vessel, and frequency of diabetes are similady distributed. The directional atherectomy 
and balloon-expandable stent groups have a greater frequency of class III and IV and unstable angina. All patients in the 
percutaneous translumina/ coronary angiopJas!y gruup had primary lesions, whereas all palients in the Wiktor (Medtronic 
Inc., Minneapolis, MN) group h;Jd previous intervention and lesion treated by directional atherectomy, and Wallsten! 
(Schneider, Suelach, Switzerland) were a mixture of these. 
CCS-Canadian cardiova5culdr class; LAD-left anterior descending; LCX-Ieft circumflex; r<CA-···righ! coronary artery. 
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Patients undergoing implantation of a sclf-
expanding stainless steel mesh stent were 
recruited at six centers involved in a nonran-
domized trial of this particular prosthesis for a 
number of indications: restenosis following pre-
vious balloon angioplasty (49%), as an adjunct to 
unsatisfactory balloon angioplasty (19%) or 
failed balloon angioplasty (14%), and primary 
coronary artery disease (18%, of which 4% were 
for chronic total occlusion) [27-30]. Balloon 
expandable tantalum coil stents were implanted 
for symptomatic angiographically documented 
restenosis follO\l\ling previous ballc)()n angioplas-
ty, also in a multicenter trial [31-33]. The respec-
tive implantation methodology and anticoagula-
tion regimens employed in association with 
implantation of each of these devices have been 
previously described [2B,32,27]. 
No specific guidelines for the actual interven-
tional procedures were imposed on participating 
institutions so that outcome of therapy with each 
device can be considered representative of rou-
tine clinical experience from multiple European 
catheterization laboratories. Follow-up angio-
graphic restudy was routinely performed 26±2 
weeks postintervention. Where repeat angiogra-
phy was carried out earlier than 16 weeks postin-
tervention and no signitlcant luminal renarrow-
ing had occurred, the patient was asked to 
undergo further arteriography during the appro-
priate time window. For the purpose of avoiding 
the potential confounding effect of their inclu-
sion, lesions that were occluded preintervention 
were excluded [34,35J. Because of the variable 
contribution of thrombosis to total coronary 
occlusion during follow-up, all lesions that 
occluded during follow-up were excluded from 
this study, since the subject at issue was the 
restenosis process and not reocclusion. Thus, 
after exclusion of 15!=) lesions that were totally 
occluded prcinterventiol1 or at follow-up, 1313 
lesions treated by balloon angioplasty, 116 by 
directional atherectomy, 92 by Walls tent, and 87 
byWiktor stent implantation. 
QUANTITATIVE CORONARY ANGIOGRAPHIC 
METHODOLOGY 
Coronary angiography was performed in all 
patients, before and immediately after interven-
tion and at a predetermined follow-up time 
interval. The angiograms were recorded to facili-
tate quantitative analysis by the cardiovascular 
angiographic analysis system (CAAS) using 
35-mm cine11lm at a recommended minimum 
speed of 25 frames per second. All necessary 
details of the interventional procedure were 
recorded in the dedicated case record forms. 
STANDARDIZATION OF ANGIOGRAPJTIC 
ACQUISITION PROCEDUHES RYINVESTIC;ATORS 
TO .b'AClTJTATE QUANTITATIVEANAI.YSIS 
Application of the following standardization 
procedures was requested from all investigators 
to allow optimum quantitative analysis at the 
angiographic core laboratory. 
1. Tntracoronary nitrate before angiography 
preintervention, postintervention, and 
follow-up 
2. Use of nonionic contrast, ideally prewanned 
to 3rC 
3. Contrast -empty catheter (at least 6 P) t1lmed 
before each injection and removal and enclo-
sure of the distal 20 cm with the cinefilm for 
micrometric measurement by the core lab 
4. Optimal arterial opacification for at least three 
full cardiac cycles 
5. Avoidance of bony strllctures, or closely 
parallel-overlapping branches 
6. At least two projections ~ 60° apart for right 
coronary artery (RCA) lesions and at least 3 ~ 
30° apart for left: coronary artery (LCA) lesions 
7. Identical projection angulations and table 
height at preintervention, postintervention, 
and at follow-up 
8. Radiopaque indicators filmed to identify the 
administration of intra coronary nitrate and 
device use, including balloon inthtions, 
atherectomy cuts, stent deployment, and 
additional stent dilatation 
9. Guidewire and balloon-atherectomy catheter 
removed before final postinterventional 
angiography 
C;ORE-LARORATORY STANDARDIZATION 
PROCEDURES FOR QUANTITATIVE ANALYSIS 
The following procedures were routinely 
observed at the angiographic core laboratory to 
ensure reproducibility of quantitative angio-
graphic analysis. 
1. Analysis performed using an automated 
edge-detection system (Cardiovascular 
Angiographic Analysis System; Pie Medical, 
Maastricht, The Netherlands) 
2. Micrometrically measured catheter tip used 
as scaling device 
3. Panel evaluation of projections and cine-
frames selected by investigator 
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4. Analysis of optimal end-diastolic frames in 
least foreshortened projections 
5. Automatic corrections for pincushion distor-
tion of image intensifiers 
6_ Comprehensive range of measurements 
provided for each segment analyzed 
7_ Polaroid print of each analysis to confirm 
matching of projections preintervention, 
postintervention; and at follow-up 
8. Careful evaluation and error check hefore 
each analysis was verified and entered on 
database using douhle data entry technique 
9. Final measurements used are the means of 
the multiple matched projections 
QUANTITATIVEANALYSrS or 
crNEANC;rOGHAMS 
All cineangiograms were analyzed using the 
computer assisted eAAS, the basis for which 
has been described in detail in many previous 
publications [17,20,21,36-38] and its advan-
tages and limitations and specific modifica-
tions in approach that have been applied to 
cope with application to new coronary inter-
ventional therapies have recently been 
reviewed [39"]. The basic approach involved 
identification of the coronary segment of inter-
est in a selected cineframe, in which an area 
measuring 6.9 mm x 6.9 nun (512 x 512 pixels) 
is digitized with a high resolution charge cou-
pling device camera. After indication of some 
points within the arterial segment by the ana-
lyst (the accuracy of which is unimportant 
because the computer automatically readjusts 
the centerline after contour detection), vessel 
contours are detected automatically, based on 
the weighted sum of first and second derivative 
functions, applied to the digitized brightness 
information, along scanlines (every 0.1 mm) 
perpendicular to the local centerline directions 
of the arterial segment. 
As previously mentioned, a computer-
derived interpolated reference diameter is pro-
vided, in contrast to the conventional method of 
arbitrarily selecting normal-appearing segments 
proximal and distal to the lesion and taking an 
average of these as the reference diameter. 
According to the process of interpolation, the 
actual lesion itself is excluded, using the cUl'va-
ture analysis (which identifies the proximal and 
distal ends of the lesion, a process that may be 
less accurate in diffusely diseased vessels). Then, 
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in a continuous fashion, the arterial contours 
over the segment containing the lesion are inter-
polated on the basis of the proximal and distal 
centerline segments and a first-degree polyno-
mial through all the diameter values, followed by 
a translation to the 80th percentile level; taper-
ing of the vessel to account for a decrease in 
arterial caliber distal to sidebranches is allowed. 
The measurement taken as the reference diame-
ter or interpolated reference diameter is the 
value of the polynomial (the so-called diameter 
function curve) at the site of the minimallumi-
nal diameter. Thus, it is believed that by this 
process the automated algorithm attempts to 
reconstruct the original disease-free arterial 
dimension at the site of obstruction. The theo-
retical basis of, and actual mathematical steps 
involved in this process, have been described in 
detail in technical publications [20J and their 
intricacies are beyond the scope of this text. 
The absolute values of the stenosis diameter 
as well as the reference diameter are derived by 
the computer using the known contrast-empty 
catheter diameter (as measured by micrometer) 
as a scaling device [17,20,21,36-38,39",40j. The 
length of the lesion is determined from the 
diameter function on the basis of curvature 
analysis and expressed in millimeters. All con-
tour positions of the catheter, the arterial seg-
ment, and the intervention device or balloon, 
are corrected for pincushion distortion intro-
duced by the image intensifiers. Because the 
algorithm cannot measure total occlusions, a 
value of 0 mm is substituted for the minimal 
luminal diameter and 100% for the percent 
diameter stenosis. In these cases the postinter-
vention reference diameter is substituted for the 
reference diameter preintervention. 
QUANTITATIVE ANGIOGRAPHIC 
MEASUREMENTS TO BE USED IN THIS STUDY 
Gain and loss, respectively, represent the absolute 
improvement in MLD achieved at intervention, 
and the absolute change during follow-up, mea-
sured in millimeters. The long-term net angio-
graphic benefit is measured as absolute net gain. 
Thus, relative gain, relative loss, and net gain 
index represent these absolute measurements 
corrected for (or normalized for) the individual 
vessel size [9",12,13··,14.·, 22,23}. Relative lumen 
is the minimal luminal diameter corrected for the 
vessel size [11·J. In this study we intend to exam-
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ine the influence of the device used on the 
restenosis process (measured as relative loss) and 
long-term outcome (measured as relative lumen 
at follow~up). These relative terms are calculated 
as follows: relative lumen-MLD/vessel size; rela-
tive gain-MLD post MLD pre/vessel size; relative 
loss-MLD post MID at follow-up/vessel size; net 
gain index-MLD at follow-up MLD pre/vessel 
size. Vessel size is measured as the interpolated 
reference diameter preintervention, as the closest 
and most objective approximation of the disease-
free vessel diameter. The reference diameter 
postintervention is subject to the influence of the 
trauma and expansion at intervention [41·], and 
at follow-up, to the pathologic process of rcsteno-
sis [18,42,43"1. Therefore the static point ofrefer-
ence for relative gain, relative loss, net gain index, 
and relative lumen preintervention, postinterven-
tion, or follow-up is the interpolated reference 
diameter p reintervention [9··,12,13··, 14··,22, 23]. 
It is of importance to point out that these relative 
measurements arc not replaceable by percentage 
diameter stenosis or changes therein, which are 
traditionally calculated using an arbitrarily select-
ed vessel segment proximal or distal to the target 
lesion, pre- and postintervention, and at follow-
up as the reference diameter. 
STATISTICAL METHODS 
Statistical analyses were carried out with the 
assistance of commercially available statistical 
software packages, ie, SAS (SAS Statistical 
Institute). A lesion-specific approach, as has 
recently become accepted for this type of evalua-
tion, was used [44·,45··,46·1. Quantitative angio-
graphic data are given as mean ± SD. Multiple 
linear regression analysis was used to determine 
the independent influence of the device used on 
each of relative luminal loss and relative lumen at 
follow-up, taking into consideration the known 
determining parameters of relative gain at inter-
vention, lesion severity pre intervention (relative 
lumen pre intervention), vessel size, and epicar-
dial lesion location. To determine whether there 
were unequal influences of these parameters 
within each treatment group, interaction terms 
between each parameter and the device category 
were included in the analysis. To illustrate the 
findings in multiple linear regression, three 
dimensional regression planes were constructed, 
with relative gain on ihe X axis, relative lumen 
preintervention on the Z axis, and relative loss or 
relative lumen at follow-up on the vertical Y axis 
(Figs. 13-1 and 13-2). 
To provide comparisons of estimated relative 
loss and relative lumen at follow-up aiter inter-
vention in a lesion of given parameters, a statis-
tical maneuver known as "centering" of the con-
tinuous independent variables was carried out. 
This procedure simply moves the intercept to 
the location ofihe mean (center) of the continu-
ous independent variables. In this study, after 
centering, the intercept in the respective model 
represents the estimated relative loss and rela-
tive lumen at follow-up, after intervention in a 
lesion of mean relative lumen preinterventioll, 
in a vessel of mean size, where a mean relative 
gain was achieved-thus called the "average 
lesion." Due to the larger group of patients treat-
ed by balloon angioplasty in this study, these 
means are inevitably biased in that direction, 
thus a second centering maneuver was carried 
out, using the mean relative gain, relative lumen 
preintervention, and vessel size for the three 
device groups to allow comparison of estimated 
outcome after intervention on a typical new 
device lesion. 
All multiple comparisons were subjected 
to Bonferroni correction, before statistically 
Significant differences were considered to be 
present. 
RESULTS 
Baseline demographic characteristics of the 
patient groups are provided in Table 13-1. 
Although age and gender are similar between 
the groups and are characteristic of patients 
undergOing percutaneous intervention, some 
distinct differences in demographics are also 
evident between the groups, particularly treated 
lesions were exclusively primary (no previous 
intervention) in the balloon angioplasty group 
and exclusively restenolic in the Wiktor stent 
group with a mixture of both primary and 
restenotic in the directional atherectomy and 
Walls tent groups. 
Table 13-2 displays quantitative angiograph-
ic measurements pre- and postintervention and 
at 6-month follow-up. The vessel size varied sig-
nificantly between the groups, with the direc-
tional atherectomy group displaying the largest 
vessel size and balloon angioplasty the smallest, 
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Figure 13-1. Thrl'c-cljmell~i(}Il<l1 r-epresenldtioll of the 
Illllitiple linear regression models to demonstrate the 
n'spective influences of r('ldtive luminal gain (GAIN, X 
axi>) at intervC'lltion and rcl"tive lumen preinh'rVl'ntioll 
(LUMEN-PRE, Z dxis) on 1"C'ldtive luminal Joss (LOSS, Y 
;-lXis) in each of the four patient groups. For cOlllparative 
purposes, the r,1I1ges of each dxis are identic"i for th!:' foUl 
patil'nt groups. The parallel lilll's running frolll side to side 
,lml front 10 b,J(. __ k within each 50-called r('gr('s~ion plane 
rcpresent lhe mean and 1, 2, and 3 50s (i the mean rela-
tive gain alld relative IUI1ll'1l preinlerv(,lltion, respectively. 
rhe bolrlboundary within each regl"e~~ion plane is to 
identify tile location of most ((\ovo 50s, 95'Yo) of the lesiom 
in each group. The dot and diamond symbols all the r 
axis represent the respl'ctive rel,ltive loss in each group 
estim,lted by the moriel after int('rv('ntion in an "ave'r,lgc 
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lesioll" (reldtive lumen preilltl'rVl'lltioll = 0.41, relative 
gain'" 0.30, vessel size = 2.72 111m) and "average ne\ov 
device lesion" (relative' IUl1Il'n preinterventioll = 0 . .30, rel-
ative' g;'lin '" 0.44, vess(·1 SiD' '" 3.08 mm), represented by 
the' C()rr('~ponding X and Z axi:... and I·egl"ession plane posi-
tions of thl:' symbols (see text ior explanation and Table 
1.3-4 for statistical comparison,,). The slopes of the I·egl"es-
sion pldlles hom front to bdck and from dglll to left Me 
Clicl.lidted tram the nluiliv;ui,lte model (Table 1.3-.3). 
fJiffCI·ences in til(' sloj)l'" of the planes from front to b¥k 
dnt! fmlll side 10 side between the gl"OUpS Cdl1 be dppreci-
dted and I·espe'(livciy ,·ep,·esenl tile (iiff('I·CllCes noted in 
the illodels in tile I·egression co-clficicnts of "clevicec X rel-
ative lumen preintervention" dnd "device X relative gain" 
telms betwC'en the groups (T,lble 13-3). 
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although no significant difference in vessel size 
\,vas evident beh,veen the patients treated by 
directional atherectomy or Wallstent or between 
those treated by Wallstent or Wiktor stenL Table 
13-2 shows significant variation between the 
groups in all parameters displayed, although the 
variation in loss index was not as statistically sig-
nificant as the other parameters. 
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Figure 13-2. Identical gl"<lphic constructioll d~ in Figure 
13-1 to del1lonstrate the respl'ctive influences of rf'i,ltive 
luminal gdin (GAIN, X axis) at int('rvention and I"l,l,llive 
lumen prcil1l('rvenlion (LUMEN-PRE, Z axis) all rcl,llive 
lumen at lullow-up (LUMEN f--UP, i' axis) in e,Kh 
of the four pdliC'111 groups. For cunsistency and COlllpar,l-
live pllrpo:'l'~, til(' r,lnges of each dxis ,He identical to 
Figure 13-1. As ill Figure 13-1, difft'H'llces in the slupes of 
After normalizing for the vessel size, lesion 
severity preintervention (relative lumen prein-
tervention) was greatest in the directional 
atherectomy group, although not significantly 
greater than in the Wiktor stent group. The rela-
tive gain at intervention was greatest in the 
Wiktor stent group, although this \,vas not signif-
icantly greater than that achieved by Wallstent 
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the re'gression pl,lI](,s are evidel1t, but Me not perhaps dS 
Vi~lI,llly convincing, which is Illdillly clue to lise of identi-
cal dxis limits as for Figure 13-'1. Allhough the estimated 
I'elative lumen at follovv-up fm thl' "average lesion" and 
the avc-r,lge "new device lesion" arc vinually :'lIperim-
post,ci on the Y axis, the significant differences between 
the patiellt groups C-ln be' appl'eciatcd (see Table 1.1-4 fOI 
statistic:ll comparisons). 
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implantation. The relative gain achieved by 
PTCA was significantly less than in each of the 
other three groups, so that the relative lumen 
postintervention was 0.87 in the Wiktor stent 
group, 0.85 in the Wallstent group, 0.77 in the 
directional atherectomy group, and 0.70 in the 
PTCA group. Relative loss during follow-up was 
significantly lower in the PTCA group, and in the 
Wallstcnt group was significantly less than in 
the Wiktor stent and directional atherectomy 
groups, leaving the largest relative lumen at fol-
low-up in the Wallstent group (0.70, P < 0.05). 
The Wiktor stent-treated group was next (0.63), 
followed by the PTCA group (0.61), and the 
smallest mean relative lumen at follow-up was 
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observed in the directional atherectomy group 
(0.55, P < 0.05, compared with all thrce other 
groups). The net gain index from baseline to fol-
low-up was greatest in the Wallstcnt group (0.28, 
P < 0.05) compared with the atherectomy (0.18) 
and PTCA groups (0.19)' although not signifi-
cantly greater than in the Wiktor stent group 
(0.25) in which the net gain index was also 
greater than in the PTCA group (P< 0.05). 
MULTIVARIATE ANALYSIS 
In multiple linear regression analysis, the inteJ'-
vcntional device was found to be a significant 
independent detcrminant of relative luminal 
loss and relative lumen at follow-up (P< 0.000l). 
TABLE 13-2. INTERGROUP COMPARISON OF QUANTITATIVE 
ANGIOGRAPHIC MEASUREMENTS GIVEN AS MEAN ± SO 
Balloon Directional 
Angiographic angioplasty atherectomy Wiktor stent Wallstent 
measurements* (n = 1247) (n = 109) (n= 86) (n = 92) Anova (p) 
Vessel size, mm 2.64±O.S3 3.26±O.63 2.87±O.49 3.06±0.49 <0.0001 
MLD 
I)reintervention, mm 1.10±O.30 1.17±0.36 1.11±0.31 1.27±O.44 <0.0001 
MLD 
postinterventlon, mm .81 ±0.35 2.43±0.43 2.4S±O.33 2.56±O.49 <f).OOOl 
MLD at 
follow-up, mm 1.S9±0.47 ·1.7S±0.56 1.81±0.SS 2.12±O.6S <0.0001 
Acute gain, mm 0.71 ±0.34 1.26±0.47 1.33±0.32 1.29±0.49 <0.0001 
Late loss, mm 0.22±0.41 0.68±0.61 0.64±0.S3 O.44±0.64 <0.0001 
Nelgain, mm 0.49±0.43 0.S8±0.S8 0.69±0.S3 O.B4±0.74 <0.0001 
Loss index 0.21±1.Sl 0.56±0.70 O.48±0.42 O.43±0.86 0.02 
Relative gain O.27±0.13 0.41 ±0.19 0.48±0.13 0.43±O.15 <0.0001 
Relative loss 0.09±0.16 0.22±0.21 O.23±0.20 0.lS±O.20 <0.0001 
Net gain index 0.19±0.16 0.18±0.18 0.25±0.20 0.28±O.24 <0.0001 
Relative lumen 
preinlervention 0.42±0.10 O.36±0.W O.39±0.1O 0.42±0.11 <0.0001 
Relative lumen 
postinlervention 0.70±0.12 0.77±0.-)9 O.87±O.) 2 0.8S±O.12 <0.0001 
Relative lumen 
at follow-up O.61±0.16 0.SS±0.17 0.6.hO.18 O.70±0.20 <0.0001 
*After Bonferroni correction for multiple comparisons, significilnt diffel'ences (PdJ.05) were ob~erved between: percutaneous 
tran~luminal coronary angioplasty (PlCA) and each of the other three grours, directional corollary atherectolllY (DCA), 
and Wiktor (Medtronic inc., Minneapolis, MN) stent; Wdllstent (Schneider, Huelach, Switzerland) and Wiktor ~tel1t and 
Wallsten! and PlCA; PTCA and each oi the other three groups; Walistent and each oj the other three groups, PlCA and 
each of the other three groups; PlCA and each of the othel' three groups; VVallstent ilncl each of the other Ihno'e groups, 
PTCA and each of the other Ihree groups; Walislent and each oj DCA and PTCA, Wiktor stent, and PlCA; borderline 
corrected difference between DCA and PlCA (p = 0.06); PTCA and eilrh of the other three groups, DCA, dnd Wiktor stent; 
Walisten! and each of the other three gl'OUpS, PTCA and each of tllf' other three groups; Wallstent and each of PlCA and 
WiklOr sten!, PlCA ilnd Wiktor stellt; PTCA and each of DCA and VViktor stl'llt. Wallslenl, dlld DCA; DCA and each of the 
other three groups, PlCA and each of the other three groups; Wallstent and eilch of the other three groups. PTCA ;mel 
each of the other three groups. 
ANOVA-analysis of variance; MLD-millimal lumen diameter. 
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Furthermore, the influence of the baseline 
lesion severity (relative lumen preintervention) 
was found to differ significantly between the 
device groups, conveyed by retention in the 
models of the so-called interaction term device 
X relative lumen preintervention. The influence 
of variations in relative gain (device x relative 
gain, Table 13-3) showed a strong trend toward a 
significant difference (P = 0.08) between the 
treatment groups. Relative gain, relative lumen 
preintervention, and lesion location in the left 
anterior descending artery (LAD) demonstrated 
TABLE 13·3. MULTIPLE lIi':EAR REGRESSION TO EVALUATE THE INFLUENCE 
OF THE DEVICE USED FOR INTERVENTION ON ESTIMATED RELATIVE LUMINAL 
LOSS DURING FOLLOW·UP AND RELATIVE LUMEN AT FOllOW·UP' 
After centering to the average lesion After centering to the average new device lesion 
Relative Relative 
Relative lumen at Relative lumen at 
loss follow-up p loss follow-up p 
Intercept 0.09 0.6.1 Intercept 0.17 0.6S 
Vessel size 0.03 ·0.01 0.0005 Vessel size 0.03 ·0.03 0.0005 
Relative lumen Relative lumen 
preintervention 0.30 0.70 <.0001 preintervention 0.29 0.70 <O.OOo-! 
R.elative gain 0.63 0.37 <.0001 Relative gain 0.62 0.37 <0.0001 
LAD 0.D4 ·0.04 <.0001 LAD 0.04 ·0.04 <0.0001 
Device 0.01 Device <0.0001 
PTCA 0.00 0.00 PTCA 0.000 0.00 
DCA 0.05 ·0.05 0.01 DCA 0.06 ·0.06 0.0008 
WallsLenLt ·0.04 0.04 0.08 Wallstent -0.07 0.D7 0.0003 
Wiktort ·0.01 0.01 0.64 Wiktor 0.01 ·0.01 0.71 
Device x Device x 
relative gain 0.08 relative gain O.OB 
PTCA 0.00 0.00 PTCA 0.00 0.00 
DCA 0.18 ·0.18 0.04 DCA 0.18 -0.18 0.Q4 
Wallstent -0.06 0.06 0.63 Wallstent -0.06 0.06 0.63 
Wiktor 0.26 ·0.26 0.09 Wiktor 0.26 -0.26 0.09 
Device x Device x 
relative lumen relative lumen 
preintervention 0.0003 preintervention 0.0003 
PTCA 0.00 0.000 PTCA 0.000 0.00 
DCA 0.39 -0.39 0.02 DCA 0.42 -0.39 0.02 
Wallstent 0.59 -0.59 0.001 Wallstent 0.60 ·0.59 0.001 
Wiktor 0.48 -0.48 0.D3 Wiktor 0.49 ·0.48 0.03 
~Takes dccount of the respective in(Juences of vessel size, relative lumen preinterventioll, acute relative lumin<11 gain, and 
lesion location. ror comparative purposes, the models have been constructed dfter "centf'ring" the continuou~ independent 
variables to their mean values (scc 5tati~tic<11 methods). Thus, relative los5 and relative lumen at follow-up <Ire estimated fOI· 
the four devke_~ after intervention in the "average le~ion" and in the "aver.1ge new device le~ion." To take account of po~~ible 
differences in the effect of relative lumen preintelvention and relative gain at intervention between the four groups, relevant 
"interaction terms" have been included in the models. The Pvalues convey the probabilily of no additional influence on the 
val"iabiJity of relative luminal 1055 by addition of the independent variable, after all the olhers have alre<ldy been entered o1nd 
retained. The model ro-efficients given represent ballooll <lllgioplasly, so for the other devices the co-efficients must be 
adjusted by the relevant co-efficient a~sociated with the particuldr uevice and the "interaction term." 
tSchneider, Buejach, Switzerland. 
*Medtronic Inc., Minneapolis, MN. 
nCA-directioll<l1 coronary atherectomy; LAD-leit anterior descending <!11ery; PTr:A-pclnltaneou~ trallslull1inal coronary 
dngioplasty. 
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significant independent innuences on relative 
loss and relative lumen al follow-up. Vessel size 
was observed to also exert a significant, if 
numerically minor, intluence. 
'ib further illustrate the dynamic interrelation-
ships between the principle continuous determi-
nants on each of relative loss and relative lumen 
at follow-up and the influence of the device, 
three-dimensional regression models were con-
structed for each patient group, with relative loss 
and relative lumen at follow-up on the relevant 
vertical Y axis, relative gain on the X axis, and rela-
tive lumen preintervention on the Z axis. No vari-
ations in the influence of LAD or vessel size 
throughout the four groups could be detected 
and are not included in the graphs, but effectively 
would act as constants, causing parallel elevation 
of the regression plane in the loss graph and low-
ering of the plane in the relative lumen at follow-
up graphs by a factor of 0.03 X vessel size and 
0.04 for LAD location, respectively. 
The slopes of the regression planes from 
front to hack and right to left in Figures 13-1 and 
13-2 convey, respectively, the regression coeffi-
cients associated with relative lumen preinter-
vention and relative gain in the models, appro-
priately modified for the coefficients associated 
with the "device X RL preintervention" and 
"device x relative gain" terms in the models. 
Thus, with progressively less severe lesions 
(increasing relative lumen preintervention) 
while relative gain is constant, greater increase 
in relative lumen at follow-up (and a concomi-
tant smaller increase in relative loss) could be 
expected by balloon angioplasty, compared with 
the other three devices. Similarly, greater 
increase in estimated relative lumen at follow-up 
(and lesser increase in relative loss during fol-
low-up) after PTCA or Wallstent compared with 
directional atherectomy orWiktor stent implan-
tation, is predicted by the models and can be 
appreciated from the figures. 
DIFFERENCES IN ESTIMATED OUTCOME AFTER 
TREATMENT OF THE AVERAGE LESION AND 
AVERAGE NEW DEVICE LESION 
The differences between the devices in estimat-
ed relative luminal loss and relative lumen at fol-
low-up at given levels of relative lumen preinter-
venti on and relative gain can he appreciated 
from Table 13-4 and from the figures conveyed 
by the locations of the Y axis values for interven-
tion in the average lesion (represented as the 
round dots in the l1gures) and the average new 
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device lesion (represented by the diamond sym-
bols). According to the models, intervention 
using the Walls tent is associated with the great-
est relative lumen at follow-up and the least rela-
tive loss, after treatment of both the average 
lesion and the average new device lesion, 
although no significant advantage over Wiktor 
stent implantation is observed for treatment of 
the average lesion (P = 0,42), but a significant 
advantage is present after treatment of the aver-
age new device lesion (P= O.002).lt is appreciat-
ed from Table 13-4 that the apparent superiority 
in outcome observed with Wallstent implanta-
tion for treatment of the average lesio11 is magni-
fied by application to the average new device 
lesion. Also, superior results of Walls tent and 
Wiktor stent implantation, as well as PTCA, over 
directional atherectorny are apparent for treat-
ment of the average ne\-\I device lesion. 
According to these results, in the patients 
and lesions studied, the device used for inter-
vention was found to exert a significant inde-
pendent determining innuence on late angio-
graphic outcome of intervention, independent 
of lesion severity preinterventlon, luminal 
increase, vessel size, and lesion location. 
DISCUSSION 
LUMINAL RENARROWING AND LATE 
ANGIOGRAPHIC OUTCOME ARE INflUENCED 
BY THE DEVICE USED FOR INTERVENTION 
Many investigators have reported the influence 
of the acute result of intervention on long-term 
outcOlTIe [6··,7,13"',14··,16,;15·" ,46" ,4 7·· ,4U, 
49 .... ,50,51]. Greater luminal increase at PTCA 
was reported by Beau and coworkers [501 to he 
associated with a greater incidence of restenosis 
defined as luminal loss 2': 0.72 mm, a finding 
which at that time was considered paradoxicaL 
More recently performed studies using continu-
ous measures of restenosis have demonstrated a 
direct linear relationship between luminal 
increase at intervention and luminal loss during 
follow-up [6 .... ,7,13··,14··,48,49 .... ], which is con-
sidered to be a clinical correlate of the generally 
accepted experimental and pathologic descrip-
tion of restenosis as a neointimal hyperplastic 
response to vessel waU injury [52,53,54·"1. 
Despite this angiographic l1nding of increas-
ing luminal renarrowing with improving acute 
luminal results, the acute postprocedural mini-
mal luminal diameter itself has been shown to 
be directly predictive of the late lumen and a 
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powerful predictor of freedom from restenosis, 
defined as a diameter stenosis greater than or 
equal to 50% at follow-up angiography [G",7]. 
Moreover, application of a multivariate general-
ized model of restenosis to examination of late 
results of directional atherectomy, stent implan-
tation, and balloon angioplasty, did not detect 
any specific influence of the device, so that the 
greatest determinant of late angiographic results 
was concluded to be the acute postprocedural 
lumen [6",7J. However, comparative evaluation 
of late angiographic results after balloon angio-
plasty and directional atherectomy found that 
despite no significant difference in minimal 
luminal diameter at follow-up angiography, 
greater estimated relative luminal loss was pre-
dicted by linear regression analysis at increasing 
levels of rclative luminal gain in lesions treated 
by directional atherectomy (rig. 13-3) {13"j. The 
matching approach was later applied to com-
pare acute and late results of stent implantation 
with balloon angioplasty, which revealed main-
tained superior late angiographic results after 
stent implantation, thanks to the considerably 
larger acute luminal increase achieved by stent 
implantation, although no significant relative 
gain or relative loss relationship was detected, 
which was believed to be due to the rather wide 
variability in the time to angiographic follow-up 
in the stent group [14··]. Comparative evalua-
tion of excimer laser angioplasty with balloon 
angioplasty in matched lesions revealed similar 
immediate results between the two groups, but 
signif1cantly greater luminal renarrowing during 
follow-up in the laser-treated group 115··1. 
Purthennore, linear regression analysis predict-
ed significantly greater degrees of relative lumi-
nalloss after excimer laser compared with bal-
loon angioplasty, with increasing relative gain. 
This was speculated to be due to the nature of 
wall injury inflicted by excimer laser in the 
achievement of luminal increase. 
In accordance with the suggestion of the 
findings of these matching studies of a possible 
device effect, the device used for intervention 
was observed to exert a signitlcant independent 
influence on relative luminal loss and relative 
lumen at follow-up. Specifically, significantly less 
TABLE 13-4. ESTIMATED RELATIVE LOSS AND RElATIVE LUMEN AT 
FOLLOW-UP FOR EACH PATIENT GROUP' 
Average lesion t 
Relative 
lumen at 
Relative loss follow-up PTCA DCA 
PTCA 0.09 0.63 0.07 
DCA 0.13 0.59 0.07 
Wallstent 0.04 0.68 0.48 0.01 
Wiktor 0.07 0.65 0.64 0.42 
Average new device lesion:!: 
Relative 
lumen at 
Relative loss follow-up PTCA DCA 
PTCA 0.17 0.65 0.005 
DCA 0.23 0.59 0.005 
Wallstent 0.10 0.72 0.002 <0.001 
Wiktor 0.18 0.65 0.71 0.13 
*Pvalues arc corrected ior multiple comparisons. 
tJ~elative gain 0.3 in a lesion of (),41 relative lumen preintervenLion in a 2.72-111111 vessel. 
tRelalive gain 0.44 in a lesion of 0.39 relativE' lumen preintervcntion in a 3.0B-mm vessel. 
~Schneider, 13uelach, Switzerland. 
§Medlronic Inc., Minneapolis, MN. 
Wallstent'II 
0.48 
0.01 
0.84 
Wallstent 
0.002 
<0.001 
0.01 
DCA-,,··rlirectional coronary atherectomy; PlCA-percutaneous trans luminal coronary angioplasty. 
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Wiktor§ 
0.64 
0.42 
0.84 
Wiktor 
0.71 
0.13 
0.01 
relative loss and a greater relative lumen at fol-
low-up could be anticipated after Walls tent 
implantation than directional atherectomy or 
PICA, after treatment of the so defined average 
lesion and indeed superior late results with 
Wallstent implantation compared with all three 
other devices were estimated for treatment of 
the defined new device lesion. Estimated out-
come by the models using the simple statistical 
maneuver of centering the continuous indepen-
dent variables to their mean values presents a 
method of comparative evaluation of the devices 
at tangible levels. Because the patient popula-
tion is numerically dominated by lesions treated 
by balloon angioplasty, the geometric mean 
lesion indices are heavily intluenced and lean 
toward a typical balloon angioplasty lesion. 
Therefore, the mean relative lumen preinterven-
tion, relative gain, and vessel size for lesions 
treated by the other three devices were also used 
as a point for comparative evaluatioll. What 
emerges from use of these comparative points is 
in fact that the apparent generally superior long-
term angiographic results of sterlt implantation, 
especially Wallstent, over directional atherecto-
my and PTCA become more significant from the 
average lesion, to the average new device lesion. 
These overall differences in estimated out-
come between the devices observed at average 
lesion values cannot be explained by variability 
in the influence of vessel size, relative gain, or rel-
ative lumen preintervention, because these are 
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already accounted for in the models. Any attempt 
to explain these differences would be speculative. 
Differences in demographic factors must be con-
sidered, the greatest difference being that lesions 
treated by Wiktor stent implantation all had pre-
vious balloon angioplasty, whereas lesions treat-
ed by balloon angioplasty had no previous inter-
vention. Because restenotic lesions are widely 
believed to be associated with a greater propensi-
ty to further renarrowing, this might partly 
explain the less favorable late results after Wiktor 
stent implantation compared with Wallstent. 
However, most lesions treated by directional 
atherectomy, which was associated "vith the 
worst estimated relative loss and relative lumen 
at follO\,v-up, were primary lesions. In the 
absence of del1nitive tangible explanations for 
the differential estimated outcome after inter-
vention with the different devices, it must be 
speculated that differential degrees of vessel 
injury may be caused by the different devices in 
the achievement of similar quantitative angio-
graphic acute luminal increase. Confirmatory 
evaluation of such an etiology might be possible 
using quantitative angiography, in patients with 
similar demographic characteristics, by identi-
cally matching lesions [13··,14 .... J for severity 
preintervention and acute postprocedurallumi-
nal increase, then comparing the late outcomes 
at follow-up. Such an investigation, in a large 
patient population with comprehensive quanti-
tative angiography pre- and postintervention and 
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at follow-up, with standardized angiographic 
acquisition and analysis using an objective and 
reproducible automated quantitative analysis 
system, would be extremely valuable. But ample 
patient numbers for a sufficiently powerful study 
may not be available just yet. Accurate evaluation 
using intravascular ultrasound might be an even 
more useful approach than quantitative angiog-
raphy and \,vould perhaps require fewer patients 
to provide as powerful an evaluation. However, at 
this time the technology to guarantee reliable and 
reproducible luminal or plaque measurements in 
a wide variety of clinical circumstances (eg, severe 
or extremely eccentric lesions, in tortuous vessels, 
or distally located) is not yet available, although 
rapid progress is being made and such a study 
might be feasible in the not too distant future. 
DIFFERENTIAL INFLUENCES OF VARIATIONS IN 
BASEliNE LESION SEVERITY AND lUMINAL 
INCREASE ACCORDING TO THE DEVICE 
The int1uence of variations in lesion severity 
preintervention on relative loss and relative 
lumen at follow-up diiTers significantly between 
the devices Cr,,'lbles 13-3 and l3-4, figs. 13-1 and 
13-2). This means that with a constant vessel 
size, wbere a given relative luminal gain is 
achieved, increasing relative lumen prcinterven-
tion (thus reducing lesion severity) is associated 
with significant differences in the incremental 
consequent change in estimated relative loss 
and relative lumen at follow-up benveen the 
patient groups. Specifically, with increasing rela-
tive lumen preintervention, intervention with 
PTCA is estimated to be associated with the least 
increase in predicted relative loss and greatest 
increase in relative lumen at follov,r-up, con-
veyed by the observation that the PTCA group 
exhibits the gentlest slope of the regression 
planes from front to back in the relative loss 
graph and the steepest slope in the relative 
lumen at follow-up graph. This finding holds 
despite the lInding of overall superior estimated 
relative lumen at follow-up for Wallstent implan-
tation compared with DCA and PTCA, at the 
average lesion and for all three other devices at 
the average new device lesion, which is con-
veyed in the relative loss and relative lumen at 
follow-up graphs by the respective Y axis loca-
tions of the two points representing the average 
lesion (the dots) and the average new device 
lesion (the diamonds). 
The influence of variations in relative gain on 
relative loss or relative hunen at follow-up did 
not differ quite as significantly between the 
patient groups, although differences in the right 
lo left slopes of the regression planes can be 
appreciated, particularly when comparing each 
of PTCA and Wallstent with DCA and Wiktor 
.stent in the relative lumen at follow-up graphs. Tt 
is possible that with increasing palient numbers 
in the new device groups, the observed differ-
ences provided in Table 13-4 might become sta-
tistically signifIcant. Tn fact, if it were assumed, 
in the current study, that the influence of varia-
tions in relative lumen preintervention on rela-
tive loss and relative lumen at follow- up is the 
same for all devices and would thus not be 
included in the analysis as an independent term, 
then significant differences would be unveiled in 
the influence of variations in relative gain 
beh,veen the devices. This would appear to be 
mainly due to the significantly greater incre-
mental increase in estimated relative lumen at 
follow-up (and less incremental increase in rela-
tive loss) if increasing relative gain is achieved by 
PTCA or Wallstent implantation compared with 
each of the other two devices (all P < .01). 
Howevel", when the possibility of variable influ-
ence of changes in relative lumen preinterven-
tion is taken into consideration and held con-
stant, the differential influence of changes in 
relative gain between devices is no longer appar-
ent, and only the differential effect of the 
changes in relative lumen preintervention is 
retained, apparently due to the strong linear 
association hetween relative gain and relative 
lumen preintervention. 
It can be concluded from this information 
that intervention in progressive milder lesions, 
at a given vessel size and luminal increase, is 
independently associated with the most favor-
able improvement in outcome parameters if 
PTCA is used for intervention, compared with 
the other three devices. If intervention is per-
formed with progressively increasing relative 
luminal gain at a given relative lumen preinter-
vention and vessel size, then Wallstent or PTCA 
are estimated to provide better improvement in 
outcome compared with directional atherecto-
my or WHetor stent implantation. 
Thus, apart from the detected differences in 
estimated outcome between the devices, which 
cannot be explained by differential influences in 
the variables studied, variation in the influence 
of changes in lesion severity at baseline (relative 
lumen preintervention), and to a lesser indepen-
dent extent variations in relative luminal gain, 
determine differential late angiographic out-
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come between the devices. These findings are 
completely at variance with previous reports 
evaluating late angiographic outcome after 
directional atherectomy, sten! implantation, or 
balloon angioplasty [6··,7]. These reports con-
cluded that the device used for intervention was 
essentially irrelevant, late angiographic outcome 
being predominantly determined by the acute 
postprocedural lumen. Identifiable differences 
between those studies and this include the usc 
of digital calipers or videodensitometry to mea-
sure coronary luminal dimensions compared 
with automated edge detection in our study. 
These different approaches are known to pro-
vide differing absolute measurements of luminal 
dimensions pre- and postintervention as well as 
of reference diameter (vessel size), exclusion of 
totally occluded lesions at baseline and at fol-
low-up in this study, use of relative measure-
ments in this study compared with absolute 
measurements in the previous studies, applica-
tion of a deliberately selective multiple linear 
regression model with avoidance of overlapping 
variables (for example acute gain and luminal 
diameter postintervention), and inclusion of 
interaction terms to consider potentially con-
founding influences. 
SPECULATION ON INTERGROUP DIFFERENCES 
IN ESTIMATED OUTCOME 
Based on experimental, pathologic, angioscopic, 
and ultrasound information already available, it 
is possible to speculate that the mode of vessel 
wall injury imparted by the different devices in 
the achievement of luminal increases may be 
inherently different and provoke inherently 
varying degrees of thrombo-fibro-proliferative 
response. Traumatic removal of portions of dis-
eased and healthy vessel wall with frequently 
extensive exposure of intramural tissue compo-
nents by directional atherectomy may provide a 
more intense provocation of the healing 
response than the vessel stretching, plaque com-
pression, fissuring, and dissection caused by bal-
loon angioplasty, injuries that may be mini-
mized by varying degrees by placement of an 
endoluminal prosthesis. In addition, variable 
degrees of clastic recoil after treatment v,lith 
these different devices may exert considerable 
influences on the propensity for late luminal 
renarrowing. The specific composition and 
structure of stents may also exert some inl1uence 
on healing according to the completeness of 
opposition of acute elastic recoil, smoothness of 
the intrastent luminal surface (protrusion of 
intimal 11aps between struts, filaments or helical 
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coiL effect on local hemodynamics in the region 
of the lesion), and thrombotic and local tissue 
reaction to the stent components. 
Arterial luminal increase by balloon dilata-
tion has been reported by intravascular ultra-
sound studies to be predominantly due to plaque 
fracture and compression with a minor and 
inconsistent contribution from stretching 
of the vessel wall [55-57,58-,59--,60",G1-], 
although a recent study has reported vessel 
stretching, perhaps facilitated by plaque fracture, 
to be the main reason for luminal increase after 
balloon angioplasty [62"]. Elastic recoil after bal-
loon angioplasty is knovvn to be associated with a 
mean loss of 50% of achievable luminal area gain 
and 33% of achievable diameter gain [63,fi4]. The 
contribution of elastic recoil to late restenosis is 
controversial; however, many studies using 
quantitative angiography report recoil to be an 
immediate phenomenon [63,64J with no 
detectable long-term effects [41-,65,66], while 
preliminary reports using intravascular ultra-
sound suggest chronic recoil may be the 
predominant feature of late renarrowing after 
successful intervention [67 .. J. Directional 
atherectomy has been reported to achieve its 
luminal increase by a combination of plaque 
removal, plaque compression, and vessel stretch-
ing, in various combinations, varying widely 
betvveen individual patients and between report-
ed series [60-,61·,62",68,G~)-], as well as achiev-
ing a reduction in acute elastic recoil compared 
with balloon angioplasty 170 .. ]. Nevertheless, it 
may be speculated that traumatic removal of 
arterial tissue, which is a feature to some extent 
in all patients undergoing successful athcrecto-
my, imparts a more extensive type of injury than 
plaque compression, fracture, and vessel stretch-
ing by balloon angioplasty, although a consistent 
relationship between depth of tissue retrieval at 
atherectomy and degree of subsequent luminal 
renarrowing has not been reported [5",47··,71 J 
and needs to be clarified by further larger 
prospective studies, ideally with the assistance of 
intracoronary ultrasound. 
Stellt implantation, particularly if optimally 
expanded, produces smoothing or wound edge 
apposition effects and creation of a circular lumi-
nal configuration [72,73J at the site of intimal 
fracture and disruption. This may reduce turbu-
lence and shear stress 132,72], which may facili-
tate rapid endothelial recovery and therefore 
retard smooth muscle cell proliferation [74J. The 
Wallstellt, a self-expanding stainless steel mesh 
stent, was initially reported to exhibit a dilating 
function [72,75] as well as an additional propell-
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sity to further luminal improvements by 24 hours 
after implantation [76J. This clearly indicates its 
negation of elastic recoil and justi11es its descrip-
tion as "self-expanding" [771. Evaluation of the 
early clinical experience with this device \vas 
unduly disconcerting, however, with an unac-
ceptably high frequency of acute and subacute 
stent thrombosis [28], which diluted, at least 
temporarily, the early enthusiasm of some of its 
proponents l781. The balloon-expandable tanta-
lum coil (Wiktor) stent was found to produce 
similar geometric improvements [32J as had 
been previously reported for the self-expanding 
stainless steel mesh stent. The smaller mean 
diameter of the stented segment (2.88 ± 0.43 
mm) compared with the mean diameter of the 
fully inflated balloon (2.98 ± 0,44 mm) suggested 
some minor recoil in the stented segment (3% 
diameter reduction, compared with a mean of 
approximately 33% diameter reduction after con-
ventional balloon angioplasty [63]). In addition, 
it was noted that the balloon did not achieve the 
diameter specified (3.35 ± 0.36 mm) at the rec-
ommended inflation pressures for stellt deploy-
ment, perhaps due to the opposing forces of both 
the stent and the arterial wall itself. Haude and 
coworkers [79-·1 have recently investigated the 
occurrence of clastic recoil immediately after' 
sequential balloon angioplasty and Palmaz-
Schatz (Johnson & Johnson Interventional 
Systems, Warren, NJ) stent implantation and 
found that this device almost completely elimi-
nated recoil (31 % diameter recoil [48% area 
recoil] for balloon angioplasty compared vvith 
3.5% [5.1% area] after sterl! implantation), thus 
decreasing the impact of long-term intimal 
hyperplasia on the residual lumen dimensions. 
Thus, the antirecoil effects of stent implantation 
represent perhaps the most important contribu-
tion of this interventional device in improving 
iong-term outcome of intervention. 
Ther'? are many confounding factors intro-
duced by the long-term presence of an endocoro-
nary prosthesis: the scaffolding effect of the 
device, the cutting and embedding effect of the 
stent filaments, the ration of metal filament to 
intimal surface area covered by the stent, the 
long-term presence of a foreign body with its 
inherent sometimes overwhelming thrombo-
genic effect and potential inllammatory effects, 
the potential molecular effect of the electrical 
charge of the stent molecules, and the unquan-
tifiable persisting barotraumatic injury of the 
self-expanding stent on the vessel wall 
[32,77,7B,80j. Karas and coworkers [80] have 
reported a greater proliferative response to 
implantation of a balloon-expandable tantalum 
coil stent than balloon dilatation in similarly 
injured porcine coronary arteries and attributed 
this to the continuous force of the stent on the 
vessel wall. These and other as yet unknown con-
siderations potentially alter the association of 
vessel wall injury and tissue response in stented 
patient groups (compared with those treated by 
atherectomy or balloon angiopiasty), although 
Schwartz and coworkers [54--] described the pro-
pOl·tional relationship between injury and su bse-
quent hyperplasia in a stented porcine model. 
Explanations for the apparently superior 
long- term angiographic outcome after Wallstent 
implantation compared with the other three 
devices and of Wiktor stent implantation com-
pared with PTCA and DCA in new device lesions 
in this study are not readily apparent. It must be 
recognized that the patients evaluated in this 
study underwent successful intervention (diame-
ter stenosis less than 50% after intervention and 
freedom from any major adverse cardiac events) 
and completed 6-month angiographic follow-up. 
Thus, patients experiencing acute and subacute 
stent thrombosis, a considerable problem in the 
early experience with both of these devices 
[28,31], are not considered. Although these unto-
ward thrombotic events are largely unpredictable 
and not necessarily related to the degree of acute 
luminal increase at stent implantation, there is 
some apriori selection of patients with better 
outcomes, so the results must be interpreted in 
the context of patients not succumbing to acute 
or subacute stent thrombosis. Accepting this lim-
itation, it may be speculated that perhaps there 
are inherent properties of stent implantation, 
particularly the Wallstent, which create a benefi-
cialluminal environment providing improved 
late angiographic benefit. If this is so, then is it 
the scaffolding effect of the device, the self-
expanding aspect, the mesh configuration, the 
stainless steel content, or a combination of these 
that is important? Could these observations indi-
cate a favorable long-term effect of this particular 
device when acute thrombotic events can be 
avoided, or could the same reasoning be applied 
to other endoluminal prostheses? These ques-
tions are not readily answerable at this time 
because the patient group treated by mesh stent 
implantation in this study is a nonhomogenous 
mixture of various clinical syndromes and they 
represent the early clinical experience with this 
device. Application of this mcthodologic 
approach to recently completed randomized tri-
als of Palmaz-Schatz stent versus balloon angio-
plasty [3",4"] will undoubtedly provide more 
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objective and valuable information. Ultimately it 
will require either matched comparisons or ran-
domized trials of different clinically efficacious 
stents to determine device-specific advantages, 
ideally using intravascular ultrasound as well as 
quantitative angiographic endpoints. 
INFLUENCE OF LESION LOCATION ON loss 
AND ANGIOGRAPHIC OUTCOME 
Previous studies using multivariate analysis have 
reported a definite independent influence of epi-
cardial lesion location on tate angiograpl1ic out-
corne of intervention, namely, either an adverse 
influence of LAD location [5"',6"',7,16,81 0 ] or a 
favorable elTect of location in the right coronary 
artery [46 0 ]. Tn agreement with previous work, 
location in the LAD was associated with a greater 
relative loss and smaller relative lumen at follow-
up in the study described here, independent of 
variations in luminal increase, vessel size, or 
lesion severity preintervention. No difTerences 
were detected between the groups in the degree 
of effect of LAD location on late results of inter-
vention. Despite the consistency of this finding 
in several current studies, there is as yet no expla-
nation why the LAD should exhibit a greater 
propensity to restenosis. Quantitative angio-
graphic studies have reported that acute elastic 
recoil, adjusted for vessel size, is significantly 
greater in the LAD than the other two vessels 
[63J. If chronic recoil is indeed a major contribu-
tor to late renarrowing, then on the basis of the 
acute findings, it is conceivable that chronic 
recoil might be most marked in the LAD. Such 
phenomena may be evaluated in serial intravas-
cular ultrasound studies. The only published 
pathologic finding that might indicate a different 
biologic substrate in LAD lesions was of 
increased frequency of primary intimal myocytic 
hyperplasia in atherectomy specimens retrieved 
from LAD compared with right or circumflex 
coronary arteries [820 J. It seems logical that the 
hyperplastic response to injury may be more 
aggressive when the intimal myocytes are already 
activated. Why this should be more frequent in 
the LAD has not been elucidated, but increasing 
experience with analysis and culture of retrieved 
atherectomy specimens may provide some 
insight in the near future. 
LIMITATIONS 
This is an observational study that includes only 
patients who underwent successful percuta-
neous intervention on nonoccluded lesions that 
did not progress to occlusion during follow-up 
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and had satisfactory quantitative angiographic 
analysis of angiograms performed pre- and 
postintervention and at follow-up. Thus, this 
could be delineated as a deliberately circum-
scribed population, particularly in the stent 
groups, where all patients experiencing acute 
and subacute occlusion were excluded. This is 
especially evident in the Wallstent group in 
"vllich the early experience with the device was 
associated with unacceptably high occlusive 
thrombosis rates [28J. The findings mllst there-
fore be cautiously applied to the general inter-
ventional patient population and recommenda-
tion of the Wallstent as the ultimate device for 
intervention should not be construed. 
The limitations oftl1e angiogram as an imag-
ing modality are widely recognized as inherent 
and must be accepted as such; however, we 
believe that analysis by computer-based quanti-
tative analysis systems, strict quality control and 
standardization of image acquisition, and use of 
multiple matched projections pre- and postin-
tervention, and at follmv-up is the most objec-
tive means to maximize its potential value. 
The relative influence of various suspected 
clinical risk factors for a greater intimal hyper-
plastic response could be considered as possibly 
modifying the relationship between the identi-
fied angiographic determinants of luminal 
renarrowing and late angiographic outcome. It is 
worth noting, however, that three previous stud-
ies failed to demonstrate any slIch confounding 
influence [4500 ,46e ,47°°J. Thus, the addition of 
clinical variables might improve the predictive 
power of the models rather than influencing the 
nature of the relationships demonstrated. The 
parameters of interest for comparative evalua-
tion of the interventional devices as indepen-
dent determining variables were selected based 
on previous experience, whereby each of the fol-
lowing, lesion severity preintervention, luminal 
increase at intervention, vessel size, and lesion 
location, have been found to be independently 
associated with the long-term angiographic out-
come after successful balloon angioplasty 
[16,4500,460,4700,661. Furthermore, basic clinical 
principles would suggest that prior to planned 
coronary intervention, regardless ef the clinical 
circumstances, an interventionalist is faced with 
a set of certain circumstances such as lesion 
severity and vessel size and that he or she IIlay 
choose from a number ofinrerventional devices. 
The interventionalist will seek to achieve some 
degree of luminal increase, the magnitude of 
which he or she may control to some extent. The 
question here is whether there might be inher-
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ent device-specific characteristics that influence 
late angiographic outcome, considered as an 
ubiquitous and continuously variable process 
149--,83"J. In these circumstances, "where the 
angiographic parameters of interest may difler 
widely between the patient groups to be evaluat-
ed, multiple linear regression analysis presents 
the only valid approach. 
CONCLUSIONS, CLINICAL RELEVANCE, AND 
IMPLICATIONS OF THE FINDINGS 
The degree of renarrowing and the lumen diame-
ter at follow-up after successful coronary inter-
vention in nonrandomized patient groups were 
demonstrated to be iniluenced by the type of 
device used for intervention, independent or, 
and in addition to lesion severity preinterven-
tinn, luminal increase at intervention, lesion 
location, and vessel size. Variations in lesion 
severity prcintervention and luminal increase are 
associated with variable effects on late outcome 
according to the device used. These findings are 
at variance with previous studies that reported 
no device effect in determining late angiographk 
results of intervention. Whether these contradic-
tory findings are a consequence of methodologic 
differences in quantitative angiographic mea-
Sllrements (automated versus user-dependent 
methods) or comparative approach, or can be 
explained by actual population demographic dif-
ferences or variations in interventional 
approach, remains to be determined. In general, 
stent implantation, particUlarly Wallstent, 
emerged from this study with the most favorable 
predicted late angiographic outcome after initial-
ly successful intervention of nonoccluded coro-
nary lesions, which did not completely occlude 
during follow-up. This finding supports contin-
ued clinical investigation of stent implantation, 
with particular focus on overcoming thrombotic 
occlusion and the need for stringent systemic 
anticoagulation and its attendant risks. Similarly, 
the comparatively unfavorable outcome predict-
ed for intervention hy directional atherectomy, in 
line with the conclusions of recent randomized 
trials [1--,2--], must conclude that the general 
use of directional atherectomy for treatment of 
coronary artery disease remains to be deter-
mined. Despite its widely criticized inherent lim-
itations in consistently achieving optimal acute 
luminal results, balloon angioplasty, with its 
comparative ease of use, high acute success 
rates, and applicability to lesions with a wide 
range of severity and in a broad range of vessel 
sizes, must still be considered a cornerstone of 
interventional cardiologic therapeutics. 
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DIFFERENCES IN RESTENOSIS PROPENSITY OF 
DEVICES FOR TRANSLUMINAL CORONARY INTERVENTION 
A quantitative angiographic comparison of balloon angiopiasty, directional atherectomy. 
steflt implantation and excimer laser angiopiasty 
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ABSTRACT 
Background: With the increasing clinical application of new devices for percutaneous coronary 
revascularization, maximization of the acute angiographic result has become widely recognized as a key factor 
in maintained clinical and angiograpmc SHeeeSil. What is unclear, however, is whether the specific mode of 
action of different devices might exert an additional independent effect on late luminal renarrowing. 
Purpose: The purpose of this study was to investigate such a difference in "restenosis propensity" among 3660 
patients, who had 4342 lesions successfully treated by balloon angiopiasty (BA, n =3797), directional coronary 
atherectomy (DCA, 11=200), Palmaz-Schatz stent implantation (PS, n=229) or excimer laser coronary 
angioplasty (ELCA, n= 116) and also underwent quantitative angiographic analysis pre- and post- intervention 
and at 6 month follow up. 
Methods: To allow valid comparisons between the groups, because of significant differences in coronary vessel 
size (VS) (BA=2.62±0.SSmm, DCA=3.28±0.62mm, ELCA=2.S1 ±0.47mm, PS=3.01 ±0.44mm; 
p < .0001), the comparative measurements of interest selected were the "relative loss" in luminal diameter 
(RLoss=loss/VS) to denote the restenosis process, and the "relative lumen at follow up" (RLfup=minimal 
luminal diameter (MLD) at follow up/VS) to represent the angiographic outcome. For consistency, lesion 
severity pre was represented by the "relative lumen pre" (RLpre=MLD pre/VS) and the luminal illcrease at 
intervention was measured as "relative gain" (RG=gain/VS). Differences in restenosis propensity between 
devices was evaluated by univariate and multivariate analysis. Multivariate models were constructed to 
detennine relative loss and relative lumen at follow up, taking account of relative lumen pre, lesion location, 
relative gain, vessel size and the device used. Tn addition, model estimated relative loss and relative lumen at 
follow-up, at fixed relative lumen pre, relative gain and vessel size, were compared between the 4 groups. 
Results: Significant differences were detected between the groups with respect to these estimates, whereby, 
Palmaz-Schatz stent implantation was associated with the most favourable angiographic outcome and excimer 
laser coronary angioplasty the least (p< .01). Significant effects of lesion severity and location, as well as 
luminal increase on late angiographic outcome were noted. In addition, the influence of luminal increase 
achieved at intervelltion on late angiograpic results differed significantly between the devices (p=.02). 
Conclusion: These findings indicate that propensity to restenosis after apparently successful intervention is 
intluenced by the device used for intervention. In view of the clinical implications of such findings, further 
evaluMion in larger randomized patient populations is warranted. 
INTRODUCTION 
Over the last decade, a number of new devices for transluminal coronary revascularizatioJl, have been 
introduced, aiming to improve acute and long tenn clinical and angiographic results of coronary balloon 
angioplasty li ,21. Through a variable combination of plaque removal, compression and vessel stretching [3-6J, 
directional coronary atherectomy (DCA) can achieve significantly greater acute luminal results than conventional 
baHoon angioplasty 17-1OJ, but randomized trials have failed to demonstrate long teml superiority of this 
apparent mechanical advantage [7,81. By vaporization of atherosclerotic plaque, excimer laser coronary 
angioplasty (ELCA) has been associated with improved acute success compared with balloon angioplasty, 
especially in complex coronary lesions [11,12, 13J, but restenosis rates in registry and observational reports have 
been relatively high r11,13,14,ISJ and the results of randomized trials are still awaited. Stellt implantation, 
through vessel expansion, opposition of natural elastic recoil r161 and establishment of a smooth and circular 
coronary lumen l17-191, has the capacity to consistently achieve superior procedural luminal increase compared 
with balloon angioplasty [17-22J. Although 2 randomized comparisons of Palmaz-Schatz stent implantation with 
balloOll angioplasty, in native primary coronary stenoses, indicate long ternl maintenance of the acute advantage 
of stelll implantation [23,24J, it is not yet known whether this is simply due to the greater acute luminal 
increase, or to additional benetits of specific mechanical or physical properties of the stem itself. 
Despite the mechanistic differences between these 4 devices, ohservational studies have concluded that 
the magnitude of the post procedural lumen alone detemlines late angiographic outcome, without ally detectable 
independent contrihution of the device useu to achieve it [l0,2S1. Conversely, studies in angiographically 
matched lesions, comparing balloon angioplasty with each of directional atherectomy [9,261. stellt implantation 
[221 and excimer laser [lS1, as well as unmatched general comparisons in patients treated by atherectomy, 
balloon angioplasty or stent implantation, have reported detinite ditferences in restenosis propensity and late 
angiographic results 127,28]. Because these prior studies comprised comparatively early experience with 
directional atherecto111Y, as well as Wallstent and Wiktor stent implantation in heterogenous patient groups, this 
study was designed to ratify the previous findings by investigating the possibility of an independent influence 
of the device used for intervention, among patient groups treated by 4 different devices: balloon angioplasty 
(BA), directional atherectomy (DCA), Palmaz-Schatz stent implantation (PS) or excimer laser curonary 
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angioplasty (ELCA), in contemporary clinical experience. 
POPULATION AND METHODOLOGY 
The study population was made up of 3660 patients (4342 lesions) treated for native coronary artery 
disease by BA (n=3797 lesions), DCA (11=200 lesions), PS (n=229 lesions) and ELCA (n=116 lesions). 
Patients treated hy BA had heen enroled in 4 international multicentre placeho controlled restenosis prevention 
trials, the details of which have already been published r30-331. Tn each of these trials the phannacological agent 
under investigation was found to have no significant effect on either clinical or angiographic outcome by both 
univariate and multivariate analyses, so, for the purposes of the present study, all the patients were pooled and 
considered as one group. Patients treated by PS had been recruited during the BENESTENT trial (a European 
multicentre randomized comparison with BA, for treatment of native primary coronary artery lesions (associated 
with stahle anginal symptoms) with a reference vessel diameter;;::: 3mm r231). Final quantitative angiographic 
follow up was 93 %. Patients treated by ELCA were treated at a single institution, using a Xenon Chloride 
device (DYDler 200 +, Advanced Interventional Systems, Inc., Irvine, California), which emits laser pulses with 
a wavelength of 308nnl, duration of 210 nsec and at a repetition rate of 20Hz. Over-the-wire laser catheters of 
1.3, 1.6 and 2.0mm, with concentric multifiber arrangement around a central lumen were employed at a fluence 
of 45-65 ml/mm2 • The excimer laser procedures were carried out according to conventional practice as 
previously reported r34]. Adjunctive BA was carried out in 98 % of lesions. Quantitative angiographic follow 
up among eligible patients was 94%. Patients were treated by DCA at two specialised institutions (The 
Thoraxcenter, Rotterdam, Netherlands and St Lut: University Hospital Brussels, Belgium; hoth of which 
participated in the Coronary Angioplasty Versus Excisional Atherectomy (CAVEAT) trial), using the Simpson 
atherectomy catheter (Devices for Vascular Intervention, San Diego, California). Primary lesions were treated 
in 80% of cases and 20% of lesions had undergone previous intervention. A 6P devit:e was used iu61 % and 
7F in 39% of cases, with a mean of 5.9±2.8 cuts made per lesion. Adjunctive BA was carried out in 16% of 
lesions. Overall quantitative angiographic follow up was 93 %. In all component studies, all aspects of 
intervention were left to the discretion of the individual physician. Successful intervention was universally 
considered as a post-procedural diameter stenosis of < 50% visually assessed by the individual investigator. 
Quantitative coronmy angiographic (QCA) methodology: Coronary angiography was pertonned, in mUltiple 
projections pre intervention and identically repeated immediately after intervention and at a pre-detemlined 6 
month follow-up. The angiograms were recorded to facilitate quantitative analysis by automated edge detection 
(using the Cardiovascular Angiographic Analysis System (CAAS», in the angiographic core lahoratory, with 
universal application of specific standardization procedures, as previollsly described f29,35,36]. 
Quantitative allgiographic measurements of interest in this study: Due to the wide range of coronary vessel 
size treated hy modern interventional devices, (as confirmed in tahle 2 in the results section), QCA 
measurements were nonualized for reference vessel size, deriving measurements of "relative gain" and "relative 
loss" in luminal diameter, as previously introduced r9,22,28,37,38]. The vessel size was represented as the 
interpolated reference diameter pre-intervention, on account of changes in reference diameter aafter 
intervention and during follow up, as previously described [16-23,28,29,38-40]. Accordingly, relative 
measurements of lumen dimension.<; pre and post intervention and at follow up were also derived by nonnalizing 
minimal luminal diameter for the interpolated reference diameter pre, producing the measurements of "relative 
lumen" pre, post and follow up, as previously des(.;ribed [41J. TIlese novel parameters thus represent 
measurements of luminal patency a~ a fraction of the ideal luminal diameter. Relative gain = GainlVessel Size; 
Relative loss = Loss/Vessel Size; Net gain index = Gain-LosslVessel Size; Relative lumen = Minimal 
luminal diameter/Vessel Size. Conventional binary measures of restenosis were also estimated applying a 
number of commonly used angiographic criteria (table 2). 
Statistical methods 
Statistical analyses wert! carried out with the assistance of a commercially available statistical software 
package (SAS, SAS Institute, Inc.). A lesion based approach was applied, as previously justified [42-44,451. 
Analysis of variance was used to compare continuous parameters and restenosis rates were compared using a 
chi-square test. In keeping with the tlndings of previous studies [6,9,10,14,15,21,22,25-29,42,44], and a recent 
specitic evaluation [46], a linear relationship was assumed between relative luminal gain at intervention and 
relative luminal loss uuring follow up. To investigate the influence of the device used on the restenosis process 
and late angiographic outcome, the relationship between relative luminal gain at intervention and each of relative 
luminal loss during follow up (representing the restenosis process) and relative lumen at follow up (as the late 
angiographic outcome), was investigated tirst in simple linear regression analysis. Then the entire patient 
population was considered as a single group and a previously described multiple linear regression model was 
cOllstmctcd, to take account of the respective detemlining influence of the vessel size, lesion severity pre-
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intervention (relative lumen pre), the influence of the physician (relative luminal gain at intervention) and the 
epicardial lesion location [291. 
To investigate whether a difference could exist between the 4 devices in the degree of relative loss 
provoked hy increasing relative gain (so called "etfect modification"), an "interaction tenn" between "device" 
and "relative gain" (denoted in the model as "device x gain") was entered as an indepelldent variable. TIle 
same procedure was performed for relative lumen pre, vessel size and lesion 10catiol1. If an "interaction tenn" 
is found to contrihute significantly to the final model, this would imply a significant difference hetween the 
devices, with respeu to the influence of that particular factor on the late angiographic results. Inter-group 
comparisons can then he performed to locate the source of the detected difference. 
For additional comparative purposes, the multivariate model was interrogated to provide estimates of 
relative luminal loss and lumen at follow up for each device group at hypothetical, hut clinically relevant, 
intelventional scenarios. Accordingly, we chose to compare estimated outcome between the 4 devices in this 
study: firstly for the "average intervention", thus, where mean relative gain (0.30, tahle 2) is achieved in a 
lesion with the mean relative lumen pre (0.38, table 2), in a vessel of mean diameter (2.67nun, table 2). 
Because of the preponderance of lesions treated by BA, the overall mean values for these parameters tend to 
retleu a typical BA scenario (table 2), so a typical "stent/atherectomy intervention" was also used to compare 
outcome where II relative gain of 0.44 is achieved in a lesion with a relative lumen pre of 0.37, in a vessel of 
3. 12nun. Finally, the third level of comparison was chosen to reflect "optimal intervention", whereby a relative 
lumen post of 1.0 is achieveu through a relative gain of 0.61 in a lesion of mean severity (0.39, table 2), in a 
vessel of 3.2mm. Statistical comparisons are provided, without systematic automatic correction for "multiple 
comparisons", in oruer to display all potential differences and trenus between the groups. To graphically 
illustrate the tindings, 3 dimensional regression planes were constmcted, as previously descrihed [291. 
RESULTS 
Baseline demographic features of the patient groups are provided in table 1, showing that the patient 
groups are broadly similar, with the exception that 20% of the patients treated by DCA had had prior 
Clngioplasty (in a previous specific analysis of this population [481, so called "restenotic lesions" were not 
associated with a greater prope1L~ity to subsequent rellarrowing so all patients were included in this study) and 
no totally occluded lesions were treated by DCA compared with 15 % treated hy ELCA. 
Table 1. Demographic data for the 4 patient groups. 
Balloon Directional Excimer Palmaz-Scbatz 
Angioplasty Alherectomy Laser Stent 
Patients 3135 190 106 229 
Lesions 3796 200 116 229 
Male/Female (80%/20%) (81 %/19%) 80%/20% 80%/20% 
Age (years) 56±9 58± 11 56±9 55±9 
Lesion (primary/restenosis) 100% 80%/20% 100% 100% 
Vessel: LAD 43% 67% 36% 65% 
RCA 33% 20% 35% 22% 
LeX 24% 13% 29% 13% 
Total occlusion pre 6% 0 15% 4% 
Diabetes 7% 6% 6% 7% 
CCS III or TV angina 62% 73% 72% 64% 
Non-exertional angina 46% 40% 52% 48% 
Aner nonnalization for vessel size, significant differences were detected between the groups for all 
parameters: Pre-procedural lesion severity was greatest in the ELCA group, which had the greatest frequency 
of total occlusion pre (relative lumen pre 0.31 or % diameter stenosis 69%). Luminal increase was greatest after 
PS (relative gain of 0.48, or 48 % increase in lumen) as was post procedural relative lumen (0.84 or 84 % of 
vessel diameter). Despite having greatest relative loss (0.21,21 % loss in vessel diameter) PS also retained the 
greatest relative lumen at follow up (0.64, or 64 % of ideal) and displayed greatest ultimate net benefit (net gain 
index 0.28, 28 % net increase in vessel diameter). 
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Table 2. Quantitarive angiographic measured and derived parameters per device group, given as mean and standard deviation (std). Vessel size differed widely (p < .0001), 
justifying the use of "relative" rather than "absolute" measurement parameters in the study evaluation. 
BALLOON DCA LASER STENT ALL AN OVA 
Mean± sd Mean ± sd Mean ± std Mean ± stu Mean ± std 'p 
Reference uiameter pre(mm) 2.62 0.55 3.28 0.62 2.51 0.47 3.01 0.44 2.67 0.57 <.0001 
Reference uiameter post(nul1) 2.67 0.53 3.34 0.52 2.68 0.49 3.19 0.41 2.73 0.55 <.0001 
Reference diameter f-up(rrun) 2.69 0.58 3.32 0.54 2.60 0.60 2.96 0.47 3.09 0.51 <.0001 
MLD pre (mm) 0.99 0.40 1.21 0.38 0.76 0.44 1.08 0.33 1.00 0.40 <.0001 
MLD post (mm) 1.73 0.37 2.41 0.43 1.66 0.39 2.51 0.36 1.80 0.40 <.0001 
MLD f-up (mm) 1.42 0.58 1.83 0.60 1.17 0.71 I. 91 0.54 1.46 0.60 <.0001 
Diameter stenosis pre (%) 61.3 14.6 63.2 10.0 68.8 18.3 63.9 10.1 61.8 14.4 <.0001 
Diameter stenosis post (%) 34.7 9.6 27.5 9.8 37.8 10.5 20.9 7.5 33.7 10.1 <.0001 
Diameter stenosis f-up (%) 46.5 19.4 41.0 16.4 55.7 23.6 35.5 14.1 45.9 19.3 <.0001 
Absolute gain (mm) 0.73 0.42 1.20 0.47 0.90 0.53 1.43 0.42 0.80 0.46 <.0001 
Absolute loss (nun) 0.30 0.53 0.58 0.60 0.50 0.72 0.60 0.50 0.34 0.55 <.0001 
Absolute net gain (mm) 0.43 0.58 0.62 0.60 0.40 0.70 0.83 0.58 0.46 0.59 <.0001 
-.j 
Relative lumen pre 0.39 0.15 0.37 0.10 0.31 0.18 0.36 0.10 0.38 0.14 < .0001 ... 
Relative lumen post 0.67 0.12 0.75 0.16 0.67 0.14 0.84 0.11 0.68 0.13 < .0001 
Relative lumen f-up 0.55 0.21 0.56 0.17 0.47 0.27 0.64 0.16 0.55 0.21 < .0001 
Relative gain 0.29 0.16 0.38 0.18 0.36 0.21 0.48 0.14 0.30 0.17 < .0001 
Relative loss 0.12 0.21 0.19 0.21 0.20 0.29 0.21 0.17 0.13 0.22 < .0001 
Net gain index 0.17 0.23 0.19 0.19 0.15 0.28 0.28 0.19 0.17 0.23 < .0001 
Loss index 0.51 3.99 0.52 0.75 0.73 1.61 0.44 0.37 0.51 3.75 .34 
Restenosis rates: Chi-square 
1. %ds ;;=: 50% at fup 36.3% 28.5% 50.9% 16.2% < .0001 
2. Loss ;;=: gain/2 41.1% 45.0% 46.6% 35.4% .17 
3. Loss;;=: 0.4nun 31.5% 59.8% 38.1 % 64.9% <.0001 
4. %ds at fup > .9%DS pre 25.3% 16.1 % 27.8% 9.2% <.0001 
Restenosis definition I = diameter stenosis;;=: 50% at follow up; 2 = loss;;=: half the initial gain; 3 = loss;;=: O.4nun (twice the post-PTCA variability of CAAS [39]; 
4 = recurrence of stenosis to within 10 % of baseline severity. BALLOON = balloon angioplasty; DCA = directional coronary atherectomy; LASER = excimer laser 
coronary angioplasty; STENT = Palmaz-Schatz stent; MLD = minimal luminal diameter. %DS = percent diameter stenosis. 
-..J 
'" 
r tgure L Llllear regressIon analYSIS (and ~J % conhdence intervals), displaying the influence of relative gain on relative loss. Significant differences are 
evident between groups in the rate of the relative loss response to increasing relative gain (p=.006). Balloon = balloon angioplasty; DCA = directional 
coronary atherectomy; laser = excimer laser coronary angioplasty. 
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Binw)! Restel10sis Rates (table 2) 
Differences hetween the groups in hinary restenosis depended on the definition applied (table 2). 
ELCAwas associateu with the highest frequency of a stenosis 2: 50 % at follow up at 51 %, followed by BA at 
36%, DCA at 29% and PS stenting at 16% (p< .0001), although PS hau the greatest frequency of a loss 2: 
O.4tum during follow up. 
Liuear regression analysis (figure 1) 
Significant differences were detected between the device groups in the relative loss response to 
increasing relative gain (p=.006, hy analysis of variance; 0.61 in the DCA group, 0.57 in the ELCA group, 
0.37 in the BA group and 0.33 in the PS group) and ill the relative lumen at follow up response to increasing 
relative gain (p=.003; -0.22 for ELCA, 0.01 for BA, 0.17 for DCA and 0.22 for PS). 
Multiple Linear Regression Allalysis (table 3, figure 2). 
Inter-device d{tj'er(!II(,(!.I' in predicted augiographic results: Each of relative luminal gain, relative lumen pre and 
lesion locatioIl in the LAD were found to be significant independent detenninants of both relative loss and 
relative lumen at follow up. Having already controlled for the influence of ves~'el size, by virtue of the use of 
relative parameters, no signiticant further independent influence of this parameter on outcome was noted. 
Significant differences were observed between the devices with respect to the influence of relative gain on each 
of relative loss and relative lumen at tOllow up (p= .02; reflected by the observed differences in the slopes of 
the 3 dimensional regression planes, from right to left in figure 2). The principle source of this difference 
appeared to he hetween the BA and each of the ELCA (p< .01) and the DCA (p=.04) groups, whereby, for 
a given relative luminal gain, 43 % would be retained as improved relative lumen at follow up if BA was used, 
compared with 23 % for DCA and 12 % for ELCA. By PS, 41 % of relative gain was predicted to be retained 
as relative lumen at follow up, which was not found to be statistically different from that predicted for DCA 
and ELCA (p=.07 versus ELCA). 
Comparison of estimated outcome between devices at the 3 pre-designated levels of comparison, as 
already desc.:ribed, revealed the following: for "average intervention", significant differences in model estimated 
relative loss and relative lumen at follow up were detected between the device groups, primarily due to 
significant differences between ELCA and each of the other 3 group!'> (table 3b, fi!,'Ure 2); for "average 
DCA/stent intervention", PS was associated with less relative loss and greater relative lumen at follow up than 
both ELCA (p< .0001) or DCA (p=.OI), also, each of BA and DCA were associated with superior late results 
than ELCA (p < .000 1 and p =. 005, respectively). No signit'icant difference in estimated outcome was observed 
between BA and either PS or DCA (table 3b, figure 2). At the third predesignated level of comparison, thus 
after "optimal intervention", similar inter-group differences as in the previous comparison were evident and, 
in addition, BA was estimated to be associated with less relative loss and a greater relative lumen at follow up 
than DCA (p=.006). 
bltlllellce (!f'totully occluded lesions: Due to the greater prevalence of totally occluded lesions at baseline in the 
ELCA group compared with the others (table 2), particularly DCA and PS, multivariate analysis was repeated 
after excluding such lesions from all groups, to be certain that the observed ditlerences could not be explained 
merely by this factor. Of the 24 successfully treated totally occluded lesions in the ELCA group, 9 (37 %) had 
re-occluded at follow up, compared with 59 of 286 (20%) in the BA group and 0 of 5 in the PS group. 
Exclusion of totally occluded lesions at baseline from the population to be analyzed resulted in no fundamental 
change in the findings of significant differences between devices ill the influence of relative gain on outcome 
and in estimated outcome, as described. 
DISCUSSION 
Restellosis rates 
Conflicting tindings regarding late angiographic results were evident from the use of different categorical criteria 
for angiographic restenosis. Such disclosure is not new having been described many times in the past f29,47J. 
AccordiIlg to the widely used "diameter stenosis 2: 50 %" criteria, PS stent implantation appeared to provide the 
greatest 6 month angiographic results and ELCA the least, with BA and DCA in between. 
These findings although not providing any insight to the problem or a possible mechanistic explanation, concur 
quite well with the results of the more comprehensive multivariate analyses. 
Simple Linear Regressioll - useful but incomplete in/onllation 
In simple linear regression, the renarrowing response to increasing luminal enlargement was found to 
differ signiticantly hetween the groups, with the least favourable response displayed by the ELCA group (figure 
I). The most favourahle outcome was predicted for the PS stent group, with least increase in relative loss and 
greatest increase in relative lumen at follow up predicted, with increasing relative gain. In addition, at the 3 
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Tablr J (a): Mullipk lincH regression model to evaluate tile influence of the device used for intervention un estimatetl relntive luminal Joss 
during follolV up nnd relative IUlllen at follow up. Oppo~ite tile independent variable "Device" 1. 2, 3, are "p' values representing analysis 
of variance of estilllatetl RLoss anti RLfup between the 4 devices at the selected levels of comparison as described in the statistical methuds 
sel:lion (1 repre~ents "aver~ge intervention", 2 repre&ents "average DCAhtent intervention", 3 represents "optimal intervention". The 
re~pcctive inlluences of relative gain ~nd relative IUlllen pre on outcome [or each individual tlevice arc provided in the 4 x 4 tables 
immedialely hclow the relevant terrn. The 'po vallle8 convey the probability of no adtli!ional int1uence on the model by atldi(jon of tile 
relevant indepentlent variable, aftcr all the uthers have already been entered. In Ihe 4 x 4 lable~. automatic pre-eom:ctinn for multiple 
c()mparis()n~ has not been applied. 
Rei Loss (r ~ .14) RLFup (r .12) 
Device 1 , , 
Device 2 * 
, 
Device 3 , , 
Vessel size 0.00 0.00 
LAD 0.02 -0.023 
RLumen pre 0.32 0.68 
Relative Gain 0.61 0.39 
Device x RG , * 
Inter-group comparisons of the influence of RG on outcome : 
Estimated RLoss Estimated. RLFup PS 
PS 0.59 0.41 
BA 0.57 0.43 .78 
DCA 0.77 0.23 .10 
ELCA 0.86 0.14 .07 
P 
.0006 
< .0001 
.0007 
.87 
.03 
<.0001 
< .0001 
.02 
BA 
.98 
.006 
.001 
Device x RLpre * * .23 
Inter-group comparisons of the influence of RLpre on outcome : 
Estimated RLoss Estimated RLFup PS 
PS 0.56 0.44 
BA 0.32 0.68 .85 
DCA 0.61 0.39 .20 
ELCA 0.38 0.62 .08 
Device x Vessel size 
Device x LAD 
Table 3 (b) 
* * 
* 
.56 
.11 
BA 
.85 
.09 
.008 
DCA 
.10 
.006 
.23 
DCA 
.20 
.09 
.48 
ELCA 
.07 
.001 
.23 
ELCA 
.08 
.008 
.48 
Estimated relative loss and relative lumen at follow up for each patient group, according to the "centering" 
procedures pert()mled, as desLTibed in the text, with inter group comparisoll'; using a 4 x 4 table (p values are 
not corrected for multiple comparisons), after: 
(i) the "average intervention" ie where a relative gain of 0.3 is achieved in a lesion with a relative lumen 
pre of O .. 39, located in a 2.67nun vessel. 
PS 
BA 
DCA 
ELCA 
Estimated R Loss Estimated RLfup 
0.11 0.58 
0.13 
0.13 
0.19 
0.55 
0.55 
0.49 
PS 
.34 
.33 
.06 
BA 
.34 
.80 
.002 
DCA 
.33 
.80 
.02 
ELCA 
.006 
.002 
.02 
(ii) the "average DCA/stent intervention" ie where a relative gain of 0.44 is achieved. in a lesion with a 
relative lumen pre of 0.37, in a 3.12nml vessel. 
Estimated R Loss Estimated RLfup PS 
PS 0.18 0.62 
BA 0.20 0.60 .14 
DCA 0.23 0.57 .01 
ELCA 0.31 0.49 < .0001 
BA 
.14 
.08 
< .0001 
DCA 
.01 
.08 
.005 
ELCA 
< .0001 
<.0001 
.005 
(iii) the "optimal intervention" : ie where a relative gain of 0.61 is achieved in a lesion of 0.39 relative lumen 
pre, located in a 3.2mm vessel. 
Estimated R Loss Estimated RLfup 
PS 0.28 0.72 
BA 
DCA 
ELCA 
0.30 
0.36 
0.47 
0.70 
0.64 
0.53 
PS 
.73 
.01 
.006 
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BA DCA ELCA 
.73 .01 .0006 
.006 .0003 
.006 .03 
.0003 .03 
Table 4 (a), Repeat multiple linear regression analysis, after exclusion of totally occluded lesions pre-
intervention. Fonnat is similar to table 3. 
Rei Loss (r = .14) RLFup (r' .12) 
Device I , * 
Device 1 * * 
Device 3 , 
* 
Vessel size 0.00 0.00 
LAD 0.Q2 -0.023 
Relative Gain 0.70 0.30 
RLutnen pre 0.23 0.77 
Device x RG * * 
Inter-group comparisons of the influence of RG on outcome: 
Estimated RLoss Estimated RLFup PS 
~ O.~ O.M 
BA 
DCA 
ELCA 
0.59 
0.77 
0.89 
0.41 
0.23 
0.11 
Device x RLpre * * 
.S5 
.20 
.03 
Inter-group comparisons of the influence of RLpre on outcome : 
Estimated RLoss Estimated RLFup PS 
~ Q~ O.M 
BA 0.23 0.77 .06 
DCA 0.61 0.39 .92 
ELCA 0.69 0.31 .33 
Device x Vessel size * * 
Device x LAD * * 
Table 4 (b) 
P 
.06 
.001 
.003 
.31 
.0009 
<.0001 
<.0001 
.03 
BA DCA ELCA 
.S5 .20 .03 
.03 .008 
.03 .48 
.008 .48 
.004 
BA DCA ELCA 
.06 .92 .33 
.04 .008 
.04 .26 
.008 .26 
.37 
.25 
(i) the tlaverage intervention" : ie. where a relative gain of 0.28 is achleveLi in a lesion with a relative lumen 
pre of 0.41, loca[eLi in a 2.67mm vessel. 
Estimated R Loss Estimated RLfup PS BA DCA ELCA 
PS 0.12 0.57 .65 .47 .04 
BA 0.13 0.55 .65 .57 .008 
DCA 0.13 0.55 .47 .57 .09 
ELCA 0.18 0.51 .04 .OOS .02 
(ii) the "average DCAJstent intervention" : ie. where a relative gain of 0.43 is achieved in a lesion with a 
relative lumen pre of 0.37, located in a 3.14mlll vesseL 
Estimated R Loss Estimated RLfup PS BA DCA ELCA 
PS 0.18 0.62 .06 .02 .0001 
BA 0.21 0.59 .06 .34 .002 
DCA 0.23 0.57 .02 .34 .06 
ELCA 0.29 0.51 .001 .002 .02 
(iii) the "optimal intervention" : ie where a relative gain of 0.61 is achieveLi in a lesion with a relative lumen 
pre of 0.29, located in a 3.2mm vessel. 
Estimated R Loss Estimated RLfup PS BA DCA ELCA 
PS 0.28 0.72 .03 .02 .0006 
BA 0.34 0.66 .03 .39 .009 
DCA 0.37 0.63 .02 .39 .06 
ELCA 0.47 0.53 .006 .009 .06 
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levels of comparison chosen, ELCA was associated with least favourable estimated outcome and PS stent the 
lllost favourable. These findings are strongly suggestive of differences between the device groups in renarrowillg 
response to luminal increase. However, because of the considerable differences in pre-procedural lesion severity , 
epicardial location and coronary vessel size between the groups and the knowll confounding enects of these 
factors on late angiographic outcome [10,14,25,26,42,44,48,491, emphatic conclusions would be premature 
without taking account of these factors in mUltiple linear regression. 
Luminal renaJ'J'Owing alld late angiographic outcome are influenced by the device used 
Multiple linear regression analysis confirmed the existence of significant differences between the 
devices with respect to the renarrowing response to luminal increase at intervention, independent of variations 
in vessel size, lesion severity or location and luminal increase at intervention. Retrospective exclusion of totally 
occluded lesions at baseliue, on the grounds of significantly greater frequency ill the ELCA group, did not lead 
to any fundamental change in the differences found by multivariate analysis between ELCA and the other 3 
groups, or to improvement in the overall predictive power of the mouel (although some changes in the final 
model were im1eed detected). Accordingly, the discussion will focus on evaluation of the complete lesion 
populations, without this a priori stratification. 
Evidence for device specific influence on late angiograpltic results was twofold. Firstly, comparison 
of estimated angiographic results between devices at 3 pre-designated levels of intervention revealed significant 
differences, Wllich became more apparent at increasing levels of relative luminal gain in larger vessel size (from 
the "average" to the "optimal" intervention), In particular, PS and BA emerged with the 1110st favourable 
predicted angiographic results in the selected circumstances. Late results of ELCA were least favourable at each 
comparative level. Secondly, the influence of luminal increase on late results differed significantly between 
devices, whereby, for ally given luminal increase signiticantly more favourable late angiograpltic results could 
be anticipated by BA, than by DCA or ELCA. These findings confiml our previous reports of inherent device 
specitic effects on the restenosis process and late angiographic outcome [9,15,22,26-28] and prompt questioning 
of the reported "generalized model" of restenosis aner intervention [10, 14,25], according to which, the device 
used for intervention exerts no independent influence on late angiographic results. 
Differences with previous studies 
Althoughit is possible that differences in patient selection, demographic factors, interventionat practices 
and quantitative angiographic methodology, may contribute to the differing findings between this and prior 
studies pO, 14,251. 3 methodological variations may also potentially explain the conflict. Firstly, in previous 
studies, absolute coronary luminal measurements were employed and the wide differences in coronary vessel 
diameter hetween patient groups treated by different devices [lO,14,25] may have exerted some confounding 
int1uence, according to our recent report of the influence of vessel size on late angiograpltic results [29]. A 
priori normalization of key angiographic parameters for vessel size in this study adequately controlled for this 
confounding influence. Secolluly, prior studies did not specifically investigate potential differences between 
devices by considering so called "effect modification" - by induding "interaction tenns" (as explained in the 
statistical paragraph), in the multivariate mouels. Accordingly, if such differences did actually exist (as we have 
found here), they wouiu not have been detected. Thirdly, we used the multivariate model to allow additional 
and practically useful, if hypothetical, direct comparison of estimated outcome between devices, whereas 
previolls studies constructed models to allow prediction of the likelihood of "binary restenosis" from the post 
procedural result, based on the multivariate findings [lO,25]. 
Clinical Implications: optimization of the acute result 
Although our findings, of an independant intluence of the device itself on late results, question the 
U1tiversal applicability of the previously reported "generalized model of restenosis" 1I0], in agreement with 
previous reports P,9, 10,25,26,29,48,50], we have also found that maximizatiull of the acute result tends to 
provide more favourable late results. Accordingly, such an approach should be reconmlended as the practical 
goal of all intetventions (since it is predicted by our multivariate models that, depending on the device, 14% -
43 % of acute angiographic luminal increase will be retained as larger lumen at follow up). By the same token, 
it must he acknowledged that such an approach does not actually "prevent restenosis", but in fact provokes 
renarrowing, because 57% - 86% of luminal increase (depending on the device) is subsequently "lost" as 
luminal renarrowing. Ultimately, optimization of the acute result is not a conclusive solution to restenosis, 
merely creating a greater lumen to accommodate the inevitably greater degrees of subsequent renarrowing. 
Thus, although the binary restenosis rate is perceptibly lower after stent implantation than balloon angiopJasty, 
significantly greater measured luminal renarrowing develops after stenting (table 2). Moreover, from our 
findings, it would appear that through systematic optimization of acute angiographic results, as has been 
previously recommended [7,9,10,25,26,29,48,50], differences in late angiographic outcome between devices 
become more apparent, thUS, evaluation of cnrrent studies investigating the dittical value of optimal atherectomy 
and stent illlplantation will provide interesting ratification of the predictive models we have used. In fact, recent 
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Figure 2a. 3 d graphs of the multiple regression analysis (table 3), already used in chapter 10. 'X' axis = relative gain, 'Z' axis = relative loss, Y axis = 
relative loss (figure 2a), relative lumen at follow up (figure 2b). Symbols represent parameter values at the three selected levels of comparison of outcome, 
whereby, the dot represents "average intervention", the diamond "average DCA/stent intervention" and the star "optimal intervention" (eorrtd. on caption 2b). 
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Figure 2b. (contd from 2a). "Average intervention" is in the centre of BA and ELCA planes, but below centre in DCA and PS planes, whereas "optimal 
intervention" is at the upper extremity of the BA plane, but within one standard deviation in the PS plane. Balloon = balloon angioplasty; DCA = directional 
atherectomy; laser = excimer laser. Loss = relative loss; Gain = relative gain; lumen pre = relative lumen pre; lumen f-up = relative lumen at follow up. 
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comparison of atherectomy with each of halloon angioplasty [261 and Palmaz-Schatz stent implantation l51] in 
lesions matched for the acute procedural result, as well as haseline severity, has shown significantly superior 
late angiographic results by halloon angioplasty and stent implantation, supporting the t1ndings of this study. 
Implications for interpretation of outcome of clinical tJials and selection of devices for intervention 
Since late angiographic results were predicted to be similar for PS and BA in this study, the reported 
superior results <liter PS compared with BA in hath the Bellestent <ltld Stre..'>s Irials [23,24], lllay now he 
concluded to he simply a consequence of the greater acute luminal results achieved by stent implantation and 
not because of any difference in actual restenosis propensity. Accordingly, for two rapidly emerging practical 
reasons, stent implantation may soon be considered the device of choice above BA, when the choice exists. 
Firstly, stent implantation, with or without adjunctive balloon dilatation, can consistently achieve optimallul1linal 
results, whereas balloon angioplasty alone clearly cannot and the hypothetical "optimal intervention" for balloon 
angioplasty is rarely ohserved. Secondly, studies with optimization of stent deployment [52,53], suggest that 
stringent anticoai:,TUlation, which carries the comiderable side effect of hleeding complications [23,241, may no 
longer he required to combat the previously reported high risk of acute and sub-acute occlusion l20j. 
Since DCA was associated with less favourable predicted late angiographic results than BA in this 
study, it could be speculated that in CAVEAT l7j and CCAT [81. its consistent achievement of greater acute 
luminal results adequately compensated for this apparently increased restenosis propensity, providing similar 
late angiographic results for DCA as BA, as had heen previously described by our group, in a comparison of 
matched coronary lesions 19J. Although optimization of the acute result by DCA was predicted to provide 
improving late angiograpilic lumen in this study, as previously reported l6,25,26], the main concern raised here 
regarding DCA i:; the greater propensity to restenosis, compared with BA and PS stent. Namely, with 
comparable increase in relative luminal gain, if DCA is used then 77 % of the increase will subsequently be lost 
as luminal renarrowing, compared with 57 % for BA and 59 % for PS), findings which, as previously mentioned, 
are in alignment with a recent comparative study l261. The place of DCA in the interventional anllimentariutn, 
tilus, remains to be tiJlil!!y clarified. 
It would be foolhardy to suggest that there is no place for laser technology in interventional cardiology, 
hased on the findings of this study, since the technology and application methodology is continuously evolving. 
In addition, its value in initially recanalizing unfavourable lesions has been we!! documented lI2,541. However, 
the 37 % reocclusion rate following recanalization of total occlusions by ELCA in this study and the 
unhlvourable late angiographic results in multivariate analysis, compared with the other devices, are not 
encouraging for the particular approach employed in the patients descrihed in this study (which was the 
conventional therapy during the period 1991-93). Combination therapy of successful recanalization of occluded 
vessels hy laser technology followed hy optimization of the result by stent implantation is a potentially 
interesting area which remains to be clinically explored. However, it is more likely that newer treatment 
applications, such as use of continuous local saline infusion during laser ahlation but even more importantly, 
integral improvements in catheter design to improve light delivery and increase ablative power while reducing 
trauma to the vessel wall. 
Potential mechanistic explanations for differences in predicted outcome between the devices 
Differences in distribution or influence of clinical or angiographic morphological factors hetweell the 
patient groups may theoretically iuiluence outcome, but previous studies, including such variahles, have not 
shown any major confounding effects, which might distort the relationships demonstrated between the 
angiographic parameters on which this study has heen concentrated [9, I 0,25,26,42.44,48,49,55j. In particular, 
a recent comparison of late clinical and angiographic outcome among our patients with stable and unstable 
angina treated by directional iltherectomy revealed no significant difference in restenosis tendency [561. 
Furthermon:, the greater frequency of total occlusion at baseline in the ELCA and BA groups in this study did 
not unduly intluence the findings. Accordingly, we have focused on the principal quantitative angiographic 
factors which are known to exert fundamental intluence on late angiographic results. 
(i) Rheological considerations - chronic recoil alld vessel remodelling 
It must be stated at the outset that any mechanistic attempt to explain the ohserved differences in 
predicted outcome would be somewhat speculative and is not based on the t1ndings of this study, hut rather 
represents an attempt to understand the findings of this study, in the light of current knowledge and emerging 
findings of ongoing investigations. Our hypothesis, based on experimental , pathological and ultrasound evidence, 
is that since the mode of vessel wa!l il~jury imparted hy the different devices appears to be considerably 
different, the "rheo-iihro-proliferative" response of the vessel also differs significantly, hetween lesions treated 
by different devices. In the first place, it is already known that acute "elastic recoil", which is an inherent 
feature of BA [57-59! and thus also ELCA [341, is partially reduced by DCA l601 and virtually abolished by 
PS !I6!. Consequently, if "chronic elastic recoil" and late "vessel remodelling" are cont1nned as important 
factors in late luminal renarrowing [61-64], it would be ex.peeted that devices with differing rheological effects 
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would produce differing late outcome, despite apparently similar acute angiographic results (thus similar acute 
luminal increase, in apparently angiographically similar lesions, could conclude in considerably different late 
angiographic results, as has heen found by our multivariate models in this study). 
(it) Fibm-proliferalive aspects of intimal response due to device specific injuries 
Secondly, if the major non-elastic component ofrenarrowing is fibroproliterativeneointimal hyperplasia 
and if this is proportional to the degree of injury imparted during intervention l65J, it seems logical that device 
specific illjuries lllay provoke particulate response levels. Ablation of tissue by ELCA, with generation of 
shockwaves [66j and of vapour bubbles l67J, can cause extensive intimal dissectioH, medial necrosis and internal 
elastic lamina ahrasion [67,681 amI ultraviolet radiation lllay he somewhat mutagenic [691. Similarly, excision 
of vessel wall components, with exposure of intramural tissue [5,6,481, as well as plaque fracture, compression 
and vessel stretching by DCA l3,4J, might create greater injury to the vessel wall than the plaque fracture, 
compression and vessel stretching caused by BA l3,4,5,70-721. Stent implantation presupposes some of the 
features of balloon injury, hut creates a larger lumen of a mainly smooth and circular contour [17-19]. 
Accordingly, it seems reasonahle to speculate that these mechanistic differences n'ay, at least partly, explain 
the observed differences in predicted n:stenosis propensity and late angiographic outcome between the devices 
studied here. 
Limitations 
Pirst, although most of the patiellts evaluated in this study were recruited during major multicentre 
ralHlomized trials and overall quantitative angiographic follow up was 93 % of eligihle patients, this is ultimately 
an observational study and final outcome certainly requires verification through similar evaluations in 
randomized comparisons of interventional devices. Second, it could be argued that specific lesion morphological 
indications for the use of the 4 devices may differ considerably and so influence late results, however, we have 
previously demonstrated that the principle angiographic detetminallts oflate angiographic outcomeafter coronary 
interventioll are the quantitative angiographic parameters included in tltis study 19,26,42,44,48,49]. Third, 
according to current intervenlional practice today, the post procedural results of DCA and stellt implantation 
might not he considered "optimal" and the paucity of lesions with "super-optimal" results may have affected 
the reliahility of the model in predicting late angiograpluc results for each device after optimal intervention. 
Nevertheless, tllese angiographic data are comparable with those obtained in STRESS, BENESTENT, CAVEAT 
ami CCAT [7,8,23,24], thus representative of diverse multinational llmlticentre experience. Fourth, focusing 
on angiographic parameters does not take account of the potentially confounding effects of clinical factors, hut, 
as previously stated, prior studies have demonstrated no distortion of angiographic relationships, when cliltical 
factors are included, so we feel justified in concentrating on the key angiographic parameters in this study. 
CONCLUSION 
Definite diflerences in the propensity to restenosis were detected hetween patient groups treated hy 
Palmaz-Schatz stent implantation, directional atherectomy, balloon angioplasty and excimer laser coronary 
angioplasty, independent of variations in lesion severity and location, coronary vessel size and procedural 
result.s. These difterences, which may represent inherent device specific characteristics of the "rheo-
fibroproliferative" response to unique vessel wall injury, require further study in larger patient groups, ideally 
with optimal interventional strategies amI intravascular ultrasound evaluation, for corroboration and possihle 
mechanistic explanation. 
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Conclusion, reflections and implications of 
the findings in this thesis 
Principal findings 
In the first part of the thesis, it emerges that quantitative angiography does not help to identify patients 
at greater risk of lesion related complications after angiopiasty, nor does angiographic imaging per se seem to 
be useful for reliable identificatiollof thrombus in the coronary lumen or for exclusion of the presence of intimal 
dissectioll. Accordingly, it seems wise to apply angiography to investigations in which it can provide the most 
reliable, reproducihle and useful infonnation, thus, for the serial measurement of luminal cbanges as it 
consequence of coronary interventions. With respect to important methodological aspects of the application of 
quantitative angiography to investigation of results of intervention, particularly in the quantification of the 
deterioration in the lumen of treated vessels - the angiographic evaluation of the process of restenosis - chapter 
4 demonstrates that quantitative analysis from multiple projections is necessary to provide reliable serial 
measurements; the tindings in chapter 5 are reassuring for the clinician, insofar as post-angioplasty angiography 
is found to be as reliable for analysis as angiography postponed for 24 hours (despite the problems of intimal 
dissection and contour haziness), and furthermore, no significant luminal deterioration is observed during that 
time. 
Scrupulous standardized quantitative angiographic analysis, of serial angiograms acquired according 
to specific guidelines (as described in the early chapters of this thesis and emphasized in each chapter), in large 
patient groups treated by different coronary devices, provided the substrate for the investigations described 
throughout the thesis and particularly in part 2. Essentially 2 messages emerge from the investigations in part 
2 : firstly, among other important factors, coronary vessel size is found to be a fundmnental detellninant of the 
late allgiographic outcome of intervention, whereby lesions located in larger vessels are hlherently associated 
with a more favourable outcome. Accordingly, this factor must thus be taken into account in comparative studies 
of the late results of intervention, between different devices which may he systematically and preferentially 
applied to smaller or larger vessels. Secondly, use of comparative measures which control for differences ill 
vessel size, allowed demonstration of intrinsic differences in restenosis propensity between different 
interventional devices - perceptible as varying levels of angiographic luminal loss after similar levels of luminal 
gain in lesions of similar severity, location and vessel size. These differences in restenosis propensity are 
speculated to be a consequence of the fundamentally differing mechanistic effects of the devices, which result 
in varying nature and degree of vessel wall tmuma, through achievement of given degrees of luminal 
enlargement, thereby provoking inherently varying degrees of neointimal andlor remodelling response. 
These device specific differences are essentially unveiled for the first time in collected studies in this 
thesis, and it lUust be stated that such findings do not meet with universal agreement. Other investigators have 
reported in several sLUdies, that the post procedural result is the principle detenninant of late angiographic 
outcome, regardless of the device used, implying that essentially the device used is irrelevant, as long as a 
policy of maximization of the acute result is universally applied. We believe the findings of chapters 8 to II 
in this thesis emphatically demonstrated that the device used actually exerts a significant independent influence 
on late results of intervention, and this must be taken into account clinically when choosing devices for 
intelvention. 
Future interventional perspectives, in the light of these findings 
BALLOON ANGIOPLASTY 
What are the clinical implications of device specific effects OIl restenosis, for the future use of these 
different devices? Firstly, it must be concluded that balloon angioplasty, according to this scheme of things, 
may have a limited future as an independent "stand alone" therapy in interventional cardiology. Now in 1995, 
18 years after the tirst halloonangioplasty procedure, restenosis remains as big a problem as ever after balloon 
dilatatiOlI and failure, sub-optimal results and acute vessel closure are still a real problem in a not inconsiderable 
proportion of cases. Tn addition, "plain old balloon angioplasty" does not have the capacity to consistently 
provide "optimal" acute results, due to the natural phenomenon of elastic recoiL and if recoil is overpowered, 
unwanted dissectioll of the vessel wall occurs (which, as seen in chapter 3, is more COlllmon than is 
angiographically apparent and in cbapter 6, is shown to he a strong predictor of unfavourable short tenn 
outcome). Tn fact, with the type of "optimal" acute angiographic results which increasing nurllhers of clinicians 
are now achieving through tbe use of stent implantation, the definition of what constitutes a "suh-optimal" 
results willlllost prohably change, because a "diameter stenosis less than 50 %" may not for much longer be 
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considered an acceptable definition of successful intervention. Requirement for a post-procedural result of less 
than 20 % diameter stenosis is already being applied in a number of ongoing clinical trials of directional 
atherectomy (OARS, BOAT and EUROCARE) and stent implantation (BENESTENT II, MUSIC, MUST, 
SOBlG, WEST). Thus, since the nature of the typical acute result offered by halloon angioplasty has nut really 
changed over the years, if the "goalposts" are moved, by a change in the definition for acute procedural success, 
the frequency of so-called "suh-optimal" acute results of balloonangioplasty will probably cOll.<iiderable increase 
in the coming years. This will lead to progressively greater use of stent impialltatiull to provide "optimal" acute 
results, so reducing the use of balloon angioplasty as a successful "stami-alone" device. It seems certain 
therefore, that the only manner in which balloon angioplasty can retain an important place as a sole and 
independently useful device in the interventional armamentarium is, if local delivery of effective biological 
agents can a) reduce recoil (for example "Biostent", a compound directed at inhibition of actin 
polymerization); b} perhaps "mend" intimal dissection (each of which would improve the acute result); and/or 
c) control the rheo-fihro-proliferative neointimal response to vessel wail injury, which would improve the long 
tenn re~ult. In other words, the "restenosis propensity" must be favourably altered, and according to our 
methodological proposal, studies in this area may best be evaluated by using either the univariate relative 
gain/relative loss relatiolL<ihip, as descrihed in chapter 2, or the multivariate approach u~ed in chapters 7 - 11, 
where additional confounding factors are also taken into account. (The concept of "primary angioplasty" for 
acute myocardial infarction, may actually provide a new avenue of survival for conventional balloonangioplasty, 
since recently puhlished randomized trial~ demonstrate significant improvement in survival after angioplasty 
compared with "best thrombolysis", although the long term results of such studies, in tenns of restenosis, 
remain to he reported.) 
DIRECTIONAL ATHERECTOMY 
Directional atherectomy does not emerge fi'om the~e comparisons with a favourable protile in temls 
of restenosi~ propensity. Despite the attractive com:ept of plaque debulking, it is clear that this procedure 
provoke~ extensive luminal renarrowing and even when achieving the same acute results as stent implantation, 
a significantly greater degree of restenosis is provoked, as observed in chapters 9 - 11. From the practical point 
of view, despite what the greatest proponents of this device claim, it is not really "directional" at this time, since 
it cannot be consistently and reliably directed at the site of greatest plaque, as evident from the tissue removed 
being frequently nonllal vessel wall structures, without atherosclerotic plaque. Accordingly, advances in catheter 
design, to include uitrasouHd guidance allowing truly directional atherectomy and also the development of 
forward-cutting, rather than side-cutting, catheters, will represent considerable advances, which would require 
thorough evaluation but might save this concept of plaque removal from being consigned to the scrap heap of 
medical treatment philosophies. Optimization of the acute result of all atherectomy procedures by systematic 
balloon angioplasty is a tine amI noble idea, but introduces considerable co~t increa~es and does not solve the 
problem of tihro-proliferative neointimal hyperplasia (encapsulated by the univariate or multivariate gain/los~ 
relationships demonstrated in chapters 9-11). The idea of adjunctive post procedural local drug delivery, may 
be a theoretical consideration, but is not logistically or practically attractive and would lead to further ~piralling 
of cost~ per procedure. The future of directional atherectomy must therefore be considered to be in serious 
douht at this time, without the technological advance~ mentioned, which, although exciting and promising, may 
not, of them~e1ves, reduce its restenosis propensity. 
EXCIMER LASER 
What about excimer laser assisted coronary angiopla~ty? This device emerges from these studies with 
a very poor prognosis for the future because of it~ apparently unfavourable inherent restenosis propensity and 
requirement for systematic adjunctive ballnon angiopla~ty. This statement must he qualified however, by 
recognizing the evolution of procedural aspects of excimer laser therapy over the past 3 years, with the 
introduction of saline infusion at the catheter tip, to reduce the problem of fast imploding and exploding vapour 
huhhle fonnation and their traumatic consequences, as well a~ the current ongoing renovation of catheter design 
to provide homogenous light distribution (HLD) at the target ~ite, which, the evidence suggests, may favourably 
alter the tissne ahlation/damage ratio. Inmlinent clinical introduction of such catheters may provide a 
metamorphosis in laser therapy from interventional villain to ultimate hero. Certainly, the provision of a new 
chalIDe! through totally occluded lesions or diffu~ely diseased vessels, sufficient to allow introduction of a 
dilating halloon, may be perceived as all important contribution to revascularization, hut it is unlikely to he 
sufficient to mandate the expen~e of this therapy, for most catheterization laboratories. In order to maintain a 
place in the interventional arsenal, laser must provide more than a mean~ to make a chamlel, so the clinical 
results of new technology which claims to allow more tissue ablation with less tissue damage will be eagerly 
awaited. If the slope of the relative gain/relative loss relationship (or los~ index, as used in chapter 8) can he 
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favourahly affected by technological advances, then the status of excimer laser in intervention may well be 
secure. 
STENT IMPLANTATION 
TIle stellt, in general, emerges from these evaluations as the most ideal device of those compared. The 
Wallstent treated lesions in chapter 10 are associated with significantly superior predicted late results ill 
multivariate analysis compared to the other 3 devices. However, before reconmlending universal application of 
this albeit extremely useful device, it must be remembered that these patients represent the "best case scenario", 
among the patients treated by Wallstent during the initial European investigation of this device, all patients with 
acute and sub-acute occlusion having been excluded (in the initial report in 1991, 21 % of patients experienced 
presumed thrombotic occlusion in the short term). Nevertheless, it can be concluded that when unfavourable 
early events are avoided, the late results, in tenns of reduction of angiographic restenosis propensity are 
extremely favourable with this device and the current policy of maximizing the acute result, with attendant 
reported reduction in thrombotic events, should augur well for tillS stent in the future. 
In the study described in chapter 10, the Wiktor stellt had been implanted only for restenosis and quite 
a high percentage of the patients presented with "unstable angina" (see chapter 10), representiIlg quite an 
unfavourable combination, in tenus of the likelihood of subsequent luminal renarrowing. It is thus perhaps not 
a fair evaluation of the Wiktor stent to chastise it on the basis of the moderate results observed in this study, 
compared with the Wallstent and balloon angioplasty. 
Palmaz-Schatz stent implantation provided significantly superior angiographic and clinical results in a 
direct comparison with directional atherectoIllY in chapter 9 and is associated with the most favourable late 
angiographic outcome in the evaluation in chapter 11. The progressively more widespread use of this stent in 
the last 2 years is therefore not surprising. However, like the other 2 stents investigated, the Palmaz-Schatz stent 
is also associated with considerable degrees of luminal renarrowing, compared with balloon angioplasty, for 
example, and it was mainly the ability to really provide greater acute results to compensate for the inevitable 
luminal renarrowing, which constituted the advantage of this device. 
Thus, stent implantation is also not the perfect intervention, since luminal renarrowing still represents 
a considerable problem and reaches clinical relevance iulO - 20% of cases (chapter 9 for example). This must 
be considered to represent a major improvement over the 35 - 50 % of patients conventionally reported to be 
affected by clilllcally relevant "restenosis" foilowingballoon angioplasty therapy, but it remailL'; a problem which 
must aHd is being addressed by researchers in the area. In order to further reduce the restenosis propensity of 
the stent, the concept of drug eluting stents, which deliver biologically active agents over a period of time to 
inhihit dle proliferative vessel wall response, represents an exciting avenue of hope and initial clinical results 
of the BENESTENT TJ trial, evaluating a heparin coated Palmaz-Schatz stent for reduction of restenosis, are 
very promising indeed. Additionally, the idea of biodegradable stents also coated with biologically active agents 
is not far from being applied in the clinical arena and may introduce a new era in stent implantation. Also, local 
dmg delivery balloon catheters may be used after stent implantation, just as after balloon angioplasty or other 
procedures and may be of some interest for restenosis reduction. If these advances can further reduce the slope 
of the "gain/loss" relationslllp (as displayed in univariate fonn in chapters 2 and 7 and in 3 dimensional foml 
in chapters 7, 10 and 11), associated with stent implantation, then it may approach the description of the "ideal 
device". If this were the case, then stenting would undoubtedly occupy the largest niche in the interventional 
armamentarium and only unfavourable morphological circumstances would mitigate against universal use. The 
challenge for the future for stent implantation, will thus partly focus on reduction of intimal hyperplasia, but 
also 011 increasing the clinical applicability, for example in lesions located in, or distal to, tortuous coronary 
segments, in the presence of established coronary thrombus and, especially, in smaller vessels, which still 
represent the majority of interventional practice (in chapter 7, more than 70% of lesions treated by balloon 
angioplasty in 4 major clilllcal trials involving over 3000 patients were located in vessels less than 3mm, which 
is still the generally accepted threshold for safe sterrt implantation). 
Final reflections on the future for intervention and imaging 
DlmULKING VERSUS DILATING - RR'ITORING OR RE-ESTAHLlSHING GLAGOVIAN BALANCE? 
It is evident from the findings in this thesis that the search for the "holy grail" in the percutaneous 
treatment of coronary artery disease is far from over, although considerable advances have been made in recent 
years. Nonetheless, of the devices compared, stent implantation shows the most promise as the ideal device for 
revascularization and further modification of its restenosis propensity may be anticipated by addition of 
antithrolllhotic or drug eluting coatings. Considerable technological improvements will he required if directional 
atherectomy and excimer laser angioplasty are to retain an important role in coronary intervention and the future 
189 
of balloon allgioplasty as a sole interventional device must be considered to be limited, unless adjunctive 
effective biological agents to reduce its restenosis propensity can be introduced in the near future. However, 
if we return to the fundamental pathophysiology of coronary artery disease and focus, in particular, on the 
phenomenon described by Glagov, of compemmtory enlargement of the coronary arteries in response to 
increasing plaque burden, it may be considered that the concept of debulking plaque represents something 
biologically more attractive (in allowing restoration of the "Glagovian balance"), than plaque compression and 
vessel stretching, by sten! implantation (which may thus establish a new Glagovian balance). It is as yet 
unknown what happens to the plaque which is displaced, compressed or crushed by stent implantation. Tn 
addition to the known tendency to neointimal hyperplasia within the stent, could this compressed plaque also 
forTH a nidus for atherosclerotic advancement, which might stimulate further compell.<latory vessel enlargement, 
or does it remain an "innocent bystander" ? It must be remembered that dehulking procedures up to now have 
heen extremely crude and uncontrolled. The sequelae of accurate and optimal plaque debulking and of the 
method of dehulking (ablation versus excision), remains to be detemlined, so that this approach to coronary 
intervention cannot yet be glibly dismissed, especially now, with the apparently imminent clinical jntroJuctioll~ 
of exciting advances in the design of atherectomy and laser catheterii. 
CORONARY IMAGING - IS QUANTITATIVE ANGIOGRAPHY A "BATTERED GOLD STANDARD" ? 
Despite the increasing use of intracoronary ultrasound, quantitative coronary angiography can continue 
to play a key role in the evaluation of new approaches to coronary intervention and the investigation of 
biological approaches to restenosis reduction, as long as technical advances in automated analysis algorithms 
continue to he explored, validated and appropriately introduced (such as gradient field transfonnatiol1, allowing 
faithful horder detection in complex and angulated lesions, a limitation of current systems), careful 
S\<IllWlrdization of image acquiiiition in multiple projections continue.s to be serially and consistently applied and 
the data derived are intelligently and sensitively evaluated. Furthennore, since intracoronary ultrasound iii even 
more invasive than angiography, with introduction of a potentially traumatic guide wire and echo catheter, non-
invasive angiographic methods, particularly Magnetic Resonance Imaging and Emission Beta Tomography, 
present the opportunity for a whole new era of contrast angiography. If further developments allow consistent 
provision of sharply defined images of both the <.:Oronary vessel wall, as well as the lumen, to facilitate 
automated quantitative analysis, the currently battered gold-standard would indeed have struck back at its critics 
to re-establish its rightful place in coronary imaging. 
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